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Abstract 
Dysphagia can be problematic for many patients after laryngectomy surgery. While 
laryngectomy patients have a low risk of aspiration, they often experience other 
symptoms of dysphagia. There is no standard protocol for swallow assessment and no 
consensus on the best evaluation tool to use post laryngectomy. The purpose of the 
first part of this study was to establish Fiberoptic Endoscopic Evaluation of 
Swallowing (FEES) as an alternative tool to Videofluroscopy for the evaluation of 
dysphagia after laryngectomy and to develop a rating scale suitable for use with both 
evaluation tools.  The purpose of the second part of the study was to examine whether 
voice prostheses have an effect on swallowing and whether an optimum voice 
prosthesis exists for swallowing and voice.  
 
A prospective observational study was carried out on 30 laryngectomy subjects who 
had simultaneous videofluroscopy and FEES swallow exams. These were rated by 3 
expert examiners to determine whether endoscopy could be established as swallow 
evaluation tool suitable for laryngectomy patients.  This was followed by a second 
prospective observational study on 41 subjects which involved each subject 
undergoing both swallowing and voice evaluations on 4-6 different voice prostheses.  
 
Results of the first part of this study establish FEES as an alternative tool to 
videofluroscopy.  A rating scale was successfully developed for use with both 
videofluroscopy and FEES post laryngectomy swallow evaluations. Results of the 
second part of this study indicate that both swallow and voicing performance can 
change for some laryngectomy patients with the use of different voice prostheses. The 
hypothesis that quality of life is altered by swallowing impairment post laryngectomy 
is confirmed. 
 
This work improves the options available to patients and clinicians for the evaluation 
of swallowing post laryngectomy.  In addition, it has highlighted that choice of voice 
prosthesis may influence swallowing ability in some laryngectomy patients. 
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Chapter 1.  Background 
 
This chapter provides information about laryngectomy (surgical removal of the voice 
box).  The anatomical changes that take place after laryngectomy are outlined, since 
an understanding of the anatomical and physiological changes that occur after 
laryngectomy surgery allows a greater appreciation of the rehabilitative challenges 
inherent in treating this patient population.  The major rehabilitative themes of 
swallowing, communication and achieving positive outcomes are then discussed in 
detail. 
 
 
1.1. The Laryngectomy procedure 
 
Laryngeal cancer ranks in the top twenty of cancers diagnosed in the UK 
(OfficeforNationalStatistics, 2007).  2,337 new cases of laryngeal cancer were 
diagnosed in 2010 with 5 times more men diagnosed than women 
(CancerResearchUK, 2011).  66.8% survive five years or more (CancerResearchUK, 
2011).  Despite improvements in chemo-radiation therapy and the adoption of organ 
preservation protocols for some head and neck cancers, total laryngectomy remains 
the treatment that often provides the best chance of survival for advanced laryngeal 
cancer.  This is radical surgery involving removal of the entire larynx resulting in the 
separation of swallowing and respiratory functions.  As a consequence patients 
breathe through a permanent open neck stoma, lose the ability to produce voice in a 
conventional manner, and experience significant changes in ability to smell and 
swallow. 
 
1.1.1. Anatomical and Physiological changes after laryngectomy 
 
The larynx (voice box) is located in the anterior neck at the approximate level C3- C6 
cervical vertebrae.  The larynx contains the vocal folds and extends vertically from 
just below the hyoid bone to the cricoid cartilage.  Pre laryngectomy anatomy is 
illustrated in Figure 1.1 
19 
 
 
 
Figure 1-1: Prelaryngectomy anatomy 
 
 
A standard total laryngectomy typically involves an initial separation and 
“skeletonisation” of the larynx from the jugular and carotid vessels on either side of 
the neck (Figure 1.2).  The larynx is usually dissected from above the hyoid bone to 
below the cricoid cartilage.  The suprahyoid muscles are then dissected off the hyoid 
bone.  The thyropharyngeus is shaved off the thyroid cartilage and the 
cricopharyngeus is removed from the cricoid cartilage.  All of these muscles are 
preserved and later reconstructed to form the pharyngoesophageal segment (PES), 
which allows for optimum voice and swallow function. 
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Figure 1-2:  Skeletonisation of the larynx 
 
 
Once the larynx is removed, the open trachea and pharynx remain.  The exposed 
upper part of the trachea is secured to an opening in the neck to form a stoma, through 
which the patient will breathe.  A surgical puncture can be performed between the 
trachea and oesophagus to permit voice prosthesis placement and facilitate restoration 
of voice.  This usually takes place at the time of laryngectomy surgery (primary 
puncture) but may also take place at a later date (secondary puncture). 
 
The open pharynx is then closed providing the first layer and first stage of closure.  
Provided enough thyropharyngeal and cricopharyngeal muscle remains, these are 
used as a second stage of closure over the repaired pharynx.  This second stage of 
closure inwardly compresses the repaired pharyngeal tissue.  At rest this is seen on 
videofluoroscopy (moving x-ray image) as a closed narrow area and is referred to as 
the pharyngoesophageal segment (PES) or reconstructed segment.  The amount, 
constriction, and muscle tone of the thyropharyngeus and cricopharyngeus muscle 
used for this second level of repair will influence voice quality post-surgery.  The 
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ability of the PES to dilate, coupled with power created at the base of tongue and the 
length of time the PES remains open dictates the patient’s ease in swallowing a 
variety of food consistencies. 
 
Reconstruction of the suprahyoids by suturing them onto the superior margin of the 
repaired thyropharyngeus (Perry et al., 1987) provides the third stage of closure over 
the repaired pharynx, which importantly is believed to prevent the formation of a 
pseudodiverticulum  (mucolised pouch at the  base of tongue). The second and third 
stages of closure together make up the second mucosal layer of closure. During the 
swallow, it is thought that the reconstructed suprahyoids maintain ability to contract 
and in doing so, pull the repaired thyropharyngeus forward and facilitate opening of 
the upper oesophagus for swallowing.  Figure 1.3 illustrates completed reconstruction 
of the pharynx after laryngectomy.  The reconstructed pharynx after laryngectomy is 
sometimes referred to as a neopharynx. 
 
 
 
 
 
 
Figure 1-3:  Completed reconstruction of neopharynx 
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A surgical procedure called a myotomy is recommended during surgery to improve 
both voice and swallow functions (Scott et al., 1993, Blom and Singer, 1981, Bayles 
and Deschler, 2004). A myotomy involves cutting individual muscle fibres.  A “short” 
myotomy involves dividing the muscle fibres running from the lower third of the 
reconstructed PES to below the tracheoesophageal puncture, approximately parallel 
with the lower stomal lip as in Figure 1.4.  Before laryngectomy, the force of the 
upper oesophageal wave prevents the bolus from refluxing back into the pharynx.  
Postlaryngectomy myotomy has the effect of reducing the upper oesophageal 
peristaltic wave force.  Furthermore, this procedure creates an air reservoir at the top 
of the oesophagus for voicing and increases the width of the oesophageal lumen for 
swallowing, helping to prevent voice prosthesis fouling and leakage.   
 
 
 
 
Figure 1-4: Short myotomy 
 
23 
 
 
An alternative procedure is the pharyngeal plexus neurectomy, which involves 
surgical denervation of middle constrictor muscle and partial denervation of 
thyropharyngeus and cricopharyngeus muscles.  3-5 nerve branches of the pharyngeal 
plexus are divided, cauterised with a segment removed as part of this procedure 
(Blom et al., 1986a, Bayles and Deschler, 2004).  Neurectomy provides similar 
surgical outcomes to a myotomy. 
 
1.1.2. Extended laryngectomy surgery 
 
Patients whose cancer has extended beyond the boundaries defined for total 
laryngectomy to areas such as the hypopharynx, postcricoid region, and cervical 
oesophagus may require a partial or total pharyngectomy or partial or total 
oesophagectomy in addition to removal of the larynx (Deschler, 2005).  This type of 
surgery generally precludes the creation of a functional neopharynx from the available 
tissues after resection.  All extended laryngectomy surgeries requiring full or partial 
pharyngectomy with or without full or partial oesophagectomy usually involve tissue 
transfer from other parts of the body such as radial forearm, anterior lateral thigh, 
pectoralis major, jejunum, and, in some cases, stomach or colon (Deschler, 2005).  
The transferred tissue allows the throat to be reconstructed in such a manner as to 
facilitate successful swallowing and communication.  The decision on the type of 
surgery and tissue transfer that the patient will have will be influenced by the extent 
and location of disease and sometime, individual surgeon’s preference (Lewin et al., 
2006).  Different types of tissue transfer used in extended laryngectomy surgeries 
such as laryngopharyngectomy and laryngopharyngoesophagectomy can be divided 
into pedicled flaps and free flaps (Deschler, 1999).   
 
A pedicled flap involves rotating tissue into the area that requires reconstruction while 
still maintaining attachment at the site of origin of the flap.  The area of attachment or 
pedicle preserves vascular supply to the reconstructed area (Deschler, 2005).  
Different types of pedicled flaps have been used successfully in reconstruction after 
extended laryngectomy surgery.  These flaps are described in the following section. 
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Figure 1-5:  Deltopectoral flap with anastomosis complete 
 
 
This flap consists of skin and underlying fatty tissue taken from the upper chest and 
shoulder (Missotten, 1983, Kingdom and Singer, 1996).  The deltopectoral flap has a 
vascular pedicle originating from the internal mammary artery via the first and second 
intercostal perforator veins close to the sternum (Deschler, 2005).  The first stage of 
surgery involves the flap being raised from the shoulder and upper chest.  The flap is 
then rotated into the upper neck where it is rolled into a tube connected to the 
oropharynx and base of tongue superiorly and partially to the oesophagus inferiorly 
allowing secretions to drain onto the chest (Bakamjian, 1965, Deschler, 2005) 
Figure1.5.  A skin graft is placed over the defect on the shoulder and chest (Deschler, 
2005).  Secretions from the oral cavity drain onto the chest for 3-6 weeks during 
which time the skin portion of the flap establishes a new blood supply from the 
surrounding tissues in the neck (Deschler, 2005).  Once this new blood supply has 
been established, the second stage of surgery occurs with the skin flap in the neck 
being formed into a complete tube and fully attached to the oesophagus (Deschler, 
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2005).  This results in the formation of a reconstructed neopharynx consisting of a 
skin lined tube running from the oropharynx to the oesophagus (Bakamjian, 1965). 
 
Deltopectoral flaps have received criticism for having a complication rate of 50% and 
for requiring lengthy hospital stays (Hanasano et al., 2012).  However, the 
deltopectoral flap remains a valuable niche option for salvage in the contemporary 
reconstruction of the head and neck area (Andrews et al., 2006). 
 
 
Figure 1-6: Pectoralis Major Flap 
 
 
In contrast to the deltopectoral flap consisting of skin and underlying fatty tissue, the 
pectoralis major flap consists of muscle and skin.  The pectoralis major flap has a 
vascular pedicle supplied by the pectoral artery and vein which runs on the under 
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surface of the pectoralis muscle (Baek et al., 1981).  The pectoralis vessels originate 
just lateral to the midpoint of the clavicle allowing tissue to be elevated inferiorly to 
superiorly while maintaining both an attachment to the clavicle and integrity of the 
vascular pedicle (Deschler, 2005) Figure 1.6.  In the case of a partial pharyngectomy, 
a strip of pharyngeal muscle and mucosa may remain posteriorly once diseased tissue 
has been removed.  The vascularised pectoralis major tissue flap is then rotated into 
the neck defect and sewn to the remaining strip of pharyngeal tissue forming a tube  
(Deschler, 2005, Hanasano et al., 2012).  When a complete pharyngectomy occurs 
and reconstruction of the entire neopharynx is required, a larger pectoralis major flap 
is harvested and rolled into a tube (Deschler, 2005).  The tube is attached superiorly to 
the oropharynx and inferiorly to the oesophagus (Deschler, 2005, Hanasano et al., 
2012). 
 
Compared to a deltopectoral flap, a pectoralis major flap offers the advantage of being 
a single stage surgical procedure (Deschler, 2005).  The post-operative rate of 
fistulisation after pectoralis major flap has been reported to range from 10-20% 
(Schuller, 1985).  Additional criticisms of the pectoralis major flap include donor site 
shoulder dysfunction, pulmonary co morbidities and cosmesis (Hanasano et al., 
2012).  However other studies have found this procedure to be both expedient and 
associated with a low complication rate (Spriano et al., 2002). 
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a
   b 
Figure 1-7 a:  Diagram of gastric pull up flap raised and b. with 
anastomosis complete 
 
 
Removal of the larynx, pharynx and the entire oesophagus is sometimes required 
because of widespread disease (Deschler, 2005).  Reconstruction of this extensive 
area can be particularly challenging.  Gastric transposition is often considered as the 
best option (Sreehariprasad et al., 2012).  It was first described by Turner in 1936 
(Hartley et al., 1999) and modified by Ong and Lee in 1960 (Ong and Lee, 1960).  
Gastric transposition is a reconstructive procedure that involves removal of the 
oesophagus through an abdominal incision.  The body of the stomach is then 
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mobilised through the thorax and attached to the oropharynx as a means of 
neopharyngeal reconstruction (Missotten, 1983), Figure 1.7. The pyloric sphincter is 
weakened to allow successful emptying of the stomach and to reduce regurgitation of 
food and secretions. 
 
The major abdominal surgery involved in this procedure can lead to significant 
postoperative complications.  Hospital mortality after this procedure has been 
reported to be between 5% and 11% (Hartley et al., 1999) although a recent study 
indicated no hospital mortality (Sreehariprasad et al., 2012).  Despite the inherent 
risks of gastric transposition, this procedure also offers a number of advantages.  
These include the single stage reconstruction nature of this surgery, the presence of a 
single anastomosis which reduces the possibility of stricture and fistulisation, and the 
existence of a rich blood supply from the gastroepiploic vessels (Deschler, 2005) 
(Kelly et al., 2008, Stepnick and Hayden, 1994, Haller, 1997, Harrison and 
Thompson, 1986, Hartley et al., 1999). Swallowing rehabilitation after this procedure 
can be limited by gastric dumping and regurgitation, which are issues specific to this 
reconstructive method (Deschler, 2005).  However, other studies (Kelly et al., 2008, 
Harrison and Thompson, 1986) (Schechter et al., 1987) report good swallowing 
outcomes following gastric transposition surgery. 
 
As previously outlined, Deltopectoral, Pectoralis Major and Gastric Transposition 
flaps all receive vascular supply from a defined pedicle which remains attached at it 
origin.  The point of rotation from which the pedicle originates can limit pedicled flap 
techniques.  Kinking or over stretching of the flap needs to be prevented during 
surgery as this could compromise vascular supply (Deschler, 2005) and ultimately 
viability of the flap.  The technique of free tissue transfer with micro vascular 
anastomosis (reconnection) emerged in the early 1980s as an alternative to the use of 
pedicled flaps (Deschler, 2005).  Free tissue flap transfer involves the mobilisation of 
tissue with an identifiable vascular supply into the area requiring reconstruction 
without any attachment to the area of origin.  In reconstruction of the head and neck 
region, the artery and vein in the vascular pedicle of a free tissue transfer are usually 
reconnected to available branches of the external carotid system and external jugular 
system respectively to ensure a stable blood supply (Deschler, 2005).  Different types 
of free tissue transfer flaps are described below. 
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a 
 
b 
 
Figure 1-8 a:  Jejunal flap raised with b anastomosis complete  
 
 
This flap involves the use of the jejunal portion of the small intestine to repair the 
neopharyngeal defect after laryngopharyngectomy (Deschler, 2005).  In this one stage 
technique the abdomen is opened and a portion of jejunum with a suitable artery and 
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vein is harvested with the two remaining ends of the small intestine reattached 
(Deschler, 2005, Birchall et al., 1983, Laing et al., 2012).  The harvested jejunum is 
then connected to the oropharynx superiorly and the oesophagus inferiorly providing 
a tubed repair (Deschler, 2005, Reece et al., 1995, PerezSmith et al., 2013) Figure 1.8.  
The artery and vein providing vascular supply to the flap are reanastomosed in the 
neck (Deschler, 2005, Birchall et al., 1983, Reece et al., 1995, PerezSmith et al., 
2013, Laing et al., 2012).   
 
Jejunum is advantageous to being used for this type of repair because it is already in a 
tube form negating the need for a long vertical suture line and thus minimising risk of 
fistulisation (Deschler, 2005).  It has a short vascular pedicle minimising risk of 
necrosis and the distal oesophagus is preserved reducing regurgitation and reflux 
(Meyer et al., 2009).  A further feature of the jejunal flap is that the mucosal lining 
produces lubricating secretions which may facilitate swallowing (Deschler, 2005).  It 
has been proposed that a bolus of fluid will stimulate the jejunum to contract like 
normal small bowel mimicking peristalsis in the oesophagus (Meyers et al., 1980).  
However, the jejunum flap may also retain independent peristaltic activity which may 
not co- ordinate with swallowing and which may block transfer of the bolus and 
contribute to dysphagia (Deschler, 2005).  Opening the abdomen to harvest jejunum 
may increase postoperative complications and recovery time (Deschler, 2005, 
Hanasano et al., 2012, PerezSmith et al., 2013).  While complications including 
hospital mortality rate of 20% (Stell et al., 1983) and distal oesophageal stump 
recurrence (Harrison, 1983) and functional outcomes inferior to fasciocutaneous flaps 
have been reported after jejunum reconstruction, other studies suggest favourable 
outcomes can be achieved (PerezSmith et al., 2013, Laing et al., 2012, Deary et al., 
2003). 
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Figure 1-9: Radial forearm flap raised with anastomosis partially complete  
 
 
The radial forearm flap is a one-step free tissue transfer flap that may be used to 
repair a neopharyngeal defect (Deschler, 2005).  This flap consists of the skin and 
subcutaneous tissues overlying the radial artery on the volar surface of the forearm 
(Anthony et al., 1994b, Deschler, 2005) (Harii et al., 1985) with vascular supply from 
the radial artery and cephalic vein (Deschler et al., 1994, Deschler, 2005).  The 
harvested flap is rolled on itself, forming a tube and is attached to superiorly to the 
oropharynx and inferiorly to the oesophagus (Deschler, 2005, Anthony et al., 1994a, 
Harii et al., 1985, Anthony et al., 1994b) Figure 1.9.  The attachment to the 
oesophagus is modified slightly by inserting a piece of skin tissue to widen the 
anastomosis at this point and prevent stenosis (Deschler, 2005).  The radial artery and 
cephalic vein are then reconnected in the neck (Deschler, 2005).  The defect on the 
forearm is covered with a split thickness skin graft taken from the thigh and splinted 
for 5-9 days to allow the skin graft to be accepted (Deschler, 2005).  While the graft 
failure rate for the radial forearm flap is low (Deschler, 1999), both rates of fistula 
(Anthony et al., 1994b, Scharpf and Esclamado, 2002) and stenosis (Deschler, 1999) 
have been reported to be higher in radial forearm flaps than in jejunal flaps. 
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Figure 1-10: Lateral thigh flap raised with anastomosis partially complete  
 
 
 
The lateral thigh flap may also be used to provide replacement tissue to either a partial 
or complete pharyngeal defect after laryngopharyngectomy (Lewin et al., 2006).  It is 
a fasciocutaneous flap (Yu et al., 2010) contains skin, subcutaneous tissue and 
underlying fascia.  This flap is harvested from the lateral thigh together with vascular 
supply arising from the deep femoral artery and the deep femoral vein.  The flap is 
formed into a tube and attached to the oropharynx superiorly and the oesophagus 
inferiorly Figure 1.10.  The flap requires an extra suture line to form a tube structure.  
However, while a fistula rate of 9% has been reported with lateral thigh flaps (Yu et 
al., 2010), this rate is comparable to the rate of fistulisation in jejunal flaps (Chang et 
al., 2002, Reece et al., 1995) and lower than radial forearm flaps (Anthony et al., 
1994b, Scharpf and Esclamado, 2002).  The lateral thigh flap is associated with 
minimal donor site morbidities (Deschler and Gray, 2004, Yu, 2004).  The lateral 
thigh flap forms a passive conduit for swallowing within the neck (Lewin et al., 2006) 
but may be too bulky (Yu et al., 2010) to ensure a good functional outcome in some 
patients.  In contrast to the jejunal flap, the anterior lateral flap does not secrete mucus 
therefore producing alaryngeal phonation that may have a less “wet” quality than the 
jejunal flap (Lewin et al., 2006).  The rate of stenosis following lateral thigh flap is 
reported (Yu et al., 2010) to be lower than both that of jejunal flaps (Reece et al., 
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1995) and radial forearm flaps (Anthony et al., 1994b).  A recent study (Lewin et al., 
2006) reported better speech and swallowing outcomes in anterior lateral thigh flap 
than in jejunal flap patients.  However, another recent study (Ho et al., 2012) found 
that only a third of anterior lateral thigh flap patients were on a normal diet by 
discharge.  One third in this group also went on to develop late pharyngeal strictures 
requiring repeat balloon dilatation. 
 
Patients with extensive disease may require extended laryngectomy surgery involving 
partial or complete pharyngectomy +/- partial or complete oesophagectomy.  There 
are a number of different tissue flaps that can be used to repair defects depending on 
extent of disease.  The development of the technique of free tissue transfer with 
microvasular anastomosis increased the options for repairing defects after extended 
laryngectomy surgery.  Patients with more extensive surgery may have more 
challenging rehabilitation needs and may require more input from multidisciplinary 
teams to achieve optimum speech and swallow outcomes.  As yet, research into the 
specific types of swallowing and speech difficulty encountered by extended 
laryngectomy surgery patients remains under explored.  This may be due to the 
relatively small numbers of patients undergoing each of individual tissue transfer 
techniques but also poor survival rates (Ward et al., 2002) for those with advanced 
disease.  In addition, many extended laryngectomy patients may be burdened with 
significant co-morbidities (Ho et al., 2012) or post-operative radiotherapy making it 
difficult to say with certainty which communication impairments and dysphagic 
symptoms have a surgical aetiology. 
 
 
1.2. Swallowing after laryngectomy 
 
In this section, the reasons why dysphagia (swallowing difficulty) has, until recently, 
been relatively unexplored in this population will be highlighted.  The common 
swallowing problems encountered by post laryngectomy patients will be discussed.  
In addition, the different types of swallow evaluation tools currently available and 
their suitability for laryngectomy patients will be outlined 
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For many years, the focus of rehabilitation after laryngectomy was on the restoration 
of communication and pulmonary function rather than on swallowing.  As swallowing 
and respiratory systems are anatomically separated after laryngectomy surgery, the 
risk of aspiration of food or liquid into the trachea is relatively low.  Aspiration, when 
it occurs may be due to fistulisation (a physiological communication that develops 
between tissues secondary to delayed healing or malignant disease) or a leaking voice 
prosthesis.  As aspiration is rare and most laryngectomy patients can manage a 
nutritionally adequate diet, swallowing was not an area that was previously seen as 
problematic. 
 
However, as the expertise of Speech and Language Therapists in dysphagia increased 
together with a greater appreciation of survivorship challenges for patients after head 
and neck cancer, swallowing after laryngectomy received more attention.  It became 
apparent that laryngectomy patients appear to experience dysphagic symptoms that 
affect quality of life, such as taking a longer time than others to eat, or an over 
reliance on modified diets.  A seminal Australian study (Ward et al., 2002) 
highlighted the significance of this problem with the suggestion that the incidence of 
dysphagia may be as high as 48% for total laryngectomy and 50% for 
pharyngolaryngectomy three years post-surgery.  A more recent study (Maclean et al., 
2009d), found an even higher incidence, with 72% of laryngectomy patients in this 
study self-reporting symptoms of dysphagia. 
 
It is now acknowledged that dysphagia is not only a real and common problem after 
total laryngectomy but one that remains under reported (Landera et al., 2010) and 
which may result in psychosocial limitations (Maclean et al., 2009c).   
 
It is understood that dysphagia in the laryngectomy population may be multifactorial.  
Dysphagia may arise because of the anatomical and physiological changes post-
surgery or as a consequence of radiotherapy and/or chemotherapy.   
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1.2.1. Causes of dysphagia after laryngectomy 
 
1.2.1.1. Pseudodiverticulum 
 
Pseudodiverticulum (Figure 1.11) has been described as a mucosalised pouch at the 
base of the tongue, separated from the remaining pharynx by a posterior tissue band 
(Deschler et al., 1996). 
 
   
 
 
Figure 1-11: Videofluroscopic image of post laryngectomy 
pseudodiverticulum 
 
The pseudodiverticulum has been alternatively called a pseudovallecula and the 
posterior tissue band a pseudoepiglottis (Landera et al., 2010) because of the 
appearance on barium swallow and other types of imaging.  It has been suggested that 
the use of the suprahyoid repair, previously described, can reinforce the area at the 
base of tongue and help prevent formation of a diverticulum (Edels, 2011).  The 
impact of a pseudodiverticulum on swallowing was first described in 1963 (Kirchner 
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et al., 1963).  A smaller diverticulum does not usually impact on functional 
swallowing ability but a larger diverticulum may impede bolus transit and collect 
significant amounts of food during meals (Landera et al., 2010).  Further symptoms of 
dysphagia arising from pseudodiverticulum can include regurgitation of undigested 
food (Sullivan and Hartig, 2001), globus sensation of food for long periods of time 
after eating and halitosis (Oursin et al., 1999).  The pseudodiverticulum is usually 
located above the pharyngoesophageal segment, which vibrates to produce voice.  A 
further complication of a pseudodiverticulum is that the airflow used to produce voice 
may cause an inadvertent vibration through collected material in the 
pseudodiverticulum distorting voice quality (Landera et al., 2010).  Behavioural 
interventions such as alternating liquid with food, changes in head posture and 
increasing swallow effort (Landera et al., 2010) have been proposed to manage 
swallowing difficulties in smaller pseudodiverticulum.  However, larger 
pseudodiverticulum may require surgical management (Brasnau et al., 2003) to close 
the defect. 
 
 
1.2.1.2. Fistula 
 
Pharyngocutaneous fistulae (Figure 1.12) are reported to be the most common non-
fatal postoperative complication of laryngectomy (Galli et al., 2009, Sullivan and 
Hartig, 2001).  A pharyngocutaneous fistula results in a communication between the 
reconstructed pharynx and the skin of the neck and may place the patient at risk of 
aspiration. 
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Figure 1-12: Videofluroscopic image of post laryngectomy fistula 
 
 
Fistula incidence reported varies from 5% to 65% (Sassler et al., 1995, Weber et al., 
2003) and occurs most commonly in the first few weeks after surgery often as a 
consequence of infection (Landera et al., 2010).  Fistulisation may delay 
commencement of oral intake and may lead to aspiration of saliva.  The diagnosis of a 
fistula beyond the perioperative stage when oral intake has been established may 
result in aspiration of food and liquid.  Development of a pharyngocutaneous fistula 
has significant implications beyond dysphagia.  Fistulisation is not only a major cause 
of morbidity but can also delay any adjuvant treatment, prolong hospitalisation and 
increase costs of care (White et al., 2012).  Larger tumours (T3, T4) requiring salvage 
laryngectomy (patients who have undergone previous radiotherapy/chemotherapy) are 
thought to pose a greater risk for fistula formation (Aarts et al., 2011, Starmer et al., 
2008).  Previous radiotherapy (Mclean et al., 2012) and chemotherapy have been 
38 
 
implicated as predisposing factors causing post-operative fistulae (Klozar et al., 2012) 
with a greater risk in those patients having concurrent chemotherapy rather than 
radiotherapy alone (Driven et al., 2009).  One study (White et al., 2012) found that 
chemotherapy was not significantly associated with fistula formation although 
previous radiotherapy was.  Other studies (Cavalot et al., 2000) (BoscoloRizzo et al., 
2008) (Jovanovic et al., 2006) have identified factors such as diabetes, liver disease, 
anaemia as predictors of fistulisation together with chronic pulmonary disease and 
congestive heart failure (Paydarfur and Birkmeyer, 2006, Fradis et al., 1995).  A 
comprehensive study (White et al., 2012) examined a number of factors for their 
association with fistula formation and found the fistula rate was higher in those 
patients with salvage laryngectomy and hypothyroidism.  It should be noted that 
overall both the fistula rate was higher and hypothyroidism more prevalent in the 
salvage laryngectomy group suggesting that hypothyroidism itself may not be 
causative for fistulas.  Neck dissection at the time of laryngectomy has been 
associated with an increased risk of fistula formation (Paydarfur and Birkmeyer, 
2006, Bohannon et al., 2010) with cervical lymph node involvement correlating with 
fistula formation (Pinar et al., 2008).   
 
Some fistulae will spontaneously resolve (Andrades et al., 2008), especially with 
treatment of co-morbidities such as hypothyroidism.  Other conservative management 
techniques for fistulisation after laryngectomy may involve the use of hyperbaric 
oxygen therapy (Korpinar et al., 2006, Narozny et al., 2005) to promote soft tissue 
healing.  Saline or antibacterial dressings and negative pressure dressings may also be 
used to promote wound contraction and the development of granulation tissue 
(Hanasano et al., 2012) to allow healing.  Should conservative techniques fail, 
surgical management is required (Landera et al., 2010) (Hanasano et al., 2012).  The 
method of surgical closure will be influenced by fistula size and condition of cervical 
soft tissues (Mclean et al., 2012).  Reconstruction of fistula following salvage 
laryngectomy may be particularly compromised by the quality of cervical skin (Iteld 
and Yu, 2007).  For smaller fistulae, direct closure of the pharyngeal defect is possible 
by elevating opposing skin flaps, turning these over and suturing together with 
surrounding local tissue advanced to cover the repair (Mclean et al., 2012) 
Fistulisation after laryngectomy may lead to pharyngeal secretions washing over an 
irradiated or skeletonised carotid sheath and increasing risk of rupture (Hanasano et 
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al., 2012).  A pectoralis myofascial sheath may be raise and sutured over the carotid 
artery facilitating drainage of secretions and converting the fistula into a safe wound 
for further surgical repair as necessary (Hanasano et al., 2012).  When insufficient 
cervical skin is available for primary closure of a fistula, a wide variety of 
reconstruction techniques have been suggested including dual paddle anterior lateral 
thigh flap (Iteld and Yu, 2007), radial forearm flap with external pectoralis major 
myofascial flap (Magdy, 2008), gastromental free flap (Carlson et al., 1997) and 
pectoralis major musculocutaneous free flap (Mclean et al., 2012) 
 
 
1.2.1.3. Stricture 
 
Neopharyngeal strictures are well known complications of the management of 
laryngeal cancer (Silverman and Deschler, 2008).  Strictures Figure 1.13 within the 
neopharynx in a laryngectomy patient may be observed on radiological imaging as an 
area of limited dilation and abnormal tightness (Landera et al., 2010).   
 
 
 
Figure 1-13: Videofluroscopic image of a post laryngectomy stricture 
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Stricture may occur at one point within the neopharynx or within the oesophagus 
(Silverman and Deschler, 2008) and generally impedes bolus flow particularly on 
more solid consistencies.  Stricture is often a result of post-operative infection, scar 
tissue, fibrosis (Landera et al., 2010), or recurrent disease.  Some studies have 
suggested that strictures are more likely to occur in patients with a history of previous 
radiotherapy or chemo radiation treatment (Silverman and Deschler, 2008) but a more 
recent study (Sweeny et al., 2012) indicated rates of stricture formation were similar 
in patients undergoing salvage laryngectomy compared to primary laryngectomy.  For 
those requiring extended laryngectomy surgery, strictures may be more common at 
the lower anastomosis of tubed flap repairs of the neopharynx such as radial forearm 
flap and anterior lateral thigh flap (Hanasano et al., 2012) compared to standard total 
laryngectomy (Sweeny et al., 2012).  Stricture formation in tubed skin flaps is 
reported in 50-60% of patients while stricture occurs in up to 20% of patients with 
jejunal flap repair (Salamoun et al., 1987, Scharpf and Esclamado, 2002, Withrow et 
al., 2007, Ayshford et al., 1999).   
 
Strictures may result in laryngectomy patients having difficulty swallowing foods 
other than liquids (Landera et al., 2010), a globus sensation and pooling in the 
neopharynx (Samlan and Webster, 2002).  Nasal regurgitation as a consequence of 
retrograde bolus flow through the reconstructed segment and into nasopharynx may 
also be symptomatic of stricture (Landera et al., 2010).  Once recurrent disease has 
been ruled out as a cause (Silverman and Deschler, 2008), strictures are usually 
managed by surgically dilating the restricted area, often regularly to prevent tissues 
scarring back to their original position (Landera et al., 2010).  Endoscopic dilation is 
usually performed in an anterograde fashion through the oral cavity using bougies 
(Silverman and Deschler, 2008).  Alternatively, anterograde passage of balloon 
dilators under radiological guidance has also been successfully implemented to treat 
neopharyngeal stricture (Harris et al., 2010). For those patients with factors such as 
trismus or oropharyngeal radio necrosis that limits an anterograde approach, 
retrograde dilation through the TEP has been proposed.  Direct application of the anti-
neoplastic agent, Mitomycin C to the newly dilated segment has been shown to 
increase the interval between necessary repeat dilation procedures (Silverman and 
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Deschler, 2008).  The use of self-expandable plastic stents for a period of 3 months 
has also been proposed as a means of preventing restricture (Somani et al., 2010).  
Behavioural intervention to encourage patients to try oral intake of more solid 
consistencies post dilation may help stretch the dilated area (Landera et al., 2010).  
Occasionally strictures may be so severe or re-occur with such frequency that surgical 
excision with flap reconstruction becomes the only management option (Landera et 
al., 2010) 
 
 
1.2.1.4. Reduced propulsion in neopharynx 
 
In the normal swallow, the tongue base retracts and the posterior pharyngeal wall 
contracts causing pharyngeal pressure to build.  As both structures make contact, the 
pharyngeal wall contraction continues progressively down the pharyngeal constrictor 
muscles (Logemann, 1998a).  This contraction ensures efficient bolus transit with 
minimal or no residue.  In laryngectomy patients, pharyngeal constrictor contraction 
is significantly altered by surgical closure of the pharynx post-surgery.  Impaired 
pharyngeal constrictor contraction results in bolus transit being achieved primarily by 
gravity, rather than by propulsive forces within the neopharynx.  Radiotherapy 
induced fibrosis has been identified as a cause of reduced pharyngeal propulsion and 
residue in head and neck patients (Langmore and Krisciunas, 2010, Pauloski, 2008).  
The stiffening of neopharyngeal tissue after laryngectomy as a result of radiotherapy 
may further contribute to reduced neopharyngeal propulsion and residue. (Walther 
and Heberhold, 1993).   
 
Intrabolus pressure (pressure within the bolus) is an additional factor which influences 
how efficiently the bolus passes through the pharynx.  Crucially in those with a 
larynx, intrabolus pressure is dependent on the resistance to flow offered by the upper 
oesophageal sphincter (UES) (Cook, 2006)  However, in laryngectomy patients the 
function of the UES is significantly affected by myotomy and those who have 
undergone extended laryngectomy surgery will no longer have a UES.  The decrease 
in UES pressure after laryngectomy was found to prolong bolus transfer after 
laryngectomy.  A recent study, using a combination of videofluoroscopy and 
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manometry, concluded that not only are pharyngeal propulsive forces impaired but 
there is also resistance to bolus flow across the pharyngoesophageal segment 
(Maclean et al., 2011).  As a result, it is not uncommon to observe reduced pharyngeal 
bolus clearance and sometimes, significant residue on videofluoroscopy examination, 
see Figure 1.4.  Efficient bolus transfer through the neopharynx may therefore be 
compromised by impaired pharyngeal contraction, pressure changes as a consequence 
of surgery and radiation therapy induced fibrosis 
 
 
 
Figure 1-14: Videofluroscopic image of neopharyngeal residue post 
laryngectomy 
 
 
The treatment of reduced propulsive forces in the post laryngectomy patient has 
involved the implementation of behavioural strategies such as reducing speed of oral 
intake and alternating liquid with food.  As it has been proposed that an intact base of 
tongue pressure can compensate for the missing contraction of the pharyngeal 
constrictor muscle (Walther and Heberhold, 1993), the use of exercises to increase 
contact between the tongue base and posterior neopharyngeal has been utilised with 
some post laryngectomy patients.  However, research is required to provide a robust 
evidence base for this management strategy. 
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1.2.1.5. Voice prosthesis leakage 
 
Placement of a voice prosthesis is now considered the gold standard for 
communication rehabilitation after laryngectomy (Elmiyeh et al., 2010) and so is 
placed in virtually all patients.  As mentioned previously, laryngectomy surgery 
involves complete anatomical separation of respiratory systems and swallowing 
systems.  The voice prosthesis is placed in a surgical puncture between the trachea 
and the oesophagus opening a potential area of communication between swallowing 
and respiration systems.  The one-way voice prosthesis is designed to open when the 
patient produces voice and stay closed during swallowing.  Certain situations may 
cause the voice prosthesis to leak either around the prosthesis or through the centre of 
the prosthesis posing a risk of aspiration into the trachea.  Causes of leakage may 
include an inaccurately sized voice prosthesis, the prosthesis approaching the natural 
end of its lifespan or colonisation by a fungal infection such as candidiasis (thrush).  
Leakage, if present, can usually be observed by asking the patient to drink water 
containing blue or green food colouring.  Leakage may also be observed on 
radiological imaging by magnification of the area where the voice prosthesis is 
located.  Figure 1.15 illustrates central voice prosthesis leakage.  Voice prosthesis 
leakage is often managed through resizing or simply placing a new or alternative 
voice prosthesis.  More complex cases of voice prosthesis leakage may require 
investigation with instrumental means such as videofluoroscopy or endoscopy to rule 
out anatomical or physiological causes of leakage.  
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Figure 1-15: Videofluroscopic image of central voice prosthesis leakage 
 
 
1.2.1.6 Reflux 
 
Anecdotal evidence suggests that some laryngectomy patients experience a degree of 
oesophageal stage swallowing disorder including delayed oesophageal transit.  
Laryngectomy patients appear to experience reduced amplitude and duration of 
contractions in the proximal oesophagus (Dantas et al., 2005).  A high incidence of 
gastro pharyngeal reflux has also been found in a small number of studies of 
laryngectomy patients.  In the immediate post-operative period, pathological reflux 
was reported in 30-40% of laryngectomy subjects (Garrido et al., 2007).  In the long 
term rates as high as 82% were found post laryngectomy (Smit et al., 1998).  Pepsin, a 
digestive stomach enzyme, was found in the tracheosophageal puncture site of 58% of 
laryngectomy subjects (Bock et al., 2010).  The treatment of reflux in laryngectomy 
patients is usually facilitated by referral to gastroenterology teams who often 
prescribe a suitable proton pump inhibitor. 
 
Laryngectomy patients may experience a myriad of swallowing difficulties 
documented in the literature including pseudodiverticulum, fistulisation, stricture, 
reduced neopharyngeal propulsion, voice prosthesis leakage and reflux.  Each of these 
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difficulties potentially results in modification of diets and compromise of the ability 
to maintain a nutritionally balanced oral intake.  However, the symptoms and 
underlying aetiologies of dysphagia after laryngectomy remain poorly understood and 
require further investigation.  Broad definitions of swallow success, such as not 
requiring tube feeding or ability to tolerate a soft diet, have historically been used to 
evaluate outcomes following different surgical techniques used in the laryngectomy 
population (Ward et al., 2002).  However, using this type of broad definition of 
swallow success conceals those laryngectomy patients who have to avoid certain 
foods (Ackerstaff et al., 1994), who can only tolerate mashed up food (Ackerstaff et 
al., 1994) or who are dependent on enteral supplements.  Monotonous dietary changes 
have been shown to result in reduced appetite, weight loss and ultimately impaired 
quality of life (Despondt and Genamo, 1995).  The past decade has brought a growing 
appreciation of the swallowing problems encountered post laryngectomy.  Dysphagia 
evaluation is the cornerstone of therapy.  The inadequate definition of dysphagia as 
ability to tolerate a soft diet or non-dependency on tube feeding has led to inadequate 
evaluation of dysphagia in the laryngectomy population.  In contrast with other 
dysphagia patient populations, there are, as yet, no published protocols or standards 
for the evaluation of dysphagia in this patient group.  In addition, there is a lack of 
unanimity about which dysphagia evaluation tool or tools may be appropriate for post 
laryngectomy patients.  The development of agreed protocols for the evaluation of 
dysphagia and the emergence of a consensus about the dysphagia evaluation tools 
appropriate for use post laryngectomy is essential to allow symptoms to be 
comprehensively investigated, documented and treated. 
 
 
1.2.2. Swallow evaluation tools post laryngectomy 
                                                                                                                                           
In order to facilitate comprehensive rehabilitation post laryngectomy, evaluation of 
swallowing function is required.  The purpose of a swallow evaluation is to identify 
and interpret the nature of the problem, examine anatomical, physiological and 
sensory aspects and probe for appropriate interventions (Langmore and Aviv, 2001)  
Swallowing involves a number of rapid and physiologically complex movements.  
The highest clinical yield from a dysphagia evaluation tool will be gained when the 
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diagnostician is able to examine structural movement as it relates to bolus movement 
and the impact of any swallowing strategies on function (MartinHarris et al., 2000).  
In the case of laryngectomy patients, it is also important to have the ability to clearly 
observe post surgical anatomical changes and the behaviour of the voice prosthesis if 
it is present.   
  
1.2.2.1. Videofluroscopy 
 
Videofluroscopy uses a dynamic form of x-ray to examine the anatomy and 
physiology of swallowing (Martin-Harris et al., 2000)  Dynamic imaging for the 
evaluation of swallowing was first pioneered with the use of cineradiography in 1965 
(Donner and Siegel, 1965) and was developed and improved most notably by 
Logemann (Logemann, 1998a).  The examination is performed with the patient in a 
sitting or standing position and generally starts with a lateral view and progresses to 
an antero posterior view.  The patient is usually asked to swallow graduated bolus 
volumes of different radio opaque consistencies.  (Logemann, 1998a, Martin-Harris et 
al., 2000).  Videofluroscopy permits the visualisation of bolus flow in relation to 
structural movement throughout the upper aerodigestive tract, permits detection of the 
presence and timing of aspiration and assists in identifying physiological causes of 
dysphagia (Martin-Harris et al., 2008, Dodds et al., 1990, Martin-Harris et al., 2000).  
Generally oral, pharyngeal and oesophageal phases (Rosenquist, 2008) of swallowing 
are screened as part of a videofluroscopic examination.  Videofluroscopy is often the 
procedure of choice for the evaluation of dysphagia by Speech and Language 
Therapists (Martin-Harris et al., 2008) despite the fact that training in interpretation is 
highly varied and sometimes sparse (Kidder et al., 1994).  Studies have found that 
standards for measuring various parameters on videofluroscopy have been 
inconsistent and yielded unacceptable inter judge reliability (McCullough et al., 2001) 
except for the well-defined parameter of aspiration (Stoeckli et al., 2003)  Aspiration 
alone is not a sufficient measure of swallowing impairment, the aim of the 
videofluroscopic examination should be to find the underlying impairment (Martin 
Harris et al., 2008)  The Modified Barium Swallow Study Measurement tool for 
Swallow Impairment, a standardised tool to quantify swallowing impairment 
(MBSImp) (Martin-Harris et al., 2008) has demonstrated favourable inter and intra 
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rater reliability following standardised training.  The authors of this study have made 
significant progress in advocating the use of standardised training, protocol, contrast 
materials and measurements in the videofluroscopic evaluation of dysphagia.   
   
 
Videofluroscopy has been used with laryngectomy patients since the 1960’s (Diedrich 
and Youngstrom, 1966) (Bentzen et al., 1976b) (Damste and Lerman, 1969a) (Daou 
et al., 1992), but most of these early studies were focused on examining oesophageal 
speech and involved relatively small numbers of subjects (Kazi et al., 2006d).  Later 
studies focused on the potential for tracheosophageal speech (Sloane et al., 1991), on 
tracheoesophageal speech itself (McIvor et al., 1990) (VanWeissenbruch et al., 2000) 
or on taking quantitative measures of the pharyngoesophageal segment primarily for 
the purposes of voice rehabilitation (Kazi et al., 2006d, VanAs et al., 2001) Currently, 
videofluroscopy swallow examination has been used to evaluate swallowing post 
laryngectomy, primarily because it is well established as an evaluation tool for 
dysphagic patients with a larynx and is readily clinically available in most hospitals.  
The status of videofluroscopy as the gold standard (Swigert, 2007) of swallow 
evaluations has been challenged by studies (Langmore et al., 1991, Wu et al., 1997a, 
Leder et al., 1998, Crary and Baron, 1996) demonstrating that FEES is as sensitive or 
more sensitive than videofluroscopy on parameters including delayed swallowing 
initiation, penetration, aspiration and pharyngeal residue.   
 
Videofluroscopy presents some limitations (Langmore, 2003).  It produces two 
dimensional images which limits the precise measurement of features such as vocal 
fold movement (Inamoto et al., 2011)   Furthermore patients need to be be strong 
enough and have sufficient mobility to be brought to a radiology suite and positioned 
either standing or sitting for the duration of the exam (Rugiu, 2007)  Some patients, 
especially those who have had radiation therapy, may state a reluctance to be exposed 
to the further radiation (Rugiu, 2007) that is required by videofluroscopy.  Xerostomia 
is a well documented side effect of radiotherapy treatment in head and neck cancer 
(Xiao et al., 2013, Chasen and Bhargava, 2009, Dost and Farah, 2013, Cooperstein et 
al., 2012).  Videofluroscopy requires the presentation of barium rather than real food, 
which can be hard to swallow if the oral cavity is dry as a consequence of radiation.  
In addition, videofluroscopy is a time and labout intensive evaluation tool that 
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frequently must be scheduled a few days to a week in advance (Sherman et al., 
1999b).  Commencing oral intake may be delayed while videofluroscopy results are 
pending (Sherman et al., 1999b).  Despite these limitations, videfluroscopy is an 
extensively researched dysphagia evaluation tool which is well established and widely 
available within the clinical setting. 
 
Videofluroscopy has been used with laryngectomy since the 1960’s (Diedrich and 
Youngstrom, 1966) (Bentzen et al., 1976b) (Damste and Lerman, 1969a) (Daou et al., 
1992), but most of these early studies were focused on examining oesophageal speech 
and involved relatively small numbers of subjects (Kazi et al., 2006d).  Later studies 
focused on the potential for tracheosophageal speech (Sloane et al., 1991), on 
tracheoesophageal speech itself (McIvor et al., 1990)  (VanWeissenbruch et al., 2000) 
or on taking quantitative measures of the pharyngoesophageal segment primarily for 
the purposes of voice rehabilitation (Kazi et al., 2006d, VanAs et al., 2001) Finally, 
videofluroscopy can sometimes provide limited visibility of the voice prosthesis, 
which can restrict assessment in patients with larygectomy.  To date however, no 
standardised protocols exist for the use of videofluroscopy as a dysphagia evaluation 
tool in laryngectomy. 
 
  
1.2.2.2. Fiberoptic Endoscopic Evaluation of Swallowing (FEES) 
 
FEES involves passing a flexible scope through the nose and towards the pharynx to 
observe swallowing in real time.  Since its development in the late 1980s (Langmore 
et al., 1988) the widespread use of Fiberoptic Endoscopic Evaluation of Swallowing 
has challenged the predominance of videofluroscopy in the clinical setting.  One of 
the significant reasons for the rise in popularity of FEES was the fact that it could 
easily be performed with patients whose poor mobility or medically fragile state 
precluded them from undergoing a videofluoroscopy swallow evaluation.  However, 
FEES offers other advantages including the avoidance of radiation exposure, allowing 
patients to be evaluated sequentially and repeatedly if required, to monitor progress 
and outcomes with behavioural, surgical or medical interventions.  Although the 
amount of radiation that a patient is exposed to during videofluroscopy has been 
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shown to be minimal (Zammit-Maepel et al., 2007), it nonetheless presents limits in 
terms of repeating the examination (Rugiu, 2007).  Real food rather than barium 
preparations is used during FEES allowing sensory components such as taste 
(Logemann et al., 1995, Ding et al., 2003), temperature (Michou et al., 2012), volume 
(Butler et al., 2011), viscosity (Butler et al., 2004) and carbonation (Michou et al., 
2012) to be explored therapeutically with the patient.  FEES offers the benefits of 
biofeedback (Crary et al., 2004, Leder et al., 2004) during therapy providing a 
rationale for exercise regimens.  In laryngectomy patients, FEES can also facilitate a 
clear view of the voice prosthesis.  While it has been indicated that videofluroscopy 
provides excellent analysis of oral, pharyngeal and oesophageal stages of swallow, 
including factors such as laryngeal elevation, upper oesophageal opening and sub 
mucosal changes such as osteophytes, FEES allows visualization of secretions, direct 
views of surface anatomy, mucosal abnormalities, altered anatomy and path of bolus 
flow (Langmore, 2006).   
 
A significant limitation of FEES is that it does not allow direct visualisation of the 
oral (Rugiu, 2007) and oesophageal (Langmore, 2003) (Bastian, 1993) stages of 
swallowing.  Early concerns about the safety of FEES as a swallow evaluation tool 
have largely been dismissed.  Several studies (Cohen et al., 2003), (Aviv et al., 2005), 
(Warnecke et al., 2009a) have found that FEES was not only safe but also well 
tolerated by patients.  One influential study (Hiss and Postma, 2003) found that when 
FEES was compared with videofluroscopy, FEES was as sensitive or superior in 
detecting laryngeal penetration, aspiration, swallowing residue and pharyngeal 
pooling in head and neck cancer patients, contributing to the extensive use of the tool 
in this population.  Although FEES is not established as an assessment tool in 
laryngectomy, it has been used extensively to assess dysphagia in other head and neck 
cancer patient groups and may be particularly suited to the needs of this patient 
population.  However, there is no data to demonstrate the benefits of FEES against 
videofloroscopy in the laryngectomy population. 
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1.2.2.3. Clinical or bedside swallow assessment  
 
Clinical or bedside swallow assessments are often used to screen symptoms of 
dysphagia prior to progressing to an instrumental evaluation if the latter is required.  It 
is not always clinically necessary or a good management of resources to perform an 
instrumental examination on every patient with signs of dysphagia (Leder et al., 
2012).   
 
The bedside swallow assessment usually includes an examination of cranial nerve 
function, an orofacial examination and swallow trials using a variety of texture 
modified food and liquid.  Sometimes, the larynx is externally palpated during the 
swallow to ascertain range of laryngeal elevation and movement.  If the patient 
demonstrates a wet voice or coughs during a bedside assessment, this may be 
considered as a sign of aspiration.  However, neither a wet voice (Linden et al., 1993, 
Warms and Richards, 2000, GrovesWright et al., 2010) nor the presence of a cough 
(Horner and Massey, 1988, Horner et al., 1990) is underpinned with strong evidence 
of a link to dysphagia.  Indeed a significant limitation of the clinical bedside swallow 
examination is that, sometimes aspiration occurs without any overt signs (silent 
aspiration) (Horner and Massey, 1988, Garon et al., 2009). 
 
A recent systematic review of bedside swallow examinations (Bours et al., 2009) 
revealed a great variety in quality with a majority of studies showing methodological 
flaws.  Evidence base for a bedside swallow test is strongest for the 3oz water 
swallow test.  This test has been shown to successfully identify patients who could be 
safely advanced onto an oral diet (Leder et al., 2012).  One of the main criteria for 
judging performance on the 3oz swallow test is whether the patient can drink water 
uninterrupted and without coughing during or immediately after completing the task.  
Typically, clinical evaluation of swallowing has not been used to evaluate dysphagia 
in laryngectomy.   
  
A clinical evaluation is significantly limited in the laryngectomy population because 
there is no larynx to palpate and an absence of a cough reflex.  The nature of the 
anatomical separation of the respiratory and swallowing systems after laryngectomy 
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means evaluation of swallowing in this patient population benefits from an 
instrumental approach. 
 
 
1.2.2.4. Ultrasound 
 
Ultrasound is a non-invasive technique that creates images of areas inside the body 
using sound waves, which are transmitted and received using externally placed 
transducers.  In contrast to videofluroscopy, this technique allows soft tissues to be 
visualised rather than the bolus (Kim and Kim, 2012).  A recent study used 
ultrasonography to examine lateral pharyngeal wall motion during swallowing and 
ultrasound has been used to analyse tongue motion (Stone and Shawker, 1986b, 
Stone, 2005).  However, most studies involving dysphagia have focused on evaluation 
of laryngohyoid elevation and associated soft tissue structures (Kim and Kim, 2012).  
Ultrasonography allows observation of hyoid movement (Steele et al., 2012) by using 
a transducer to send and receive high frequency sound waves during swallowing.  The 
hyoid bone lies on top of the larynx and is anchored by muscles that aid tongue 
movement and swallowing.  The hyoid bone has been described as typically 
generating a dark shadow on a sagittal ultrasound image which appears as a line 
running from the posterior aspect of the geniohyoid muscle and intersecting the 
posterior surface of the tongue.  This shadow moves from posterior to anterior oral 
cavity on the image during swallow.  This is useful to examine because the onset of 
superior hyoid movement is associated with onset of the pharyngeal stage of 
swallowing (Lof and Robbins, 1990).  In addition, movements of the tongue may 
involve or cause displacement of the hyoid and allow inferences about swallowing to 
be made (Stone and Shawker, 1986a, Sonies et al., 1996).  Ultrasound poses some 
limitations (Steele et al., 2012), which have restricted the use of this tool in the 
clinical arena.  These limitations include the largely subjective nature of determining 
when the shadow of the hyoid has reached its maximum displacement.  In addition it 
can be difficult to determine the visual boundaries of the hyoid shadow itself raising 
the possibility of inconsistency in timings measures.  To date, ultrasound has not been 
used with laryngectomy patients because of the absence of the hyoid bone in this 
population together with the relative rarity of this tool in the clinical setting. 
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1.2.2.5. Scintigraphy 
 
Scintigraphy is a nuclear medicine technique in which the patient swallows measured 
amounts of a radioactive substance (Muz et al., 1994) (Silver et al., 1991, Silver and 
VanNostrand, 1992).  The bolus is imaged during the swallow using a gamma camera 
and the amount of penetration and aspiration can be quantifiably measured 
(Logemann et al., 2005).  The patient can either be lying down or standing up for the 
procedure (Fattori et al., 2007) allowing those with poor mobility access to this tool.  
Scintigraphy is easy to use and is usually well tolerated by the patient (Fattori et al., 
2007).  Scintigraphy is the only instrumental diagnostic procedure currently available 
which can quantifiably measure residue (Logemann, 1998b) in the oral and 
pharyngeal cavities.  It also allows any tracheal bronchial aspiration to be quantified 
and allows calculation of transit time of the bolus (Fattori et al., 2007).  However a 
significant limitation of scintigraphy is that the physiology and anatomy of the mouth 
and pharynx cannot be visualised making the cause of swallow dysfunction difficult 
to identify (Logemann, 1998b) (Fattori et al., 2007).  In addition, timing measures of 
swallow such as duration of oropharyngeal opening and airway closure cannot be 
determined (Logemann et al., 2005).  The use of scintigraphy has also been limited to 
date because it is not widely available in the clinical setting. 
 
1.2.2.6. Electromyography 
 
Electromyography (EMG) involves placing electrodes on or in the muscles involved 
in swallowing in order to evaluate the timing and relative amplitude of selected 
muscle contractions during swallowing (Logemann, 1998b).  In this manner, EMG 
can be used to identify muscle function that is negatively affecting oral intake.  EMG 
work on swallowing in animals is greatly respected for its early contribution to 
understanding of the process of deglutition (Doty and Bosma, 1956). Much of the 
swallow research on EMG using the human model has concentrated on muscles 
associated with oral and pharyngeal stages due to difficulty inserting electrodes into 
the oesophagus (Perlman, 2006).  A seminal study in the field (Perlman et al., 1999) 
collected simultaneous EMG recordings from laryngeal, pharyngeal and sub mental 
muscles during swallowing.  This study found that the sequence of normal 
swallowing is preceded by contraction of the sub mental musculature followed by 
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contraction of the superior pharyngeal constrictor and then relaxation of the 
cricopharyngeal muscle.  Much of the EMG data on dysphagia patients relates to 
those with neurological diseases or disorders affecting the lower motor neurone 
system such as myositis (Sonies, 1997), myasthenia gravis (Carpenter et al., 1979) 
and motor neuron disease (Shipe and Zivkovic, 2004).  Different types of electrodes 
have been used in studies of swallowing with electromyography including surface 
(O'Kane et al., 2010), hooked wire (Perlman et al., 1999), suction cup (Palmer et al., 
1989) and needle.  One of the limitations of EMG is that diagnostically, concentric 
needle electrodes are usually required (Cohen et al., 2003).  These are placed into the 
muscle of interest but doing so can limit the execution of a comfortable and normal 
swallow (Perlman, 2006).  In contrast, surface EMG electrodes which are more 
commonly available in the clinical arena have been recommended as more suitable 
for use as a biofeedback tool than for diagnostic purposes (Cram and Kasman, 1998) 
and have been demonstrated to be effective for therapeutic purposes (Crary et al., 
2004).  Some EMG studies have been hampered by methodological issues such as the 
use of surface electrodes when the muscles of interest are deep to the surface 
(Perlman, 2006) and require measurement with needle electrodes.  While EMG has 
contributed much to our understanding of the process of deglutition and will 
undoubtedly continue to do so, the clinical use of EMG for evaluation purposes is not 
yet widespread. 
 
1.2.2.7. Cervical Auscultation 
 
Cervical auscultation is a general term that describes evaluation techniques yielding 
different acoustic information (Zenner et al., 1995).  In the field of dysphagia, cervical 
auscultation generally refers to assessment of sounds of swallowing and/or respiration 
(Logemann, 1998b) using a stethoscope placed on the neck.  The main features to 
listen for have been described as two clicks and a swallow apnea followed by an 
expiratory breath (Marks and Rainbow, 2001) and clear breath sounds after the 
swallow (Zenner et al., 1995).  The “two clicks” are thought to reflect the parting of 
the mucus membrane surrounding the pharyngeal cavity as the bolus flows through 
the pharynx (Lear et al., 1965).  In some facilities where there is no access to well 
established dysphagia evaluation tools such as videofluroscopy and endoscopy, 
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cervical auscultation has gained a degree of popularity.  One study (Leslie et al., 
2007) sought to assess the relationship between swallow sounds and physiologic 
events as measured by cervical auscultation, simultaneously recorded respiration 
patterns and simultaneous laryngoscopy.  This study found that no individual sound 
component was consistently associated with a physiological event and concluded that 
there is no evidence that cervical auscultation should be adopted as clinical practice.  
The lack of robust evidence underpinning the used of cervical auscultation has limited 
the clinical use of this technique. 
 
1.2.2.8. Pulse Oximetry 
 
Pulse oximetry allows the continuous non-invasive measurement of the amount of 
haemoglobin that is oxygen saturated (Smith and Connolly, 2003).  It has been 
suggested that aspiration of food and fluid into the airways can cause reflex 
bronchoconstriction that leads to a desaturation of arterial blood (RodriguezRoisin et 
al., 1991).  This insight led to the proposal that measuring pulse oximetry during 
swallowing evaluation could provide a cost effective and non-invasive method of 
identifying aspiration events.  Measurement of pulse oximetry occurs through a clip 
or wrap sensor placed on a finger or earlobe which contains one red and one infrared 
light emitting diode (Collins and Bakheit, 1997).  A drop in arterial oxygen saturation 
of 2% or more is considered clinically significant (Collins and Bakheit, 1997)   An 
early study of simultaneous videofluroscopy and pulse oximetry in dysphagic stroke 
patients found that pulse oximetry reliably predicted aspiration or lack of it in 81.5% 
of subjects (Collins and Bakheit, 1997).  A further study indicated that dysphagic 
patients who aspirated or penetrated during swallowing without clearing had a 
significant decline in pulse oximetry measurements compared with patients who 
penetrated but cleared or in whom no penetration was observed (Sherman et al., 
1999a).  A large study (Ramsey et al., 2006) of stroke patients who underwent a 
modified bedside assessment of swallowing with simultaneous pulse oximetry was 
critical of the technique.  This study involved subjects swallowing a dilute radio 
opaque liquid and having chest radiograph within 30 minutes to check for aspiration.  
This study found that pulse oximetry has inadequate sensitivity, specificity and 
predictive values for detection of aspiration.  Another study investigated pulse 
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oximetry, heart rate and blood pressure measurements taken pre FEES, during FEES 
and post FEES (Leder, 2000).  The use of these measures as indirect markers of 
aspiration was not supported.  While a further study found no relation between pulse 
oximetry and aspiration although subjects who aspirated had lower Sp02 levels 
before, during and after feeding (Colodny, 2000).  Similarly, a study found that while 
respiratory status in dysphagic subjects may become altered during feeding, there was 
no clear cut relationship between pulse oximetry and aspiration (Sellars et al., 1998).  
The lack of a strong evidence base for pulse oximetry has limited the widespread use 
of this technique. 
 
 
1.2.2.9. Electroglottography 
 
Electroglottography or EGG is a system which provides information on the 
impedance changes of the vocal folds by measuring electrical resistance between two 
electrodes placed on each side of the larynx at the level of the thyroid lamina (Nozaki 
et al., 1997).  It is used frequently in speech science and voice clinics to measure the 
fundamental frequency of the vocal fold during phonation.  EGG can be modified to 
allow identification of maximum laryngeal displacement and the duration of laryngeal 
movement during swallowing (Perlman and Grayhack, 1991, Perlman and Liang, 
1991, Schultz et al., 1994).  EGG has also been suggested as being of therapeutic use 
in teaching compensatory swallow techniques such as the Mendelssohn manoeuvre 
(Perlman and Grayhack, 1991).  EGG is limited by the need to place electrodes so that 
an optimal signal shape could be obtained consistently during the testing session.  
Incorrect placement of electrodes can negatively affect accurate interpretation of the 
onset and duration of laryngeal displacement (Perlman and Grayhack, 1991)  The 
technique may also be limited by size and shape of the laryngeal framework, 
specifically one study found that signals from a female subject were not interpretable 
(Perlman and Grayhack, 1991).  The interpretation of the EGG signal may be 
compromised by signal interference from events during the oral swallow such as 
excessive tongue motions prior to the swallow (Perlman and Grayhack, 1991)  These 
limitations along with a lack of research into EEG and dysphagia have restricted the 
use of EGG in the clinical realm. 
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1.2.2.10. Magnetic Resonance Imaging MRI  
 
Magnetic resonance imaging (MRI) is an technique that uses a strong magnetic field 
and radio waves to produce detailed images of soft tissues of the body (Brown and 
Sonies, 1997).  MRI provides much more precise information about soft tissues in the 
head and neck than videofluroscopy as the focus of the latter is on bolus flow rather 
than movements of anatomical structures (Kitano et al., 2002).  However, 
conventional MRI is limited in the evaluation of dysphagia because of the inability to 
generate a moving picture (Kitano et al., 2002), (Brown and Sonies, 1997).  In the late 
1980’s technology evolved to allow the development of ultra-fast magnetic imaging 
which were based on echo-planar (Evans et al., 1993) and turbo FLASH (Gauger et 
al., 1993) techniques, both of which provide high temporal resolution and generated a 
moving picture.  More recently cine-magnetic resonance imaging has become 
available within the clinical setting.  This technique creates dynamic high speed MRI 
using a video system and turbo flash methods (Gauger et al., 1993).  Cine MRI is an 
non-invasive procedure and does not use ionizing radiation (Panebianco et al., 2010, 
Kreeft et al., 2012).  Patients are required to lie supine for cine-MRI (Panebianco et 
al., 2010) The first study to investigate dysphagia using cine MRI successfully 
quantified swallowing ability in oral surgery patients using the parameter of laryngeal 
elevation and angle of the epiglottis (Kitano et al., 2002).  Another early study in this 
field (Hartl et al., 2003) describes the use of cine –magnetic resonance imaging to 
visualise the dynamic structures of the oral cavity and oropharynx in normal subjects.  
This study demonstrated that oral preparatory, oral and or pharyngeal stages of 
swallowing were visible.  In addition, spatial resolution allowed anatomical 
measurements of parameters such as laryngeal elevation, or pharyngeal diameter, 
tongue base and soft palate displacement.  A subsequent study by the same authors 
(Hartl et al., 2006) used cine MRI techniques on post treatment head and neck cancer 
patients with persistent dysphagia to successfully analyse the morphology and 
mobility of oral, or pharyngeal and laryngeal structures.  Information about cause of 
dysphagia was increased in 5 of the 6 cases.  A recent study (Kreeft et al., 2012) of 
advanced oral and or pharyngeal cancer patients found that cine MRI swallowing 
evaluation yielded additional information when compared to videofluroscopy.  This 
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additional information included visualisation of the geniohyoid and genioglossus 
tongue muscles, floor of mouth and its mobility and visualisation of the tumour.  
Currently, weaknesses of cine MRI as an evaluation tool in dysphagia include low 
temporal resolution (Kreeft et al., 2012, Panebianco et al., 2010), the presence of 
motion artefact (Kreeft et al., 2012) and the need for patients to lie in a supine 
position altering compensatory patterns in those who rely on gravity for swallowing 
(Hartl et al., 2006) and potentially increasing aspiration in those with severe 
dysphagia (Kreeft et al., 2012).  Further research and development of this promising 
instrument (Panebianco et al., 2010) is likely to increase the use of this tool within the 
clinical setting. 
 
 
1.2.2.11. Functional Magnetic Resonance Imaging MRI 
 
Functional magnetic resonance imaging is based on the same technology as magnetic 
resonance imaging.  Instead of creating images of organs and tissues, fMRI measures 
brain activity by detecting the changes in blood oxygenation and flow in response to 
neural activity (Malandraki et al., 2011).  It is a safe, non-invasive procedure that 
allows large cerebral areas to be examined with ease (Ugurbil et al., 2003).  It has 
been suggested that neuroimaging techniques could be used to evaluate swallowing 
and provide a high level of evidence for the effectiveness of dysphagia interventions 
pre and post treatment (Malandraki et al., 2011).  Several studies have attempted to 
identify the neural correlates of swallowing in healthy individuals.  One study found 
activations in the caudal sensorimotor cortex, anterior insula, pre motor cortex, frontal 
operculum, anterior cingulate and pre frontal cortex, anterolateral and posterior 
parietal cortex, and precuneus and superiomedial temporal cortex (Hamdy et al., 
1999).  Other studies (Mosier et al., 1999, Martin et al., 2001, Toogood et al., 2005) 
reported similar results.  A subsequent study found a neural differentiation to 
individual components of swallowing with pharyngeal components relying more 
heavily on subcortical networks and oral components depending on cortical 
sensorimotor cortex innervation (Malandraki et al., 2009).  A recent study described 
the use of fMRI to acquire neural data while simultaneously using dynamic MRI to 
image the muscular structural components of the oropharynx during swallowing 
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(Paine et al., 2011).  This study provides the potential for increased understanding of 
the direct clinical correlates between neural and muscular functions during 
swallowing.   
 
Studies of fMRI in the dysphagic population have been largely confined to date to 
those presenting with neurological aetiologies.  One study of right and left hemisphere 
stroke patients found greater contra lesional activation of swallowing related areas for 
both groups (Li et al., 2009b).  A study of ALS (Amyotrophic Lateral Sclerosis) 
patients with and without dysphagia found that the ALS patients with dysphagia 
demonstrated reduced activation signal in the primary sensory cortex when compared 
with the normal control group.  The ALS patients without dysphagia showed similar 
activation to the normal controls (Li et al., 2009a).  A study of Alzheimer’s patients 
that used both fMRI and videofluroscopic dysphagia evaluation tools found that the 
changes in cortical control of swallowing may begin long before the dysphagia 
becomes apparent (Humbert et al., 2010).  A significant limitation of fMRI in the 
dysphagia population is the need to lie supine for the examination, a position that may 
increase aspiration risk.  In addition, it may be challenging for patients with postural 
issues to lie flat on their back for the several minutes at a time required.  To date, 
fMRI studies of dysphagia have not involved head and neck cancer patients although 
the impact of head and neck surgery on neural activation of swallowing could be an 
intriguing area of future research. 
 
1.2.2.12. Computed Tomography 
 
Computed tomography (CT) is a diagnostic procedure that uses x ray technology 
techniques to produce cross sectional images and three dimensional (3D) images 
(Fujii et al., 2011).  The use of conventional CT in swallowing research has been 
limited by the lack of adequate temporal resolution to capture the quick movements 
that occur in swallowing (Fujii et al., 2011).  The first studies of CT in swallowing 
research successfully utilised an ultrafast electron beam technique to enable dynamic 
imaging of pharyngeal swallowing in the transverse plane (Lindbichler et al., 1998) 
and to measure the volumes of the pharyngeal cavity (Ergun et al., 1993).  However, 
the electron beam technique was limited in that information on the co-ordination of 
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function of the pharynx and vocal folds or size was not provided.  Helical 
computerised tomography offered continuous dynamic images with scan times of 100 
milliseconds.  This technique improved the feasibility of dynamic imaging of the 
pharynx allowing bolus movement to be followed continuously throughout the 
swallow together with visualisation of the pharyngo oesophageal segment (Takehara 
and Chu, 2004).  Dynamic CT techniques involve high doses of radiation (Kobayashi 
et al., 2012) which limited the use of both electron beam and helical techniques.   
 
Recent studies have reported on the use of 320 detector row multislice CT (320 
MSCT) to analyse swallow function (Fujii et al., 2011, Inamoto et al., 2011, 
Kobayashi et al., 2012).  This technique can detect all oropharyngeal structures during 
swallowing and allows morphological analysis of 3D images and dynamic analysis of 
four dimensional (4D) images (Inamoto et al., 2011, Kobayashi et al., 2012).  320 
MSCT has been proposed as a technique suitable for the assessment of changes in 
swallowing after head and neck cancer surgery and brain stem infarction (Fujii et al., 
2011).  A recent study successfully depicted normal swallowing including the 
simultaneous visualisation of the components of laryngeal closure: glottal closure, 
laryngeal vestibule closure and inversion of the epiglottis together with information 
on the timing of these events using 320 MSCT techniques (Inamoto et al., 2011).  
Concerns have been expressed about the amount of radiation exposure required to 
complete a swallow evaluation using 320 MSCT techniques.  However, the risk of 
radiation injury to the patient or operator due to x-ray exposure during the use of 320 
MSCT to evaluate swallowing was found to be negligible during a recent study 
(Kobayashi et al., 2012).  320 MSCT is clearly a technique in development and 
currently presents with some limitations including the need for patients to lie in a 
semi reclining position (Fujii et al., 2011).  Future studies of 320 MSCT will benefit 
from larger sample sizes and the use of dysphagic as well as healthy volunteers 
(Inamoto et al., 2011) and will promote the development of knowledge regarding 
swallowing processes.  At present, 320 MSCT remains a tool with limited availability 
and one that is confined to the research realm. 
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1.2.2.13. Manometry  
 
This tool involves measuring bolus pressure and timing of contractile wave during 
swallowing at anatomical points such as tongue base, upper oesophageal sphincter, 
and lower oesophageal sphincter.  An early study (RoedPetersen et al., 1979), using 
manometry was used to investigate a correlation between resting PE sphincter 
pressure, intelligibility and dysphagia, but was limited by the inability to find a resting 
PE pressure in more than 3 out of 17 subjects and the lack of simultaneous imaging to 
confirm manometric sensor position.  Combining manometry with videofluroscopy in 
the 1980s (McConnel et al., 1986a) revealed that the post laryngectomy pharynx 
offered greater resistance to bolus flow.  This was compensated for by increased 
lingual propulsion in laryngectomy subjects without lingual impairment.  The use of 
videomanometry was limited at this time by a lack of pressure norms for patients 
without a larynx.  A more recent study (Maclean et al., 2011) combined 
videofluroscopy and manometry in post laryngectomy patients and compared these 
subjects to normal controls.  Peak mid pharyngeal, tongue and intrabolus pressures 
together with anatomical derangements, post swallow residue and pharyngeal 
dimensions were measured.  This seminal study demonstrated impaired propulsive 
contractile forces of the reconstructed pharynx after laryngectomy with increased 
resistance to bolus flow across the PE segment and suggested that these adverse 
biomechanical effects can be influenced by surgical techniques.  Mucosa and muscle 
pharyngeal reconstruction resulted in higher peak mid pharyngeal pressures and a 
more efficient swallow with reduced pharyngeal residue compared to closure with 
mucosa alone.  However, the availability of videomanoflurography outside of larger 
medical centres is limited and like videofluroscopy, it involves radiation exposure.  
Nonetheless, videomanoflurography is undoubtedly a very beneficial dysphagia 
evaluation tool whose use has led and will continue to lead to important discoveries 
about post laryngectomy swallowing. 
   
Videofluroscopy, Fiberoptic Endoscopic Evaluation of Swallowing, Clinical swallow 
assessment, Ultrasound and Manometry are all tools used to evaluate dysphagia.  The 
specific advantages and limitations with each tool have been outlined.  It is important 
to consider that no one tool is likely to be superior to others, and some patients may 
benefit from the different perspectives on dysphagia offered by the use of one or more 
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mechanisms of evaluation.  Videofluroscopy, FEES and clinical swallow assessment 
are currently the most frequently used dysphagia tools in clinical practice.  It is now 
acknowledged that laryngectomy patients present with symptoms of dysphagia (Ward 
et al., 2002, Landera et al., 2010, Maclean et al., 2009d).  However, data regarding the 
use of dysphagia evaluation tools in this population is limited.  The comprehensive 
investigation of dysphagia symptoms encountered post laryngectomy will ensure that 
effective and appropriate interventions are chosen to treat this patient population.  In 
order to achieve this goal, the best method of evaluation swallowing post 
laryngectomy requires examination. 
 
 
1.3. Communication after laryngectomy 
 
In order to make sound, a moving column of air and a vibratory source is required.  In 
normal voice production, air vibrates the vocal folds as it is expired from the lungs 
producing voice.  This sound is then amplified by the resonating cavities of the 
pharynx, oral cavity and nasal cavity and modified by the articulators (tongue, teeth, 
lips, hard and soft palates) to produce speech (Chen et al., 2010) Figure 1.16.. 
 
Normal anatomy before laryngectomy 
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Figure 1-16: Normal anatomy before laryngectomy 
 
After laryngectomy, the larynx, including vocal folds, is removed and the neopharynx 
is reconstructed.  As a result, the patient now breathes by taking air in through a 
stoma in the neck rather than through the mouth and nose and has no means to 
produce normal voice.  In order to communicate, a new vibratory source is required to 
replace the vocal folds.  This vibratory source can be produced by mechanical or 
physiological means 
 
 
1.3.1.  Mechanical vibratory sources 
 
There are two main types of external hand held vibratory devices used by 
laryngectomy patients.   
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1.3.1.1.  An electro larynx communication aid  
 
This requires either external placement of the device, see Figure 1.17 against the neck 
or cheek, or internal placement in the oral cavity via attachment of a small tube.  The 
electrolarynx transmits a vibratory sound to the reconstructed pharynx or the oral 
cavity and this sound is shaped by the articulators to produce speech.  These devices 
are battery powered and produce an understandable but electronic sound with limited 
intonation.   
 
Electrolarynx (Servox) 
 
Figure 1-17: Electrolarynx (Servox) 
 
 
 
1.3.1.2.  Pneumatic Artificial larynx 
 
This requires placement of the posterior end of device over the stoma with the 
attached anterior plastic tube placed over the lips, see Figure 1.18.  Expired air from 
the lungs is then directed through a rubber membrane in the device and sound is 
produced.  This sound is then transmitted to the oral cavity and shaped by the 
articulators to produce speech. 
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Pneumatic artificial larynx (Tokyo) 
 
 
Figure 1-18: Pneumatic artificial larynx (Tokyo) 
 
 
It is generally accepted that communication with an electrolarynx or artificial larynx 
is associated with lower intelligibility and poor listener acceptability (Liu and Ng, 
2007).  However, this method of communication can be very beneficial for those have 
difficulty producing voice through the physiological means as described below.   
 
 
1.3.2.  Physiological vibratory sources 
 
The pharyngoesophageal segment (PES) within the reconstructed segment has the 
potential to vibrate and produce sound.  In this manner, the PES becomes a 
physiological replacement for the vocal folds.  The two main types of physiological 
vibratory sources are described below: 
 
1.3.2.1.  Oesophageal speech 
 
Oesophageal speech involves trapping air in the oral cavity and injecting it into the 
oesophagus by pushing the tongue against the hard palate or inhaling air into the 
oesophagus during the respiratory cycle.  Air then passes from the oesophagus 
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through the PES causing a vibration and producing voice.  This sound is then shaped 
by the articulators to produce speech.  However, oesophageal speech can be 
challenging for some patients to learn (Chen et al., 2010).  During oesophageal speech 
a smaller volume of air reaches the PES compared with methods of lung-powered 
speech such as tracheosophageal speech described below.  As a result, phrases are 
often shorter than normal (Salmon, 2005).  In addition, vocal behaviours such as the 
sound of air being injected or inhaled into the oesophagus can interrupt the message 
being communicated. 
 
 
1.3.2.2. Early tracheoesophageal prostheses for voice rehabilitation after 
laryngectomy 
 
Since the first laryngectomy was performed by Dr Theodor Bilroth in 1873 
(Schwartz, 1978), attempts were made to restore communication in a manner that 
resembled normal laryngeal voice.  Dr Bilroth’s assistant, Dr Carl Gussenbauer, 
developed one of the earliest voice prostheses.  This voice prosthesis, which was a 
modified tracheostomy tube with an upward cannula attached, was placed into a 
surgically created fistula between the trachea and pharynx at the level of the base of 
the tongue.  This device allowed the patient to direct exhaled air to the pharynx and 
produce voice by causing a metal reed within the trachesotomy tube to vibrate, see 
Figure 1.19.  
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Figure 1-19: Gussenbauer voice prosthesis 
 
 
Although this prosthesis successfully produced voice, patients experienced significant 
leakage around the surgically created fistula between the trachea and pharynx 
exposing the patient to infection secondary to aspiration of saliva, liquid and food into 
the trachea and lungs.  Further similar devices were developed including those by 
Bottini (Cavalot et al., 2000) and Caselli (Weir, 1990) in the late 19
th
 century with 
varying degrees of success.  In 1932 Guttman described successful voice 
rehabilitation using a diathermy needle to create a fistula between the trachea and 
hypopharynx (Guttman, 1932, Guttman, 1935).  However, this procedure was limited 
because of spontaneous closure of the fistula (Bien et al., 2008). 
 
The development of voice prostheses in the late 19
th
 and early 20
th
 centuries was 
limited by a number of factors.  These included poor peri and post-operative mortality 
of patients during and after laryngectomy surgery (Singer and Blom, 1985) 
discomfort of Caselli and Gussenbauer voice prostheses (Bien et al., 2008), 
spontaneous closure/leakage of surgical fistula created to accommodate voice 
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prostheses and the relative success of oesophageal speech compared to voice 
prostheses (Bien et al., 2008). 
 
 
1.3.3.  Mucosal and skin fistulas for voice rehabilitation after laryngectomy 
 
The mid-20
th
 century saw the emphasis on surgical intervention for voice restoration 
after laryngectomy move towards the development of mucosal or skin fistula that did 
not require a voice prosthesis.  Examples include those developed by Briani in 1952, 
Conley in 1958, Asai in 1960 (Bien et al., 2008) and Staffieri in 1976 (Staffieri, 
1976).  Each of these is described below. 
 
Briani described a surgical technique (Briani, 1952) that involved the construction of 
a skin lined fistula with the proximal end located superior to the stoma and the distal 
end opening into the reconstructed pharynx.  This fistula was directed downwards to 
prevent aspiration of liquid, food or saliva into the trachea (Bien et al., 2008).  
Voicing was achieved through placing a valved plastic device over the stoma and 
proximal fistula redirecting expired air into the pharynx and producing sound at the 
vibratory segment. 
 
Conley (Conley et al., 1958) introduced the tracheoesophageal vein graft fistulisation 
procedure (Snyderman, 1991).  This created a fistula between the trachea and 
oesophagus using vein tissue and oesophageal mucosa.  This fistula had to be dilated 
with a catheter to remain open.  Voicing was achieved using a tracheostomy tube 
placed in the stoma with an adaption to redirect air from the trachea to the oesophagus 
and vibratory segment (Bien et al., 2008).   
 
Asai’s technique (Asai, 1972) involved the construction of an internal cervical skin 
tube and was only suitable for those without subglottic extension of disease as it 
required preservation of all of the tracheal rings.  This surgery was completed in 3 
separate surgical stages (Bien et al., 2008).  The first stage took place at the time of 
laryngectomy and involved making a tracheostomy, or surgical opening above the 
stoma.  This was followed by a creation of a pharyngostomy at the base of tongue.  
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The third and final stage connected the tracheostomy with the pharyngostomy through 
the construction of a skin-lined fistula.  Voice was achieved by covering the proximal 
fistula above the stoma to redirect air from the trachea to the reconstructed pharynx 
and vibratory segment.  However, this technique was limited by the requirement of 
patients to use finger pressure to close the fistula to prevent aspiration during 
mealtimes (Bien et al., 2008).   
 
Staffieri’s technique involved developing a “phonatory neoglottis” (Staffieri, 1976) 
by preserving a proximal stump of trachea and making a low tracheostome.  A flap of 
pharyngeal mucosa was secured over the preserved trachea (Bien et al., 2008).  A slit 
was then made in the pharyngeal mucosa creating a fistula between the tracheal stump 
and adjacent oesophageal wall.  The fistula was designed to be small enough to 
prevent aspiration.  It was also designed to be large enough to allow air to be 
redirected from the trachea to the vibratory segment within the reconstructed 
pharyngoesophageal segment when covered with a finger.  In practice this technique 
was often complicated by aspiration, stenosis of the fistula (Snyderman, 1991) and 
poor voice outcome because the fistula was too small (Snyderman, 1991) 
 
The use of mucosal or skin fistula techniques were limited by aspiration (Bien et al., 
2008) stenosis or closure of fistula (Snyderman, 1991), wound failure and inconsistent 
voice quality (Perry, 1983).  While some of these techniques were often effective in 
the hands of the surgeons who designed them, they could be difficult to perform and 
replicate (Deshpande, 2010) 
 
Concern with the high rate of failure with mucosal and skin fistulas led to a renewed 
interest in the development of voice prostheses 
 
 
1.4. Voice prosthesis development in the late 20th century 
 
In 1972, Taub and Spiro introduced an external voice prosthesis, the “Voice Bak” 
(Taub and Spiro, 1972).  This was the first commercially available voice prosthesis 
(Snyderman, 1991).  This prosthesis was fitted into a surgical fistula created between 
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the trachea and lateral wall of the hypopharynx or cervical oesophagus (Taub and 
Spiro, 1972).  The Voice Bak had a built in valve that stayed open during normal 
breathing.  However, on forced expiration, the valve closed directing air into the PE 
segment, causing a vibration and the production of sound.  The Voice Bak was a 
bulky prosthesis and required frequent cleaning and adjustment.  It’s use was also 
limited by the prohibitive cost of the device and unsuitability for irradiated patients 
(Taub and Spiro, 1972).   
 
The concept of a miniaturised voice prosthesis was introduced by Mozolewski in 
Poland in 1972 (Bien et al., 2008).  Mozolewski described using a 5mm diameter 
piece of polyvinyl tubing with a 0.007mm thick piece of polyethylene foil welded to 
the inside of the polyvinyl tubing to form a simple voice prosthesis.  Mozolewski’s 
technique involved placing the voice prosthesis in a fistula above the tracheostoma 
using a retrograde insertion technique (introducing the prosthesis through the mouth, 
guiding it through the reconstructed throat and pulling it through the tracheosphageal 
fistula from the oesophageal side).  Mozolewski’s device remained in use until the 
late 20
th
 century in parts of Poland.  However, attempts to popularise this work 
internationally were limited by papers describing his techniques being written in 
Polish rather than English and by the political barriers that existed at the time. 
 
In 1979, Dr Eric Blom, a Speech Pathologist and Dr Mark Singer introduced a 
surgical method of voice restoration that has become the gold standard for voice 
rehabilitation after laryngectomy and a voice prosthesis that has stimulated the 
development of other similar devices.  The voice prosthesis developed was a one-way 
valve that allowed inspired air to be shunted from the lungs into the oesophagus and 
then via the PES, which vibrated to produce voice.  The Blom Singer voice prosthesis 
was placed in the puncture site between the trachea and oesophagus created using an 
endoscopic technique.  The procedure was initially designed as a secondary and 
separate procedure to laryngectomy surgery.  The procedure and the Blom Singer 
prosthesis rapidly became the intervention of choice for voice restoration after 
laryngectomy and is the method of communication post laryngectomy that most 
closely approximates normal laryngeal voice (Elmiyeh et al., 2010).   
 
70 
 
 Several crucial factors contributed to the longevity of success of the Blom Singer 
voice prosthesis and subsequent similar voice prostheses compared with those 
previously described in this chapter.  These factors are described below: 
 
1.  Use of a surgically created puncture rather than a fistula 
Dr Blom and Dr Singer were inspired by a report of a Chicago butcher with a 
laryngectomy (Woods, 1980).  Based on this individual’s intimate knowledge of 
anatomy, he used an ice pick to create a puncture between the trachea and 
oesophagus.  Voicing was achieved by covering the stoma and redirecting air to the 
vibratory segment to produce sound.  Crucially, the butcher used a quill to keep the 
puncture open and in this way prevented stenosis.  Many of the previously described 
techniques used a surgically created fistula as opposed to a puncture.  The properties 
of a puncture allowed tissue to close down around a device and retain it.  In contrast, a 
fistula may not retain a device effectively and could stenose or enlarge with the latter 
potentially resulting in aspiration.   
 
2.  Use of silicone as a material 
Another important consideration for Dr Singer and Dr Blom was the application of 
silicone for the development of medical devices.  Silicone became commercially 
available in the 1940s (Colas and Curtis, 2004), and in contrast to materials used in 
previously developed voice prostheses, had several properties that facilitated its 
application to medical devices.  These include biocompatibility (ability of a material 
to have a minimal adverse effect on a host) and bio durability (ability of the host to 
have a minimal impact on the biomaterial) (Colas and Curtis, 2004).  In addition, 
silicone’s chemical stability and elastic nature made it suitable for long term 
implantation in humans as described in relation to bile duct repair (Lahey, 1946).  
Another early medical application of silicone included the Holter hydrocephalus shunt 
(Baru et al., 2001, Carrington, 1959), a one way valve shunt catheter with a valve that 
allowed excess cerebrospinal fluid to be drained but closed to prevent backflow when 
the pressure equalised (Colas and Curtis, 2004).  By the 1970’s silicone was being 
used in numerous medical applications such as kidney dialysis components, heart 
valves and breast implants. 
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3.  Lack of complications 
Creating a puncture between the trachea and oesophagus avoids injury to the great 
vessels of the neck (Snyderman, 1991).  Skin and mucosal fistulas previously 
described in this chapter were often complicated by stenosis or closure of the fistula.  
The development of silicone voice prosthesis as opposed to an internal skin or 
mucosal lined shunt maintained patency of the puncture and prevented stenosis 
(Snyderman, 1991, Perry, 1983).  The frequent forward displacement and 
expectoration of early Blom Singer devices was ameliorated through the introduction 
of an oesophageal flange that retained the device in the oesophagus.  Inward 
displacement of the prosthesis into the oesophagus was similarly solved with the early 
addition of a tracheal flange.  Aspiration was prevented through use of a one-way 
valve design that opened to allow air to reach the vibratory segment to produce voice 
but effectively stayed shut during swallowing to prevent aspiration of food or liquid 
into the trachea.  Early duckbill designs featured a slit in the rounded oesophageal end 
of the voice prosthesis that opened for voicing and remained shut during swallowing.  
Development of the low-pressure device resulted in an alternate hinged valve that 
required lower pressure to open for voicing and remained shut during swallowing. 
 
4.  Simplicity of design 
The design of the Blom Singer enabled it to be placed easily by a clinician in an 
anterograde fashion.  This method enabled the prosthesis to be inserted into the 
proximal or tracheal part of the tracheoesophageal fistula through the trachestoma.  
Retrograde insertion methods involve the prosthesis being placed through the oral 
cavity and pulled out through the distal or oesophageal part of the tracheosophageal 
fistula, often under anaesthesia (Deshpande, 2010) Use of an anterograde insertion 
method facilitated placement and removal of the prosthesis within a clinic setting 
without the need for anaesthesia.  This simplicity of placement also facilitated some 
patients with adequate visual, fine motor and cognitive skills to develop the ability to 
self-change their own voice prosthesis and therefore experience an increased level of 
independence after laryngectomy surgery. 
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5.  Cost effectiveness and ease 
The Blom Singer voice prosthesis was relatively inexpensive (Snyderman, 1991, 
Perry, 1983) and therefore accessible to more patients compared to previous 
prostheses such as the Voice Bak. 
 
 
1.5. Modifications to the Blom and Singer method 
 
The success of the Blom Singer voice prosthesis generated the development of 
alternate devices.  Most of these devices employed similar principles to the Blom 
Singer voice prosthesis.  These devices are described below. 
 
1.5.1. Panje method 
 
The Panje voice button was developed by an Iowa surgeon, Dr William Panje (Panje, 
1981, Panje et al., 1981).  This system was similar to that of Blom and Singer in that a 
one way silicone voice prosthesis was placed within a tracheoesophageal puncture to 
enable air to be redirected to the vibratory segment within the reconstructed throat to 
produce sound.  However, in contrast to the Blom Singer method, the 
tracheoesophageal puncture was made specifically at the level of the anterior 
midpoint of the oesophagus, slightly inferior to that of the Blom Singer approach.  
Panje indicated that tracheoesophageal wall at this level was a standard thickness in 
all patients so the Panje voice button came in one size only obviating the need for 
measuring the puncture.  Passage of redirected air was achieved in Panje’s voice 
prosthesis through a slit opening in the rounded oesophageal end of the device again 
similar to that of Blom and Singer’s device.  However, Panje’s technique differed to 
that of Blom and Singer in that the puncture was made at the time of laryngectomy 
surgery and stented open by placing a rubber catheter through the tracheoesophageal 
puncture and directing this catheter towards the stomach.  The proximal end of the 
catheter is tied in a knot to prevent regurgitation of stomach fluids and taped to the 
neck adjacent to the stoma.  Approximately 7-14 days after surgery, the patient 
returns to clinic to have the voice button fitted.  The Panje voice prosthesis had to be 
removed for cleaning on a daily basis by the patient, which was thought to lead to 
73 
 
irritation of the puncture site and eventual thickening of the tracheosophageal wall 
(Perry, 1983) 
 
1.5.2. Groningen method   
 
The Groningen voice prosthesis was introduced in 1982 in the Netherlands (Nijdam et 
al., 1982).  This was a silicone one-way valve that was placed into a 
tracheoesophageal puncture and produced voice in a similar manner to the Blom 
Singer and Panje devices.  Like both of the aforementioned devices, the Groningen 
featured a slit opening in the rounded oesophageal end of the device.  The Groningen 
offered an advantage over the Blom Singer and Panje voice prostheses in that it could 
be placed whilst the tracheosophageal puncture was created either during or after 
laryngectomy surgery (Annyas et al., 1984).  Primary placement of the voice 
prosthesis prevented the need for the puncture site to be stented open for a period of 
time after surgery.  In addition, the Groningen was also notable as the first voice 
prosthesis designed to stay in situ for a number of weeks without having to be 
removed for cleaning.  This kind of voice prosthesis became known as an 
“indwelling” that was changed only by a trained clinician rather than the patient 
themselves. 
 
1.5.3. Low pressure voice prostheses 
 
As voice prostheses (Panje, Blom Singer and Groningen) became used more 
frequently, there was recognition that some patients required a lot of effort to produce 
voice.  These patients were considered to have high airway resistance.  Airway 
resistance has been defined as the opposition that voice prostheses placed in the 
tracheosophageal puncture offer to the flow of air through them to produce voice 
(Weinberg and Moon, 1986b).  In order to solve this problem, a number of “low 
pressure” voice prostheses were developed, low pressure Panje voice button 1985, 
low pressure Blom Singer 1985, Bivona low pressure voice prosthesis (Weinberg and 
Moon, 1984)   
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1.5.4. Provox method 
 
A self-retaining low resistance voice prosthesis was developed by Hilgers in 1990 
(Hilgers and Schouwenburg, 1990a).  This voice prosthesis was made of silicone and 
placed in a tracheoesophageal puncture.  Placement of the indwelling voice prosthesis 
took place at the time of surgery.  Retrograde placement of the voice prosthesis was 
achieved using a guide wire placed in the tracheosophageal puncture and pushed into 
the oral cavity.  The voice prosthesis is then connected to the guide wire and pulled 
through the puncture site. 
 
Laryngectomy patients require a new vibratory source to communicate after 
laryngectomy.  This source may be provided mechanically (electrolarynx or artificial 
larynx) or by physiologically vibrating tissue within the reconstructed throat after 
laryngectomy.  This physiological area of vibration is known as the 
pharyngoesophageal (PE) segment and provides a more natural sounding sound that 
that made through mechanical means.  Some patients self-vibrate the PE segment to 
produce sound by learning oesophageal speech.  However, oesophageal speech can be 
difficult to learn for some patients and others may have physiological constraints that 
prevent the effective use of oesophageal speech.  Several options for stimulating 
physiological vibration of the PE segment through surgical means (mucosal and skin 
lined fistulae) and through early voice prosthesis use (Gussenbauer and Caselli) have 
been described.  The continued development of voice prosthesis in the late 20
th
 
century culminated in the Blom Singer device.  This miniaturised voice prosthesis 
benefitted from the development of silicone, a material suitable for implantation in the 
human body.  In addition the innovation of using a puncture rather than a fistula 
between the trachea and oesophagus for placement of the Blom Singer voice 
prosthesis ensured effective retention of the prosthesis and prevented leakage and 
aspiration.  The Blom Singer prosthesis was subsequently modified and developed by 
the inventors of the device and other companies to provide the array of effective 
devices available to laryngectomy patients today. 
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1.6. Outcomes after treatment for advanced laryngeal cancer 
 
Outcome research has been defined as the study of the end result of the provision of 
health services and interventions which provides scientific evidence for decisions 
made by all who participate in healthcare, including patients (Clancy and Eisenberg, 
1998).  Health outcomes can include the following (Clancy and Eisenberg, 1998): 
 Objective measures of disease processes (e.g. blood sugar measurements in 
diabetes)   
 Survival after intervention (e.g. surgery to remove a life threatening advanced 
cancer 
 Quality of life (the satisfaction and wellbeing that an individual experiences 
on daily basis) 
 Subjective measures of illness or psychosocial adjustment (e.g. patient self-
report of coping, anxiety or depression) 
 Functional status (ability to perform tasks of everyday life) 
 Cost  
 Compliance (ability of the patient to adhere to recommendations of health 
professionals) 
The next section will examine two of the most important outcomes in relation to post 
laryngectomy patients: survival and quality of life.   
 
 
1.6.1. Survival 
1.6.1.1. Non-surgical organ preservation vs. Total laryngectomy 
 
The main endpoints of interest in clinical trials and in the treatment of cancer are 
treatment response and survival (Oeffinger et al., 2011).  Survival or quantity of life 
(Terrell et al., 1998) outcomes have been considered to be a more traditional measure 
(Hanna and Sherman, 1999) than quality of life and function.  For some time survival 
was the only objective measure in the field of oncology research (Bindewald et al., 
2007).  Survival remains the most important measure of laryngeal cancer treatment 
(Bindewald et al., 2007) and has strongly influenced patterns of management 
particularly with regard to the question of organ preservation vs. non organ 
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preservation (laryngectomy).  The organ preservation vs. non-organ preservation 
debate in advanced laryngeal cancer was initially focused on survival outcomes but 
soon provided a strong impetus for the development of quality of life scales as a 
means of comparing different interventions.  Non-surgical organ preservation is 
particularly relevant to this study because of the high number of patients initially 
treated with this approach that then went on to have salvage laryngectomy surgery.  In 
this section, I will discuss survival outcomes within the context of non-surgical organ 
preservation.   
 
Until the early 1990’s advanced laryngeal cancer was treated primarily with 
laryngectomy or laryngectomy and post-operative radiotherapy resulting in 5 year 
survival rates of 0-50% (Shah and Tollefsen, 1974, Hawkins, 1975, Jesse, 1975, Wolf 
et al., 1991).  In the early 1980’s, investigators (Decker et al., 1983, Ensley et al., 
1984) discovered that cisplatin and infusional 5 fluorouracil, as induction 
chemotherapy in previously untreated head and neck cancer patients was associated 
with a response rate as high as 94%.  In addition, those patients with a good response 
to induction chemotherapy proved to be good candidates for subsequent radiotherapy.  
The addition of platinum based chemotherapy before radiotherapy (induction 
chemotherapy) emerged as a treatment for advanced laryngeal cancer in the late 
1980s (Schuller et al., 1988, Price et al., 1985).  Induction chemotherapy and 
radiotherapy regimes appeared to result in a high rate of tumour regression and 
survival comparable to surgery without the significant anatomical alterations of the 
latter.   
 
1.6.1.2. First generation of non-surgical organ (larynx) preservation research - 
Impact of induction chemo radiation on survival 
 
A seminal multi institutional clinical study (Wolf et al., 1991) from the Department of 
Veteran Affairs Laryngeal Cancer Study Group (VALG) involved the randomisation 
of 332 subjects with stage III or IV laryngeal cancer to two groups: (i) Induction 
chemotherapy followed by radiotherapy (organ preservation), (ii) Surgery (mostly 
total laryngectomy) followed by radiotherapy (non organ preservation).  
Chemotherapy for group (i) consisted of cisplatin followed by fluorouracil for 5 days 
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and was repeated on days 22 and 43.  Tumour response to chemotherapy was 
evaluated with indirect laryngoscopy on days 18-21.  Subjects with at least a partial 
response at primary tumour site and no progression of neck adenopathy progressed to 
3
rd
 cycle of chemotherapy.  Subjects without at least a partial response to 
chemotherapy underwent surgical resection and postoperative radiotherapy.  On 
completion of 3 cycles of induction chemotherapy, a direct laryngoscopy, tumour 
assessment and biopsy of primary tumour area were performed to assess histological 
response to treatment.  All patients received radiotherapy either after chemotherapy or 
after surgery.  Definitive radiotherapy consisted of 6600-7600Gy to the primary 
tumour site.  12 weeks after radiotherapy, tumour response was assessed with direct 
laryngoscopy.  Patients with persistent disease in the larynx underwent salvage 
laryngectomy whereas those with persistent neck disease, but control of primary 
tumour, underwent neck dissection alone.  Surgery for group (ii) consisted of a wide 
field laryngectomy except for rare instances where a supraglottic primary tumour 
could be resected adequately with a horizontal partial laryngectomy. 
 
The 2 year overall survival rate for both groups was 68% with cancer being the most 
frequent cause of death.  The larynx was successfully preserved in 107 (64%) of 
subjects assigned to group (i) induction chemotherapy followed by radiotherapy.  59 
subjects (35.5%) required total laryngectomy, 30 before definitive radiotherapy and 
29 after radiotherapy.  Late salvage laryngectomy for recurrent cancer was required in 
11 additional subjects from group (i). 
 
This landmark study indicated that a treatment strategy involving induction 
chemotherapy and definitive radiotherapy was effective in preserving the larynx in a 
high percentage of patients (64%) without compromising overall survival rates.  The 
findings of this study led to the global adoption of organ preservation strategies using 
chemo radiotherapy to treat advanced laryngeal cancer (Robertson et al., 2011, 
Nakayama et al., 2012, Stenson et al., 2012, Nguyen et al., 2012a).  This treatment 
strategy was based on the hypothesis that cure was achievable while avoiding radical 
surgery (Robertson et al., 2011).  Laryngectomy surgery was thus reserved as a 
salvage technique for those who failed initial chemo radiation.   
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The case for organ preservation in advanced laryngeal cancer was further 
strengthened by long term follow up data from the Department of Veteran Affairs 
Laryngeal Cancer Study trial (Hillman et al., 1998).  Functional outcomes were 
compared for 166 subjects in the initial study (Wolf et al., 1991) who received (i) 
induction chemotherapy followed by radiotherapy (organ preservation) and 166 
subjects in the initial study who received (ii) laryngectomy surgery and post-operative 
radiotherapy (non organ preservation) at a median of 5 years after treatment.  Results 
suggested that the group (i) induction chemotherapy followed by radiotherapy had 
better intelligibility and communication scores than group (ii) laryngectomy surgery 
and post-operative radiotherapy group (Hillman et al., 1998) although there were few 
differences between groups for the non-speech related items of swallowing, eating 
and employment status.  The second part of the same study focused on 
communication related outcomes for laryngectomy surgery and postoperative 
radiotherapy therapy group.  The majority of the group were found to use an electro 
larynx (55%) or tracheosophageal speech (31%) for communication.  8% were non-
vocal and 6% used oesophageal speech.  The relevance of this follow up data to 
current laryngectomy rehabilitation has been questioned (Robertson et al., 2011) 
given that less than a third of the surgery group in the VA study achieved 
tracheoesophageal speech (Robertson et al., 2011) compared to modern practice 
levels of over 90% (Frowen and Perry, 2001) 
 
The findings of several studies in the 1990s suggested that combined chemo radiation 
protocols were resulting in a significant impact on specific aspects of health related to 
head and neck cancer such as oropharyngeal swallowing motility and efficiency 
(Lazarus et al., 1996), inability to eat a normal solid diet (List et al., 1997), 
xerostomia (List et al., 1997), depression (List et al., 1997) and pain (Pfister et al., 
1995).  However, multidimensional quality of life studies of organ preservation 
protocols in head and neck cancer, and specifically in laryngeal organ preservation, 
were hampered by the lack of a well validated instrument for measurement (Terrell et 
al., 1998).  The Head and Neck Quality of Life instrument (HNQRL) (Terrell et al., 
1997) was developed and validated to meet this need.  The HNQRL contains 20 
questions on head and neck cancer symptoms that generate scores for 4 domains of 
quality of life: communication, eating, pain and emotional wellbeing (Terrell et al., 
1997).  The development of HNQRL reflected the increasing understanding and 
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acceptance that not only was survival important for head and neck cancer patients, but 
the ability to live life with a sense of wellbeing and satisfaction was also equally 
important.  The HNQRL was an early quality of life tool used with laryngeal cancer 
patients and was an instrumental part of the 10-year VALG follow up study described 
below. 
 
The objective of the 10 year follow up study (Terrell et al., 1998) was to assess long 
term quality of life in surviving patients with advanced laryngeal cancer from the 
original Department of Veteran Affairs Laryngeal cancer study group (Wolf et al., 
1991).  71% (46) of the 65 surviving patients who could be reached from the original 
study participated in the 10-year follow up.  There were 76 known survivors from the 
original study.  21 were from group (i) induction chemotherapy and radiotherapy 
(organ preservation) and 25 from group (ii) Surgery and postoperative radiotherapy 
(non-organ preservation).  All subjects completed the University of Michigan Head 
and Neck Quality of Life instrument (HNQRL) (Terrell et al., 1997), Medical 
Outcomes Studies Short Form 36 (SF-36) (Ware et al., 1993), general health survey, 
Beck Depression Inventory (Beck and Beamesderfer, 1974) as well as smoking and 
alcohol consumption surveys.  In terms of quality of life, subjects originally 
randomised to group (i) induction chemotherapy and radiotherapy (organ 
preservation) had both significantly better QOL scores on the SF-36 mental health 
domain and HNQRL pain scores than subjects originally randomised to group (ii) 
Surgery (mostly total laryngectomy) and post-operative radiotherapy.  With regard to 
quality of life, when subjects who had undergone a laryngectomy (33) were compared 
with those with an intact larynx (13), the latter had significantly less bodily pain, 
better scores on the SF-36 mental health and better HNQOL emotion scores.  Mean 
speech domain scores on the HNQOL instrument were similar for both laryngectomy 
subjects and subjects with a preserved larynx in contrast to the five year follow up 
study (Hillman et al., 1998) which demonstrated better intelligibility and 
communication in those with a preserved larynx.  In the 10 year follow up 
study(Terrell et al., 1998) most of the laryngectomy group had a means of artificial 
voice allowing them to communicate reasonably well.  This may have accounted for 
the similar mean communication scores attained on the HNQOL for both 
laryngectomy and larynx preserved subjects.  In addition, the long-term laryngectomy 
subjects may have had time to adjust and become less bothered by difficulties with 
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volume and overall clarity.  Finally, it is possible that the speech differences are 
minimal between both groups because they both have substantial difficulty with 
communication.  28% of the laryngectomy subjects were depressed compared with 
15% of those with an intact larynx.  It is notable that of all the study subjects 
evaluable at 10 year follow up, 22.5% (n-10) had moderate to severe depression and 9 
of those were laryngectomy patients. 
 
The initial Department of Veteran Affairs Laryngeal Cancer Study Group study (Wolf 
et al., 1991) randomising advanced laryngeal cancer patients to an organ preservation 
or non-organ preservation was ground-breaking in its effect on the management of 
advanced laryngeal cancer.  This study established that response to adjuvant 
chemotherapy could be used as a biomarker to selecting which subjects with 
advanced laryngeal cancer were likely to benefit from organ preservation using 
chemo radiation techniques (Wolf, 2010).  The subsequent 5 year follow up study 
(Hillman et al., 1998) was equally influential for its focus on functional outcomes and 
the finding that intelligibility and communication was better for those who had 
undergone organ preservation compared with total laryngectomy.  The 10 year follow 
up study (Terrell et al., 1998) acknowledged the importance of quality of life when 
evaluating long term outcomes in organ preservation vs.  non organ preservation 
protocols and highlighted the increase in depression and poorer emotional scores in 
laryngectomy patients.  The long-term patient oriented data showed similarities 
between speech production in those with a preserved larynx and those with a 
laryngectomy.  This resulted in a re-evaluation of a classic study (McNeil et al., 1981) 
indicating that prospective advanced laryngeal cancer patients would trade off 
quantity of life or survival because of an expected decrease in quality of life and 
communication after laryngectomy surgery compared with chemo radiation to 
preserve the larynx.   
 
While the VALG studies focused on the outcome of organ preservation techniques in 
laryngeal cancer, a series of studies (Lefebvre et al., 1996, Lefebvre et al., 2012) 
investigating organ preservation for hypo pharyngeal cancer were also published by 
the European Organisation for Research and Treatment of Cancer (EORTC) group.  
Hypo pharyngeal cancer is an aggressive cancer that generally presents at an 
advanced stage.  As the hypo pharynx includes the piriform sinus, the posterior 
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cricoid area and shares a wall with the larynx, the larynx may need to be sacrificed in 
the case of advanced disease (Chung et al.) 
 
The preliminary study from the EORTC group (Lefebvre et al., 1996) compared an 
organ preservation approach to laryngectomy surgery for T2, T3, and T4 squamous 
cell carcinoma of the piriform sinus or hypo pharyngeal aspect of the ariepiglottic 
fold.  194 patients were eligible for randomisation to (i) Chemo radiation group and 
(ii) Surgery group.  Group (i) Patients had up to 3 cycles of induction chemotherapy.  
If a complete response occurred, then the patient progressed to radiotherapy, 
otherwise they were conventionally treated with surgery.  Group (ii) Patients 
underwent total laryngectomy with partial pharyngectomy and partial closure 
followed by radiotherapy.  All 100 subjects randomised to the chemo radiation group 
were analysed despite 3 subjects not starting chemotherapy because of refusal or 
unsuitable medical condition.  Similarly, all 94 subjects randomised to the surgery 
group were analysed despite 2 subjects not undergoing surgery because of inoperable 
medical conditions.  Median follow up time was 51 months (range 3-106 months), 
which was considered by the authors as a sufficient length of time for evaluation of 
outcomes in hypo pharyngeal cancer.  At the time of analysis, survival rate in the 
chemo radiation group was 39% and 41% in the surgery group.  However, median 
overall survival duration was longer in the chemo radiation group (44 months) than in 
the surgical group (25 months).  It was noted that 14% of the chemo radiation group 
had limiting toxic side effects during treatment including one fatality.  This study 
concluded that laryngeal preservation appeared feasible without jeopardising survival. 
 
The second EORTC study (Lefebvre et al., 2012) undertook a 10.5 year median 
follow up of the original data (Lefebvre et al., 1996).  The 10 year overall survival 
rate was 13.1% in the chemotherapy group and 13.8% in the surgery group.  The 
overall difference in median survival seen in the previous study (Lefebvre et al., 
1996) disappeared in the 10 year follow up study mainly due to the appearance of 
distant metatheses, which were delayed in the chemo radiation group.  This study 
concluded that laryngeal preservation did not compromise disease control or survival 
with over half the survivors (5 out of 8) in the chemo radiotherapy group retaining 
their larynx without local disease evolution, tracheotomy or feeding tube.   
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Both the initial EORTC study (Lefebvre et al., 1996) and the follow up EORTC study 
(Lefebvre et al., 2012) supported the use of laryngeal preservation with the finding of 
similar 10 year survival rates between the chemo radiation group and the surgery 
group.  The toxic side effects of chemo radiation were highlighted (Lefebvre et al., 
1996) with the authors indicating that acute toxicities can compromise tolerance and 
compliance with treatment whereas later toxicities may compromise the reliability 
and feasibility of salvage surgery. 
 
The discovery of platinum and fluorouracil as effective chemotherapy agents in the 
treatment of head and neck cancer (Decker et al., 1983, Ensley et al., 1984) led 
directly to the development of organ preservation as an alternative treatment paradigm 
to laryngectomy for patients with laryngeal cancer.  Both the VALG (Wolf et al., 
1991) and EORTC (Lefebvre et al., 1996) trials were large randomised studies 
signifying the first generation of organ preservation research comparing conventional 
treatment (total laryngectomy and post-operative radiotherapy) with an experimental 
approach of induction chemotherapy using platinum and fluorouracil followed by 
radiotherapy for those with a complete or partial response to chemotherapy.  Those in 
the experimental arm with no change or progressive disease following induction 
chemotherapy went on to receive surgery and post-operative radiotherapy in both 
studies.  While the VALG study was concerned with organ preservation in laryngeal 
cancer and the EORTC study focused on organ preservation in hypo pharyngeal 
cancer, both studies found that the experimental approach of induction chemotherapy 
followed by radiotherapy did not compromise disease control or survival and that it 
was possible to preserve the larynx in 40-60% of patients (Lefebvre et al., 2009).  The 
significant influence of the VALG study in particular, (Wolf et al., 1991) and the 
emergence of an evidence base for induction chemotherapy followed by radiotherapy 
in laryngeal cancer, placed the concept of organ (larynx) preservation at the forefront 
of clinical care in the 1990s.  In addition the 5 and 10 year follow up VALG studies 
(Hillman et al., 1998, Terrell et al., 1998) initiated a move away from disease survival 
and larynx preservation as the only meaningful outcomes of treatment to an emphasis 
on functional outcomes and quality of life. 
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1.6.1.3. Second generation of non-surgical organ (larynx) preservation research  
Impact of alternative methods of chemo radiation techniques on survival 
 
Following publication of the VA study, induction chemotherapy followed by 
radiotherapy became the standard alternative to total laryngectomy for patients with 
locally advanced laryngeal cancer (Forastiere et al., 2003).  As the value of adding 
chemotherapy to radiotherapy and the optimal timing of chemotherapy was unknown, 
the second generation of laryngeal preservation trials emerged.  These trials 
questioned the use of induction chemotherapy and looked to alternative options such 
as concurrent chemotherapy, alternating cycles of chemotherapy and radiotherapy and 
the use of chemotherapy alone.  The results of these studies are discussed: 
 
The Radiation Therapy Oncology Group (RTOG) in the US reported on a randomised 
trial (Forastiere et al., 2003) which compared the rates of laryngeal preservation 
associated with three laryngeal preservation treatment groups.  547 subjects were 
randomised to the following groups: (i) induction chemotherapy (cisplatin plus 
fluorouracil) followed by radiotherapy if there was a response to chemotherapy, (ii) 
radiotherapy with concurrent administration of cisplatin and (iii) radiotherapy alone.  
Although overall survival rates were similar for all groups, the proportion of patients 
who had an intact larynx at 2 years post treatment was best for group (ii) radiotherapy 
with concurrent cisplatin at 88% compared to 75% for group (i) induction 
chemotherapy followed by radiotherapy and 70% for group (iii) radiotherapy alone.  
Mucosal toxicity of concurrent radiotherapy and cisplatin was nearly twice as 
frequent as the mucosal toxicity of the other two treatments during radiotherapy and 
probably contributed to the delayed recovery of swallowing in this group.  Despite the 
toxicities encountered, this study recommended that radiotherapy with concurrent 
cisplatin should be considered standard care for patients with an appropriate disease 
stage (T2, T3, low grade T4) who desired laryngeal preservation.  This study led to a 
change in the treatment paradigm for larynx preservation from induction cisplatin and 
fluorouracil followed in good responders by radiotherapy, to concomitant cisplatin 
and radiotherapy. 
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A follow up study (Forastiere et al., 2013) to the initial RTOG study (Forastiere et al., 
2003) was recently published.  Follow up of 547 subjects took place at a median of 
10.8 years.  Only 11.7% of the initial group were alive at the time of 10 year of follow 
up study.  One subject withdrew consent and 26 were declared retrospectively 
ineligible leaving a total of 520 eligible subjects for analysis from the initial study.  
174 in group (i) induction chemotherapy (followed by radiotherapy if there was a 
response to chemotherapy), 174 in group (ii) concomitant chemo radiotherapy and 
172 in group (iii) radiotherapy alone.  Subcutaneous, salivary gland, pharynx, 
oesophagus and larynx toxicities were the most frequent serious events and were 
found to have led to fatalities in all 3 groups.  A total of 148 subjects had undergone 
laryngectomy with laryngeal preservation rates of 67.5% in group (i) induction 
chemotherapy, 81.7% in group (ii) concomitant chemo radiotherapy, 63.8% in group 
(iii) radiotherapy alone.  Speech and swallowing were reported in surviving subjects 
who were disease free with a larynx during years 2 to 5.  Impaired speech quality 
fluctuated from 3%-9% in group (i) induction chemotherapy, 4%-8.5% in group (ii) 
concomitant chemo radiotherapy and 5%-8.5% in group (iii) radiotherapy alone.  
Swallowing dysfunction (can only swallow soft foods or worse) was also reported for 
each group during years 2 to 5.  Swallow dysfunction fluctuated from 13%-14% for 
group (i) induction chemotherapy, 17%-24% for group (ii) concomitant chemo 
radiotherapy and 10%-17% for group (iii) radiotherapy alone.  The authors note that 
interpretation of impaired speech and swallow dysfunction percentages is limited 
because of both diminishing numbers of subjects and missing subjects.  Nonetheless, 
no substantive difference in quality of speech and swallow function is shown based on 
treatment group.  Overall survival did not differ significantly although there was a 
possibility of worse outcome in the group (ii) concomitant chemo radiotherapy group 
(28% at 10 years) relative to group (i) induction chemotherapy group (39% at 10 
years).  Overall, the 10-year results shown in this study show that induction 
chemotherapy followed by radiotherapy and concomitant chemo radiotherapy show 
similar efficacy for laryngectomy free survival.  Larynx preservation is significantly 
improved with concomitant chemotherapy compared with group (i) or (iii). 
 
The European Organisation for Research and Treatment of Cancer (EORTC) 24954 
randomised phase 3 trial was a collaboration between the EORTC Head and Neck 
cancer cooperative group and the EORTC Radiation Oncology group (Lefebvre et al., 
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2009).  450 subjects with advanced primary SCC of the larynx (T2-4) or hypo 
pharynx (T2-4) that would have required a total laryngectomy +/- partial 
pharyngectomy with primary closure under standard practice were recruited.  Subjects 
were randomised to two groups (i) Sequential schedule– 4 cycles of chemotherapy 
(cisplatin and 5 fluorouracil) followed by radiotherapy (ii) Alternating schedule – 4 
cycles of chemotherapy (cisplatin and 5 fluorouracil) and 3 x 2 week courses of 
radiotherapy each of 20 gy.  Radiotherapy was given in the 2-week intervals between 
chemotherapy cycles to those subjects who had responded to 2 cycles of cisplatin and 
fluorouracil.  Median follow up was 6.5 years.  5 year overall survival rate was 48.5% 
in the sequential group and 51.9% in the alternating group.  5-year survival with a 
functional larynx was 30.5% in the sequential group and 36.2% in the alternating 
group.  Acute toxic effects (grade 3-4 mucositis) were statistically higher in the 
sequential group (32%) than in the alternating group (21%).  This can be accounted 
for by the higher median dose of 71.5gy of radiotherapy received by the sequential 
group compared to median dose of 62.8 gy received by the alternating group.  
However, late mucosal tissue sequelae (necrosis, oedema), late connective tissue 
sequelae (fibrosis, sclerosis) and later nervous system sequelae (neuropathy) were 
similar in both groups.  This group concluded that larynx preservation, progression 
free interval and overall survival in both sequential and alternating groups were 
similar as were acute and late toxic effects and suggested that the optimal approach 
for laryngeal preservation has not yet been identified. 
 
A randomised phase III trial (Pointreau et al., 2009) was carried out by the French 
Head and Neck Oncology Radiotherapy Group to investigate whether the addition of 
docetaxel (T) to cisplatin (P) and 5 Fluorouracil (F) in an induction chemotherapy 
regime followed by radiotherapy would improve laryngeal preservation.  Subjects 
were randomised to induction chemotherapy with TPF (docetaxel, cisplatin and 5 
Fluorouracil) or induction chemotherapy with PF (cisplatin and 5 Fluorouracil).  
Preliminary findings have shown higher rates of laryngeal preservation with the 
induction TPF regime probably due to better response rate from the induction regime 
of 80% with TPF compared to 59% with PF.  The Radiotherapy Oncology Group 
(RTOG) (Ang et al., 2011) investigated concomitant cisplatin and radiotherapy with 
and without cetuximab in stage III/IV head and neck cancer.  The addition of 
cetuximab did not improve progression free or overall survival. 
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One study (Divi et al., 2010) hypothesised that treating advanced laryngeal cancer 
with chemotherapy alone in patients with highly chemo sensitive tumours could avoid 
the side effects of radiotherapy and result in improved swallow and voice outcomes.  
A complete histologic tumour response occurred in only 4 of 32 patients and these 
patients were initially treated with chemotherapy alone without initially requiring 
further intervention.  All 4 subsequently experienced recurrence and were treated with 
surgery and postoperative radiotherapy.  The authors concluded that treating advanced 
laryngeal cancer with chemotherapy alone was not feasible for long term control of 
regional disease.   
 
 
A recent study (Dziegielewski et al., 2012) compared  2 and 5 year survival rates in 3 
categories of subjects with T3/T4 tumours:  total laryngectomy with chemo 
radiotherapy, radiotherapy only and chemo radiotherapy.  The total laryngectomy 
with chemo/radiotherapy group had the best survival rates for 2 and 5 years at 89% 
and 70% respectively.  The chemo radiotherapy group had 2 and 5-year survival rates 
of 66% and 52% respectively while the radiotherapy only group had the worst 2 and 
5-year survival rates at 48% and 18% respectively.  The authors (Dziegielewski et al., 
2012) concluded that total laryngectomy surgery with radio/chemotherapy provided 
better survival for T3/T4a laryngeal cancer than organ preservation techniques of 
radiotherapy or chemo radiotherapy.   
 
The second generation of organ (larynx) preservation research was characterised by 
different studies in the US and Europe (Forastiere et al., 2003, Forastiere et al., 2013, 
Lefebvre et al., 2009) investigating which schedule of chemo radiation using cisplatin 
was optimum for providing laryngeal preservation with good survival and whether the 
addition of alternative chemo therapy agents (Pointreau et al., 2009, Ang et al., 2011) 
were more effective in controlling disease.  One study (Divi et al., 2010), which 
examined the possibility of providing chemo therapy alone found that this was not a 
feasible approach for the long term control of disease.  The ROTG study (Forastiere et 
al., 2003) was particularly influential in demonstrating the superiority of concomitant 
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chemo radiation over induction chemotherapy and radiation and radiation alone.  As a 
consequence, in the clinical arena, there was a move away from treatment of 
advanced laryngeal cancer with induction chemotherapy and radiation to concomitant 
chemo radiation techniques.   
 
 
1.6.1.4. Third generation of non-surgical organ (larynx) preservation research-   
Treating large volume disease and the emergence of new radiation therapy 
techniques 
 
Patients with large volume laryngeal locally advanced cancers e.g.  T4 with cartilage 
or tongue base invasion were not historically included in organ preservation trials 
(Stenson et al., 2012).  One of the reasons for this was the increased risks of 
metachronous (not synchronous) second primaries (Nakayama et al., 2012) (Yilmaz et 
al., 2005) when treating laryngeal cancer with cartilage invasion with chemo 
radiation.  There was also an assumption that patients with T4 laryngeal disease with 
cartilage invasion would have a non-functioning larynx following treatment with 
organ preservation techniques (Forastiere et al., 2003) because of the increased 
curative doses of chemo radiation required and the subsequent toxicities(Nguyen et 
al., 2012a, Daly et al., 2011).  These consequences included risk of 
chondroradionecrosis (Stenson et al., 2012), oedema and fibrosis (Nguyen et al., 
2012a) together with severely compromised communication and swallowing 
functions (Nguyen et al., 2012a).  The effect of such toxicities may potentially defeat 
the purpose of laryngeal preservation. (Sanguineti et al., 2007, Nguyen et al., 2007).  
As newer radiotherapy techniques emerged, these were also investigated as a means 
of reducing toxicity while maintaining effective disease control and survival. 
 
It has recently been demonstrated that chemo radiation can be a definitive option in 
patients with locally advanced head and neck cancer invading bony or cartilaginous 
structures (Samant et al., 2001) and locally advanced T4 laryngeal SCC with cartilage 
invasion (Worden et al., 2009).  A study (Stenson et al., 2012) of 80 subjects with 
large locally advanced laryngeal cancers (T4) treated with definitive intent concurrent 
chemo radiotherapy was recently undertaken.  55 of these subjects had large volume 
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disease involving extension of the tumour to at least one of the following: tongue 
base, soft tissues of the neck, oesophagus or cartilage erosion.  Two and five year 
survival rates for the group as a whole were 65.8% and 48.7% respectively whereas 2 
and 5 year survival rates for subjects with large volume disease were 68.3% and 
51.3%.  Swallowing function was examined in the 65 subjects who had pre-treatment 
videofluroscopic study to allow comparison with post swallow function.  Mean length 
of time between pre-treatment and post treatment videofluroscopies was 27.6 months.  
44 of these 65 subjects scored 5 or less indicating various degrees of swallowing not 
requiring a gastrostomy tube.  On the basis of these figures, a functional preservation 
rate of 67.7% was extracted despite the fact that lack of a gastrostomy tube does not 
necessarily indicate a functional swallow.  Post treatment 22 of these 65 required a 
tracheostomy and 6 of the 22 with a tracheostomy went on to require a salvage 
laryngectomy.  The study indicated that overall biology of the disease rather than 
extent of tumour plays a significant role in outcome in patients undergoing chemo 
radiation for T4 laryngeal tumours reflecting findings of a previous study (Worden et 
al., 2009).  This study (Stenson et al., 2012)concluded that chemo radiation represents 
an effective option for patients with locally advanced T4 laryngeal cancer, including 
those with large volume tumours, which provides satisfactory survival together with 
preservation of function.   
 
The introduction of newer 3D therapeutic radiation techniques such as Intensity 
Modulated Radiotherapy (IMRT) and image guided radiotherapy (IGRT) offers the 
potential to reduce toxicity by sparing dose to normal tissue (Nguyen et al., 2012b, 
Nguyen et al., 2011, Nguyen et al., 2012c) and theoretically increases feasibility for 
use with locally advanced T4 laryngeal cancer.  The Simultaneous Integrated Boost 
(SIB) use of IMRT and IGRT has been described (Nguyen et al., 2012a) as allowing 
selective assignment of the dose of treatment to different target levels so that the 
tumour receives the highest dose and subclinical disease a lower dose.  Thus, this 
technique allows greater control of the radiation dose received by normal tissues close 
to the targeted area of disease (Nguyen et al., 2012a).  Clearly defining tumour 
volume pre-treatment using positron emission tomography (PET) as opposed to the 
lesser quality CT scans is crucial to prevent marginal miss of disease (Nguyen et al., 
2012a).  27 subjects with locally advanced laryngeal cancer underwent concurrent 
chemo radiation using new tissue sparing radiotherapy techniques (Nguyen et al., 
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2012a).  19 had IGRT and 8 had IMRT radiotherapy techniques.  The laryngeal 
preservation rate was 89% and similar to the RTOG study group findings (Forastiere 
et al., 2003) despite the fact that most of the subjects in the latter had T2-3 laryngeal 
disease.  At median follow up of 20 months (range 6-27 months), 4 of the 27 (14.8%) 
developed local recurrence and underwent salvage laryngectomy.  Of the 23 subjects 
who preserved their larynx with no signs of recurrence, 95% reported normal or near 
normal voice.  However, toxicities were not avoided by IMRT and IGRT and of the 
23 subjects with a preserved larynx, 14.8% had severe dysphagia requiring long term 
tube feeding or chronic aspiration.  The study concluded that although new 
radiotherapy techniques such as IMRT and IGRT may be effective for anatomic and 
functional laryngeal preservation in patients with locally advanced laryngeal 
carcinoma, severe dysphagia and aspiration still remain limiting factors for surviving 
patients secondary to excessive radiation dose to the pharyngeal muscles. 
 
In contrast to (Nguyen et al., 2012a) another study (Miah et al., 2012) investigated the 
use of induction chemotherapy followed by dose escalated IMRT with concomitant 
chemotherapy in l laryngeal and hypo pharyngeal cancer (T1-4, N0-3, M0).  A 
sequential cohort phase I/II dose escalation design was employed.  Dose level 1 
(DL1) was designed as a feasibility study of hypo fractionated IMRT equivalent to 70 
gy in 35 fractions.  Dose escalation to Dose level 2 (DL2) represented an increase in 
biologically equivalent dose of 9% for the primary tumour (76gy).  There were 15 
subjects in each group, local control rates at 2 years were 70.8% in DL1 and 85.9% in 
DL2 with laryngeal preservation rates of 88.7% and 96.4%.  Results indicated high 
degrees of acute dysphagia, 59% in DLI and 87% in DL2.  Acute dysphagia was 
higher in DL2 and persisted for longer.  Mucositis, dermatitis, pain and fatigue were 
similar in both groups.  Xerostomia was higher in DL2 at 26% compared to DL1 
10%.  However high grade acute side effects did not translate to a higher incidence of 
long term toxicities The conclusions of this preliminary study is that dose escalated 
chemotherapy IMRT with moderate acceleration is safe, feasible and appears to 
improve locoregional control rates (Miah et al., 2012).  However this study 
acknowledges that small numbers limits it.  Further research is planned with a phase 
III study initiated to determine whether there is an improvement of locregional failure 
free rate at 2 years compared with standard dose chemotherapy-IMRT. 
 
90 
 
The third generation of organ (larynx) preservation research has reviewed patient 
selection for this approach and has challenged the exclusion of locally advanced T4 
laryngeal tumours from organ preservation approaches.  A recent study (Stenson et 
al., 2012) has indicated that biology of the disease rather than extent of tumour maybe 
the crucial factor in determining outcome.  Studies investigating the use of 3D 
radiation therapy techniques such as IMRT and IGRT (Nguyen et al., 2012a) (Miah et 
al., 2012) have highlighted the toxicities involved in both approaches.  It is likely that 
further investigation of novel radiotherapy techniques will continue to inform and 
influence organ preservation approaches. 
 
 
1.6.2. Patient’s perspective on non-surgical organ (larynx) preservation 
 
In examining the evolution of organ preservation of the larynx, it is important to 
consider the patient’s perspective.  An early study (McNeil et al., 1981) asked a group 
of 37 healthy volunteers whether they would be willing to accept a reduced survival 
rate in order to preserve their voice if they faced a diagnosis of T3 glottic cancer 
amenable to total laryngectomy or radiotherapy.  20% were willing to accept a 
reduction in their voice and to have radiotherapy rather than total laryngectomy.  
However, this study was undertaken at a time when the options for communication 
after rehabilitation were predominantly oesophageal speech or electrolarynx rather 
than the now well established technique of surgical voice restoration with a 
prosthesis.  In addition, evidence to suggest that the addition of chemotherapy to 
radiotherapy in the treatment of advanced laryngeal carcinoma provided similar 
survival rates compared to total laryngectomy and post-operative radiotherapy (Wolf 
et al., 1991) in the treatment of advanced laryngeal carcinoma had not yet emerged.  
A more recent study (Laccourreye et al., 2012) investigated results of an anonymous 
questionnaire given to 309 volunteers to determine their position if they faced the 
diagnosis of advanced laryngeal carcinoma amenable to total laryngectomy or chemo 
radiation.  24.6% made survival their main consideration in making their decision and 
would not consider any reduction in cure rate in order to avoid a total laryngectomy.  
62.5% chose larynx preservation even if that choice reduced cure rate.  12.9% were 
unable to determine their position from the 2 treatment options offered. 
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1.6.3. Non-surgical organ (larynx) preservation – the impact on current clinical 
practice 
 
Clinical research in the area of organ preservation in advanced laryngeal cancer has 
shifted initial treatment paradigms away from surgery to chemo radiation.  This 
philosophy has had a significant impact on clinical practice.  Many patients with 
advanced laryngeal cancer now have a preserved larynx, good function and no 
complications or recurrence as a consequence of the increased use of chemo radiation 
techniques rather than surgery.  In addition, the need to examine functional outcomes 
other than overall survival in organ preservation research has helped initiate the 
development of various quality of life instrument tools.  However, with the increasing 
popularity of organ preservation techniques in advanced laryngeal cancer, there has 
also been an increase in salvage laryngectomy along with the associated surgical 
morbidities of this technique (Robertson et al., 2011, Olsen, 2010).  There has also 
been an increase in the well documented toxic effects of organ preserving chemo 
radiation including mucositis, fatigue, xerostomia, oedema, fibrosis (Kazi et al., 
2006b) (Fung et al., 2005).  It is of some relevance to consider costs of organ 
preservation vs. surgery in laryngeal cancer patients.  One study found that the cost of 
total laryngectomy with post-operative therapy was almost $3,000 less than induction 
chemotherapy with radiotherapy followed by salvage surgery for patients failing 
chemotherapy (Davis et al., 2005).  However, a more accurate estimate of cost of both 
interventions would involve not just initial treatment costs but all costs through the 
follow up period including lost time at work for the patient as well as cost to the 
patient in time for hospital visits and procedures (Olsen, 2010).  It has been suggested 
that current practice now involves trying chemo radiation as a first treatment option 
with salvage laryngectomy reserved for failure without due consideration being given 
to the selection of appropriate patients. (Olsen, 2010).   
 
It is significant that the decrease in survival outcomes for advanced laryngeal cancer 
in the mid-1990s appeared to coincide with the increase in chemo radiation and the 
decrease in surgery as initial management in the early 1990s.  Survival rates for 
laryngeal cancer have reported to have deteriorated in the last 20 years (Hoffman et 
al., 2006) (Andrews et al., 2011) in the US where evidence supporting organ 
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preservation originated.  This is particularly notable because the larynx is the only site 
of the body showing survival deterioration after cancer treatment in the USA 
(Nakayama et al., 2012).  In contrast 10 year survival rates for laryngeal cancer from 
the 1970s to the present in England and Wales demonstrate modest gains of 50.5% in 
1971-72 to 55.1% in 1990-91 with predicted survival trend of 59.6% in 2007 (Cancer 
Research UK 2011).  A further study (Chen and Halpern, 2007) has also questioned 
the benefits of organ preservation in advanced laryngeal cancer.  This study 
investigated factors predictive of improved survival in advanced laryngeal cancer 
patients registered with the National Cancer Database (NCDB) in the USA between 
1995 and 1998.  This study found that total laryngectomy patients had significantly 
greater survival than patients having chemo radiation or radiation alone for T4 
cancers (Chen and Halpern, 2007).  This study also found that T3 laryngeal cancer 
patients treated with chemo radiation had a significantly increased death rate 
compared with total laryngectomy alone.   
 
Although organ preservation has been robustly defended (Wolf, 2010, Forastiere, 
2010), both studies (Hoffman et al., 2006, Chen and Halpern, 2007) have led to a re - 
evaluation of whether survival deterioration in the larynx is attributable to changes in 
management and the increasing use of organ preservation techniques (Hoffman et al., 
2006).  In response to concerns about the long term benefits of organ preservation and 
impact on survival, a consensus document was recently published outlining key 
recommendations for the design of larynx preservation clinical trials (Ang, 2010).  
These recommendations included the specific guidelines for patient selection based 
on stage of disease, exclusion of patients with laryngeal dysfunction such as recurrent 
pneumonia or tracheostomy, exclusion of patients over 70 and inclusion of baseline 
pre and post treatment assessments of speech, swallow and voice function.  Crucially 
these recommendations also recommend a broad endpoint of laryngoesophageal 
dysfunction (LED) free survival to define outcome that measures not just survival, 
cure or preservation of a functional larynx.  The criteria for not achieving LED free 
survival will include death, local relapse, total laryngectomy, presence of a 
tracheostomy after 2 years or presence of a feeding tube after 2 years.  While it 
appears the optimum treatment strategy for advanced laryngeal cancer has yet to be 
decided, the reality of clinical practice is that total laryngectomy remains the only 
viable treatment option for some patients.  It is also of clinical relevance that there are 
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a significant number of patients undergoing salvage laryngectomy who present with 
complex rehabilitation needs.  The evolution of the definition of survival has evolved 
from one that simply meant cure to one that now encompasses but one that 
functioning with good communication, swallowing and quality of life.  The next 
section will explain quality of life; the models that have helped influenced the 
importance quality of life as a concept and the development of standards to facilitate 
measurement of quality of life. 
 
 
1.6.4. Quality of Life 
 
Quality of life can be defined as the satisfaction and wellbeing that an individual 
experiences on a daily basis (Morton and Izzard, 2003).  For cancer patients, quality 
of life is a multidimensional construct of an individual’s subjective assessment of the 
impact of an illness or treatment on his or her physical, psychological, social, and 
somatic functioning and general well-being (Murphy et al., 2007, Rogers et al., 2007).  
Historically medicine was delivered according to a biomedical approach to care that 
emphasised the physical aspects of the disease (Bornbaum et al., 2013).  This 
biomedical model underpinned the International Classification of Impairments, 
Disabilities and Handicaps (ICIDH) (WHO, 1980) which was published by the 
World Health Organisation (WHO) in 1980.  The purpose of ICIDH was to provide a 
tool for the classification of the consequences of disease and the effects of those 
consequences on the lives of individuals (Eadie, 2003).  This model assumed that any 
disability, impairment or handicap could be traced back to the medical basis of the 
problem (Eadie, 2003, Threats, 2006).  Several criticisms of this tool emerged.  These 
included the lack of recognition that it is possible to have a disability or handicap 
without necessarily having a concomitant impairment (Eadie, 2003).  For instance, a 
head and neck cancer patient may have had surgery to remove a tumour and survived 
disease free for 5 years.  Theoretically, this patient is considered medically cured 
although they may be living with a change in physical appearance and other 
psychosocial factors related to their treatment for cancer which may be limiting both 
social participation and health (Eadie, 2003).   
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As improvements in surveillance and treatment options for cancer have increased over 
time, it has been recognised that cancer patients have a variety of concerns unique to 
survivorship (Bornbaum et al., 2013).  Concerns for adult cancer survivors include 
fatigue, cognitive changes, body image, sexual health and functioning, infertility, fear 
of recurrence, family/caregiver distress, post-traumatic stress syndrome, distress, 
anxiety and depression (Alfano and Rowland, 2006).  In addition, a head and neck 
cancer survivor may be dealing with late side effects of treatment.  These may include 
feeding tube dependency, dysphagia, laryngeal dysfunction, mucositis, weight loss, 
infection, fistula (Machtay et al., 2012), vascular damage, fibrosis (Stewart, 2011) 
oral and dental infection and jaw radio necrosis (Epstein et al., 2012).  It has been 
proposed that healthcare professionals serve as vital gatekeepers to services that will 
help optimise cancer survivors physical and psychosocial outcomes (Alfano and 
Rowland, 2006).  Given the complexities and numerous potential concerns of 
individual cancer survivors, there was a need for an overarching framework to guide 
the provision of care (Bornbaum et al., 2013).   
 
The inadequacies of biomedical model in healthcare led to the development of the bio 
psychosocial model (Engel, 1977) which emphasises the multidimensional nature of 
health concerns (Bornbaum et al., 2013).  The bio psychosocial model takes into 
account biological factors contributing to health but also psychological and social 
factors (Eadie, 2003).  Recognising that there was a need to identify and attend to the 
multidimensional health related concerns of individuals, (Bornbaum et al., 2013) the 
World Health Organisation developed the International Classification of Functioning, 
Disability and Health (ICF) guided by the bio psychosocial model (Bornbaum et al., 
2013).  The ICF framework was designed to provide a common basis for terminology 
(Bornbaum et al., 2013) together with a classification system to describe an 
individual’s health and health related domains (Eadie, 2003).  The domains are 
described from the perspective of the body, the individual and society relative to 3 
levels (i) Body Functions and Structures  (ii) Activities and (iii) Participation (Eadie, 
2007).  Body functions are defined as the physiological and psychological functions 
of a body system, whereas structures refer to the anatomical parts of the body such as 
organs, limbs and their components.  Activities are the execution of specific actions 
by individuals (Eadie, 2007, Threats, 2006).  Participation encompasses involvement 
in life situations (Eadie, 2007).  All levels of functioning are influenced by Contextual 
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factors.  Contextual factors includes Environmental factors (e.g.  social support, work, 
government agencies, laws, attitudes of others and cultural beliefs) which are largely 
out of an individual’s control (Threats, 2008) and Personal factors (e.g.  age, race, 
gender, education, coping, personality traits, lifestyle) (Threats, 2006, Eadie, 2007).  
As the ICF is firmly rooted in the interactionist bio psychosocial model, it is intended 
to be universally applicable to any individual in any state of health or infirmity 
(Bornbaum et al., 2013) 
 
The comprehensive perspective offered by the ICF has proved popular in the field of 
Oncology leading to its use in areas as diverse as (Bornbaum et al., 2013): evaluating 
functioning of cancer patients (Ajovalasit et al., 2009, Tschiesner et al., 2009a), 
guiding assessment in oncology rehabilitation (Eadie, 2003, Eadie, 2007), assessing 
the comprehensiveness of outcome measures (Becker et al., 2010, Tschiesner et al., 
2008), assisting in HRQOL instrument selection (Tschiesner et al., 2008, Cieza and 
Stucki, 2005) and comparing primary concerns of patients with their health care 
professionals (Tschiesner et al., 2010a).  The benefit of using ICF in the area of 
oncology is that it offers a broader and better alternative to existing models of care 
such as activities of daily life (Katz S, 1963, Katz, 1983), health belief (Yarbrough 
and Braden, 2001) and cognitive behavioural (White, 2000, Donovan et al., 2007).  In 
addition the ICF model promotes multidisciplinary collaboration through the use of 
common terminology and improves communication among healthcare professionals, 
researchers, policy makers and the public (Bornbaum et al., 2013).  While the ICF has 
multiple strengths, it also presents with key conceptual shortcomings (Bornbaum et 
al., 2013).  These include difficulties with terminology used such as “health 
condition” described as a static entity (Bornbaum et al., 2013) which fails to recognise 
dynamic changes in functioning and well-being after the health condition or cancer 
has been eliminated.  The term “health state” has been proposed as one that may be 
more suitable to representing a dynamic continuum of functioning (Bornbaum et al., 
2013).  Additional shortcomings of the ICF include insufficient exploration of co 
morbidities (Bornbaum et al., 2013) often prevalent in cancer survivors, and under 
development of the personal factors component (Bornbaum et al., 2013).  One of the 
strongest criticisms is that the ICF asks clinicians and researchers to classify some 
behaviours that are neither agreed upon nor well researched (Threats, 2008). 
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The assessment of function and quality of life has become increasingly relevant in the 
outcome measurement of head and neck cancer (Cella et al., 1993, Bindewald et al., 
2007, Howren et al., 2010, Weymuller et al., 2001).  However, the heterogeneity of 
head and neck cancer patients (including those with a Laryngectomy) in terms of 
location of disease, diversity of surgical approaches, chemo radiation regimes and 
differences in patient specific responses to these variables makes it difficult to 
precisely describe function, quality of life and other outcomes (List and Bilir, 2004, 
Tschiesner et al., 2010b).  It was recognised that having a set of agreed standards to 
assess and report on functioning and health in head and neck cancer was crucial 
(Rogers et al., 2010b).  These standards would function as means of measuring 
outcomes.  In addition, they could also provide a benchmark to rate the content 
validity of the various quality of life instruments available so that the appropriate 
tools for the specific needs of an individual patient could be chosen (Tschiesner et al., 
2010b). 
 
Core sets have been extracted from the ICF to produce disease specialised sets of 
categories that can serve as minimal standards for the assessment and documentation 
in clinical studies, clinical encounters and multiprofessional comprehensive 
assessment (Rogers et al., 2010b) ICF core sets have been developed for 16 health 
conditions including stroke (Geyh et al., 2004) obesity (Stucki et al., 2004) pain 
(Cieza et al., 2004), breast cancer (Brach et al., 2004) and head and neck cancer 
(Tschiesner et al., 2009b).  ICF core sets are created at 2 levels, a brief set to define 
categories as minimal standards to assess and report on functioning and health in any 
patient with the defined disease and a comprehensive core set applicable to 
multidisciplinary assessment (Rogers et al., 2010b).  Categories within both 
comprehensive and brief core sets are grouped according to body functions, body 
structures, activities and participation and environmental factors (Tschiesner et al., 
2010b).  The comprehensive ICF core set for head and neck cancer has 112 categories 
whereas the Brief ICF core set for this disease has 19 categories (Rogers et al., 2010b) 
(appendix).  The categories in the brief core set were fundamental in directing the 
final choice of quality of life scales used in this study.  The quality of life scales 
considered for this study and the rationale for the instruments ultimately chosen will 
be discussed in chapter 5. 
 
97 
 
 
This chapter has outlined surgical procedures for standard total laryngectomy in 
addition to different types of extended laryngectomy surgeries for those with more 
extensive disease.  The causes of swallowing difficulty after laryngectomy and the 
various swallow evaluation tools that could be used with this patient population have 
been described.  Communication after laryngectomy has been explained with 
reference to the historical development of this important area of rehabilitation.  
Outcomes after laryngectomy have been considered in relation to the important areas 
of survival and the impact of organ preservation and quality of life.  Swallowing, 
communication and quality of life post laryngectomy are the major themes 
investigated in this PhD thesis.  There remain questions regarding how best to 
evaluate these areas of function post laryngectomy.  Swallowing post laryngectomy 
remains the least researched and least understood area of function.  Questions remain 
as how to most effectively evaluate swallowing post laryngectomy and which tool is 
the optimum to use.  Thus the first part of this thesis, chapter 2, describes a study in 
which Fiberoptic Endoscopic Evaluation of Swallowing (FEES) is compared with 
Videofluroscopic evaluation of swallowing to investigate whether the former is a 
suitable alternative tool to the latter.  The past twenty years have seen significant 
development and refinements of voice prostheses used post laryngectomy.  The next 
section of this thesis has been inspired by patient observations that different 
prostheses affect swallowing ability.  The investigation of this previously unexamined 
area is explored in chapter 3.  In addition to the investigating the effect of different 
voice prostheses on swallowing, the effect of different voice prostheses on voice 
quality was researched and is discussed in chapter 4.  Chapter 5 describes an 
investigation of quality of life post laryngectomy.  Chapter 6 outlines conclusions and 
future work.   
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Chapter 2. Evaluation of swallowing using simultaneous 
videofluroscopy and endoscopy 
 
 
2.1 Summary 
 
This chapter describes the use of simultaneous videofluroscopy and endoscopy to 
investigate whether endoscopy is a useful tool for the evaluation of swallowing post 
laryngectomy.  The introduction outlines the previous research into tools to 
investigate dysphagia in both laryngectomy and patients with a larynx and explains 
the rationale for choice of videofluroscopy and FEES for this study. 
The sections 2.3 to 2.5 describe three preliminary studies carried out to develop the 
tools required for the main study (section 2.6). Section 2.3 describes the development 
of a rating scale for use by the experts who rated the patient swallow evaluation 
images in the main study. No such scale existed previously and it was required to 
judge the images produced by both examinations reliably. Section 2.4 outlines how 
this developed rating scale was then tested for reliability and adapted prior to use. 
Section 2.5 then discusses the development of a patient questionnaire to assess the 
patients’ preferred method of the swallow evaluation.  
Section 2.6 then describes the main study comparing the two methods of swallow 
evaluation. Finally, section 2.7 summarises the conclusions from this body of work. 
 
 
2.2. Introduction 
 
As outlined in chapter 1, the anatomical changes post laryngectomy result in a 
separation of respiratory and digestive systems.  As a result, it is not possible for a 
laryngectomy patient to aspirate food or liquid unless a fistulisation occurs or leakage 
occurs through or around the voice prosthesis.  As a consequence, research into 
rehabilitation after laryngectomy has focused primarily on the restoration of 
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communication (Damste, 1958) (Curry and Snidecor, 1961, Taub and Spiro, 1972, 
Blom and Singer, 1979, Singer and Blom, 1980) (Leder and Erskine, 1997b, Leder et 
al., 2005b, Hancock et al., 2005, Hilgers et al., 2010b, Hilgers et al., 2010a) and the 
improvement of pulmonary function (Hilgers et al., 1991, Hess et al., 1999, 
Ackerstaff et al., 1999, Jones et al., 2003, Merol et al., 2012, Hilgers et al., 2012). The 
area of dysphagia post laryngectomy has only begun to receive attention in the past 
decade (Ward et al., 2002, Maclean et al., 2009b, Maclean et al., 2009d, Landera et 
al., 2010) and continues to remain relatively unexplored.  There is currently no 
consensus on the best tool to use for the evaluation of swallowing post laryngectomy.  
Although videofluroscopy is often used, there are no protocols or standardised 
procedure for the use of this tool post laryngectomy. 
 
 
2.2.1. Fluoroscopic x-ray imaging studies for the evaluation of dysphagia post 
laryngectomy 
 
X-ray imaging was first adopted for use in the laryngectomy population in 1922 
(Seeman, 1922) and continued to be developed with this population throughout the 
twentieth century (Morrison, 1941) (McCall, 1943). (Robe et al., 1956, Lindsay et al., 
1944) (Vrticka and Svoboda, 1961) (Diedrich and Youngstrom, 1966) (Damste and 
Lerman, 1969b). However, these studies focused predominantly on the assessment of 
the pharyngoesophageal segment (vibratory segment) for the purposes of producing 
oesophageal voice.   Nonetheless a limited number of early x-ray imaging studies 
included the investigation of dysphagia in the post laryngectomy patient.  These 
studies are summarised below. 
The first x-ray imaging study to examine dysphagia attributed post laryngectomy 
dysphagia to cricopharyngeus spasm observed on barium swallow (Schobinger, 
1958). A study of 100 laryngectomised speakers (Vrticka and Svoboda, 1961) stated 
that swallowing was normal in all subjects investigated.  Another early study 
(Kirchner et al., 1963) examined a barium bolus passing through the pharynx using 
both fluoroscopic x-ray imaging and manometry in 35 laryngectomised subjects.  This 
study found that a pouch like recess (apparently a pseudo epiglottis) was exhibited in 
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30 subjects. This study also noted that postoperative dysphagia may occur in post 
laryngectomy not only as a result of pseudo epiglottis but also as a consequence of 
ineffective contractions of the constrictor muscles of the pharynx particularly on solid 
food. A later study (Bentzen et al., 1976a) investigated the pseudo glottis in 41 post 
laryngectomy subjects using videofluroscopy and the simultaneous recording of 
voice.   While the focus of this study was primarily on voice production, it is notable 
that the methodology of using both lateral and A/P (Antero/Posterior) views was 
introduced.  However, lateral views were described as superior to A/P, as the latter 
were somewhat blurred by the spine.  The presence of stricture was noted in one 
subject. This was reported as being treated with bouginage to improve voice but no 
reference was made to stricture in relation to swallow. Spasm was noted in 3 subjects 
with the location landmarked using cervical vertebrae.   
The first major study (Jung and Adams, 1980) to use x-ray imaging to specifically 
evaluate swallowing after laryngectomy reviewed records of 226 laryngectomised 
patients over a 9 year period.  36 of these had a significant dysphagia, 16 had benign 
stricture, 14 had recurrent disease, 2 had a lower oesophageal stricture and 4 had 
malignant oesophageal carcinoma. This study suggested calculating the posterior 
pharyngeal space ratio as a means of assessing retropharyngeal soft tissue in healthy 
as well as asymptomatic subjects.  This measurement was calculated as a ratio of the 
width of the retropharyngeal space opposite the 4
th
 cervical vertebra to the anterior 
posterior diameter of the 4
th
 cervical vertebra. This study noted a statistically 
significant increase in this ratio in patients with recurrent disease. Calculation of the 
posterior pharyngeal space ratio was subsequently used in other studies (Balfe et al., 
1982, Davis et al., 1982). This study recommended the use of barium swallow for 
laryngectomy as a means of showing early signs of recurrence that may not be 
detectable on endoscopy.  
Acknowledging the insufficiency of the clinical bedside examination in the evaluation 
of dysphagia after laryngectomy, an important study (Balfe et al., 1982) attempted to 
define appropriate criteria for judging radiographic appearance of the pharynx and 
oesophagus after laryngectomy.  This study highlighted the lack of information in 
literature describing the normal radiographic appearance of the pharynx after 
laryngectomy.  Radiographic and clinical data was retrospectively reviewed on 45 
laryngectomy subjects.  40 of these subjects had been referred with pharyngeal 
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symptoms.  5 subjects who had no symptoms attributable to the previous surgical 
procedure served as controls. Examinations were taken with the subjects standing and 
both lateral and A/P views were imaged.  The pharynx was coated with high-density 
liquid barium and subjects were asked to forcibly expel swallowed air against closed 
lips for maximum distension of the pharynx. Results indicated that the normal 
appearance of the neopharynx after laryngectomy was that of a simple tapered 
inverted conical shaped tube.  Only residual fibres of the cricopharyngeus muscle 
remain to indent the posterolateral surface of the neopharyx.  Benign strictures were 
described as having a tendency to be either short (less than 5mm) and occurring at the 
distal surgical closure or long (greater than 3cm) and occurring usually at the mid 
portion of the neopharynx.  The latter was considered as probably due to radiation.   
Fistulae tended to extend from the base of tongue to the skin of the anterior neck and 
usually occurred near the stoma site. Several subjects had a cricopharyngeus 
impression, which could be distinguished from tumour recurrence by its ability to 
change shape on swallowing.  This finding of a cricopharyngeus impression may have 
been influenced by the fact that none of subjects in this study had had a myotomy.  
The authors of this study concluded that the barium exam is a useful adjunct to the 
physical exam and pharyngoscopy in evaluating the cause of dysphagia in patients 
after total laryngectomy. 
The early post-operative hypo pharyngeal anatomy of 37 consecutive post 
laryngectomy patients was correlated with “T” vs. “vertical” surgical closure using 
barium swallow (Davis et al., 1982). Only 28 subjects were evaluable using barium 
swallow.  Of these, 21 had a pseudo epiglottis, which occurred in 100% of subjects 
with vertical closures vs. 67% of subjects with “T” shaped closures.    29% of the 
sample had dysphagia, 39% had stricture, 18% had fistula and 14% had sinus tracts. 
The difference between the posterior pharyngeal space ratio in stricture vs. non 
stricture subjects was statistically significant. Complications were noted to occur 
more frequently in the vertical closure group.   
Initial studies on dysphagia after laryngectomy using x-ray imaging either attributed 
symptoms to a cricopharyngeal spasm (Schobinger, 1958) or indicated that 
swallowing was normal (Vrticka and Svoboda, 1961).  Kirchner and colleagues’ 
comprehensive study (Kirchner et al., 1963) utilising both fluoroscopy x-ray imaging 
and manometry found a high rate of pseudo epiglottis but also highlighted that 
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dysphagia could occur as a consequence of ineffective contractions of the constrictor 
muscles of the pharynx especially on solid food.  Subsequently, a large study (Jung 
and Adams, 1980) focusing specifically on the investigation of swallowing post 
laryngectomy using x-ray imaging, identified stricture as a potential cause of 
dysphagia.  This study proposed the posterior pharyngeal space ratio as a means of 
discriminating between benign and malignant strictures.  The study by Balfe and 
colleagues (Balfe et al., 1982) was notable for introducing the use A/P as well as 
lateral views for fluoroscopic x-ray imaging.  This study described not only the 
normal radiographic appearance of the pharynx after laryngectomy but also 
radiographic features that indicated benign strictures, recurrent tumour, 
cricopharyngeus impression and fistula. A large proportion of subjects in this study 
had more than one abnormality.  The final study (Davis et al., 1982) described found 
a high proportion of pseudo epiglottis overall.  However, this study also attributed 
both increased rate of pseudo epiglottis and complications to type of surgical closure. 
Each of these studies (Schobinger, 1958, Kirchner et al., 1963, Jung and Adams, 
1980, Balfe et al., 1982, Davis et al., 1982) increased knowledge about the anatomical 
causes of dysphagia of laryngectomy but provided limited information on the 
symptoms that may result. Each of these studies was limited by methodology, which 
evaluated swallowing using a single consistency, barium liquid only. Subsequent 
research studies examining dysphagia after laryngectomy combined videofluroscopic 
x-ray imaging with manometry.  These studies are described in the following section. 
 
2.2.2. Manometry and videofluroscopic x-ray studies for the evaluation of 
dysphagia post laryngectomy. 
 
The central aim of one of the first studies (McConnel et al., 1986b) to investigate 
dysphagia after laryngectomy, was to examine manoflurography as an alternative 
evaluation tool to a fluoroscopic barium x-ray swallow.  While fluoroscopic x-ray 
swallows provide direct information about the forces that propel the bolus, 
manometry reveals changes in motility patterns and upper sphincter behaviours.  
Manoflurography is the simultaneous use of manometry and videofluroscopy.  Alone, 
manometry measures pressure changes and reveals changes in motility and upper 
sphincter patterns.  The use of simultaneous manometry with videofluroscopy ensures 
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manometric sensors are accurately placed and that pressure events are precisely 
related to bolus passage timing (McConnel et al., 1988).   
9 total laryngectomy subjects were studied.  Subjects were divided into two groups (i) 
Total laryngectomy n-4 and (ii) Total laryngectomy with tongue impairment n-5 
(including 1 hemiglossectomy, 1 glossectomy, 1 bilateral hypoglossal paralysis and 2 
unilateral hypoglossal paralysis). Results indicated swallow dysfunction in both 
groups and highlighted the effect of anatomical changes after laryngectomy.  This 
study indicated that removal of the larynx itself increases resistance to bolus flow.  
The tongue acts as a piston to drive the bolus through the low compliance and 
essentially acontractile pharynx post laryngectomy. Elevation of the distorted 
pharyngeal tissues of the post laryngectomy patient may kink the tortuous pharynx 
during swallowing to further impede bolus passage.  Laryngectomy subjects with 
tongue impairment were limited in their ability to generate sufficient tongue base (to 
posterior pharyngeal wall) driving force.  They were also limited by impaired 
contraction of the pharynx. Laryngectomy subjects with lingual impairment 
experienced multiple efforts to swallow, prolonged transit time and poor mucosal 
clearance. Both these factors contributed to an inability to propel the bolus through 
the reconstructed pharynx in one swallow.   Manoflurography was found to facilitate 
analysis of the significance of anatomical and functional abnormalities in 
laryngectomy patients.  One of the major findings of this study was the increased 
resistance found in the pharynx after laryngectomy and the major role of the tongue as 
a pressure generator in post laryngectomy swallowing.  The authors suggested that the 
incidence of dysphagia after laryngectomy may be underestimated but cautioned that 
the mere presence of an abnormality does not indicate dysfunction. 
 
Manoflurography was not used again in the post laryngectomy population until a later 
study (Maclean et al., 2011) used this technique to compare 24 total laryngectomy 
subjects with normal controls. This study contrasts to (McConnel et al., 1986b) in that 
swallow biomechanics in relation to pharyngeal reconstruction and intrabolus 
pressure is measured. Although an increased resistance to bolus flow was found 
within the pharynx post laryngectomy (McConnel et al., 1986b), the effect of type of 
pharyngeal reconstruction on the biomechanics of swallow, swallow efficiency or 
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symptom severity remains unknown. An earlier study (Maclean et al., 2008) found a 
marked variation in both level and orientation of closure for pharyngeal repair after 
laryngectomy.  The aim of this study (Maclean et al., 2011) was to determine how 
laryngectomy surgery affects swallow biomechanics, pharyngeal peak deglutitive 
pressure and hypopharyngeal intrabolus pressure.  A further aim was to determine 
whether the changes in pressure correlate with specific surgical closure after total 
laryngectomy or with dysphagia severity. 50% of the laryngectomy subjects had self-
reported dysphagia.  18 had undergone adjuvant treatment with all of these receiving 
radiotherapy and 3 receiving chemoradiation.  20 had a mucosa and muscle closure 
whereas 4 subjects had the pharynx closed with mucosa alone.  12 subjects had a ‘T’ 
or ‘Y’ closure, 8 had a vertical closure, 1 a transverse closure and 3 had unspecified 
direction of closure.  Myotomy had been performed on 14 of the 24 subjects. 
In contrast to the study by (McConnel et al., 1986b), which investigated swallowing 
of liquid barium only, subjects in this study were presented with multiple volumes of 
liquid boli trials together with puree and bread. Single swallows of multiple volumes 
of liquids were recorded in A/P view.  Results indicated reduced peak mid pharyngeal 
intraluminal pressures in laryngectomy subjects compared to controls.  Peak mid 
intraluminal pressure provides an indication of the forces generated by the pharyngeal 
constrictor muscles during swallowing. Results also indicated increased hypo 
pharyngeal intrabolus pressure compared to controls.  Hypo pharyngeal intrabolus 
pressure varies as a function of forces exerted on the bolus as well as from resistance 
to bolus flow as it moves to the pharyngoesophageal junction. Intrabolus pressure 
therefore provides crucial information about the upper oesophageal sphincter of 
which the cricopharyngeus is a major component.  Post swallow pharyngeal residue 
was observed in most subjects for all consistencies and volumes. Post swallow bolus 
residue correlated with bolus volume and increased viscosity across the cohort.  
Subjects with self-reported dysphagia had a minimal pharyngeal diameter compared 
to those without dysphagia.  No significant relationship was found between direction 
or levels of closure and self-reported dysphagia.  Subjects with muscle and mucosa 
closure for pharyngeal reconstruction had higher peak mid pharyngeal pressures 
compared to mucosa alone.  Combined mucosa and muscle closure was associated 
with reduced post swallow residue indicative of a more efficient swallow.  11 subjects 
were found to have a pseudo epiglottis and 10 had diverticulum in which post 
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swallow material collected.  Most patients had difficulty tolerating a 20ml bolus 
swallowing it in 2-3 piecemeal swallows.  18 subjects required more than 1 swallow 
to clear a bread bolus.  Data from 20ml liquid bolus and bread swallows were 
therefore eliminated from final analysis of this study. 
Manometry alone has been carried out in the oesophagus post laryngectomy in a 
limited number of studies. Early studies of oesophageal manometry (Hanks et al., 
1981, Sandberg, 1969) post laryngectomy indicated that the resting and maximum 
pressures of the Upper Oesophageal Sphincter (UES) were lower in laryngectomy 
subjects compared to normals but that motility of the oesophageal body and the lower 
oesophageal sphincter showed no change. In contrast, a further study (Duranceau et 
al., 1976) found that motility of the oesophageal body was lower than that of normals. 
One study (Choi et al., 2003) investigated how total laryngectomy changes the resting 
and maximum contracting pressure of the upper oesophageal sphincter.  A further aim 
was to examine how laryngectomy affects coordination of the contraction and 
relaxation between the pharynx and upper oesophageal sphincter muscles.  15 total 
laryngectomy subjects and 15 normal controls were examined using manometry.  
Results indicated a statistically significant difference in the laryngectomy group for 
both resting and maximum contracting pressures as well as for co-ordination and 
relaxation of the upper oesophageal sphincter. Proximal oesophageal body pressure 
and peristaltic waves were significantly reduced in the laryngectomy group and 
negatively affecting motility.  No significant difference was seen between groups for 
degree of lower oesophageal sphincter co-ordination and relaxation.  A recent small 
study (Maclean et al., 2012) also found that all 9 laryngectomy subjects who 
underwent oesophageal manometry had aperistalsis supporting the findings of 
(Duranceau et al., 1976) and (Choi et al., 2003).   
Both studies using manoflurography have provided seminal information about 
swallowing after laryngectomy.  McConnel and colleagues (McConnel et al., 1986b) 
provided an understanding of pressure and anatomical changes post laryngectomy, 
which in turn elucidated the importance of the driving force of the tongue base and 
the impaired contractions of the pharynx.  In contrast to previous studies (Schobinger, 
1958, Kirchner et al., 1963, Jung and Adams, 1980, Balfe et al., 1982, Davis et al., 
1982), the work of McConnel and colleagues (McConnel et al., 1986b) described 
some of the symptoms of post dysphagia laryngectomy including multiple swallows, 
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quantitative descriptions of prolonged transit times and poor mucosal clearance.  
Maclean and colleagues (Maclean et al., 2011) study elaborated on (McConnel et al., 
1986b) by using manoflurography to investigate swallow mechanics in relation to 
pharyngeal reconstruction and extra bolus pressure. While no significant relationship 
was found between closure and self-reported dysphagia, it is notable that symptoms of 
post laryngectomy dysphagia were described including residue, multiple swallows 
and piecemeal swallows.  This study (Maclean et al., 2011) is also noteworthy in that 
residue was correlated with bolus volume and increased viscosity underlining the 
importance of evaluating post laryngectomy with consistencies other than liquid 
barium.  Oesophageal manometry remains a limited area of study post laryngectomy.  
However, it appears that both the function of the UES (Choi et al., 2003) and 
oesophageal peristalsis and motility (Duranceau et al., 1976, Choi et al., 2003, 
Maclean et al., 2012) are altered after laryngectomy.  Further study is clearly required 
in this field. 
While manoflurography has contributed much important knowledge to the field of 
dysphagia post laryngectomy, it can be a technically difficult procedure to execute.  In 
addition, it is labour intensive requiring a Gastroenterologist together with a Speech 
and Language Therapist, Radiologist and Radiographer.  Manometry is also not 
readily available in most clinical settings.  For these reasons, it was decided not to 
pursue manoflurography as a tool for this study. The next section describes the use of 
a further dysphagia evaluation tool post laryngectomy, swallow sound auscultation. 
 
2.2.3. Auscultation of swallow sounds for the evaluation of dysphagia post 
laryngectomy 
 
The use of swallow sounds to evaluate swallowing efficiency in those with a larynx 
was previously discussed in the introduction.  Swallow sounds in those with a larynx 
are usually only detectable using auscultation (typically with a stethoscope) or 
transduction (with a mini accelerometer or microphone) (Hamlet et al., 1992) from 
the neck surface. An abrupt acoustic spectral change in accelerometer signal recorded 
from the throat during swallow has been found to be associated with bolus flow 
through the upper oesophageal sphincter in those with a larynx (Hamlet et al., 1990).  
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One study (Hamlet et al., 1992) sought to find whether a comparable featured signal 
could be found during swallowing in post laryngectomy.   Subjects recruited included 
13 total laryngectomy patients and 17 normal controls.  Subjects underwent 
videofluroscopic evaluation of swallow of liquid and paste.  Synchronous recordings 
of acoustic neck swallow sounds were recorded using a mini accelerometer placed 
2cm anterior and below the angle of the mandible. Overall duration and peak 
amplitude of swallow signal along with abrupt acoustic spectral change was 
determined by computer analysis.  Videoflurosopic data were inspected to determine 
physiological events taking place near the time of abrupt acoustic spectral change. 
Signal differences associated with liquid and paste consistency found in normals were 
less evident in laryngectomy swallow signals.  Acoustical analysis of accelerometer 
signals during swallow revealed that amplitude, duration and a spectral features of 
signals for liquid and paste swallow in laryngectomy were not significantly different 
contrasting with data from normal controls. In laryngectomy patients, abrupt signal 
change occurred in conjunction with rapid bolus flow into the oesophagus but it was 
not possible to confidently relate this to onset of passage through the 
pharyngoesophageal segment.   
The aim of a recent study (Moriniere et al., 2011) was to describe variation in 
swallow sound signal using acoustic and radiological analysis before and after surgery 
in 14 partial laryngectomy and 9 total laryngectomy subjects.  The laryngectomy 
subjects had a tie clip microphone placed in front of the pharynx 2 cm above the 
tracheostoma and were asked to swallow 6 x 10ml of liquid barium under 
videofluroscopy.  Delimitation of beginning and end of swallow was extracted from 
videofluroscopic recordings.   Total sound duration was significantly shorter in 
laryngectomy subjects post-surgery compared with pre surgery.  Laryngeal ascent 
sound, corresponding to ascent of the larynx when the bolus is in the pharynx or hypo 
pharynx was predictably present more frequently in pre-operative laryngectomy 
patients than post operatively.  Upper oesophageal sphincter opening sound was 
present in 100% of recordings in pre and post-surgery laryngectomy subjects although 
its duration was significantly shorter after surgery.  The authors of this study 
concluded that the main variations of pharyngeal swallow sounds induced by total 
laryngectomy could be described using acoustic analysis although they acknowledged 
that the study was limited by small sample size. 
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Both studies (Hamlet et al., 1992) and (Moriniere et al., 2011) describe the 
auscultation of swallow sounds to evaluate dysphagia post laryngectomy.  Both 
studies were undertaken in conjunction with videofluroscopy but the findings of 
(Hamlet et al., 1992) appear limited compared with the data elicited from normal 
controls and the findings of (Moriniere et al., 2011) are limited by small sample size.  
Further investigation of this area of evaluation may be beneficial in the future.  The 
next section describes the evaluation of post laryngectomy dysphagia within the 
context of endoscopy. 
 
2.2.4. Endoscopy for the evaluation of dysphagia post laryngectomy 
 
Fibreoptic endoscopic evaluation of swallowing is well established as an evaluation 
tool for dysphagia in stroke (Leder and Espinosa, 2002, McCullough et al., 2005, 
Warnecke et al., 2009c, Warnecke et al., 2009b, Teisman et al., 2010, Teismann et al., 
2011, Sun et al., 2013), progressive neurological diseases (Leder et al., 2004, 
Warnecke et al., 2008, Warnecke et al., 2010), intensive care patients (McGowan et 
al., 2007, Hafner et al., 2008, Tadié et al., 2010, Mirzakhani et al., 2013) and 
paediatrics (Willging and Thompson, 2005, Arvedson, 2008, Averin et al., 2012).  
While FEES has also been used extensively to evaluate swallowing in the head and 
neck cancer population, (Langmore et al., 1988, Leder and Sasaki, 2001, Hiss and 
Postma, 2003, Rosenthal et al., 2006, Teguh et al., 2008, Deutschmann et al., 2013), it 
has not as yet, been used to evaluate swallowing in the laryngectomy population. 
To date flexible endoscopy (VanAs et al., 2004) has been used predominantly to 
assess neoglottic function, alaryngeal voicing and visualisation of the voice prosthesis 
but not dysphagia.  An early study (Mohri et al., 1994) undertook EMG, manometry 
and fibreoptic endoscopy in 7 subjects who had undergone tracheosophageal puncture 
at the time of laryngectomy surgery. Flexible endoscopy allowed direct visualisation 
of the dynamics of the hypo pharynx with the lumen closed during the resting phase 
but providing a channel for air to escape during phonation.  One study (Oh et al., 
2002) described a novel use of flexible fiberoptic endoscopy to examine not only the 
pharyngoesophageal segment and upper oesophagus but also distal end of the 
prosthesis in 5 laryngectomy cases.  All 5 laryngectomy patients were unable to 
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produce voice despite accurate prosthesis fitting and adequate training to use 
tracheosophageal voice.  The flexible fibre endoscope was passed through the nose 
and advanced to the pharyngoesophageal segment.  The anatomical relationship 
between the distal end of the prosthesis and the posterior oesophageal wall was 
examined.  Valve activity and prosthesis function were then evaluated during 
phonation and photographically documented to facilitate problem solving. Problems 
observed included distal end of the prosthesis partially impacted against posterior 
oesophageal wall, crimping of the retention collar of the prosthesis by the 
oesophagus, oesophageal retention collar seated within crater like defect within the 
anterior oesophageal wall, reduced anterior to posterior diameter of oesophageal 
lumen and granulation arising from the anterior wall of the oesophagus obscuring the 
distal end of the prosthesis.  None of the patients experienced discomfort during the 
procedure or suffered post procedure complications.  The authors of this study 
emphasised the pivotal role played by flexible fibre endoscopy in determining the 
cause of abnormal symptoms and allowing prompt and effective problem solving.  
They concluded that flexible fibre endoscopy was safe and cost effective and 
facilitated an accurate and timely diagnosis. 
The objective of a more recent pilot study (Pilsworth, 2011) was to discover whether 
the routine use of flexible endoscopy (nasendoscopy) in laryngectomy patients was 
beneficial to Speech and Language Therapy management.  Nasendoscopy was 
attempted on 50 separate occasions on 18 subjects over a period of 4 months. On each 
occasion, patients completed a short self-evaluation questionnaire on their experience 
of nasendoscopy. Successful nasendoscopy was defined as the ability to see the 
tracheosophageal prosthesis or tracheoesophageal puncture.  Using this criterion, 
nasendoscopy was successfully performed on 90% of occasions. The episodes in 
which nasendoscopy was not successful were due to an inability to tolerate the 
nasendoscope and inability to visualise the prosthesis because of oesophageal 
stricture. Nasendoscopy provided additional information and improved management 
when compared to clinical observations alone on 73% of occasions.  The presence of 
granulation or excess tissues interfering with valve placement was identified on 44% 
of occasions and led to the prevention of accidental closure of the TEP in 2 subjects. 
Of the 50 nasendoscopies performed, 29 were conducted without local anaesthetic. 
Patients reported the procedure was uncomfortable for 50% of nasendoscopies 
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performed but discomfort was rated as mild on the majority of these occasions with 
only one patient reporting severe discomfort. Several patients reported informally that 
the use of nasendoscopy was reassuring.  It was concluded that combining clinical 
observations with nasendoscopy assessment provided a more thorough picture of TEP 
and voice prosthesis issues. 
FEES is well established as a swallow evaluation tool for a number of different 
patient groups, including those with head and neck cancer.  However, the use of 
flexible endoscopy in the laryngectomy population has mostly been limited to the 
assessment of neoglottic function during voicing.  The use of the fibreoptic endoscopy 
(Oh et al., 2002) to visualise the distal end of the voice prosthesis enabled problem 
solving of voice prosthesis issues without patient discomfort or post procedure 
complications.  The findings of a later study (Pilsworth, 2011) reinforced the benefits 
of flexible endoscopy as a routine tool for voice prosthesis problem solving and 
indicated that discomfort was mild for the majority of subjects. Flexible endoscopy 
appears both to be of clinical benefit for voice prosthesis problem solving and to be 
well tolerated by patients.  Given the successful use of FEES with other patient 
groups with dysphagia, it seems reasonable that this tool may be of benefit in the 
evaluation of swallowing in the post laryngectomy population.  In order to investigate 
whether FEES is of benefit as a swallow evaluation tool post laryngectomy, it is 
necessary to compare it against another tool.  Videofluroscopy was chosen as the 
comparison tool as it is currently the most commonly used dysphagia evaluation tool 
in the laryngectomy population.  The next section describes previous research 
comparing FEES and videofluroscopy. 
 
2.2.5. Simultaneous FEES and Videofluroscopy 
 
While several studies (Langmore et al., 1991, Bastian, 1993, Wu et al., 1997b, Perie 
et al., 1998) (Madden et al., 2000) have attempted to compare videofluroscopy and 
FEES, these studies are inherently limited because individuals with dysphagia often 
show variable abilities to swallow and both exams were carried out at different times.  
One study involving laryngectomy patients executed both endoscopy and 
videofluroscopy consecutively rather than simultaneously. This study (Nayar et al., 
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1984) undertook endoscopic examination of the neopharynx with a flexible fibreoptic 
scope followed by a videofluroscopy barium swallow exam in 20 post laryngectomy 
patients.  All studies were carried out in the second postoperative week.  All subjects 
underwent postoperative radiotherapy with the postoperative course of each subject 
monitored for 6 months. On endoscopy, the neopharynx was found to be a gradually 
narrowing tubular structure with mucosal rugosities running along its axis.  A pseudo 
epiglottis was demonstrated radiologically in 3 subjects but only one of these was 
observed on endoscopy.  Only 2 subjects in the study reported dysphagia and the 
authors suggest dysphagia is rarely a complaint post operatively unless recurrence is 
present.  The technical difficulties of simultaneous videofluroscopy and endoscopy 
have limited the number of studies using this technique.  Studies utilising 
simultaneous videofluroscopy and endoscopy to evaluate dysphagia are now 
described. 
The goal of the first study (Rao et al., 2003) was to determine sensitivity and 
specificity for laryngeal penetration, aspiration and pharyngeal residue of both 
videofluroscopy and FEES.  This prospective consecutive study involved 
simultaneous videofluroscopy and FEES on 11 subjects with suspected laryngeal or 
pharyngeal abnormality or dysphonia that required a swallow evaluation. Subjects 
were presented with a variety of consistencies including liquids, puree and solids.  
Sensitivity and specificity were calculated twice, once using videofluroscopy as the 
gold standard and once using FEES as the gold standard.  Results indicated agreement 
of 89.6% for FEES and Videofluroscopy on presence/absence of laryngeal 
penetration, 96.7% for presence/absence of aspiration and 84.4% for 
presence/absence of pharyngeal residue.  It was noted that FEES detected pharyngeal 
residue 14 times when Videofluroscopy did not, and videofluroscopy detected residue 
one time when FEES failed to do so.  Results also indicated that sensitivity values 
were higher when FEES was used as a gold standard and specificity was higher when 
videofluroscopy was used as a gold standard. The one exception to this was 
sensitivity for aspiration, this was similar regardless of which tool was used as the 
gold standard. 
The aim of a subsequent study (Kelly et al., 2006) was to investigate whether type of 
instrumental examination (FEES or videofluroscopy) influenced perception of post 
swallow pharyngeal residue.  This study undertook simultaneous FEES and 
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Videofluroscopy examinations in 15 subjects with a larynx.  Subjects had all been 
referred for dysphagia evaluation of mixed aetiology including neurological, head and 
neck cancer and reflux.  All subjects recruited to this study were taking food or fluid 
by mouth and were not judged to be at high risk of aspiration. Each subject was given 
1x liquid barium bolus and 1x puree (yoghurt) barium bolus with a rinsing water 
swallow in between.  Videofluroscopy was screened in lateral view only. 15 raters 
independently scored both FEES and videofluroscopy exams for residue using a 
categorical scale (none, coating, mild, moderate, severe).  Results indicated that type 
of instrumental examination influences perception of post swallow residue.  There 
were significant differences between FEES and videofluroscopy pharyngeal residue 
severity scores with FEES residue scores consistently higher than those found on 
videofluroscopy.  As pharyngeal residue severity influences clinical judgement of 
aspiration, it was concluded that the findings of this study had clinical significance.  
A further analysis (Kelly et al., 2007) of simultaneous FEES and videofluroscopy of 
the same group of patients investigated whether types of dysphagia examination 
(FEES or videofluroscopy) influences scoring of penetration and aspiration.  15 
subjects and methods were the identical to those previously described (Kelly et al., 
2006).  15 raters scored both FEES and videofluroscopy exams using the Penetration 
Aspiration Scale (PAS)(Rosenbek et al., 1996).  All 15 raters consistently awarded 
higher scores (more severe) PAS scores to FEES images than to videofluroscopic 
images of the same swallow.   
As simultaneous FEES and videofluroscopy can be technically difficult to execute, 
several studies have undertaken the use of these tools consecutively (Bastian, 1993, 
Langmore et al., 1991, Perie et al., 1998, Wu et al., 1997b, Madden et al., 2000).  An 
early study (Nayar et al., 1984) using consecutive flexible endoscopy and 
videofluroscopy in the laryngectomy population has been described.  While only 10% 
of the sample of this study reported dysphagia, this research indicated that flexible 
endoscopy was possible in the laryngectomy population for the purpose of swallow 
evaluation.  The simultaneous FEES and endoscopy study carried out by Rao and 
colleagues (Rao et al., 2003) indicated a good level of agreement between both tools 
on a number of criteria.  In addition this tool found that FEES detected pharyngeal 
residue more often than videofluroscopy.  Simultaneous FEES and videofluroscopy 
studies by Kelly and colleagues (Kelly et al., 2006) found that type of swallow 
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evaluation tool influences perception of post swallow residue with FEES residue 
scores consistently higher than on videofluroscopy.  A second simultaneous FEES 
and videofluroscopy study by the same group (Kelly et al., 2007) investigated 
whether type of evaluation tool influenced scoring of penetration and aspiration. 
Higher penetration and aspiration scores were consistently awarded by raters to 
images of FEES.  The simultaneous FEES and videofluroscopic studies described 
were all undertaken in subjects with a larynx.  The first part of this PhD study is the 
first investigation of simultaneous videoflurosopy and FEES to evaluate dysphagia in 
post laryngectomy patients. 
 
 
2.3 Methodologies 
This section describes (i) the development and use of a patient questionnaire to 
indicate which tool, if any, they preferred for the evaluation of swallowing. (ii)  the 
development and use of a scale for expert raters to judge videofluroscopic and 
endoscopic swallow exams (iii) the procedure for comparison of simultaneous 
videofluroscopy and endoscopy 
 
This section outlines patients’ views on videofluroscopy and FEES swallow 
examinations.  The methods used to design this questionnaire are discussed. The 
involvement of patients in the design and format of the questionnaire is outlined.  The 
topics identified by patients as important when considering swallow evaluations that 
they have had in the past are highlighted and described. 
 
2.3.1 Background 
 
The first part of this study compared FEES and Videofluroscopy as methods of 
assessing dysphagia in patients with laryngectomy. As a preliminary to this study, it 
was important to explore patients’ experience of the two examination techniques. If 
patients’ have strong preferences regarding invasive examinations they may refuse to 
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consent to the procedures. A review of the literature indicated that patients have not 
been surveyed about their preference for swallow evaluation tools. Clinical 
experience has indicated that some patients appreciate the ability to access endoscopy 
swallow examinations during routine clinical appointments instead of waiting up to 2 
weeks for a videofluroscopy swallow examination.  Some patients have mentioned 
that they find the videofluroscopy suite intimidating. Patients specifically disliked the 
need to change into a hospital gown, the often large number of health professionals 
present and the fact that the room is darkened for the assessment. There are some 
patients who dislike having an endoscope passed through their nose.  However, the 
experience of this clinician is that the majority of patients welcome the ability to have 
a FEES assessment without having to change into a gown, with just two health 
professionals present and with real food used instead of barium as part of their 
assessment.  Giving subjects participating in this research study the opportunity to 
express a preference for which swallow evaluation tool they preferred was central to 
this part of the study. The ultimate goal was to be able to make clear 
recommendations as to the best method to use to evaluate dysphagia in this patient 
group. Patient acceptance of the assessment method is important in making this 
recommendation.  
2.3.2 Objective  
To design a questionnaire to establish patient preference for the dysphagia evaluation 
tools of FEES and Videofluroscopy.  
2.3.3 Hypothesis 
Patients will have no preference for a dysphagia evaluation tool 
2.3.4 Methods:  
In order to establish the provisional content of the questionnaire, patients were 
surveyed about their opinion of possible issues that may be of importance to patients 
undergoing FEES and/or Videofluroscopy. 
10 patients who consented to participate in the survey, were selected over a period of 
5 weeks between July 15
th
 and August 19
th
 2010.  Patients were consecutively 
sampled as they attended Joint Head and Neck Clinic at Charing Cross Hospital 
during the timeframe specified. All patients approached to participate in this survey 
were attending a routine visit for clinical treatment.  All patients surveyed had 
undergone total laryngectomy or extended laryngectomy at least 3 months previously.   
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Once participants had consented to participate, they were interviewed about their 
experiences of having videofluroscopic swallow assessments with Speech and 
Language Therapy and endoscopic examinations during routine Otolaryngology 
appointments.  All laryngectomy patients have an endoscopic examination when 
attending routine Otolaryngology appointments.  Some patients also have experience 
of having an endoscopic examination with SLT to check voice prosthesis placement 
so patients were interviewed about their experience of both settings for endoscopy. 
Examples of preferred questionnaire types were also explored with the participants to 
establish which type of scale should be used e.g. Likert, VAS multiple choice.   
 
The responses were noted and transcribed for later simple thematic analysis. 
 
  The issues that arose were as follows: 
 
 Waiting for an appointment for a swallow evaluation can be frustrating and 
stressful for patients 
 Many patients dislike the taste of barium 
 Some patients dislike having an endoscope passed through their nose 
 Some patients would like to use the food they have difficulty swallowing as 
part of their swallow exam. 
 Some patients were concerned about radiation exposure 
A draft questionnaire was drawn up and re-circulated to the patients for further 
comment. Face validity was good with 100% of those surveyed indicating that this 
tool measured what it was supposed to.  Patients reported that this tool was 
appropriate to their needs and would be easy to complete as part of a research study. 
The final version of the questionnaire was again circulated for approval to the group 
of participants. 
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2.3.5 Results 
80% of patients expressed a preference for a Likert scale format.  Patients reported 
that they preferred indicating their opinion with words rather than marking a line on a 
VAS type tool.  Patients also indicated that the multiple choice style format appeared 
long and harder to complete than the Likert form. 
 
The following table presents topics identified by patients as important when 
interviewed about swallow evaluations and this questionnaire.  
Table 2-1: Topics identified by patients when interviewed about swallow 
evaluations 
 
Topics discussed by patients  Number of patients who identified this 
topic 
Dislike taste of barium 7 
Would prefer real food 8 
Dislike having endoscope passed 
through nose 
1 
Concerned about radiation with VF 
exams 
8 
Like seeing swallow exam on screen as 
it happens 
5 
Long waiting time in hospital for VF to 
start 
4 
Having more than 2 health 
professionals present for swallow exam 
3 
Having to put on a hospital gown for a 
swallow exam 
2 
Being provided with a choice for 
swallow exam 
7 
Having to remove earrings or other 
jewellery for VF  
2 
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The most common issues were used to formulate the questionnaire. Initially the 
questionnaire had 8 questions.  This was considered by patients to be too many so 2 
questions related to waiting time for exams and the ability to view swallow exams 
were eliminated. The final questionnaire was a 6 question 5-point Likert format 
questionnaire. For details of the final version please see appendix (appendix 1). 
Each subject was asked to complete the questionnaire after participating in 
simultaneous videofluroscopy and endoscopy swallow evaluation. 
2.3.6 Discussion 
 
The aim of this patient survey was to develop a questionnaire to establish patient 
preference for the dysphagia evaluation tools of FEES and Videofluroscopy.   In order 
to develop this questionnaire, it was considered essential to survey patients about their 
opinions on both FEES or endoscopy and Videofluroscopy.  The two most frequently 
occurring topics identified by patients were their preference to have real food during 
swallow evaluations and their concern about radiation exposure during 
Videofluroscopy exams.  The preference for real food is understandable and the issue 
of dislike of the taste of barium is closely related to this.  Many laryngectomy subjects 
have been treated with radiotherapy and sometimes chemotherapy in addition.  As a 
consequence of these treatments, they may experience xerostomia and taste alterations 
(Pelletier, 2007).  It is possible that these changes may have a negative effect when 
patients asked to swallow a viscous and sticky consistency such as barium.  The 
number of patients who expressed concern about radiation exposure was surprising 
given that Videofluroscopy swallow evaluation is considered a safe procedure 
(Bonilha et al., 2013). A study (Zammit-Maempel et al., 2007) of 230 subjects over a 
45 month period found that the effective dose associated with a typical 
videofluoroscopy dose-area product is 0.2 mSv.  This study also indicated that 
videofluroscopy could be performed using minimal doses.  When this issue was 
explored further with patients, most mentioned their concern about having any further 
radiation given their history of radiotherapy during treatment for head and neck 
cancer and the negative effects of that treatment. 
Being provided with a choice of swallow evaluation tool was identified as an 
important issue during this survey.  Head and neck cancer patients are typically well 
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informed and want to be in partnership with their medical or healthcare provider.  The 
recently published Choice Framework (DOH, 2013) by the Department of Health 
supports patient choice within the NHS when possible. Several patients indicated that 
they liked seeing their swallow evaluation on screen.   Often, patients don’t have the 
opportunity to watch videofluroscopy swallow evaluations immediately after they are 
performed as the clinic is typically busy.  While most patients have the opportunity to 
view videofluroscopic exams at a later date, those who had FEES welcomed the 
ability to watch their swallow on screen as it happened.  The effective use of FEES as 
a feedback tool during therapy has been documented (Leder et al., 2004).  It is 
possible that providing patients with feedback during swallow evaluation may be 
beneficial to patients. 
Other issues which were highlighted less frequently but may be no less important for 
individual patients included having to wait a long time in hospital for appointments 
such as videofluroscopy although this could also apply to FEES.  Dislike of a large 
number of health professionals during swallow examinations is a pertinent issue 
particularly in a large teaching hospital where students may need to be 
accommodated.  It is a relevant to consider this issue and to have a discussion with 
patients to ascertain their level of comfort with observers.  Generally patients are 
asked to place a hospital gown over clothing during videofluroscopic swallow 
evaluations to protect against spillage of barium but 2 of the subjects surveyed 
disliked this practice.   It may be helpful to check with patients whether their 
preference is to use a gown or not and to clarify that the purpose of suggesting a gown 
is to protect clothing rather than to infer that invasive medical procedure is about to 
take place.  Understandably, 2 patients disliked having to remove jewellery for the 
purposes of a Videofluroscopic swallow evaluation.  Once jewellery does not obscure 
imaging of the anatomical area under investigation, patients are usually encouraged to 
leave jewellery in place.  Only one subject complained that they disliked having a 
nasendoscope passed because of the discomfort that ensues.  Clinical observations 
support a typically high tolerance for passage of the nasendoscope in head and neck 
cancer patients. 
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2.3.7 Conclusions 
This patient survey facilitated the development of a questionnaire to establish patient 
preference for the dysphagia evaluation tools of FEES and Videofluroscopy.  
Although the sample involved was relatively small, involving patients directly in this 
survey strongly influenced and informed the development of the patient preference for 
the dysphagia evaluation tools questionnaire subsequently used in this study. 
 
 
2.4 The development of a scale for expert raters to judge 
Videofluroscopic and FEES swallow evaluations 
2.4.1 Introduction 
 
The first part of this study compared FEES and Videofluroscopy as methods of 
evaluating dysphagia in patients with laryngectomy. As a further preliminary to this 
study, it was important to identify a scale that could be used by expert raters to judge 
both of these tools in post laryngectomy patients.   While rating scales (Rosenbek et 
al., 1996, Huckabee, 2004, Martin Harris et al., 2008) exist for use with dysphagia 
patients with a larynx, at present no such scale exists for post laryngectomy patients.  
In addition, most of scales available are not designed for use with more than one type 
of swallow evaluation tool.  It was therefore necessary to develop a rating scale that 
evaluated the specific aspects of swallowing that were relevant to the laryngectomy 
population but which was also appropriate for use with both FEES and 
Videofluroscopy. 
2.4.2 Objective:  
 
To develop a rating scale that could be used to compare videofluroscopic and 
endoscopic laryngectomy swallow examinations for identification of symptoms of 
swallowing difficulty, judgment of voice quality and ease of visibility of voice 
prosthesis 
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2.4.3 Methods:  
 
Following a literature review of available rating scales for dysphagia, (Rosenbek et 
al., 1996), (Huckabee, 2004),  (Huckabee and Cannitto, 1999), (Martin Harris et al., 
2008), and for alaryngeal voice, (Hurren et al., 2009b), it was identified that the scale 
needed to include the following components:  
 Anatomical features pre swallow,  
 Phonation,  
 Voice prosthesis visibility,  
 Amount of residue post swallow,  
 Leakage through and around voice prosthesis 
 Reflux 
A draft rating scale was formulated based on the above components. This draft scale 
was subsequently refined through consultation with Head and Neck Surgeons, Speech 
and Language Therapists and patients.  The following section describes the process of 
establishing content and face validity. 
2.4.3.1 Content and Face Validity 
 
The face and content validity of the scale was established through discussion and 
consultation with experienced Head and Neck Surgeons and Speech and Language 
Therapists.  Additionally, a meeting with the laryngectomy support group at Charing 
Cross Hospital was convened to facilitate input from laryngectomy patients about the 
crucial aspects of their swallow difficulty and what should be included on this rating 
scale.  Patients identified excessive secretions as sometimes causing a barrier to 
swallowing.  Patients also indicated that the scale should include a component about 
voice prosthesis leakage particularly on thin liquids.  Patients said that while they 
often have food left behind in their throat after swallowing, it was important to look at 
how much food was left behind and not just the presence or absence of food residue.  
Patients made the point that food left behind and having to swallow several times was 
much more of an issue on solid foods.  This input resulted in the inclusion of 
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secretions, voice prosthesis leakage and degree (rather than just presence or absence) 
of residue after individual food consistency swallows.  This consultation process with 
Head and Neck Surgeons, expert Speech and Language Therapists and patients 
resulted in further refinement of the draft rating scale and the inclusion of the 
following list of items: 
 
 Presence and degree of secretions 
 Presence of pseudo epiglottis 
 Visibility and ease of visibility of voice prosthesis 
 Type and diameter of voice prosthesis 
 Position of voice prosthesis at rest 
 Quality of alaryngeal voice 
 Tonicity of alaryngeal voice 
 Ease of identification of vibratory segment 
 Presence and degree of stricture 
 Presence and degree of spasm 
 Presence and degree of residue on thin liquids, puree, soft and solid food 
consistencies 
 Presence and degree of leakage through voice prosthesis 
 Presence and degree of leakage around voice prosthesis 
 Presence and degree of bolus backflow/reflux. 
2.4.3.2 Expert raters 
 
Expert raters were chosen because they had at least 5 years’ experience working in a 
large Head and Neck cancer centre where they managed laryngectomy patients on a 
daily basis.  In addition, all 3 raters had completed the 6-day Royal Marsden 
Advanced Laryngectomy Rehabilitation continuing education module. The raters 
chosen were as follows: 
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Table 2-2: Expert rater details 
Name Title NHS Trust 
Ms. Yvonne Edels Macmillan Consultant SLT (Head and 
Neck/ENT) 
Imperial College Healthcare 
NHS Trust 
Ms. Sarah 
Pilsworth 
Macmillan Senior Specialist SLT  
(Head and Neck/ENT) 
Cambridge University Hospitals 
NHS Foundation Trust 
Ms. Sarah Adams Clinical Lead SLT (Head and Neck/ENT) Royal Marsden NHS Foundation 
Trust 
 
 
However, the scale also need to be assessed for intra and inter rater reliability. Good 
agreement between raters on what they are seeing when looking at both 
videofluroscopy and endoscopy exams would indicate that the scale is fit for purpose.  
If inter-rater reliability is poor, further rater training may be required or the scale may 
need to be adapted.  Intra-rater reliability is equally important to ensure that raters are 
being consistent when they are judging exams. The next sections describe first the 
training of the raters and then the assessment of inter- and intra-rater reliability. 
 
 
2.4.3.3 Training of expert raters to assess acceptability and feasibility of rating 
scale. 
 
 It is an important principle of psychometric measurement that a scientific test is 
objective and unbiased. Any human observer that takes clinical measures or has to 
score an instrument can be subject to bias. The raters in this study underwent training 
in an effort to maintain objectivity.   
The rating scale was presented to the 3 expert raters at the start of 2 days of training.  
A visual analogue scale and tick box format was chosen by the investigator for the 
scale and approved by each rater. The first day of training involved piloting and 
123 
 
refining the rating scale by watching, rating and discussing 10 Laryngectomy and 
other Head and Neck cancer videofluroscopy and endoscopy swallowing exams.   
Inconsistencies in rating scale results were discussed until a consensus was reached 
suggesting the scale was acceptable.  The second day of training involved rating only 
laryngectomy videofluroscopy and FEES swallow exams on 10 further patients.  This 
exercise confirmed that the rating scale was appropriate for use with both types of 
laryngectomy swallow exams.  Feasibility of the rating scale was discussed with each 
expert rater. Rating of each individual exam during the second day of training was 
timed with each exam taking less than 25 minutes to rate. Agreement was reached that 
it would be possible to rate each videofluroscopic and endoscopic swallow exam in 
less than 30 minutes.  This timing was important in calculating how long raters 
required away from clinical work to complete the rating of exams for 30 subjects and 
also in formulating a schedule to allow raters time to take 2 hourly breaks in rating 
exams.  It was estimated that rating would take 30 hours excluding breaks. 
The training session and subsequent review by the chosen expert raters showed the 
scales to be acceptable and feasible to use in a research setting. The mean time taken 
to complete the set of scales on training images from patients was 19 minutes for VF 
and 24 minutes for FEES. 
 
2.4.4 Results 
The objective of developing a rating scale that could be used to compare 
videofluroscopic and endoscopic laryngectomy swallow examinations for 
identification of symptoms of swallowing difficulty, judgment of voice quality and 
ease of visibility of voice prosthesis was achieved.  The final rating scale consists of 
25 main questions, with further sub questions, about pre swallow anatomy, voice 
prosthesis, phonation and swallow in a visual analogue scale with tick box format, see 
appendix for further details (appendix 2, Expert VF and FEES swallow rating scale 
for study 1).  Content and face validity were successfully established for this rating 
scale. 3 expert Speech and Language Therapists with extensive experience and 
training in voice and swallowing rehabilitation of laryngectomy patients were 
identified.  These clinicians kindly agreed to participate in this research study and 
124 
 
undertook 2 days training.  Acceptability and feasibility of the rating scale was 
demonstrated during training.  
 
 
 
2.4.5 Discussion 
 
There are several rating scales available to facilitate evaluation of swallowing in 
patients with a larynx (Rosenbek et al., 1996, Huckabee, 2004, Martin Harris et al., 
2008).  Some rating scales such as the MBSImP (Martin Harris et al., 2008) are 
designed specifically for use with Videofluroscopy.  One of the challenges in 
completing preliminary work for this study was the absence of a suitable rating scale 
for use with laryngectomy patients.  This lack of a suitable scale led to the 
development of one that was clinically relevant, acceptable and feasible. One of the 
crucial features of this scale is its’ suitability for use with both Videofluroscopic and 
FEES swallow evaluation tools.  Expert raters needed to be identified and trained in 
the use of the scale.  There is little guidance in the literature about the optimum 
amount of training required for Speech and Language Therapists to use a swallow 
evaluation scale effectively. An online course is offered to train Speech and Language 
Therapists to use the MBSImP (Martin Harris et al., 2008), a swallow rating scale 
used for the evaluation of videofluroscopy. Proficiency in scoring is reported to 
develop after only a short period of routine clinical use of the MBSImP. Seasoned 
MBSImP clinicians average 10 to 15 minutes to adequately score a study.  During 
training for this study, expert raters took an average of less than 24 minutes to rate 
each Videofluroscopic and FEES examination. FEES examinations took longer than 
Videofluroscopic examinations to rate.  The increased time required to rate FEES 
examinations is possibly due to initial rater unfamiliarity with using this tool to rate 
laryngectomy swallows. The difference between the time the time taken to rate a 
swallow evaluation with the MBSImP and the time taken by raters using the scale 
developed for this study may be due to the increased complexity involved in judging 
larygectomy swallows compared to the patients with a larynx.  While the scale 
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developed for this study is clinically relevant, it was primarily designed for use with a 
research study and its length reflects this.   
 
 
2.4.6 Conclusions 
 
This section described the development of a rating scale to compare videofluroscopic 
and endoscopic laryngectomy swallow examinations for identification of symptoms 
of swallowing difficulty, judgment of voice quality and ease of visibility of voice 
prosthesis.  Identification and training of 3 expert raters was also described.   
Once the rating scale had been developed, and expert raters had been identified and 
trained, the next task was to establish reliability for the scale.  The following section 
describes how this was achieved. 
 
 
2.5 Inter- and Intra rater reliability of experts’ rating scales 
 
2.5.1 Introduction 
 
The previous section described the methods used to develop two tools to collect 
important data for the first phase of this research programme.  These tools were (i) 
Patient questionnaire to assess preferred method of swallow evaluation (ii) Expert 
rating scale to judge Videofluroscopy and Endoscopy swallow evaluation. 
The expert rating scales were the main method of assessing the outcomes from the 
comparison of Videofluroscopy and FEES.  30 patients were recruited to have 
simultaneous FEES and VF assessments facilitating a direct comparison between the 
two techniques. Expert raters were blinded and independently assessed the 30 FEES 
evaluations and the 30 Videofluroscopy evaluations in order to rate them for 
anatomical features, phonation quality, visibility of voice prosthesis, presence and 
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degree of residue post swallow on each consistency and presence and degree of reflux 
or bolus backflow.  Unless raters demonstrate reliable scoring using the developed 
scales, the comparison between the methods will be potentially biased.   
 
Thus, I next undertook a study to test the developed scales for intra-rater reliability. 
The principles of psychometric measurement with a focus on reliability are discussed 
in this section.  The methods used to test intra rater and inter rater reliability are 
explained together with the statistical analysis used to analyse data.  Results are 
presented and discussed. 
 
2.5.2 Background 
In the process of developing a rating scale for both videofluroscopic and FEES 
examinations, principles of psychometric measurement were considered. 
Measurement is a way of understanding, evaluating and differentiating characteristics 
of people and objects (Portney and Watkins, 2009).  Measurement forms the basis for 
making decisions or drawing conclusions in scientific research.  (Rust and Golombok, 
2009) explain that the psychometric principles that maximize the quality of any 
assessment, test or rating scale are validity, standardization, objectivity and reliability. 
Validity concerns the extent to which an instrument measures what it’s supposed to. 
Face validity and content validity of this rating scale was easily established by getting 
expert opinions that the scale measured what is was supposed to and that it contained 
an adequate sample of the swallowing impairments that affect laryngectomy patients. 
Standardisation allows observations of an event to be made in a prescribed manner. 
For this reason, all raters were provided with and asked to use identical colour coded 
rating scales for both videofluroscopy and endoscopy swallow examinations. 
 
While validity, standardization and objectivity are vital components of psychometric 
measurement, the most crucial pre requisite for maximizing an assessment is 
reliability or how stable and dependent a test is (Portney and Watkins, 2009).  Portney 
and Watkins (Portney and Watkins, 2009) indicate that clinical expertise may not 
always match the level of precision required for research.   Intra rater reliability refers 
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to the stability of data recorded by one individual over one or more trials. Inter rater 
reliability concerns variation between 2 or more raters who measure the same group 
of subjects (Portney and Watkins, 2009).  In this study, inter rater reliability examined 
the variation between raters as they score the rating scale for both videofluroscopy 
and FEES.  As intra rater reliability should be established for each individual rater 
before comparing raters to each other (Portney and Watkins, 2009), intra rater 
reliability was investigated first.  
It is important that each rater can demonstrate an ability to score each scale with 
predictable consistency.  If statistical reliability is established then the accuracy of the 
data is robust and any research conclusions drawn are strengthened.   
 
2.5.3 Objective:  
 
To establish intra and inter rater reliability for the rating scale for expert raters when 
judging endoscopic and videofluroscopy swallow examinations. 
 
2.5.4 Results 
2.5.4.1 Intra rater reliability 
ICC and free marginal kappa of >0.6 was considered to indicate a good level of 
intrarater reliability.  Good intrarater reliability is demonstrated in greyscale in Table 
2.3. (Note questions indicated on this table and table 2.4 correspond to questions 
indicated in red on Expert VF and FEES swallow rating scale for study 1, see 
appendix 2.) Good intra rater reliability was observed on 40/66 questions (61%). As 
this represents the majority of questions, the hypothesis was accepted.  
 
 
Table 2-3: Inter rater reliability of expert rater scale to judge both 
Videofluroscopic and FEES swallow exams 
Q.  VF 
SP 
FEES 
SP 
VF SA FEES 
SA 
VF YE FEES 
YE 
1 Presence of 0.7 1.0 1.0 1.0 1.0 1.0 
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secretions kappa kappa kappa kappa 
2 Rate degree of 
secretions 
 
No 
varian
ce 
0.99icc 
0.99ca 
No 
variance 
0.99icc 
0.99ca 
No 
variance 
0.82icc 
0.90ca 
 
3 Presence of 
pseudo epiglottis 
1.0 1.0 1.0 1.0 1.0 0.4 
4 Ease of 
identification of 
pseudo epiglottis 
0.99ic
c 
0.99c
a 
0.99icc 
0.99ca 
0.98icc 
0.99ca 
1.0icc 
1.0ca 
No 
variance 
-0.02icc 
-0.04ca 
5 Voice prosthesis 
(vp) visibility 
No 
varian
ce 
1.0 1.0 1.0 1.0 1.0 
6 Ease of 
visualisation of vp 
0.95ic
c 
0.97 
ca 
0.78icc 
0.87ca 
0.93icc 
0.96ca 
1.0icc 
1.0ca 
0.85icc 
0.92ca 
0.35icc 
0.52ca 
7 Rate overall voice 
quality 
0.96ic
c 
0.98c
a 
0.92icc 
0.96ca 
0.96icc 
0.98ca 
0.96icc 
0.98ca 
0.92icc 
0.96ca 
0.99icc 
0.99ca 
8 Presence of tonic 
voice 
1.0 1.0 1.0 1.0 0.8 1.0 
9 Rate voice 
tonicity 
0.99ic
c 
0.99c
a 
0.99icc 
0.99ca 
0.57icc 
0.73ca 
0.99icc 
0.99ca 
0.93ic 
0.96ca 
0.99icc 
0.99ca 
10 Evidence of 
spasm 
1.0 1.0 1.0 1.0 1.0 1.0 
11 Identification of 
vibratory source 
1.0 1.0 1.0 1.0 0.7 1.0 
12 Ease of 
identification of 
vibratory source 
0.91ic
c 
0.95c
a 
0.97icc 
0.99ca 
0.64icc 
0.78ca 
No 
variance 
0.84icc 
0.91ca 
0.99icc 
0.99ca 
13 Evidence of 
stricture 
1.0 1.0 1.0 1.0 1.0 1.0 
14 Degree of 
stricture 
0.99ic
c 
0.99 
ca 
1.0icc 
1.0ca 
No 
variance 
No 
variance 
0.94icc 
0.97ca 
0.80icc 
0.89ca 
15 Neopharynx 
visible post thin 
liquids 
1.0 1.0 1.0 1.0 1.0 1.0 
16 Neopharyngeal 
residue visible 
post thin liquids 
1.0 1.0 1.0 0.4 1.0 1.0 
17 Ease of 0.64ic 0.84icc 0.85icc No 0.43icc 0.99icc 
129 
 
identification of 
neopharyngeal 
residue thin 
liquids 
c 
0.78c
a 
0.91ca 0.93ca variance 0.60ca 0.99ca 
18 Rate 
neopharyngeal 
residue on thin 
liquids 
0.94ic
c 
0.97c
a 
0.91icc 
0.95ca 
0.82icc 
0.90ca 
No 
variance 
0.90icc 
0.95ca 
0.99icc 
1.0ca 
19 Vp residue thin 
liquids 
1.0 1.0 1.0 1.0 1.0 1.0 
20 Ease of 
identification of 
vp residue thin 
liquids 
0.88ic
c 
0.94c
a 
0.94icc 
0.97ca 
0.99icc 
1.0 ca 
-0.15 icc 
-0.35ca 
0.1icc 
0.18ca 
0.50icc 
0.66ca 
21 Rate vp residue 
on thin liquids 
0.93ic
c 
0.97c
a 
0.96icc 
0.98ca 
1.0icc 
1.0ca 
0.84icc 
0.91ca 
-0.32icc 
-0.65ca 
0.88icc 
0.84ca 
22 Presence of 
oesophageal 
residue on thin 
liquids 
1.0 1.0 1.0 1.0 1.0 1.0 
23 Ease of 
identification of 
oesophageal 
residue on thin 
liquids 
No 
varian
ce 
 
1.0icc 
1.0ca 
0.26icc 
0.41ca 
0.27icc 
0.43ca 
0.60icc 
0.75ca 
0.82icc 
0.90ca 
24 Rate oesophageal 
residue on thin 
liquids 
No 
varian
ce 
 
0.96icc 
0.98ca 
0.67ic 
0.80ca 
0.97icc 
0.99ca 
0.57icc 
0.72ca 
0.56icc 
0.71ca 
25 Neopharynx 
visible post puree 
1.0 1.0 1.0 1.0 1.0 1.0 
26 Neopharyngeal 
residue visible 
post puree 
1.0 1.0 1.0 0.1 1.0 1.0 
27 Ease of 
identification of 
Neopharyngeal 
residue on puree 
0.74ic
c 
0.85c
a 
0.71icc 
0.83ca 
1.0icc 
1.0ca 
No 
variance 
0.84icc 
0.91ca 
1.0icc 
1.0ca 
28 Rate 
neopharyngeal 
residue on puree 
0.92ic
c 
0.96c
a 
0.63icc 
0.77ca 
0.97icc 
0.98ca 
No 
variance 
0.95icc 
0.98ca 
0.89icc 
0.94ca 
29 Vp residue on 
puree 
1.0 1.0 1.0 1.0 1.0 1.0 
30 Ease of 
identification of 
VP residue on 
puree 
0.96ic
c 
0.98c
a 
0.78icc 
0.87ca 
0.67icc 
0.80ca 
0.15icc 
0.25ca 
0.88icc 
0.93ca 
0.20icc 
0.34ca 
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31 Rate vp residue 
on puree 
0.21ic
c 
0.34c
a 
0.22icc 
0.36ca 
0.88icc 
0.93ca 
0.94icc 
0.97ca 
0.59icc 
0.74ca 
0.26icc 
0.41ca 
32 Presence of 
oesophageal 
residue on puree 
1.0 1.0 1.0 1.0 1.0 0.7 
33 Ease of 
identification of 
oesophageal 
residue on puree 
0.98ic
c 
0.99c
a 
0.85icc 
0.92ca 
0.68icc 
0.81ca 
0.045icc 
0.086ca 
0.78icc 
0.88ca 
0.77icc 
0.87ca 
34 Rate oesophageal 
residue on puree 
1.0icc 
1.0 ca 
0.65icc 
0.79ca 
0.66icc 
0.79ca 
0.67icc 
0.80ca 
0.84icc 
0.92ca 
0.13icc 
0.24ca 
35 Neopharynx 
visible post soft 
1.0 1.0 1.0 1.0 1.0 1.0 
36 Neopharyngeal 
residue visible on 
soft 
0.7 1.0 1.0 0.1 1.0 1.0 
37 Ease of 
identification of 
neopharyngeal 
residue on soft 
-
0.14ic
c 
-
0.33c
a 
0.92icc 
0.96ca 
0.83icc 
0.90ca 
No 
variance 
0.06icc 
0.12ca 
 
0.94icc 
0.97ca 
38 Rate 
neopharyngeal 
residue on soft 
0.98ic
c 
0.99c
a 
0.96icc 
0.98ca 
0.95icc 
0.98ca 
No 
variance 
0.95icc 
0.97ca 
0.98icc 
0.99ca 
39 Presence of vp 
residue on soft 
1.0 1.0 1.0 1.0 1.0 1.0 
40 Ease of 
identification of 
residue on vp on 
soft 
0.77ic
c 
0.87c
a 
0.89icc 
0.94ca 
0.99icc 
0.99ca 
0.62icc 
0.76ca 
0.89icc 
0.94ca 
-0.34icc 
-1.05ca 
41 Rate vp residue 
on soft 
0.96ic
c 
0.98c
a 
0.99icc 
0.99ca 
0.99icc 
1.0ca 
0.98icc 
0.99ca 
-0.23icc 
-0.58ca 
0.88icc 
0.94ca 
42 Presence of 
oesophageal 
residue on soft 
1.0 1.0 1.0 1.0 1.0 0.7 
43 Ease of 
identification of 
oesophageal 
residue on soft 
0.99ic
c 
0.99c
a 
0.50 icc 
0.66ca 
0.88icc 
0.95ca 
0.11icc 
0.20ca 
0.61icc 
0.75ca 
0.04icc 
0.07ca 
44 Rate oesophageal 
residue on soft 
0.95ic
c 
0.97c
a 
0.80icc 
0.88ca 
 
0.95icc 
0.97ca 
0.97icc 
0.98ca 
0.90icc 
0.95ca 
-0.09icc 
-0.19ca 
45 Neopharynx 1.0 1.0 1.0 1.0 1.0 0.7 
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visible post solid 
46 Neopharyngeal 
residue visible on 
solid 
1.0 0.7 1.0 1.0 1.0 0.7 
47 Ease of 
identification of 
neopharyngeal 
residue on solid 
0.81ic
c 
0.89c
a 
0.77icc 
0.87ca 
1.0icc 
1.0ca 
No 
variance 
0.70icc 
0.80ca 
0.002icc 
0.003ca 
48 Rate 
neopharyngeal 
residue on solid 
0.87ic
c 
0.93c
a 
0.93icc 
0.96 ca 
0.95icc 
0.97ca 
No 
variance 
0.93icc 
0.96ca 
0.96icc 
O.98ca 
49 Presence of vp 
residue on solid 
1.0 0.7 1.0 1.0 0.7 1.0 
50 Ease of 
identification of 
vp residue on 
solid 
0.92ic
c 
0.96c
a 
0.85icc 
0.93ca 
0.95icc 
0.98ca 
-0.09icc 
-0.20ca 
-0.08icc 
-0.17ca 
 
0.73icc 
0.84ca 
51 Rate residue on 
vp on solid 
0.56ic
c 
0.72c
a 
0.99icc 
0.99ca 
0.96icc 
0.98ca 
0.88icc 
0.93ca 
0.58icc 
0.73ca 
0.97icc 
0.98ca 
52 Presence of 
oesophageal 
residue on solid 
1.0 1.0 1.0 1.0 0.7 0.7 
53 Ease of 
identification of 
oesophageal 
residue on solid 
No 
varian
ce 
0.98icc 
0.99ca 
0.97icc 
0.98ca 
-0.20icc 
-0.49ca 
0.12icc 
0.21ca 
-0.30icc 
-0.85ca 
54 Rate oesophageal 
residue on solid 
No 
varian
ce 
0.93icc 
0.96ca 
0.90icc 
0.95ca 
0.99icc 
0.99ca 
0.82icc 
0.90ca 
0.87icc 
0.93ca 
55 Central leakage 
of vp 
1.0 0.4 1.0 1.0 1.0 1.0 
56 Ease of 
identification of 
leakage through 
vp 
0.99ic
c 
0.99c
a 
0.20icc 
0.33ca 
No 
variance 
No 
variance 
No 
variance 
No 
variance 
57 Rate central vp 
leakage 
0.92ic
c 
0.96c
a 
0.52icc 
0.69ca 
No 
variance 
No 
variance 
No 
variance 
No 
variance 
58 Peripheral vp 
leakage 
1.0 1.0 1.0 1.0 1.0 1.0 
59 Ease of 
identification of 
peripheral vp 
leakage 
No 
varian
ce 
No 
variance 
No 
variance 
No 
variance 
No 
variance 
No 
variance 
60 Rate peripheral No No No No No No 
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vp leakage varian
ce 
 
variance variance variance variance variance 
61 Presence of 
backflow/reflux 
1.0 1.0 1.0 1.0 0.7 0.7 
62 Ease of 
identification of 
backflow/reflux 
0.70ic
c 
0.82c
a 
0.46icc 
0.63ca 
No 
variance 
No 
variance 
0.99icc 
0.99ca 
No 
variance 
63 Rate 
backflow/reflux 
0.93ic
c 
0.96c
a 
0.93icc 
0.96ca 
No 
variance 
No 
variance 
0.06icc 
0.11ca 
No 
variance 
64 Vp type 1.0 1.0 1.0 1.0 1.0 1.0 
65 Vp diameter 1.0 1.0 1.0 1.0 0.73 1.0 
66 Vp position at 
rest 
1.0 1.0 1.0 1.0 1.0 1.0 
 
 
2.5.4.2 Results inter rater reliability 
ICC and free marginal kappa of >0.6 was considered to indicate a good level of inter 
rater reliability.  Good inter rater reliability is demonstrated in greyscale in table 2.4.  
Good inter rater reliability was observed on 22/66 questions (33%) on 
videofluroscopy and 25/66 (38%) questions on FEES. As this does not represent the 
majority of questions, the hypothesis was rejected.   
Table 2-4: Inter rater reliability of expert rater scale to judge both 
Videofluroscopic and FEES swallow exams 
 
 
Q Description VF 1
st
 rating VF 2
nd
 
rating 
FEES 1
st
 
rating 
FEES 2
nd
 
rating 
1 Presence of secretions 0.79 kappa 0.99 kappa 0.99 kappa 0.99 kappa 
2 Rate degree of secretions No variance No 
variance 
0.88 icc 
0.88 ca 
0.95 icc 
0.94 ca 
3 Presence of pseudo 
epiglottis 
0.79 kappa 0.79 kappa 0.60 kappa 0.60 kappa 
4 Ease of identification of 
pseudo epiglottis 
0.72 icc 
0.72 ca 
0.73 icc 
0.73 ca 
-0.04 icc 
-0.04 ca 
0.53 icc 
0.55 ca 
5 Voice prosthesis (vp) 
visibility 
0.60 kappa 0.60 kappa 0.99 kappa 0.99 kappa 
6* Ease of visualisation of vp 0.39 icc 
0.47 ca 
0.39 icc 
0.31 ca 
0.06 icc 
0.24 ca 
0.27 icc 
0.5 ca 
7 Rate overall voice quality 0.76 icc 
0.80 ca 
0.73 icc 
0.75 ca 
0.87 icc 
0.86 ca 
0.80 icc 
0.77 ca 
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8* Presence of tonic voice 0.33 kappa 0.59 kappa 0.39 kappa 0.39 kappa 
9* Rate voice tonicity 0.35 icc 
0.31 ca 
0.64 icc 
0.60 ca 
0.65 icc 
0.77 ca 
0.69 icc 
0.80 ca 
10* Evidence of spasm 0.59 kappa 0.60 kappa 0.39 kappa 0.39 kappa 
11* Identification of vibratory 
source 
0.60 kappa 0.39 kappa 0.19 kappa 0.19 kappa 
12* Ease of identification of 
vibratory source 
0.75 icc 
0.73 ca 
0.55 icc 
0.56 ca 
-0.56 icc 
-0.85 ca 
-0.83 icc 
-0.16 ca 
13 Evidence of stricture 0.19 kappa 0.19 kappa 0.79 kappa 0.79 kappa 
14 
* 
Degree of stricture -0.21 icc 
-0.25 ca 
-0.20 icc 
-0.19 ca 
0.72 icc 
0.72 ca 
0.56 icc 
0.56 ca 
15 Neopharynx visible post 
thin liquids 
0.99 kappa 0.99 kappa 0 kappa 
(no 
agreement) 
0 kappa (no 
agreement) 
16 Neopharyngeal residue 
visible post thin liq 
0.60 kappa 0.60 kappa -0.1 kappa -0.3 kappa 
17 
* 
Ease of identification of 
neopharyngeal residue thin 
liquids 
-0.13 icc 
-0.82 ca 
-0.09 icc 
-0.288 ca 
-0.70 icc 
-0.60 ca 
-0.45 icc 
-0.41 ca 
18 Rate neopharyngeal residue 
on thin liquids 
0.49 icc 
0.52 ca 
0.55 icc 
0.59 ca 
0.64 icc 
0.64 ca 
0.36 icc 
0.51 ca 
19 Vp residue thin liquids 0.39 kappa 0.39 kappa 0.99 kappa 0.99 kappa 
20 
* 
Ease of identification of vp 
residue thin liquids 
0.58 icc 
0.80 ca 
-0.21 icc 
-0.03 ca 
0.65 icc 
0.70 ca 
0.36 icc 
0.52 ca 
21 Rate vp residue on thin 
liquids 
0.77 icc 
0.77 ca 
0.21 icc 
0.19 ca 
0.83 icc 
0.87 ca 
0.72 icc 
0.74 ca 
22 Presence of oesophageal 
residue on thin liquids 
0 kappa (no 
agreement) 
0 kappa 
(no 
agreement) 
0.19 kappa 0.19 kappa 
23 
* 
Ease of identification of 
oesophageal residue on thin 
liquids 
-0.10 icc 0.34 icc 
0.24 ca 
-1.13 icc 
-1.0 ca 
-0.83 icc 
-1.6ca 
24 Rate oesophageal residue on 
thin liquids 
0.19 icc 
0.21 ca 
0.28 icc 
0.30 ca 
0.35 icc 
0.42 ca 
0.15 icc 
0.27ca 
25 Neopharynx visible post 
puree 
0.99 kappa 0.99 kappa 0 kappa 0 kappa 
26 Neopharyngeal residue 
visible post puree 
0.60 kappa 0.60 kappa -0.1 kappa -0.39 kappa 
27 
* 
Ease of identification of 
Neopharyngeal residue on 
puree 
-0.40 icc 
-0.38 ca 
-0.36 icc 
-0.49 ca 
-1.23 icc 
-2.1 ca 
-1.7 icc 
-8.1 ca 
28 Rate neopharyngeal residue 
on puree 
0.87 icc 
0.91 ca 
0.83 icc 
0.87 ca 
-0.25 icc 
-0.27 ca 
0.20 icc 
0.22 ca 
29 Vp residue on puree 0.39 kappa 0.39 kappa 0.79 kappa 0.79 kappa 
30 
* 
Ease of identification of Vp 
residue on puree 
-0.32 icc 
-0.86 ca 
-0.43 
-0.99ca 
0.31 icc 
0.88 ca 
-0.16 icc 
-1.11 ca 
31 Rate vp residue on puree 0.44 icc 
0.51 ca 
0.23 icc 
0.27 ca 
0.10 icc 
0.03 ca 
0.35 icc 
0.43 ca 
32 Presence of oesophageal 0.19 kappa 0.19 kappa 0.49 kappa 0.60 kappa 
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residue on puree 
33 
* 
Ease of identification of 
oesophageal residue on 
puree 
-0.12 icc 
-0.14 ca 
-0.07 icc 
-0.15 ca 
0.45 icc 
0.57 ca 
0.13 icc 
0.26 ca 
34 Rate oesophageal residue on 
puree 
0.14 icc 
0.20 ca 
0.25 icc 
0.31 ca 
0.31 icc 
0.79 ca 
0.47 icc 
0.71 ca 
35 Neopharynx visible post soft 0.99 kappa 0.99kappa 0 kappa 
(no 
agreement) 
0 kappa (no 
agreement) 
36 Neopharyngeal residue 
visible on soft 
0.79 kappa 0.79 kappa -0.10 kappa -0.30 kappa 
37 
* 
Ease of identification of 
neopharyngeal residue on 
soft 
0.008 icc 
0.01 ca 
0.42 icc 
0.52 ca 
-0.33 icc 
-0.45 ca 
-0.43 icc 
-0.55 ca 
38 Rate neopharyngeal residue 
on soft 
0.91 icc 
0.91 ca 
0.91 icc 
0.91 ca 
0.70 icc 
0.73 ca 
0.70 icc 
0.73 ca 
39  Presence of vp residue on 
soft 
0.39 kappa 0.39 kappa 0.60 kappa 0.60 kappa 
40 
* 
Ease of identification of 
residue on vp on soft 
0.45 icc 
0.73 ca 
0.57 icc 
0.77 ca 
-0.16 icc 
-0.26 ca 
-0.93 icc 
-0.24 ca 
41 Rate vp residue on soft 0.28 icc 
0.24 ca 
0.97 icc 
0.97 ca 
0.96 icc 
0.96 ca 
0.96 icc 
0.95 ca 
42 Presence of oesophageal 
residue on soft 
0.39 kappa 0.46 kappa 0.70 kappa 0.70 kappa 
43 
* 
Ease of identification of 
oesophageal residue on soft 
-0.00 icc 
-0.00 ca 
-0.53 icc 
-1.01 ca 
0.064 icc 
0.113 ca 
-0.02 icc 
-0.04 ca 
44  Rate oesophageal residue on 
soft 
0.26 icc 
0.25 ca 
0.47 icc 
0.51 ca 
-0.063 icc 
-0.955 ca 
0.077 icc 
0.24 ca 
45 Neopharynx visible post 
solid 
0.99 kappa 0.99 kappa 0 kappa 0 kappa 
46 Neopharyngeal residue 
visible on solid 
0.79 kappa 0.79 kappa -0.30 kappa -0.30 kappa 
47 
* 
Ease of identification of 
neopharyngeal residue on 
solid 
0.22 icc 
0.22 ca 
0.61 icc 
0.65 ca 
-0.025 icc 
-0.032 ca 
0.59 icc 
0.65 ca 
48 Rate neopharyngeal residue 
on solid 
0.94 icc 
0.93 ca 
0.92 icc 
0.95 ca 
0.66 icc 
0.67 ca 
0.64 icc 
0.67 ca 
49 Presence of vp residue on 
solid 
0.19 kappa 0.19 kappa 0.99 kappa 0.99 kappa 
50 
* 
Ease of identification of vp 
residue on solid 
0.0 icc 
0.3 ca 
-0.42 icc 
-1.5 ca 
0.29 icc 
0.56 ca 
0.11 icc 
0.27 ca 
51 Rate residue on vp on solid 0.18 icc 
0.23 ca 
0.73 icc 
0.75 ca 
0.93 icc 
0.98 ca 
0.88 icc 
0.91 ca 
52 Presence of oesophageal 
residue on solid 
0 kappa 0.19 kappa 0.30 kappa 0.39 kappa 
53 
* 
Ease of identification of 
oesophageal residue on solid 
0.18 icc 
0.34 ca 
0.15 icc 
0.35 ca 
0.02 icc 
0.18 ca 
0.19 icc 
0.39 ca 
54 Rate oesophageal residue on 
solid 
0.25 icc 
0.30 ca 
0.25 icc 
0.30 ca 
0.12 icc 
0.39 ca 
0.18 icc 
0.49 ca 
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55 Central leakage of vp 0.79 kappa 0.79 kappa 0.60 kappa 0.79 kappa 
56 
* 
Ease of identification of 
leakage through vp 
0 icc 
0 ca 
0 icc 
0 ca 
0 icc 
0 ca 
0 icc 
-3.3 ca 
57 
* 
Rate central vp leakage 0 icc 
0 ca 
0 icc 
-3.3 ca 
0 icc 
0 ca 
0 icc 
0 ca 
58 Peripheral vp leakage 0.99 kappa 0 kappa 
(no 
agreement) 
0.99 kappa 0.99 kappa 
59 Ease of identification of 
peripheral vp leakage 
No variance No 
variance 
No 
variance 
No variance 
60 Rate peripheral vp leakage No variance No 
variance 
No 
variance 
No variance 
61 Presence of backflow/reflux 0.19 kappa 0.19 kappa 0.60 kappa 0.60 kappa 
62* Ease of identification of 
backflow/reflux 
-0.14 icc 
-0.34 ca 
-0.19 icc 
-0.49 ca 
0.30 icc 
0.29 ca 
0 icc 
-3.3 ca 
63 Rate backflow/reflux 0.89 icc 
0.16 ca 
0.58 icc 
0.61 ca 
0.43 icc 
0.44 ca 
0 icc 
0 ca 
64 Vp type 0.52 kappa 0.52 kappa 0.99 kappa 0.99 kappa 
65 Vp diameter 0.46 kappa 0.28 kappa 0.64 kappa 0.64 kappa 
66 Vp position at rest 0.64 kappa 0.64 kappa 0.64 kappa 0.64 kappa 
 
2.5.5 Hypotheses 
 
 Raters will demonstrate good intra rater reliability on the majority of questions 
on the rating scale developed to judge both videofluroscopic and endoscopic 
swallowing evaluations 
 Raters will demonstrate good inter rater reliability on the majority of questions 
on the rating scale developed to judge both videofluroscopic and endoscopic 
swallowing evaluations 
 
2.5.6 Methods  
DVDs were prepared with movie recordings from 10 patients for both FEES and VF. 
These were anonymised so the raters were blinded to the patients they were assessing. 
All raters in this study were asked to rate 5 FEES examinations and 5 
videofluroscopic examinations twice with an interval of 7 days between each episode 
of rating. In an effort to reduce the possibility of raters being influenced by their 
memory of the first rating episode, all exams were blinded and a period of a week 
between both rating episodes was stipulated. Each set of movies were assessed using 
136 
 
the newly developed rating scales and following the first episode of rating, these 
scores were immediately returned to the investigator, so the rater had no record of 
their previous score when completing the second episode of rating. 
 
 
2.5.5.1 Statistical analysis of reliability 
 
Data elicited from the rating scale included both ratio level data from the VAS 
questions and categorical data from the “tick box” questions (see appendix 2, Expert 
VF and FEES swallow rating scale for study 1).  Portney and Watkins (Portney and 
Watkins, 2009) caution against the use of correlation coefficients as a method of 
testing reliability.  Correlations provide a measure of co variance rather agreement. 
This study requires the simultaneous reliability of 3 raters assessment and correlations 
are bivariate meaning that only 2 raters or ratings can be compared at a given time.  A 
further limitation of correlation as a measure of reliability is that they cannot separate 
out variance that arises because of error or true differences in a data set. 
The intraclass correlation coefficient was used to examine both intra rater and inter 
rater reliability on ratio level data. The intra class correlation coefficient is a means of 
producing a single index to describe reliability. Of clinical significance, the ICC can 
be used to assess reliability among 2 or more ratings and does not require the same 
number of raters for each test. Importantly, the ICC supports the generalizability 
model (Cronbach et al., 1972), (Mitchell, 1979) proposed by Cronbach as a 
comprehensive estimate of reliability.   It is calculated using variance estimates and 
can indicate both degree of correspondence and agreement among ratings.  It has a 
range of 0.00 to 1.00.  Statistical analysis of both intra rater and inter reliability of 
ratio level data was undertaken using PASW Statistics 19 software package.  
For intra rater reliability, two way mixed model design was used for analysis. In the 
two way mixed model, the rater is considered a fixed effect as they have been 
purposely, not randomly selected (Portney and Watkins, 2009).  In this model, 
subjects are considered a random effect because they were randomly chosen from the 
population of laryngectomy patients. The two way mixed model has been described as 
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the appropriate statistic to measure intra rater reliability as the measurements of a 
single rater cannot be generalised to other raters (Shrout and Fleiss, 1979). Single 
measures were extracted from the ICC for intra rater reliability because scores from 
individual raters were examined.   
For inter rater reliability, two way random model design was used for analysis.  In the 
two way random model, both raters and subjects are considered to be randomly 
chosen. The randomness may only be theoretical as raters and subjects are chosen 
who are believed to represent populations of interest (Portney and Watkins, 2009).  
The two way random model is chosen when each subject is assessed by the same set 
of raters and the intent is to demonstrate that measurement reliability can be applied 
to others (Portney and Watkins, 2009). Average measures were extracted from the 
ICC for intra rater reliability because the mean of all three raters was used as the unit 
of reliability (Portney and Watkins, 2009). 
Fleiss multi rater kappa is a chance adjusted index of agreement for multirater 
categorisation of nominal variables that is appropriate for fixed marginal 
validity(Fleiss, 1971).  Marginals are fixed when raters already know the quantity of 
cases that should be distributed into each category (Randolph, 2005).  In this study 
raters were not forced to assign a certain number of cases to each category and 
therefore had free rather than fixed marginals.  As this study also involved 3 raters, 
the multirater free marginal kappa was used to examine both intra and inter rater 
reliability for categorical data.  Statistical analysis of data of intra rater reliability of 
categorical data was undertaken using an online free marginal kappa calculator 
http://justusrandolph.net/kappa/ 
 
2.5.6 Discussion 
 
These results show that the rating scale had reasonable intra-rater reliability but poor 
inter-rater reliability. Due to these results, item reduction was undertaken and the 22 
questions marked with an asterisk were eliminated, reducing the rating scale to 44 
questions.  Following item reduction, 25/44 questions on FEES demonstrated inter 
rater reliability representing the majority of questions and supporting the original 
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hypothesis.  The modified 44 question rating scale was subsequently used by raters to 
judge videofluroscopic and endoscopic swallowing exams. 
The questions eliminated included those related to presence of tonic voice and degree 
of voice tonicity.  As will be discussed in a subsequent chapter, tonicity refers to the 
amount of pressure used to produce alaryngeal voice.  Questions related to tonicity 
were originally included because information about voice quality can sometimes 
assist with problem solving swallowing issues.  For example, if a patient presents with 
increased voice tone (hypertonicity), there may be increased tightness within the 
reconstructed throat which may limit swallowing in addition to voicing.  However, 
tonicity is a complex parameter that can vary significantly among individuals (Hurren 
et al., 2009a).  Given the poor inter rater reliability demonstrated, questions relating to 
tonicity were eliminated. 
Evidence of spasm was also eliminated as a question as poor inter rater reliability had 
been demonstrated.  Spasm is induced by insufflation of air into the oesophagus and 
neopharynx during voicing.  Normally closure of the constrictor muscles inhibits 
reflux and facilitates bolus advancement to the stomach but in laryngectomy patients, 
this phenomenon can limit air advancing to the neopharynx and can prevent voicing 
(Bayles and Deschler, 2004). If a patient undergoes a myotomy as described in 
chapter 1, 1.1.1 Anatomical and Physiological changes after laryngectomy p.20, this 
procedure generally prevents spasm.  
Identification of the vibratory source and ease of identification of the vibratory source 
were further questions related to voice.  However, similarly to the question about 
tonicity, questions relating to the vibratory source were initially included because 
information about the vibratory source may be relevant to problem solving 
swallowing problems.  For example, surgical treatment for dysphagia may include 
dilation if there is a narrowing or stricture within the reconstructed throat causing an 
obstruction to bolus flow.  Over dilation may have a negative effect on the ability of 
tissues to vibrate to produce voice.  While swallowing is of paramount importance in 
the rehabilitation of laryngectomy patients, the successful treatment of dysphagia 
often involves balancing the patient’s need to maintain a functional alaryngeal voice.  
However, as questions relating to the vibratory source did not demonstrate good inter 
rater reliability, these questions were eliminated. 
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Stricture is an area of limited dilation and abnormal tightness within the reconstructed 
throat or oesophagus after laryngectomy (Landera et al., 2010) which may impede 
bolus flow particularly on more solid food consistencies (Silverman and Deschler, 
2008).  Stricture is discussed in detail in chapter 1, 1.2.1.3, p38.  As poor inter rater 
reliability was demonstrated for this question, stricture was eliminated from the rating 
scale. 
During training, raters helped to refine and develop the expert rating scale.  Questions 
relating to “ease of identification….” of various variables were initially included on 
the request of raters.  Raters indicated that these questions may facilitate comparison 
on Videofluroscopic and FEES swallow examinations.  However, as inter rater 
reliability was poor for these questions, it was agreed that they should be eliminated. 
 
2.5.7 Conclusions 
While intra rater reliability of the rating scale was good, inter rater reliability was 
poor for several questions.  Item reduction was undertaken to eliminate the less 
reliable questions and to improve inter rater reliability for the majority of questions. 
The objective of this study was to establish intra and inter rater reliability for a rating 
scale for expert raters when judging endoscopic and videofluroscopy swallow 
examinations.  This objective was achieved.   
 
 
2.6 Comparison of simultaneous videofluroscopy and endoscopy 
2.6.1 Objectives 
 
To investigate which dysphagia evaluation tool more accurately identifies specific 
anatomical and physiological features (voice prosthesis type, secretions, 
pseudoepiglottis and regurgitation/reflux 
1. To investigate which dysphagia evaluation tool more accurately identifies 
presence of residue in three anatomical locations:  
 Neopharynx 
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 Voice prosthesis 
 Oesophagus 
2. To investigate whether subjects have a preference for one dysphagia 
evaluation tool 
 
 
 
2.6.2 Hypotheses 
1. There is no difference in the ability of Videofluroscopy and FEES imaging to 
examine the following parameters post laryngectomy. 
 Identification of type of voice prosthesis 
 Presence and degree of secretions 
 Presence of pseudoepiglottis 
 Presence and degree of bolus backflow or reflux 
 Presence and degree of residue in the neopharynx on thin liquids, 
puree, soft and solid 
 Presence and degree of residue on the voice prosthesis on thin liquids, 
puree, soft and solid 
 Presence and degree of residue in the oesophagus on thin liquids, 
puree, soft and solid. 
2. Patients will have an equal preference for both videofluroscopy and 
endoscopy swallow evaluation tools. 
 
 
 
2.6.3 Methods 
 
This section describes the procedure to compare simultaneous videofluroscopy and 
endoscopy,  
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2.6.3.1 Subjects 
Subjects with a laryngectomy were recruited to this study, from the outpatient 
caseload at Imperial College Healthcare NHS Trust, Charing Cross Hospital.  This is 
a large tertiary head and neck cancer referral centre which is part of the Northwest 
London cancer network. 
2.6.3.1.1 Inclusion criteria  
Women and men who had undergone either total laryngectomy or extended 
laryngectomy and who had undergone surgical voice restoration with a voice 
prosthesis in situ.  
2.6.3.1.2 Exclusion Criteria 
Subjects without voice prostheses, documented cognitive dysfunction, less than 3 
months post-surgery, less than 3 months post completion of postoperative radiation 
treatment or chemotherapy, or unable to easily tolerate placement of flexible 
nasendoscope were excluded 
2.6.3.2 Ethics 
Ethics application was submitted 26/02/2010 with approval granted by West London 
REC 3 on 24/05/2010. Ethics reference number is10/H0706/25.  Imperial College 
Healthcare Trust Joint Research Office approval was obtained on 05/08/2010. JRO 
reference number is JROHH0033.  A substantive amendment was submitted 
13/07/2010 to allow gastrografin contrast to be used as an alternative to liquid barium.  
In addition, an amendment was sought at this time to facilitate subjects taking drinks 
of water if needed in between trial swallows.  These amendments were sought to 
increase visualization of endoscopic view during swallow examination and to increase 
patient comfort during exam.  These amendments were approved 05/08/2010. 
(Approval letters, copy of consent and Patient Information Sheet (PIS) in appendix) 
 
 
2.6.3.3 Study process 
Suitable subjects were identified from the clinical caseload and invited to take part. 
Interested patients were then booked for an appointment where the following data 
were collected: 
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Weight, height and BMI  
  
Each subject then had his or her swallowing examined and recorded using 
simultaneous videofluroscopy and Fiberoptic Endoscopic Evaluation of Swallowing 
(FEES)  
 
FEES exams were recorded onto the Kay Pentax Swallow Work Station Model 7127e 
(Pentax New Jersey, USA) and videofluroscopy exams onto a Sony DVD recorder 
DVO 1000MD, (Sony, Weybridge, UK). The fluoroscopy unit GE Medical Systems 
Model UIH40CCD JK (GE, Amersham, UK) was used to capture images at a rate of 
30 frames per second. Each subject was initially positioned in the fluoroscopy 
machine in the lateral oblique plane to allow a clear view of the voice prosthesis.  A 
Pentax FNL10RBS flexible nasendoscope (Pentax New Jersey, USA) was passed 
through right nares and advanced from the velopharyngeal port, past the base of 
tongue to the level of the voice prosthesis. If the subject experienced discomfort when 
the scope was passed through the right nares, the scope was removed and passed 
through the left nares.  
The subject was then asked to swallow 3 trials each of 4 consistencies: thin fluid, 
puree, soft and solid.  These consisted, respectively, of: 
 10ml of Gastrografin radio opaque contrast (Bayer PLC, Newbury UK) with 
0.5ml Silver Spoon green food colouring, (British Sugar PLC) 
 10ml of Ambrosia Devon custard (Premier foods, St Albans UK) with barium 
(made from 150ml of custard mixed with 3 tablespoons of E-Z-HD barium 
sulfate powder (Bracco UK Ltd, High Wycombe, UK), 
 1 cm thick slice of a medium yellow banana smeared with 3ml of custard and 
barium mix, as described above. 
 ¼ digestive biscuit smeared with 3ml barium custard mix.   
 
The bolus was followed and recorded from the oral cavity to the upper oesophagus on 
all consistencies. After completion of 3 trials of each individual consistency, the 
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subject was asked to take a water rinse swallow.  The subject was then placed in the 
antero/posterior plane with flexible nasendoscope remaining in place.  The subject 
was then presented with 1 trial each of 4 consistencies: thin fluid, puree, soft and solid 
as before.  The bolus was followed and recorded from oral cavity to oesophagus on all 
consistencies in anterior/posterior plane.  It was considered important to observe 
patients swallowing in both planes in order to screen all stages of swallowing, 
including the oesophageal phase.   
 
Occasionally reflux or aerophagia (swallowing excess air) can occur which may 
impact on swallowing ability, and this can only be assessed by observing the 
oesophageal phase of the swallow using the antero/posterior plane. 
 
After the swallow examination, each subject was asked to complete a short 
questionnaire comparing FEES and videofluroscopy swallow exams using a 5 point 
Likert questionnaire with 6 questions, see appendix 1 Patient self-evaluation 
questionnaire, preference for swallow evaluation tool. See (section 2.4 The 
development of a scale for expert raters to judge Videofluroscopic and FEES swallow 
evaluations), for description of the development of this questionnaire. 
 
2.6.3.4 Methods of image data collection 
 
Using the dynamic recordings from both FEES and videofluroscopy, individual 
swallows from both simultaneous Videofluroscopy and FEES were extracted in AVI 
format for endoscopy and MPEG2 format for videofluroscopy. Both exams needed to 
be matched up using timelines for each subject.  In order to achieve this, both exam 
types had to be placed in Apple Final Cut Pro version 6.06, (Apple Inc., California, 
USA) which is a non-linear editing software application.  The MPEG2 
videofluroscopy exam format did not play natively in Final Cut Pro and needed to be 
placed in Handbrake version 0.9.5, a video transcoding programme to enable MPEG2 
to be converted into M4V format.  Each videofluroscopy exam took approximately 45 
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minutes to convert. Both the AVI files from endoscopy exams and the converted 
M4V files from the videofluroscopy exams were then put in the Final Cut Pro 
timeline. The M4V exams were recognised by Final Cut Pro but required further 
conversion into a QuickTime file (Apple Inc., California, USA) in order to be played 
natively in the timeline along with the AVI files extracted from the endoscopy exams. 
This conversion took approximately 1 hour for each videofluroscopy exam. Both 
endoscopy AVI files and the twice-converted videofluroscopy exams for individual 
subjects were then matched up for pre swallow anatomy, voice prosthesis, phonation 
and individual swallows by order and consistency using Final Cut Pro. This took an 
average of 3 hours per subject. The exams were then combined and titles were added 
to indicate subject number, pre swallow anatomy, voice prosthesis, phonation and 
individual swallows including order and consistency type. Finally, both endoscopy 
and videofluroscopy exams were re-exported in high definition 720pHD format to be 
viewed using Apple QuickTime player.  Apple QuickTime player was chosen over 
Windows Media Video (wmv) because the former was quicker to export to and 
offered better high definition visual quality. Apple QuickTime movies were then 
exported to 3 Western Digital My Passport 500GB super speed USB external hard 
drives (Western Digital, California, USA) for presentation to raters.  
Three independent expert raters with at least 5 years specialist knowledge of working 
with swallowing in head and neck cancer rehabilitation and with a post graduate 
diploma in laryngectomy rehabilitation were asked to judge pre swallow anatomy, 
voice and swallowing for both videofluroscopy and FEES using a visual analogue 
rating scale which was developed, quantified and standardized by the investigator (see 
2.4 The development of a scale for expert raters to judge Videofluroscopic and FEES 
swallow evaluations).  This scale includes the following parameters: 
 
 Ease of ability to identify specified anatomical features  
 Ease of ability to rate tonicity of voice 
 Presence or absence of voice prosthesis leakage 
 Ease of ability to identify voice prosthesis 
 Ease of ability to identify and rate amount of pharyngeal residue  
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The outcomes outlined above are routinely considered as part of dysphagia 
assessment but are normally judged through clinical expertise or informal rating 
scales.  
All recordings were anonymised and arranged in a random order prior to presentation 
to the raters. 
 
 
2.6.3.5 Measurement details 
 
All raters were presented with external hard drives containing videofluroscopy exams 
for each subject (including all trials and both planes of view) and from this data were 
asked to make assessments of the relevant parameters using the Expert VF and FEES 
swallow rating scale (see appendix 2).  Similarly, they were presented with endoscopy 
exams for each subject (all trials) and also asked to rate the parameters. 
Anonymisation and the random order of presentation of the images meant that the 
raters were not able to link each individual’s examinations from the different 
evaluation tools.  Thus, the raters would give an independent assessment of each 
videofluroscopy exam and each endoscopy exam, minimising assessment bias. 
 
2.6.3.6 Statistical Analysis 
The Statistical Advisory Service at Imperial College London provided a power 
calculation which determined sample size. 
Data was entered and analysed in IBM SPSS (Statistical Product and Service 
Solutions) version 20 (IBM Armonk, New York).    
Data was analysed for reliability and agreement. 
For categorical data, reliability was investigated for all 3 raters on videofluroscopy 
and on FEES using free marginal kappa.  For continuous data, reliability was 
investigated for all 3 raters using Intraclass Correlation Coefficient (ICC). 
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Analysis of agreement between FEES and Videofluroscopy was then undertaken. For 
agreement of categorical data, a consensus score for 3 raters was calculated from the 
ratings of each clinician.  Consensus score was calculated when 2 or more raters 
agreed.  When no consensus was achieved, this was indicated within the data.  For 
agreement of continuous data, consensus score was derived from an average of all 3 
raters. 
For agreement of categorical data, a contingency table was arranged quoting the 
number of positive responses. Data was then analysed using McNemars to assess 
whether the differences between videofluroscopy and FEES were significant. 
For agreement of continuous data, the difference between both FEES and 
Videofluroscopy as measured in millimetres on the visual analog scale was plotted 
against the mean score for each subject to produce a Bland-Altman plot. In 
calculating the difference between FEES and Videofluroscopy, Videofluroscopy was 
subtracted from FEES, therefore a positive mean difference represents a higher score 
from FEES, whereas a negative mean difference represents a higher score from 
Videofluroscopy.  The Mean and SD is quoted and a t-test was undertaken to assess 
significance. 
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2.6.4 Results  
 
2.6.4.1 Simultaneous Videofluroscopy and Endoscopy 
Complete data set was obtained for 30 subjects, which included 24 males and 6 
females. An additional 2 subjects were excluded due to failure of endoscopy 
recording equipment. Demographic characteristics are shown in Table 2.2.  
 
 
Table 2-5: Demographic characteristics 
Characteristic Mean SD Min Max 
Age (years) 66.3 8.6 43 81 
Time since surgery (mths) 89.9 63.25 4 225 
Gender Female 6 (20%) 
Male 24 (80%) 
Ethnicity Black/Black British 1 (3%) 
White 26 (87%) 
Asian/Asian British 10% 
Tumour Type T1 1 (0.3%) 
T2 4 (13.3%) 
T3 7 (23.3%) 
T4 11 (36.7%) 
Unknown 7(23.3%) 
Surgery 
 
Total Laryngectomy 22 (73.3%) 
Pectoralis Major Flap 3 (10%) 
Jejunum 3 (10%) 
Jejunum and pectoralis major 1 (3.3%) 
Radial forearm flap 1 (3.3%) 
Myotomy Yes 24 (80%) 
Not applicable 3 (10%) 
Unknown 2 (6.7%) 
Radiotherapy History Pre-operative XRT 13 (43.3%) 
Postoperative XRT 12 (40%) 
Pre and postoperative XRT 2 (6.7%) 
None 3 (10%) 
Chemotherapy History 
 
Pre op chemo 5 (16.7%) 
No chemo 25 (83%) 
Salvage surgery Yes 17 (56.7%) 
No 13 (43.3%) 
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BMI for each subject was calculated using the following formula: weight (kg)/[Height 
(m)]
2
  and is presented according to categories provided by the World Health 
Organisation (WHO, 2006), see Table 2-6. 
Table 2-6: BMI categories 
Category Value No. of subjects % of sample 
Underweight >18.5 0 0 
Normal 18.5-24.9 11 36.6% 
Overweight 25-29 11 36.6% 
Obese <30 8 26.6% 
 
 
 
 
 
Hypothesis 1 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
examine the following parameters post laryngectomy. 
 Identification of type of voice prosthesis 
 Presence and degree of secretions 
 Presence of pseudoepiglottis 
 Presence and degree of bolus backflow or reflux 
 Presence and degree of residue in the neopharynx on thin liquids, 
puree, soft and solid 
 Presence and degree of residue on the voice prosthesis on thin liquids, 
puree, soft and solid 
 Presence and degree of residue in the oesophagus on thin liquids, 
puree, soft and solid. 
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Parameter 1 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the type of voice prosthesis. 
Frequency analysis was undertaken to calculate percentage of correct prosthesis 
ratings from the following question on the dysphagia rating scale (described in section  
2.4 The development of a scale for expert raters to judge Videofluroscopic and FEES 
swallow evaluations) (see appendix 2 for full scale): Q 64 What type of voice 
prosthesis can you see? 
The results showed that in 40% (12/30) cases FEES imaging enabled an accurate 
identification of the prosthesis, however only 13.3% (4/30) of cases using 
Videofluroscopy imaging enabled an accurate identification (p=0.018). This result is 
significant, the parameter that there is no difference in the ability of Videofluroscopy 
and FEES imaging to enable accurate identification of the type of voice prosthesis is 
rejected. 
 
Parameter 2 
There is no difference in the ability of FEES and Videofluroscopy imaging to 
enable accurate identification of the presence and degree of secretions. 
Reliability was analysed for Q1 of the dysphagia rating scale: Are there secretions 
present? There was no variance amongst raters for reliability for FEES as all raters 
identified secretions on FEES on all subjects.  Similarly, all raters identified no 
secretions for each subject on Videofluroscopy.  Free marginal kappa for reliability of 
raters for FEES and for Videofluroscopy was 1.0 indicating good reliability.  
Agreement for Q1 was investigated by calculating the frequency of positive 
identification of secretions.  The results indicated that using FEES, 100 % of cases 
(30/30) had secretions identified, but 0% of cases using Videofluroscopy identified 
secretions (p value not possible to compute, as one variable is a constant). 
Degree of secretions was explored using Q2 of rating scale: Rate degree of 
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secretions?  Reliability for FEES on ICC = 0.86 indicating good reliability amongst 
raters. Reliability for Videofluroscopy on ICC =- 0.04 indicating poor reliability for 
this question. Agreement for Q2 was then investigated. Bland Altman analysis for 
degree of secretions as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of secretions of 19.3mm (SD=19.5). This was confirmed with a one-sample t-
test of the mean diff between FEES and Videofluroscopy.  Mean diff (CI 95%) 19.3 
(12.01, 26.58) p=0.000, p <0.05, indicating a significant difference between tools for 
degree of secretions. 
 
As the mean difference is not close to 0, the two swallow evaluation tools do not 
agree. As the SD is not close to 0, there is a large amount of variation between tools.  
The limits of agreement were -18.92 (LL) to 57.52 (UL) mm. It is expected that 95% 
of differences lie within the LL and UL interval.  In this case, there is a wide interval 
that 95% of the values lie within. 
 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of secretions, and this parameter was therefore rejected, FEES 
imaging enables greater identification of secretions.  It also appeared that FEES 
enabled a greater visualization of the degree of secretions compared to 
Videofluroscopy. 
 
Parameter 3 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence of pseudoepiglottis. 
Reliability was analysed for Q3 of the dysphagia rating scale: Is there a 
pseudoegiglottis present? Free marginal kappa amongst raters for FEES was 0.68 
indicating good reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.51 which approaches reliability. Agreement for Q3 was investigated by 
calculating the frequency of positive identification of pseudoepiglottis. The results 
showed that using both FEES and Videofluroscopy 10% (3/30) of cases had 
pseudoepiglottis identified (p=1.0). Therefore, this parameter was accepted and it was 
concluded that both imaging methods enabled identification of pseudoepiglotis with 
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similar accuracy. Degree of pseudoepiglottis was not judged on the rating scale as 
clinically this feature is noted to be present or absent and degree is not usually 
examined. 
 
Parameter 4 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of bolus backflow or 
reflux 
Reliability was analysed for Q61 of the dysphagia rating scale: Can you see bolus 
backflow or reflux?  Free marginal kappa amongst raters for FEES was 0.38 
indicating poor reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.07 indicating poor reliability.  Agreement for Q61 was investigated by 
calculating the frequency of positive identification of bolus backflow or reflux. The 
results showed that using FEES, 30 % of cases (10/30) had bolus backflow or reflux 
identified, while using Videofluroscopy 40% of cases (12/30) using FEES identified 
bolus backflow or reflux. p=0.74, >0.5 is not significant for one tool scoring more 
positive identifications of presence of bolus backflow or reflux. 
 
Degree of bolus backflow or reflux was explored using Q63 of rating scale: How 
would you rate degree of bolus backflow or reflux? Reliability for FEES on ICC = 
0.82 indicating good reliability amongst raters.  Reliability for Videofluroscopy on 
ICC = 0.39 indicating poor reliability amongst raters. Agreement for Q63 was then 
investigated.  Bland Altman analysis for degree of bolus backflow/reflux as indicated 
on the visual analogue scale comparing FEES with Videofluroscopy showed a mean 
difference between FEES and Videofluroscopy for degree of bolus backflow or reflux 
of 2.49mm (SD=17.8). As the mean difference is not close to 0, the two swallow 
evaluation tools on average disagree.  This was confirmed with a one sample t-test of 
the mean diff between FEES and Videofluroscopy. t-test mean diff (95 C.I) 2.49 (-
4.15, 9.13) p = 0.45, >0.5 is not significant. As the SD is not close to 0, there is a 
large amount of variation between tools indicating disagreement for individual 
subjects.  The limits of agreement were -32.39 (LL) to 37.37 (UL) mm. It is expected 
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that 95% of differences within the LL and UL interval.  In this case, there is a wide 
interval that 95% of the values lie within. 
This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence and degree of bolus backflow/reflux, and the parameter was therefore 
accepted. 
 
Parameter 5 
There is no difference in the ability of FEES and Videofluroscopy imaging to 
enable accurate identification of the presence and degree of residue on thin liquids 
in the neopharynx 
Reliability was analysed for Q16 of the dysphagia rating scale: Is neopharyngeal 
residue visible on thin liquids? Free marginal kappa amongst raters for FEES was 
0.11 indicating poor reliability.  Free marginal kappa amongst raters for 
Videofluroscopy was 0.2 indicating poor reliability.  Agreement for Q16 was 
investigated by analysing the frequency of positive identification of presence of 
neopharyngeal residue. The results showed that using FEES, 23.3 % of cases (7/30) 
had residue on thin liquids in the neopharynx identified, while using Videofluroscopy 
100% of cases (30/30) had residue on thin liquids in the neopharyx identified, p=0.00, 
<0.5 significant for FEES and Videofluroscopy being different to each other, with 
Videofluroscopy scoring more positive identifications of presence of residue on thin 
liquids in the neopharynx. 
 
Degree of residue on thin liquids in the neopharynx was explored using Q18 of rating 
scale: How much neopharyngeal residue is there on thin liquids? Reliability for FEES 
on ICC = 0.45 indicating poor reliability amongst raters. Reliability for 
Videofluroscopy on ICC = 0.76 indicating good reliability. Agreement for Q18 was 
then investigated. Bland Altman analysis for degree of neopharyngeal residue as 
indicated on the visual analogue scale comparing FEES with Videofluroscopy showed 
a mean difference between FEES and Videofluroscopy for degree of neopharyngeal 
residue on thin liquids of -10.98 mm (SD=15.87). As the mean difference is not close 
to 0, the two swallow evaluation tools on average do not agree.  This was confirmed 
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with a one-sample t-test of the mean diff between FEES and Videofluroscopy. t-test 
mean diff (95 C.I) -10.98 (-16.90, -5.05) p = 0.001, <0.5 significant for the two tools 
being different to each other. 
As the SD is not close to 0, there is a large amount of variation between tools 
indicating disagreement for individual subjects.  The limits of agreement were -42.09 
(LL) to 20.12 (UL) mm. It is expected that 95% of differences within the LL and UL 
interval.  In this case, there is a wide interval that 95% of the values lie within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of thin liquid residue in the neopharynx, and the parameter was 
therefore rejected, Videofluroscopy imaging enables greater identification of thin 
liquid residue in the neopharynx.  It also appeared that Videofluroscopy enabled a 
greater visualization of the degree of thin liquid residue in the neopharynx compared 
to FEES. 
 
Parameter 6 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue on puree in the 
neopharynx 
Reliability was analysed for Q26 of the dysphagia rating scale: Is neopharyngeal 
residue visible on puree?  Free marginal kappa amongst raters for FEES was 0.11 
indicating poor reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.24 indicating poor reliability.  Agreement for Q26 was investigated by 
calculating the frequency of positive identification of presence of neopharyngeal 
residue on puree. The results showed that using FEES, 6.6 % of cases (2/30) had 
residue on puree in the neopharynx identified, while using Videofluroscopy 83.3% of 
cases (25/30) had residue on puree in the neopharynx identified on FEES, p=0.00, 
<0.5 significant for FEES and Videofluroscopy being different to each other, with 
Videofluroscopy scoring more positive identifications of presence of residue on puree 
in the neopharynx. 
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Degree of residue on puree in the neopharynx was explored using Q28 of rating scale: 
How much neopharyngeal residue is there on puree? Reliability for FEES on ICC = -
0.05 indicating poor reliability amongst raters.  Reliability for Videofluroscopy on 
ICC = 0.78 indicating good reliability amongst raters. Agreement for Q61 was then 
investigated. Bland Altman analysis for degree of neopharyngeal residue as indicated 
on the visual analogue scale comparing FEES with Videofluroscopy showed a mean 
difference between FEES and Videofluroscopy for degree of neopharyngeal residue 
on puree of -20.11 mm (SD=22.92). As the mean difference is not close to 0, the two 
swallow evaluation tools on average do not agree.  This was confirmed with a one-
sample t-test of the mean diff between FEES and Videofluroscopy. t-test mean diff 
(95 C.I) -20.11 (-28.67, -11.55) p = 0.000, <0.5 significant for the two tools being 
different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
65.03 (LL) to 24.81 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of puree residue in the neopharynx, and the parameter was 
therefore rejected, Videofluroscopy imaging enables greater identification of puree 
residue in the neopharynx.  It also appeared that Videofluroscopy enabled a greater 
visualization of the degree of puree residue in the neopharynx compared to FEES. 
 
 
Parameter 7 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
neopharynx on soft 
Reliability was analysed for Q36 of the dysphagia rating scale: Is there neopharyngeal 
residue visible on soft.  Free marginal kappa amongst raters on FEES was 0.02 
indicating poor reliability.  Free marginal kappa amongst raters on Videofluroscopy 
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was 0.51 approaching reliability.  Agreement for Q36 was investigated by calculating 
the frequency of positive identifications of presence of neopharyngeal residue on soft. 
Results showed that using FEES, 13.3 % of cases (4/30) had residue on soft in the 
neopharynx identified, while using Videofluroscopy 86.6% of cases (26/30) had 
residue on soft in the neopharynx identified on FEES, p=0.00, <0.5 significant for 
FEES and Videofluroscopy being different to each other, with Videofluroscopy 
scoring more positive identifications of presence of residue on soft in the neopharynx. 
 
Degree of residue on soft in the neopharynx was explored using Q38 of rating scale: 
How much neopharyngeal residue is there on soft? Reliability for FEES on ICC = 
0.53 which approaches reliability amongst raters.  Reliability for Videofluroscopy on 
ICC = 0.87 indicating good reliability amongst raters.  Agreement for Q38 was then 
investigated.  Bland Altman analysis for degree of neopharyngeal residue as indicated 
on the visual analogue scale comparing FEES with Videofluroscopy showed a mean 
difference between FEES and Videofluroscopy for degree of neopharyngeal residue 
on soft of -14.55 mm (SD=24.61). As the mean difference is not close to 0, the two 
swallow evaluation tools on average do not agree.  This was confirmed with a one-
sample t-test of the mean diff between FEES and Videofluroscopy. t-test mean diff 
(95 C.I) -14.55 (-23.74, -5.36) p = 0.003, <0.5 significant for the two tools being 
different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
62.79 (LL) to 33.69 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of soft residue in the neopharynx, and the parameter was 
therefore rejected, Videofluroscopy imaging enables greater identification of soft 
residue in the neopharynx.  It also appeared that Videofluroscopy enabled a greater 
visualisation of the degree of soft residue in the neopharynx compared to FEES. 
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Parameter 8 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
neopharynx on solid 
Reliability was analysed for Q46 of the dysphagia rating scale: Is neopharyngeal 
residue visible on solid? Free marginal kappa amongst raters for FEES was 0.2 
indicating poor reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.6 indicating good reliability. Agreement for Q46 was investigated by 
calculating the frequency of positive identifications of neopharyngeal residue on 
solid. Results showed that using FEES, 6.6 % of cases (2/30) had residue on solid in 
the neopharynx identified, while using Videofluroscopy 80% of cases (24/30) had 
residue on solid in the neopharynx identified on FEES, p=0.00, <0.5 significant for 
FEES and Videofluroscopy being different to each other, with Videofluroscopy 
scoring more positive identifications of presence of residue on solid in the 
neopharynx. 
 
Degree of residue on solid in the neopharynx was explored using Q48 of rating scale: 
How much neopharyngeal residue is there on solid? Reliability for FEES on ICC = 
0.47 indicating poor reliability.  Reliability for Videofluroscopy on ICC = 0.86 
indicating good reliability. Agreement for Q48 was then investigated.  Bland Altman 
analysis for degree of neopharyngeal residue as indicated on the visual analogue scale 
comparing FEES with Videofluroscopy showed a mean difference between FEES and 
Videofluroscopy for degree of neopharyngeal residue on solid of -19.44 mm 
(SD=27.51). As the mean difference is not close to 0, the two swallow evaluation 
tools on average do not agree.  This was confirmed with a one-sample t-test of the 
mean diff between FEES and Videofluroscopy. t-test mean diff (95 C.I) -19.44(-
29.72, -9.17) p = 0.001, <0.5 significant for the two tools being different to each 
other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
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34.48 (LL) to 73.36 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of solid residue in the neopharynx, and the parameter was 
therefore rejected, Videofluroscopy imaging enables greater identification of solid 
residue in the neopharynx.  It also appeared that Videofluroscopy enabled a greater 
visualization of the degree of solid residue in the neopharynx compared to FEES. 
 
Parameter 9 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue on the voice 
prosthesis on thin liquids 
Reliability was analysed for Q19 of the dysphagia rating scale: Is there residue on the 
voice prosthesis on thin liquids.  Free marginal kappa amongst raters for FEES was 
0.6 indicating good reliability.  Free marginal kappa amongst raters for 
Videofluroscopy was 0.33 indicating poor reliability.  Agreement for Q19 was 
investigated by calculating the frequency of positive identifications of presence of 
residue on the voice prosthesis on thin liquids. Results showed that using FEES, 80 % 
of cases (24/30) had residue on thin liquids on voice prosthesis in the neopharynx 
identified, while using Videofluroscopy 73.3% of cases (22/30) had residue on the 
voice prosthesis on thin liquids identified, p=0.18, >0.5 not significant for FEES and 
Videofluroscopy being different to each other in terms of positive identifications of 
presence of residue on thin liquids on the voice prosthesis. 
 
Degree of residue on thin liquids on the voice prosthesis was explored using Q21 of 
rating scale: How much residue is on the voice prosthesis on thin liquids?  Reliability 
for FEES on ICC = 0.56 approaches reliability amongst raters.  Reliability for 
Videofluroscopy on ICC = 0.28 indicating poor reliability amongst raters.  Agreement 
for Q21 was then investigated.  Bland Altman analysis for degree of neopharyngeal 
residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
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degree of voice prosthesis residue on thin liquids of 22.03 mm (SD=21.68). As the 
mean difference is not close to 0, the two swallow evaluation tools on average do not 
agree.  This was confirmed with a one-sample t-test of the mean diff between FEES 
and Videofluroscopy. t-test mean diff (95 C.I) 22.03(13.93, 30.12) p = 0.001, <0.5 
significant for the two tools being different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
20.46 (LL) to 64.42 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are the same for assessing the 
presence of thin liquid residue on the voice prosthesis, but different for assessing the 
degree of thin liquid residue on the voice prosthesis.  The parameter was therefore 
rejected. It also appeared that FEES enabled a greater visualisation of the degree of 
thin liquid residue on the voice prosthesis compared to Videofluroscopy. 
 
 
Parameter 10 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue on the voice 
prosthesis on puree 
Reliability was analysed for Q29 of the dysphagia rating scale: Is there residue on the 
voice prosthesis on puree?  Free marginal kappa amongst raters for FEES was 0.64 
indicating good reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.51 which approaches reliability.  Agreement for Q29 was investigated by 
calculating the frequency of positive identifications of presence of residue on the 
voice prosthesis on puree.  Results showed that using FEES, 0 % of cases (0/30) had 
residue on puree on the voice prosthesis in the neopharynx identified, while using 
Videofluroscopy 90% of cases (27/30) had residue on the voice prosthesis on puree 
identified, p=0.0, <0.5 significant for FEES and Videofluroscopy being different to 
each other, with Videofluroscopy scoring more positive identifications of presence of 
residue on puree on the voice prosthesis. 
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Degree of residue on puree on the voice prosthesis was explored using Q31 of rating 
scale: How much residue is on the voice prosthesis on puree? Reliability for FEES on 
ICC =0.49 indicating poor reliability.  Reliability for Videofluroscopy on ICC =0.48 
indicating poor reliability.   
Agreement for Q31 was then investigated.  Bland Altman analysis for degree of 
neopharyngeal residue as indicated on the visual analogue scale comparing FEES 
with Videofluroscopy showed a mean difference between FEES and Videofluroscopy 
for degree of voice prosthesis residue on puree of 0.72 mm (SD=22.05). As the mean 
difference is not close to 0, the two swallow evaluation tools on average, do not agree.  
This was confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 0.72 (-7.51, -8.95) p = 0.859, >0.5 not 
significant for the two tools being different to each other. 
As the SD is not close to 0, there is a large amount of variation between tools 
indicating disagreement for individual subjects.  The limits of agreement were –
42.48(LL) to 43.93 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence of puree residue on the voice prosthesis, but similar for assessing the degree 
of puree residue and the parameter was therefore rejected. Videofluroscopy imaging 
enables greater identification of puree residue on the voice prosthesis.  However, 
videofluroscopy and FEES are similar in terms of visualisation of the degree of puree 
on the voice prosthesis. 
 
Parameter 11 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue on the voice 
prosthesis on soft 
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Reliability was analysed for Q39 of the dysphagia rating scale; Is there residue on the 
voice prosthesis on soft?  Free marginal kappa amongst raters for FEES was 0.42 
indicating poor reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.29 indicating poor reliability.  Agreement for Q39 was investigated by 
calculating the frequency of positive identifications of presence of residue on the 
voice prosthesis on soft. Results showed that using FEES, 93 % of cases (28/30) had 
residue on soft on the voice prosthesis in the neopharynx identified, while using 
Videofluroscopy 80% of cases (24/30) had residue on the voice prosthesis on soft 
identified, p=0.22, >0.5 not significant for FEES and Videofluroscopy being different 
to each other. 
Degree of residue on puree on the voice prosthesis was explored using Q41 of rating 
scale: How much residue is on the voice prosthesis on soft? Reliability for FEES on 
ICC = 0.76 indicating good reliability.  Reliability for Videofluroscopy on ICC =0.63 
indicating good reliability. 
 
Agreement for Q41 was then investigated.  Bland Altman analysis for degree of 
neopharyngeal residue as indicated on the visual analogue scale comparing FEES 
with Videofluroscopy showed a mean difference between FEES and Videofluroscopy 
for degree of voice prosthesis residue on soft of 9.11 mm (SD=26.74). As the mean 
difference is not close to 0, the two swallow evaluation tools on average, do not agree.  
This was confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 9.11 (-0.87, 19.1) p = 0.72, >0.5 not 
significant for the two tools being different to each other. 
As the SD is not close to 0, there is a large amount of variation between tools 
indicating disagreement for individual subjects.  The limits of agreement were -
43.3(LL) to 61.52 (UL) mm. It is expected that 95% of differences within the LL and 
UL interval.  In this case, there is a wide interval that 95% of the values lie within. 
This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence and degree of soft residue on the voice prosthesis, the parameter was 
therefore accepted. 
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Parameter 12 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue on the voice 
prosthesis on solid 
Reliability was analysed for Q49 of the dysphagia rating scale: Is there residue on the 
voice prosthesis on solid.  Free marginal kappa amongst raters on FEES was 0.07 
indicating poor reliability.  Free marginal kappa amongst raters on Videofluroscopy 
was 0.33 indicating poor reliability.  Agreement for Q49 was investigated by 
calculating the frequency of positive identifications of presence of residue on the 
voice prosthesis on solid.  
Results showed that using FEES, 93.3 % of cases (28/30) had residue on solid on the 
voice prosthesis identified, while using Videofluroscopy 66.6% of cases (20/30) had 
residue on the voice prosthesis on solid identified, p=0.39, >0.5 not significant for 
FEES and Videofluroscopy being different to each other. 
Degree of residue on puree on the voice prosthesis was explored using Q51 of rating 
scale: How much residue is on the voice prosthesis on solid?  Reliability for FEES on 
ICC = 0.67 indicating good reliability.  Reliability for Videofluroscopy on ICC = 0.66 
indicating good reliability. 
Agreement for Q51 was then investigated.  Bland Altman analysis for degree of voice 
prosthesis residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of voice prosthesis residue on solid of 5.88 mm (SD=25.02). As the mean 
difference is close to 0, the two swallow evaluation tools on average agree.  This was 
confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 5.88 (-3.46, 15.22) p = 0.21, >0.5 not 
significant for the two tools being different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
43.16(LL) to 54.92 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
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This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence and degree of solid residue on the voice prosthesis, the parameter was 
therefore accepted. 
 
Parameter 13 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
oesophagus on thin liquids 
Reliability was analysed for Q22 of the dysphagia rating scale: Is there oesophageal 
residue on thin liquids.  Free marginal kappa amongst raters on FEES was 0.07 
indicating poor reliability.  Free marginal kappa amongst raters on Videofluroscopy 
was 0.33 indicating poor reliability. Agreement for Q22 was investigated by 
calculating the frequency of positive identifications of presence of oesophageal 
residue on thin liquids. 
Results showed that using FEES, 93.3 % of cases (28/30) had residue on thin liquids 
in the oesophagus identified, while using Videofluroscopy 90% of cases (27/30) had 
residue on thin liquids in the oesophagus identified, p=1.0, >0.5 not significant for 
FEES and Videofluroscopy being different to each other. 
Degree of residue on thin liquids in the voice oesophagus was explored using Q24 of 
rating scale: How much oesophageal residue is there on thin liquids? Reliability for 
FEES on ICC = 0.41 indicating poor reliability amongst raters.  Reliability for 
Videofluroscopy on ICC = 0.26 indicating poor reliability amongst raters.  
 
Agreement for Q24 was then investigated.  Bland Altman analysis for degree of voice 
prosthesis residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of voice prosthesis residue on thin liquids of 18.58 mm (SD=18.25). As the 
mean difference is not close to 0, the two swallow evaluation tools on average, do not 
agree.  This was confirmed with a one-sample t-test of the mean diff between FEES 
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and Videofluroscopy. t-test mean diff (95 C.I) 18.58 (11.76, 25.39) p = 0.00, <0.5 
significant for the two tools being different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
17.19(LL) to 54.35 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence of thin liquid residue in the oesophagus but different for assessing the degree 
of thin liquid residue in the oesophagus.  The parameter was therefore rejected. It also 
appeared that FEES enabled a greater visualization of the degree of thin liquid residue 
in the oesophagus compared to Videofluroscopy. 
 
 
Parameter 14 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
oesophagus on puree 
Reliability was analysed for Q32 of the dysphagia rating scale: Is there oesophageal 
residue on puree? Free marginal kappa amongst raters for FEES was 0.51 
approaching reliability.  Free marginal kappa amongst raters for Videofluroscopy was 
0.6 indicating good reliability.  Agreement for Q32 was investigated by calculating 
the frequency of positive identifications of presence of oesophageal residue on puree. 
Results showed that using FEES, 93.3% of cases (28/30) had residue on puree in the 
oesophagus identified, while using Videofluroscopy 96.6% of cases (29/30) had 
residue on thin liquids in the oesophagus identified, p=1.0, >0.5 not significant for 
FEES and Videofluroscopy being different to each other. 
Degree of residue on puree in the oesophagus was explored using Q34. How much 
oesophageal residue is there on puree? Reliability for FEES on ICC = 0.33 indicating 
poor reliability amongst raters.  Reliability for Videofluroscopy on ICC = 0.53 
approaching reliability. 
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Agreement for Q34 was then investigated.  Bland Altman analysis for degree of voice 
prosthesis residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of oesophageal residue on puree of 5.57 mm (SD=16.84). As the mean 
difference is not close to 0, the two swallow evaluation tools on average, do not agree.  
This was confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 5.57 (-72, 11.85) p = 0.81, >0.5 not 
significant for the two tools being different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were – 
27.05(LL) to 38.19 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence and degree of puree residue in the oesophagus.  The parameter was therefore 
accepted. 
 
 
Parameter 15 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
oesophagus on soft 
Reliability was investigated for Q42 of the dysphagia rating scale: Is there 
oesophageal residue on soft? Free marginal kappa amongst raters for FEES was 0.38 
indicating poor reliability.  Free marginal kappa amongst raters for Videofluroscopy 
was 0.28 indicating poor reliability.  Agreement for Q42 was investigated by 
calculating the frequency of positive identifications of presence of oesophageal 
residue on soft.  Results showed that using FEES, 93.3 % of cases (28/30) had residue 
on soft in the oesophagus identified, while using Videofluroscopy 80% of cases 
(24/30) had residue on soft in the oesophagus identified, p=0.75, >0.5 not significant 
for FEES and Videofluroscopy being different to each other. 
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Degree of residue on soft in the oesophagus was explored using Q44. How much 
oesophageal residue is there on soft? Reliability for FEES on ICC = 0.56 approaching 
reliability amongst raters.  Reliability for Videofluroscopy on ICC = 0.65 indicating 
good reliability amongst raters.  
Agreement for Q44 was then investigated.  Bland Altman analysis for degree of 
oesophageal residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of oesophageal residue on soft of 10.3 mm (SD=21.34). As the mean 
difference is not close to 0, the two swallow evaluation tools on average, do not agree.  
This was confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 10.3 (2.32, 18.28) p = 0.13, >0.5 not 
significant for the two tools being different to each other. 
However, as the SD is close to 0, there is a small amount of variation between tools 
indicating agreement for individual subjects.  The limits of agreement were -31.6 
(LL) to 52.2 (UL) mm. It is expected that 95% of differences within the LL and UL 
interval.  In this case, there is a wide interval that 95% of the values lie within. 
This indicates videofluroscopy and FEES imaging are similar for assessing the 
presence and degree of soft residue in the oesophagus.  The parameter was therefore 
accepted. 
 
Parameter 16 
There is no difference in the ability of Videofluroscopy and FEES imaging to 
enable accurate identification of the presence and degree of residue in the 
oesophagus on solid 
Reliability for Q52 of the dysphagia rating scale: Is there oesophageal residue on 
solid? Free marginal kappa amongst raters on FEES was 0.55 approaching reliability.  
Free marginal kappa amongst raters on Videofluroscopy was 0.28 indicating poor 
reliability.  Agreement for Q52 was investigated by calculating the frequency of 
positive identifications of presence of oesophageal residue on solid.   
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Results showed that using FEES, 96.6 % of cases (29/30) had residue on solid in the 
oesophagus identified, while using Videofluroscopy 66.6% of cases (20/30) had 
residue on solid in the oesophagus identified, p=0.01, <0.5  significant for FEES and 
Videofluroscopy being different to each other. 
Degree of residue on solid in the oesophagus was explored using Q54. How much 
oesophageal residue is there on solid? Reliability for FEES on ICC = 0.6 indicating 
good reliability amongst raters.  Reliability for Videofluroscopy on ICC = 0.53 
approaching reliability amongst raters. 
Agreement for Q54 was then investigated.  Bland Altman analysis for degree of 
oesophageal residue as indicated on the visual analogue scale comparing FEES with 
Videofluroscopy showed a mean difference between FEES and Videofluroscopy for 
degree of oesophageal residue on solid of 7.93 mm (SD=20.86). As the mean 
difference is not close to 0, the two swallow evaluation tools on average, do not agree.  
This was confirmed with a one-sample t-test of the mean diff between FEES and 
Videofluroscopy. t-test mean diff (95 C.I) 7.93 (0.14, 15.72) p = 0.46, <0.5 significant 
for the two tools being different to each other. 
However, as the SD is not close to 0, there is a large amount of variation between 
tools indicating disagreement for individual subjects.  The limits of agreement were -
32.95 (LL) to 48.81 (UL) mm. It is expected that 95% of differences within the LL 
and UL interval.  In this case, there is a wide interval that 95% of the values lie 
within. 
This indicates videofluroscopy and FEES imaging are different for assessing the 
presence and degree of solid residue in the oesophagus.  The parameter was rejected.  
FEES imaging enables greater identification of solid residue in the neopharynx.  It 
also appeared that FEES enabled a greater visualization of the degree of solid residue 
in the neopharynx compared to FEES. 
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Table 2-7: Summary of results: Anatomical and Physiological Features 
 
Parameters Rejected X 
Accepted  
Positive significant 
difference between 
tools? 
Identification Degree 
There is no difference in the 
ability of Videofluroscopy and 
FEES imaging to enable 
accurate identification of the 
type of voice prosthesis. 

 X 
 
FEES  
 
 
n/a 
 
There is no difference in the 
ability of Videofluroscopy and 
FEES imaging to enable 
accurate identification of the 
presence and degree of 
secretions. 

X       

 
FEES 
 
FEES 
There is no difference in the 
ability of Videofluroscopy and 
FEES imaging to enable 
accurate identification of the 
presence of pseudoepiglottis. 

 
  
There is no difference in the 
ability of Videofluroscopy and 
FEES imaging to enable 
accurate identification of the 
presence and degree of 
backflow/reflux. 

 
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Table 2-8: Summary of results: Residue in the neopharynx 
Parameters Rejected  X 
Accepted  
Positive significant 
difference between 
tools? 
Identification Degree 
There is no difference in the ability of 
Videofluroscopy and FEES imaging to 
enable accurate identification of the 
presence and degree of residue on thin 
liquids in the neopharynx 
 


X
           
   
 
 
 
VF 
 
 
VF 
  
There is no difference in the ability of 
Videofluroscopy and FEES imaging to 
enable accurate identification of the 
presence and degree of residue on puree 
in the neopharynx 
 


X 
 
 
VF 
 
 
VF 
There is no difference in the ability of 
Videofluroscopy and FEES imaging to 
enable accurate identification of the  
presence and degree of residue on soft 
food in the neopharynx 
 


X
   
 
 
 
VF 
 
 
VF 
There is no difference in the ability of 
Videofluroscopy and FEES imaging to 
enable accurate identification of the 
presence and degree of residue on solid 
food in the neopharynx 
 


X
    
 
 
VF 
 
 
VF 
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Table 2-9: Summary of results: residue on the voice prosthesis 
Parameters Rejected X 
Accepted  
Positive significant 
difference between 
tools? 
Identification Degree  
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on thin liquids on 
the voice prosthesis 
 

 
X
 
 
 
FEES  
 
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on puree on the 
voice prosthesis 
 


X
 
 
 
VF 
 
 
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on soft food on the 
neopharynx 
 


 
  
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on solid food on 
the voice prosthesis 
 


 
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Table 2-10: Summary of results: residue in the oesophagus 
Parameters Rejected X 
Accepted  
Positive significant 
differences between 
tools? 
Identification Degree 
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on thin liquids in 
the oesophagus 
 
 


 X 
 
 
   VF  
 
 
FEES  
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on puree in the 
oesophagus 
 



 
  
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the presence and 
degree of residue on soft food in the 
oesophagus 
 


 
  
There is no difference in the ability 
of Videofluroscopy and FEES 
imaging to enable accurate 
identification of the of the presence 
and degree of residue on solid food 
in the oesophagus 
 


 X 
 
    
FEES 
 
   
FEES 
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Hypothesis 2 
Patients will have an equal preference for both videofluroscopy and endoscopy 
swallow evaluation tools. 
 
 
When surveyed about the experience of videofluroscopy and FEES, 50% expressed a 
preference for endoscopy over videofluroscopy for swallow evaluation. A further 
26% had an equal preference for either tool. 50% expressed a preference for 
swallowing real food if possible during swallow assessment and 30% indicated that 
they found barium difficult to swallow. 10% expressed concern about radiation use 
during videofluroscopy swallow assessment. See table 2.11 for details. 
 
 
 
Table 2-11: Survey of experience of videofluroscopy and FEES swallow 
exam 
Questions Yes 
The scope is comfortable 76% 
I am concerned about radiation exposure 10% 
I find barium is difficult to swallow 30% 
I would prefer real food for swallow test 50% 
I would prefer scope for swallow test 50% 
I would prefer x-ray for swallow test 23% 
Equal preference for x-ray or scope for 
swallow test 
27% 
 
2.6.5 Discussion 
 
The demographics of the subjects in this study are consistent with most of the 
characteristics associated with a laryngectomy caseload at a large centre treating head 
and neck cancer patients.  The majority of the cohort was male (83.3%) although 
females (17.7) were well represented. The most frequently diagnosed size tumour on 
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presentation was T4 (23.3%).  Only 10% of subjects had no history of radiotherapy 
while 83% had no history of chemotherapy.  Over half the group (56.7%) had 
undergone salvage laryngectomy reflecting contemporary treatment philosophy of 
organ preservation as an initial management option for many advanced laryngeal 
cancers.  Interestingly, none of the subjects in the group were underweight but 63.2% 
were overweight or obese.  Being overweight can be due to a number of factors but 
further research may elucidate the causes in this patient population. 
FEES has not been previously used as a dysphagia evaluation tool in the 
laryngectomy caseload. Although there are no standardised protocols for the use of 
Videofluroscopy with laryngectomy patients, it is currently frequently used in this 
patient population.  It was necessary to compare FEES with Videofluroscopy to 
ascertain whether FEES was at least similar to Videofluroscopy for measuring 
parameters of swallowing.  If FEES is similar or better than Videofluroscopy then, its 
use as a clinical tool with this patient population could be considered. 
The first objective of this study was to investigate which dysphagia evaluation tool 
more accurately identified anatomical and physiological features (voice prosthesis 
type, secretions, pseudoepiglottis and regurgitation and reflux). FEES appeared better 
for identification of voice prosthesis type and secretions.  Both tools were similar for 
identification of pseudoepiglottis and reflux.  
Although neither tool had a high level of accurate identification of the voice 
prosthesis type, FEES was statistically more accurate in identifying voice prosthesis 
type (40%) compared to videofluroscopy (13.3%).  The ability to identify voice 
prosthesis type on imaging can be important clinically to help ascertain whether the 
patient has the correct voice prosthesis for their needs.  Removing the voice prosthesis 
will allow accurate identification of type but, in the case of an indwelling voice 
prosthesis, this may result in the unnecessary premature removal of an expensive 
device.  FEES was also more accurate in identifying secretions (100%) in the 
reconstructed throat compared to (0%) on videofluroscopy.  It is possible these 
secretions represent pooled saliva.  There is little research into the effect of pooled 
secretions in laryngectomy patients.  However, pooled secretions are clinically 
important in this population because they can cause a “wet” voice quality. In addition, 
pooled secretions may contribute to voice prosthesis leakage into the trachea. During 
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the consultation process for the development of the dysphagia rating scale used in this 
study, laryngectomy patients specifically requested the inclusion of secretions as a 
question.  They reported that excess secretions in the throat, may at times, cause a 
barrier when swallowing.  Further research is required into this area but if patients 
complain that excess secretions negatively affect swallowing ability, it is important 
that an appropriate evaluation tool is chosen to investigate this.   
Pseudoepiglottis (pseudodiverticulum) has been discussed in chapter 1, (section 
1.2.1.1 Pseudodiverticulum).  Pseudoepiglottis may be asymptomatic but can obstruct 
bolus flow during swallow.  Only 10% of subjects in this study had a 
pseudoepiglottis.  This finding is in contrast to (Maclean et al., 2011), which found a 
rate of 46% of pseudoepiglottis. The identification of pseudoepiglottis is important so 
that appropriate surgical treatment may be implemented if necessary.  Neither FEES 
nor Videofluroscopy was superior in identifying pseudoepiglottis. The function of the 
Upper Oesophageal Sphincter is altered during laryngectomy surgery when a 
myotomy is carried out.  The purpose of this procedure is to prevent voice limiting 
spasm.  Myotomy is discussed further in chapter 1, (section 1.1.1 Anatomical and 
Physiological changes after laryngectomy).  The usual function of the Upper 
Oesophageal Sphincter (UES) is to prevent any refluxed material reaching the 
pharynx. The reduced UES resting pressure in laryngectomy subjects compared to 
normals (Sandberg, 1969, Hanks et al., 1981) may contribute to a rate of 
reflux/regurgitation as high as 82% (Smit et al., 1998) in the laryngectomy 
population.  If reflux reaches the level of the voice prosthesis in the oesophagus, it 
may contribute to leakage through the voice prosthesis and into the trachea.  In 
addition, reflux to the level of the voice prosthesis can contribute to failure of the 
tracheosophageal puncture and voice prosthesis (Pattani et al., 2009).  Neither FEES 
nor Videofluroscopy was superior in identifying backflow or regurgitation.  As FEES 
views the upper oesophagus only and Videofluroscopy has the potential to screen 
swallow throughout the length of the oesophagus in A/P view, Videofluroscopy may 
be considered as the tool of choice for screening reflux post laryngectomy. 
The next objective of this study was to ascertain which dysphagia evaluation tool   
more accurately identified presence of residue in the neopharynx, on the voice 
prosthesis and in the oesophagus. Residue is important for laryngectomy patients 
because it delays their swallow, necessitates the need to alternate food with swallow 
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to clear residue and causes patients to swallow more than once. Poor mucosal 
clearance resulting in residue was initially described by (McConnel et al., 1986b) and 
more recently by (Maclean et al., 2011). For the purposes of this study, the 
neopharynx was defined as the area running from the inferior margin of the base of 
tongue to the inferior margin of the reconstructed segment or anastomosis.  
Videofluroscopy provided greater identification of thin liquid residue than FEES on 
all consistencies in the neopharyx. FEES provided greater identification of residue on 
thin liquids on the voice prosthesis whereas Videofluroscopy provided greater 
identification of residue on the voice prosthesis on puree.   Both tools were similar in 
identifying residue on the voice prosthesis on soft and solid consistencies.  
Videofluroscopy was provided greater identification of residue in the oesophagus on 
thin liquids and soft although FEES indicated greater identification of degree of soft 
residue in the oesophagus.  FEES also provided better identification of residue in the 
oesophagus on solid.  These findings disagree with a previous simultaneous 
videofluroscopy and FEES study (Kelly et al., 2006), which found that FEES scores 
were consistently higher than those found on videofluroscopy.  Apart from the 
neopharynx, it would appear that FEES is at least similar to Videofluroscopy in the 
ability of this tool to identify and measure degree of residue on the voice prosthesis 
and in the oesophagus. 
Generally residue on thin liquids is minimal.  However, the consistent finding of 
residue on thin liquids in this study may reflect the use of dye. It was necessary to add 
a small amount of green food colouring to the clear gastrografin contrast in order to 
visualise it on endoscopy.   Surprisingly, no residue was identified on the voice 
prosthesis on puree using FEES, yet raters measured a degree of residue on this 
consistency on the voice prosthesis on FEES.  Reviewing the data and notes written 
by raters, this anomaly appeared to have been due to raters inability to see residue on 
the voice prosthesis because the view of the nasendoscope has been obscured by the 
puree consistency (custard) used.  While the raters couldn’t actually see residue on the 
voice prosthesis, they appeared to surmise that residue was there when they measured 
degree as they could discern the colour of the custard on the obscured nasendoscope.  
In retrospect, the scale was limited by offering categories yes, no only in response to 
categorical questions about identification of residue on different food consistencies 
and would have benefitted from the addition of a “can’t see” category. 
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The final objective of this study was to investigate whether subjects had a preference 
for a swallow evaluation tool.   FEES involves passing a flexible scope through the 
nose and could be perceived as uncomfortable for patients.  If patients considered 
FEES as an uncomfortable and invasive tool, this would limit its use.  However, 
results of the patient questionnaire regarding experience of Videofluroscopy and 
FEES revealed that FEES was acceptable to subjects.  76% indicated that they found 
the scope comfortable.  50% indicated that they would prefer FEES to 
Videofluroscopy and a further 26% had an equal preference for both tools.  10% 
expressed concern about radiation exposure reflecting a theme previously identified 
by patients in relation to Videofluroscopy.  30% found barium difficult to swallow 
and 50% expressed a preference for real food.  Given that residue is an issue for 
laryngectomy patients, it is possible that the changes in viscosity that result from 
adding barium to food increase swallowing difficulty for some patients.   
Limitations of this study included small sample size, which may have constrained the 
degree of difference observed between both FEES and Videofluroscopy.  In addition, 
the study may have been limited in assessing the true degree of residue on various 
food consistencies because of the need to mix food with barium for the purposes of 
simultaneous FEES and Videofluroscopy procedures.  The use of barium appeared to 
increase incidences of the nasendoscope view being obscured by liquid and food 
consistencies. 
 
 
2.7 Conclusions 
 
This study compared FEES and Videofluroscopy and found that FEES was similar or 
better than Videofluroscopy on most parameters of swallowing examined.  In 
particular, FEES was better than videofluroscopy in identifying voice prosthesis type 
and secretions.  Videofluroscopy was better than FEES at identifying residue in the 
neopharynx.  While FEES was better at identifying residue on the voice prosthesis on 
thin liquids, Videofluroscopy was better at identifying residue on the voice prosthesis 
on puree.  Both tools were similar at identifying voice prosthesis residue on soft and 
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solid.  In the oesophagus, Videofluroscopy was better at identifying residue on thin 
liquids and soft although FEES was better at identifying residue on solids in this 
anatomical location.  Patient acceptability for FEES was demonstrated with 76% of 
subjects finding the scope comfortable and 77% indicating that they would either 
prefer to have a FEES examination to Videofluroscopy or have an equal preference 
for both tools.  The finding that FEES is similar or better than Videofluroscopy on 
most swallowing parameters examined and is acceptable to patients supports the 
consideration of the use of FEES as an additional swallow evaluation tool within the 
clinical setting. 
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Chapter 3. Double blind study evaluating the effect of 
different voice prostheses on swallowing using FEES. 
3.1 Summary  
This chapter describes an investigation into whether voice prostheses differ in their 
effect on swallowing.  Chapter 2 outlined an introduction into dysphagia evaluation 
tools post laryngectomy. The section 3.2 outlines an introduction for describing the 
nature of dysphagia post laryngectomy (section 3.2.1), the evolution of voice 
prostheses (section 3.2.2) and previous studies comparing voice prostheses (section 
3.2.3).  Section 3.3 describes a study investigating into the effect of different voice 
prostheses.  Finally section 3.4 summarises the conclusions from this body of work.   
 
 
3.2 Introduction 
The introduction outlines previous research into tools to investigate dysphagia in both 
laryngectomy and those with a larynx and explains the rationale for the choice of 
videofluroscopy and FEES for this study.  While the area of dysphagia evaluation 
post laryngectomy has received some attention, there is limited research into the type 
of dysphagia symptoms that laryngectomy patients experience.  There is significant 
inconsistency in definitions of what constitutes dysphagia after laryngectomy with 
successful swallowing often being considered as an ability to maintain nutrition 
without tube feeding (Coleman et al., 1987) or alternatively as the ability to tolerate a 
modified soft diet (Surkin et al., 1984).  It has been suggested (Ward et al., 2002) that 
while such definitions may be adequate for evaluating the outcomes of different 
surgical techniques, they fail to accurately reflect the number of laryngectomy 
patients post-surgery who are unable to resume their normal pre morbid swallow 
function.  The introduction to this chapter outlines existing research into the nature of 
dysphagia post laryngectomy and studies that have compared different voice 
prostheses. 
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3.2.1 Research into the nature of dysphagia post laryngectomy 
 
The objective of a seminal study (Ward et al., 2002) examining swallowing difficulty 
after laryngectomy was to determine the incidence of dysphagia at hospital discharge 
and beyond one-year post surgery.  This study also examined the impact of persistent 
dysphagia on levels of disability, handicap and well-being in laryngectomy patients.  
55 total laryngectomy subjects and 37 pharyngolaryngectomy subjects were 
consecutively sampled over a period of 5 years.  Notably this study proposed a new 
definition of dysphagia after laryngectomy.  Dysphagia was defined as any inability to 
manage a full diet of normal consistencies i.e. swallow all liquid and solid foods 
without any texture alteration and without a requirement for supplementary non-oral 
nutrition.  Previous definitions have included the ability to maintain nutrition without 
dependence on enteral feeding (Coleman et al., 1987) and have been used primarily to 
evaluate outcomes of surgical techniques.  A retrospective review was undertaken of 
medical and speech pathology notes of subjects.  The following 6 categories were 
used to classify the dietary status of each patient.   
 Normal 
 Soft selective (soft options of a normal diet) 
 Soft Mechanical (soft chewable consistencies) 
 Soft puree (foods blended with added gravy or sauce) 
 Liquid puree 
 Non oral feeding 
 
Swallowing complications were identified from symptoms observed on clinical 
assessment or radiological imaging and were divided into early post-surgical (one 
month post-surgery) and late post-surgical (beyond one month post-surgery).  Follow 
up was conducted 1-6 years post-surgery.  Of the 92 subjects involved in the initial 
retrospective review, 36 of the total laryngectomy subjects and 14 of the 
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pharyngolaryngectomy subjects were contactable during follow up.  These patients 
were interviewed to identify (i) current dietary status and (ii) levels of perceived 
swallowing disability, handicap and well-being/distress using the Therapy Outcome 
Measure Dysphagia Scale (TOM) (Enderby and John, 1997). 
Results indicated that on discharge from hospital after surgery, only 1 subject (total 
laryngectomy) was on a normal diet.  89% of the total laryngectomy group and 100% 
of the pharyngolaryngectomy group were classified as dysphagic at this stage.  65% 
of the pharyngolaryngectomy group experienced a statistically higher incidence of 
early swallowing complications (within the first month of surgery) compared with 
27% of the total laryngectomy group.  These complications included nasal 
regurgitation, fistulae, pooling, pouch formation, poor motility and wound 
breakdown.  There was no statistical difference between groups for incidence of late 
swallowing complications (beyond first month of surgery) with rates of 36% for the 
laryngectomy group and 40% for the pharyngolaryngectomy group.  However, 
stricture emerged as a late swallowing complication.  Long-term follow up indicated 
that 42% of the total laryngectomy group and 50% of the pharyngolaryngectomy 
group were not on a normal diet and therefore dysphagic at 3 years post-surgery.  
Subjects experiencing long-term dysphagia identified significantly increased levels of 
disability, handicap and distress on the TOM. 
 
The aims of a subsequent study (Maclean et al., 2009d) were to investigate the 
prevalence and nature of self-reported dysphagia after laryngectomy and to document 
the effects of dysphagia on social activities and participation.  197 total laryngectomy 
patients were sent a 21 item postal questionnaire to complete.  Each subject was first 
asked if he/she had any difficulty eating in eating or swallowing and if so, to describe 
the swallow dysfunction and impact of dysphagia on diet and social activity.  The 
questionnaire covered demographic details, laryngectomy surgery details, and any 
noted changes to ability to swallow after surgery.  Information regarding changes to 
social life following laryngectomy and a rating of general distress associated with 
swallowing were also obtained using a Likert scale.  Demographic and surgical 
information were gathered using a simple categorical scale while information 
regarding swallowing was elicited using open and closed questions.  Swallowing 
180 
 
questions included respondents being asked to provide specific information about 
swallowing difficulty based on symptoms such as food sticking in their throat, 
difficulty chewing, feeling of tightness and taking a longer time to swallow than 
previously.   
110 usable questionnaires were returned.  The majority of returned questionnaires 
were from subjects who were male (89.1%, over 65 (63.3%) and had undergone 
surgery more than 12 months previously (87.3%).  78.2% had had radiotherapy, 7.3% 
chemotherapy and 10.9% were treated with laryngectomy alone.  Results of this study 
indicated that 71.8% (n-79) of the sample experienced difficulty with swallowing 
with the majority (45.6%) experiencing difficulty immediately following surgery.  
The next most common time to experience dysphagia was 1-6 months post-surgery 
(19%).  Of the subjects who had difficulty with swallowing, 71.8% had to change 
their diet, 86% required liquid to wash food down, 49.4% had difficulty swallowing 
oral medications, and 57% had less saliva.  61% of dysphagic subjects reported they 
made lifestyles changes as a result of this impairment.  These lifestyle changes 
included avoiding eating in restaurants and participating in social activities.  73 of the 
79 subjects with dysphagia indicated the amount of distress that dysphagia caused 
them.  20.5% reported no distress, 22% mild distress, 17.8% moderate distress and 
39.7% severe distress.  25.5% provided detailed written comments about their 
swallowing.  Four themes emerged from this analysis: (i) consistency of food (not 
being able to eat steak, or bread and cakes); (ii) regurgitation/reflux; (iii) increased 
time to swallow; and (iv) social consequences of swallowing impairment.   
A further study (Maclean et al., 2009a) by the same authors investigated the effect of 
dysphagia on quality of life, functioning and well-being.  The following questionnaire 
measures were sent to 197 laryngectomy patients: Demographic questionnaire, the 
World Health Organisation Quality of Life – Bref (WHOQoL-Bref), the University of 
Washington QOL (U0W-QOLv4) and the Depression Anxiety and Stress Scale 
(DASS).  Subjects were also asked to report whether they had any change in their 
ability to swallow and/or the need to change the texture of their diet following 
surgery.  110 questionnaires returned were analysable.  The demographics of the 
group were the same as that in the previously described study (Maclean et al., 2009d).  
71.8% stated that they had experienced difficulty with swallowing since their surgery 
and results on the WHOQoL-Bref, the UW-QOL and the DASS were compared for 
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laryngectomy subjects with and without dysphagia.  No significant differences 
between groups were found on the WHOQoL-Bref scores.  However, the mean scores 
from the entire sample were found to be significantly lower for physical, 
psychological and social domains compared with Australian population norms.  On 
the UOW-QOL, Laryngectomy subjects with dysphagia had lower scores on 
questions addressing H-RQoL and overall QOL over the past 7 days than 
laryngectomy subjects without dysphagia.  Examining subscale scores of the UOW-
QoL, Laryngectomy subjects with dysphagia had significantly lower mean physical 
and social scores than those without dysphagia.  Laryngectomy subjects with 
dysphagia also had worse mean scores on the following individual item questions of 
the UOW-QoL: recreation, swallowing, speech, mood and anxiety.  On the DASS, 
laryngectomy subjects with dysphagia had significantly higher levels of depression, 
anxiety and stress that those without dysphagia. 
The aim of a recent study (Govender et al., 2012) was to develop and validate a 
laryngectomy specific questionnaire to investigate swallow function to facilitate early 
and appropriate intervention for dysphagia and avoid later complications.  Two 
separate focus groups of 6 Speech and Language Therapists and 10 laryngectomy 
patients were convened to generate appropriate questionnaire items.  Information 
gleaned from the focus groups was categorised according to the WHO International 
Classification Framework of (i) Impairment (ii) Activity limitation and (iii) 
Participation (Eadie, 2003) and this framework was used to formulate the 
questionnaire.  This questionnaire underwent revision to include an item on saliva 
production suggested by laryngectomy patients.  A final 17-item questionnaire was 
generated.  Each item on the questionnaire assessed one swallow feature in terms of 
severity using a 3-point scale (no, a little, a lot) together with the significance of the 
symptom in terms of “bother” to the patient.  Examples of questions on the Swallow 
Outcome After Laryngectomy questionnaire (SOAL) include “Do you have a problem 
swallowing thin liquids/thick liquids/soft mashed/dry solid consistencies? Does 
food/liquid stick in your throat when you swallow? Do you need to swallow many 
times on each mouthful to help the food or drink go down? Does it take longer to eat a 
meal? Has your enjoyment of food reduced?  The SOAL was validated on three 
groups of subjects, (i) non complaining normals n -20, (ii) Laryngectomy n-19 (iii) 
Radiotherapy (subjects at least 3 months post chemoradiation treatment for head and 
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neck cancer with known dysphagia n-19).  The SOAL was found to have good 
internal consistency, could discriminate groups with known differences in swallow 
function and related to instrumental findings following radiotherapy.  Further 
validation of the SOAL is planned. 
The studies described in this section have been published largely in the last decade.  
These studies have increased knowledge about the nature of dysphagia and the impact 
of this on the well-being of post laryngectomy patients.  The first study (Ward et al., 
2002) provided a more comprehensive definition of dysphagia post laryngectomy to 
include those unable to tolerate a regular diet, rather than simply those with an ability 
to maintain adequate nutrition without being dependent on enteral feeding.  This study 
is also notable in that symptoms of dysphagia post laryngectomy were described 
including nasal regurgitation, fistulae, pooling, pouch, poor motility and stricture with 
a higher incidence of swallow complications observed in pharyngolaryngectomy 
subjects.  This study indicated that dysphagia was could be a long-term problem for 
some patients with increased levels of disability, handicap and distress as a 
consequence.  The study by Maclean and colleagues (Maclean et al., 2009d) found an 
incidence of 71.8% of dysphagia based on patient self-reporting of symptoms.  Those 
patients with dysphagia who included written comments, described symptoms such as 
difficulty tolerating solids foods, reflux, regurgitation, increased time to swallow and 
negative social consequences.  The impact of dysphagia on lifestyle including the 
avoidance of eating in restaurants and participating in social activities was highlighted 
by this study.  Another study by the same group (Maclean et al., 2009a) emphasised 
the impact of post laryngectomy dysphagia on quality of life, well-being and 
functioning.  Results of this study indicated that laryngectomy patients with 
dysphagia had lower scores on the UOW QOL v4 scale and higher levels of 
depression, anxiety and distress on the DASS than non-dysphagic laryngectomy 
patients.  The development of SOAL questionnaire (Govender et al., 2012) based on 
focus group input from laryngectomy subjects and clinicians highlighted the 
relevance of dysphagia symptoms including food sticking, difficulty swallowing 
individual food consistencies, having to swallow more than once, taking longer to eat 
a meal and reduced enjoyment of food.  Each of these studies has increased the 
understanding of the symptoms of dysphagia.  Anecdotally, patients have indicated 
that different voice prostheses may sometimes impact on how they swallow, however, 
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to date; no study has investigated whether voice prostheses affect swallowing after 
laryngectomy.  The following section describes the evolution of different voice 
prostheses and the possible effect of voice prostheses on swallowing post 
laryngectomy.  Existing research comparing different voice prostheses is outlined. 
 
3.2.2 The evolution of voice prostheses 
 
The first widely commercially available voice prosthesis for post laryngectomy 
communication was the Blom Singer duckbill (Blom and Singer, 1979, Singer and 
Blom, 1980).  Since this voice prosthesis was introduced, there are have been 
numerous developments and improvements to design and functionality.  These 
include introduction of an indwelling prosthesis (Nijdam et al., 1982), development of 
a prosthesis with less airway resistance (Weinberg and Moon, 1986b), changes to 
device shape to improve patient comfort (Leder and Erskine, 1997a), development of 
a candida resistant voice prosthesis (Hilgers et al., 2003a, Leder et al., 2005b), 
changes to insertion methods (Hilgers et al., 2010b) and valve design features to 
reduce mucosal interference (Hilgers et al., 2010a).  As a result, a wide range of voice 
prostheses, are currently available.  However, there has been little systematic research 
comparing different voice prostheses (Hancock et al., 2012).  In those studies that are 
available, most have focused on the comparison of voice quality using perceptual and 
acoustic measures.  None have investigated the effect of voice prostheses on swallow 
function.  Figure 3.1 illustrates the position of the voice prosthesis within the 
reconstructed throat.    
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Figure 3-1: Illustration of voice prosthesis within the tracheosophageal 
puncture 
 
The distal end of the voice prosthesis sits within the oesophagus and therefore lies in 
the path of bolus flow during swallowing.  Clinically, some patients have reported 
that they have noticed a change in swallowing when a different voice prosthesis is 
placed.  Figure 3.2 illustrates the voice prostheses used in this study; the oesophageal 
flange of each prosthesis is differently shaped. 
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Figure 3-2: Voice prostheses used in this study: (A) Provox NID (B) Provox 
Vega (C) Blom Singer Advantage (D) Blom Singer Classic Indwelling, (E) 
Blom Singer Low Pressure (F) Blom Singer Duckbill 
 
 
 
The Provox NID, the Provox Vega and the Blom Singer low pressure all have flaps 
surrounded by a hood that protrudes slightly into the oesophagus and which may 
gather residue during swallow.  If a significant amount of residue sits on a prosthesis 
flap, this may lead to aspiration when voicing occurs and as the flap opens to allow air 
to be redirected to the vibratory segment.  Residue on the voice prosthesis flap may 
also lead to a “wet” voice quality.  The Blom Singer duckbill prosthesis has a “bullet” 
shaped nose containing a slit valve rather than a flap valve.  Depending on the amount 
of space between the anterior and posterior walls of the oesophagus, this prosthesis 
may sometimes touch the posterior wall of the oesophagus and could hypothetically 
obstruct bolus flow during swallowing.  In contrast to the other voice prostheses 
described, both the Blom Singer Classic indwelling and Blom Singer advantage have 
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a relatively flat oesophageal flange containing recessed flaps.  It is notable that the 
Blom Singer advantage voice prosthesis has a larger oesophageal flange than the 
other prostheses described.  It is hypothesised that the different configurations in 
oesophageal flanges across voice prostheses may negatively affect swallowing ability 
in some subjects. Further information about each individual voice prosthesis is 
contained in (section 4.3 Description of voice prostheses used in this study).  Existing 
studies comparing voice prostheses are described in the following section. 
3.2.3 Studies comparing voice prostheses 
 
An early study (Pauloski et al., 1989) compared the Blom Singer duckbill voice 
prosthesis with the Blom Singer low pressure voice prosthesis to determine whether 
the acoustic properties of TEP voice differed statistically based on prosthesis type and 
method of occlusion of the tracheostoma (digital occlusion vs. tracheostomal valve).  
12 male and 12 female total laryngectomy subjects sustained /a:/ to elicit maximum 
phonation time and read the first paragraph of the Rainbow passage (Fairbanks, 
1960).  Speech tasks were performed under 4 conditions (i) Blom Singer duckbill 
with Blom Singer Tracheostoma valve (ii) Blom Singer duckbill prosthesis with 
digital occlusion, (iii) Blom Singer low pressure voice prosthesis with Tracheostoma 
valve and (iv) Blom Singer low pressure prosthesis with digital occlusion  Acoustic 
analysis of the recorded speech sample included frequency, intensity, temporal and 
noise measures.  Results indicated that TEP voice produced with the Blom Singer low 
pressure voice prosthesis was significantly different to that produced with a Blom 
Singer duckbill on a weighted linear combination of eight acoustic variables including 
words per minute, harmonics to noise ratio, jitter, intensity, periodic phonation, and 
directional shimmer.  TEP voice produced with a Blom Singer low-pressure voice 
prosthesis had significantly more periodic phonation than voice produced with a Blom 
Singer duckbill voice prosthesis.  The use of a tracheostomal valve did not have a 
significant impact on acoustic measures. 
The Groningen (Annyas et al., 1984), Nijdam (Nijdam et al., 1990) and Provox 1 
(Hilgers and Schouwenburg, 1990b) were compared in a study (VanDenHoogen et 
al., 1996) of 845 voice prosthesis replacement procedures performed in 158 subjects 
over a 2 year, 6 month period.  Results indicated that leakage was the main reason for 
replacement with the Nijdam requiring replacement more often than the Groningen or 
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Provox 1.  However the Nijdam had a significantly longer life time (19 weeks) than 
that of the Groningen (15.8 weeks) and the Provox 1 (13 weeks).  Increased airflow 
resistance (or effort to produce voice) was a significantly more frequent reason for 
voice prosthesis replacement with the Groningen (45.4%), Nijdam (45.9%) than with 
the Provox 1 (22.7%).  Complications during the replacement process were rare 
occurring in less than 10% of the sample but were more common in subjects with a 
Nijdam voice prosthesis.  
A prospective study (Delsupehe et al., 1998) compared Blom Singer Classic 
indwelling and Provox 1 voice prostheses.  A total of 113 voice prostheses were 
randomly placed in 55 total laryngectomy and extended laryngectomy with partial 
pharyngectomy subjects.  50 were Blom Singer voice prostheses and 63 were Provox 
1.  Subjects were recorded reading a standard text at 1 and 4 months after starting 
Speech and Language Therapy.  Recordings were subjectively rated by 8 experts for 6 
different voice parameters (i) intonation, (i) intelligibility (iii) acceptability (iv) 
extraneous noise, (v) loudness and (vi) speech rate.  Results indicated no statistically 
significant difference in voice parameters between prostheses although there was a 
tendency towards better voice quality on all parameters for the Blom Singer Classic 
Indwelling.  Objective acoustic voice analysis was undertaken for number of syllables 
on one breath, maximum phonation time, fundamental frequency and minimum and 
maximum loudness.  For minimal loudness, the Blom Singer prosthesis was better 
than the Provox but there were no statistically significant differences on other 
acoustic analysis measures.  Subjects also provided a subjective self-assessment that 
included overall assessment of voice prosthesis, own perception of voice quality and 
ease of cleaning management.  Results of self-assessment revealed that subjects in the 
Blom Singer group had better overall assessment and better voice quality than those 
with Provox prostheses.  However, those in the Provox group found daily prosthesis 
maintenance easier than the Blom Singer group.  Overall Blom Singer and Provox 1 
were considered to give similar voice quality, lifetime and patient satisfaction. 
The aim of one study (Hancock et al., 2005) was to examine the feasibility of and 
patient satisfaction with the Provox NID voice prosthesis.  15 subjects who had 
previously used Blom Singer low-pressure voice prosthesis underwent a 6-week trial 
with the Provox voice prosthesis.  7 subjects had a total laryngectomy and 8 a 
pharyngolaryngectomy with jejunal reconstruction.  As part of this study, subjects 
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completed a comparative questionnaire to rate the Provox NID voice prosthesis with 
the Blom Singer low-pressure voice prosthesis.  In general the Provox NID was 
preferred mainly because of its safety and better, less effortful speech.  The fact that 
Provox prosthesis did not open when swallowing hard was included in the patient 
comments on this prosthesis.  In addition measurements of pull out force, maximum 
phonation time and loudness were made for both prostheses.  The pull out force for 
the Provox NID was significantly higher than that for the Blom Singer low pressure.  
There were no significant differences between prostheses for maximum phonation 
time and loudness measures.  In vitro measures of airflow characteristics of both 
prostheses were made.  The airflow resistance at lower airflows is higher for the 
Provox NID voice prosthesis compared to the Blom Singer low pressure.  This feature 
avoids inadvertent opening of the valve at low pressures preventing leakage on 
inhalation and swallowing. 
The objective of a randomised crossover study (Ward et al., 2011) comparing Provox 
Vega with the Blom Singer Classic indwelling voice prosthesis was to ascertain 
whether design enhancements of the newly developed Vega resulted in any positive 
benefits in vivo.  31 subjects were recruited, 17 had undergone total laryngectomy and 
14 had undergone a pharyngolaryngectomy with free jejunal graft.  Each subject’s 
performance with the Provox Vega and the Blom Singer Classic indwelling were 
compared during a 3-week trial of each voice prosthesis.  The order of voice 
prostheses was randomly allocated.  At the end of each 3-week trial, subjects were 
recorded reading a standard passage.  These recordings were then perceptually judged 
by 4 expert Speech and Language Pathologists.  2 participants completed the Blom 
Singer Classic indwelling trial but withdrew during the Provox Vega trial.  After each 
voice prosthesis trial, subjects completed a questionnaire regarding effort, bloating 
and perceived advantages of the device.  Subjects indicated which device they 
preferred during the final comparative questionnaire conducted at the end of the 
second voice prosthesis trial.  Results indicated that 72% of subjects considered voice 
quality to be better with the Provox Vega.  52% reported it took less effort to phonate 
with the Provox Vega.  Results of perceptual ratings by expert listeners indicated 
voice samples with the Provox Vega were less strained, easier to understand, 
produced with less effort and had better speech overall when compared with sample 
from the Blom Singer Classic Indwelling.  This study concluded that aerodynamic 
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design improvements in the Provox Vega facilitated enhanced voice and speech 
qualities. 
The aim of a subsequent study (Hancock et al., 2012) was to determine patient 
perceptions of 2 indwelling prostheses (Provox Vega and Blom Singer Classic 
indwelling in relation to insertion, cleaning, care, voice and voice related function.  In 
addition, this study also examined the factors influencing patient perception when 
using an indwelling voice prosthesis.  31 subjects were recruited, 17 had undergone a 
total laryngectomy and 14 had undergone a pharyngolaryngectomy with free jejunal 
graft.  Each subject participated in a 3-week trial of each voice prosthesis with the 
order of voice prosthesis randomly allocated.  2 participants completed the Blom 
Singer Classic indwelling trial but withdrew during the Provox Vega trial.  Data 
elicited related to (i) insertion and removal process, (ii) cleaning and care, (iii) 
voicing, (iv) other device related issues and (v) overall preference.  Results indicated 
that a significantly higher proportion of subjects felt that voice effort, overall voicing, 
bloating and ease and effectiveness of cleaning were superior for the Provox Vega.  
No preference was noted for insertion process.  While distinct patterns of preference 
for one device over the other was observed, the high degree of diversity in patient 
responses was also noted.  Some individuals had experiences that were different to or 
completely opposite to others within the group.  This study concluded that patients do 
not perceive all indwelling prostheses as equal and should have the opportunity to 
trial different prostheses to find the best one for their needs. 
 
The studies described in this section all involve comparing voice prostheses.  The first 
study (Pauloski et al., 1989) found that TEP voice with a Blom Singer low-pressure 
voice prosthesis was significantly different to that produced with a Blom Singer 
duckbill prosthesis across a range of acoustic measures.  A subsequent study 
(VanDenHoogen et al., 1996) compared the Groningen, Nijdam and Provox 1 voice 
prostheses and found that the Nijdam had a significantly longer lifetime than the 
Groningen and Provox 1.  However, complications during the replacement of the 
Nijdam were more common than with the Groningen and Provox 1.  The large study 
carried out by Delsupehe and colleagues (Delsupehe et al., 1998) compared the Blom 
Singer Classic Indwelling voice prosthesis with the Provox 1 using perceptual 
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analysis judged by raters, acoustic measures and notably, self-assessment of patients.  
Overall, both prostheses were judged to be similar for voice quality, lifetime and 
patient satisfaction on this study.  However, the Blom Singer Classic indwelling was 
better than the Provox on a single acoustic measure (minimal loudness).  Self-
assessment by patients indicated a better overall assessment and better voice quality 
with the Blom Singer Classic indwelling although daily prosthesis maintenance was 
easier with the Provox 1.  A study (Hancock et al., 2005) comparing the Provox NID 
and Blom Singer low pressure found that subjects preferred the Provox NID because 
of its safety and less effortful speech.  This study also found that airflow resistance at 
lower airflows was higher for the Provox NID resulting in this prosthesis staying 
closed and preventing leakage even when subjects swallowed hard.  A study (Ward et 
al., 2011) comparing the indwelling Provox Vega and the indwelling Blom Singer 
Classic found that both subject self-assessment and perceptual analysis favoured the 
Provox Vega.  A study focusing on patient perception (Ward et al., 2011), compared 
the Provox Vega and the Blom Singer Classic indwelling.  Patients indicated a 
preference for the Provox Vega.  However, this study noted a high degree of diversity 
in patient responses and highlighted that patients do not perceive all indwelling 
prostheses as equal.  Taken as a whole, these studies do not indicate a consensus on 
which prosthesis is best. 
 
 
3.3 Investigation into the effect of different voice prostheses on 
swallowing 
 
3.3.1 Objectives 
 To investigate whether subjects have a preference for a voice prosthesis for 
swallowing. 
 To investigate whether expert raters consider one voice prosthesis as best for 
swallowing for subjects. 
 To investigate whether subjects and raters will agree on best prosthesis for 
swallowing. 
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 To investigate whether there is a difference between voice prostheses in terms 
of amount of residue on the voice prosthesis and in the oesophagus. 
3.3.2 Hypotheses 
1. Scores for individual voice prostheses on patient self-evaluation will be 
equally distributed and will not indicate a preference for an individual voice 
prosthesis for swallow. 
2. Analysis of raters’ choice of best prosthesis for each subject will not identify 
an overall best prosthesis for swallow. 
3. Subjects and raters will agree on best prosthesis for swallow. 
4. There is no difference between prostheses on the degree of residue observed 
by expert raters on the following parameters of liquid and food consistencies 
and specific anatomical locations: 
 Thin liquid residue on the voice prosthesis  
 Puree residue on the voice prosthesis  
 Soft residue on the voice prosthesis 
 Solid residue on the voice prosthesis  
 Thin liquid in the oesophagus  
 Puree in the oesophagus  
 Soft in the oesophagus 
 Solid in the oesophagus 
 
3.3.3 Methods 
3.3.3.1 Subjects 
42 subjects who have had a laryngectomy were screened and consented for this study.  
Each of the subjects agreed to attend 2 appointments within a 7-day period and trial 
up to 6 voice prostheses.  1 subject was excluded because he failed to attend the 
second appointment. 
41 subjects attended 2 appointments within a 48-hour period with one subject 
attending 2 appointments within a 72-hour period.   
3.3.3.2 Ethics 
Ethics application was submitted 26/02/2010 with approval granted by West London 
REC on 24/05/2010.  Ethics reference number is 10/H0706/25.  Imperial College 
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Healthcare Trust Joint Research Office approval was obtained 05/08/2010.  JRO 
reference number is JROHH0033. A substantial amendment was sought to change the 
number of voice prostheses used in the study from 5 to 6.  This was to accommodate 
the inclusion of the Provox Vega and Provox NID voice prostheses and to exclude the 
Blom Singer increased pressure voice prosthesis. Approval for substantial amendment 
was granted 14/02/11.  A minor amendment was sought to allow the addition of green 
food colouring to apple puree to facilitate visualisation of this consistency FEES.  
Confirmation that this was a minor amendment which could be implemented 
immediately was received 15/03/2011.  Please see appendix for letters of approval 
from ethics. 
3.3.3.3 Study procedure 
 
Visit 1 
Each subject’s weight and height were measured during this visit and BMI was 
calculated.  Current diet, use of dietary supplements and type of voice prosthesis was 
recorded.  Each subject also completed the MDADI and the UOW QOL v4 scales if 
these had not been administered previously in study 1. 
Each subject’s voice prosthesis was initially removed.  The length and diameter of the 
removed prosthesis was noted.  During this first appointment the tracheoesophageal 
puncture (TEP) was sized and 3 prostheses in the appropriate size were selected.  
Randomised selection was made from the following prostheses: 
 Provox NID (Atos Medical, Horby, Sweden) 
 Provox Vega (Atos Medical, Horby, Sweden) 
 Blom Singer Duckbill (InHealth Technologies, California, USA) 
 Blom Singer Low Pressure (InHealth Technologies, California, USA)  
 Blom Singer Classic Indwelling (InHealth Technologies, California, USA) 
 Blom Singer Advantage (InHealth Technologies, California, USA).  
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Randomisation for all prostheses was performed for each subject using the “Research 
Randomizer” programme on the website http://www.randomizer.org/.  Based on 
randomised selection, the initial 3 prostheses in the randomisation sequence were 
chosen for placement during the initial appointment.  Subjects could see the voice 
prosthesis but were blinded to the name of the prosthesis and the manufacturer.  Each 
prosthesis was placed according to individual manufacturer’s instructions including 
use of the gel cap insertion system for Blom Singer prostheses.  The absence of 
central and peripheral leakage for each individual prosthesis was confirmed by asking 
each subject to take 3 sips from 200ml of water coloured with 2ml of Silver Spoon 
blue food colouring (British Sugar PLC).  The following protocol was then followed: 
 
 
1. A Pentax FNL10RBS flexible nasendoscope (Pentax, Slough, UK) was 
passed through the right nares where possible.  If the subject experienced 
discomfort when the scope was passed through the right nares, the scope 
was removed and passed through the left nares. 
2. When the voice prosthesis was identified, dynamic recording of the 
examination using the Kay Pentax Swallow Work Station Model 7127e 
(Pentax, Slough, UK) was commenced. Swallow trials for each of the 
following consistencies were recorded: 
 10ml of 2% semi skimmed milk (Sainsbury’s PLC, London, UK) 
 10ml of Davison’s apple total fruit compote, (Davison’s Canners Limited, 
Armagh, Northern Ireland) taken from 2 x 90g pots with 2ml of Silver 
Spoon green food dye, (British Sugar PLC, Peterborough UK) added. 
 1 cm thick slice of a medium yellow banana 
 ¼ Mc Vitie’s digestive biscuit, (United Biscuits UK Ltd, Middlesex, UK) 
 
3. Each consistency was given 3 times following a standard protocol.  Each 
subject had a swallow of water after every individual consistency trial to 
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rinse any remaining residue.  If subjects had difficulty swallowing a 
particular consistency, the number of trials given was reduced to two and 
occasionally one.   
4. After each prosthesis trial, the subject was asked to rate their experience of 
swallow and voice quality using a 5 point Likert Self Evaluation 
questionnaire with 5 questions relating to swallow and 6 relating to voice, 
(see appendix 13) 
 
Steps 1-5 were then repeated with the remaining 2 prostheses.  Once the last 
prosthesis has been removed, the prosthesis that the subject had in situ on arrival was 
replaced.  The subject’s follow up appointment time and date was confirmed. 
 
Visit 2  
 
Each subject’s voice prosthesis was initially removed and the first of the remaining 2 
prostheses in the randomisation sequence (if the subject had a 20fg prosthesis 
diameter measurement) or the remaining 3 prostheses in the randomisation sequence 
(if the subject had a 16fg prosthesis diameter measurement) was placed.  The 
procedure described for visit 1 (preceding section 3.3.3.3) was then repeated. 
The patient was then asked to indicate their favourite overall voice prosthesis. 
3.3.3.3 Outcome measurement 
 
A description of the FEES imaging process can be found in section 2.6.3 Methods.  A 
description of how the FEES images were processed can be found in section 2.6.3 
Methods.  Briefly the dynamic recordings of each individual swallow were extracted 
in AVI format.  Subject number and consistency were the added as labels to these 
files and identifying information was removed.  The images were then placed on 
external hard drives in a random order before presentation to the expert raters. Raters 
were blinded to both subjects and prosthesis. (Details about the expert raters can be 
found in section 2.4.3.2 Expert raters.)  From this data, raters were asked to make an 
evaluation of both swallowing and voice.  Thus, the raters gave an independent 
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evaluation of each FEES exam.  Following evaluation of FEES exams for each 
prosthesis, for each subject, raters were asked to indicate separately the prosthesis 
they considered “best” for swallow for that subject. 
3.3.3.4 Statistical analysis 
The Statistical Advisory Service at Imperial College London provided a power 
calculation which determined sample size. 
Data was entered and analysed in IBM SPSS (Statistical Product and Service 
Solutions), version 20, IBM Armouk, New York. 
 
3.3.4 Results 
 
Demographics and treatment details 
42 subjects were recruited to this study; one subject was excluded because of failure 
to attend the second appointment.  Analysis was therefore undertaken on 41 subjects.  
All subjects used exclusively Blom Singer voice prostheses prior to recruitment to 
this study.  97.6% (n-40) were primarily tracheoesophageal speakers, 2.4% (n-1) 
chose to use primarily oesophageal speech although this subject had good functional 
tracheoesophageal voice.  However, tracheosophageal voice samples were recorded 
for all subjects for the purposes of this study.  Further details regarding subjects in 
this study are outlined in Tables 3.1, 3.2 and 3.3. 
Table 3-1: Age and years since surgery  
Characteristic Median Mean SD SE Min Max 
Age (years) 64.41 66.33 
 
9.07 1.41 43  84.75  
Time since 
surgery 
(years) 
8.05  
 
6 7 1.09 4 29 
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Table 3-2: Demographics 
Gender Male 35 (85%) 
Female 6 (15%) 
Ethnicity Black/Black British  (n-5) 12.2% 
White (n-31) 75.6% 
Asian or Asian British (n-1) 2.4% 
Other ethnic groups (n-4) 9.8% 
Marital status Single (n-10) 24.4% 
Married/long term partner (n-26) 63.45% 
Divorced (n-1) 2.4% 
Widowed (n-3) 7.3% 
Separated (n-1) 2.4% 
 
Table 3-3: Surgical and treatment details 
Surgery Total Laryngectomy (n-30) 73.2% 
Pectoralis Major Flap (n-6) 14.6% 
Jejunum 4 (n-3) 7.3% 
Jejunum & pectoralis major flap 2 (4.9%) 
Myotomy/Neurectomy Yes (n-35) 70% 
No (n-12) 24% 
Unknown (n-3) 6% 
Closure Horizontal (n-26) 63.4% 
Circumferential (n-10) 24.4% 
Unknown (n-5) 12.2% 
Neck dissection Bilateral (n-10) 24.4% 
Unilateral (n-8) 19.5% 
None (n-18) 43.9% 
Unknown (n-5) 12.2% 
Timing of tracheosophageal puncture Primary TEP n-30 (73.2%) 
Secondary TEP n-11 (26.8%) 
Radiotherapy History Pre-operative XRT (n-18) 43.7% 
Postoperative XRT (n-17)  41.5% 
Pre and postoperative XRT (n-2) 4.9% 
None (n-4) 9.8% 
Chemotherapy History 
 
Pre op chemo (n-6) 14.6% 
Post op chemo (n-2) 4.9% 
No chemo (n-33) 80.5% 
Salvage Yes (n-21) 51.2% 
No (n-20) 48.8% 
TL only n- 4 ( 9.7%) 
Post op XRT only (%) 
XRT/Chemo Pre op XRT/Chemo (%) 
Post op XRT/Chemo (%) 
None (%) 
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Hypothesis 1 
Scores for individual voice prostheses on patient self-evaluation will be equally 
distributed and will not indicate a preference for an individual voice prosthesis for 
swallow. 
5 questions relating to swallow from a “Communication and Swallowing with voice 
prostheses self-evaluation questionnaire” were scored.  Scores from each swallow 
question were then added to provide a total swallow score for each prosthesis for each 
individual subject.  The higher the score achieved, the more negatively subjects 
evaluated swallow.  This data represented a single factor, repeated measures design 
with 6 experimental conditions.  Therefore this data required analysis using the non-
parametric measure Friedman Two Way Analysis of Variance by Ranks.  Median 
descriptive scores were elicited for each prosthesis.  Median descriptive scores and 
Friedman test results are indicated in Table 3.4. 
Table 3-4: Median descriptive scores for each prosthesis and Friedman test 
results – Subject preference for voice prosthesis for swallow 
Prothesis type n Percentiles – scores for swallow 
25th 50
th
 (median) 75th 
Blom Singer 
Duckbill  
 12 14 17 
Blom Singer low 
pressure  
 10 13 15 
Blom Singer 
Classic 
Indwelling  
 10 14 15 
Blom Singer 
Advantage  
 12 12 14 
Provox Non 
Indwelling (NID)  
 10 13 16 
Provox Vega   10 13 14 
Friedman test Chi-Square 7.89 
df 5 
Significance 0.16 
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As the Friedman p is >0.05, the null hypothesis of equality of scores is accepted.  
Scores are equally distributed for swallow.  
   
 
Hypothesis 2 
Analysis of raters’ choice of best prosthesis for each subject will not identify an 
overall best prosthesis for swallow.   
 
First, a consensus score for best voice prosthesis for swallow for each subject was 
calculated from the ratings of each clinician.  Consensus score was calculated from 
the prosthesis that 2 or more raters considered best for swallow.  When no consensus 
was achieved, this was indicated within the data.   
 
Frequency analysis for choice of “best” prosthesis based on consensus scores from 
Clinicians is presented in table 3.5.  This analysis indicates that the Blom Singer low 
pressure and Blom Singer classic indwelling were most frequently chosen (9.8% of 
sample respectively) as best prosthesis for swallow.  Neither the Blom Singer duckbill 
nor the Blom Singer Advantage was chosen on any occasion by clinicians as best for 
swallow.  For a large proportion of the sample (68.3%), no consensus was reached 
among raters on best prosthesis for swallow.    
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Table 3-5: Frequency analysis of Clinician consensus of best prosthesis for 
swallow 
Prosthesis  Frequency Percentage of sample 
Blom Singer Duckbill 0 0% 
Blom Singer Low pressure  4 9.8% 
Blom Singer Classic 
Indwelling 
4 9.8% 
Blom Singer Advantage 0 0% 
Provox NID 3 7.3% 
Provox Vega 2 4.9% 
No consensus best 
prosthesis for swallow 
28 68.3% 
 
Hypothesis 3 
Subjects and raters will agree on best prosthesis for swallow. 
 
Subjects completed a Likert Self Evaluation questionnaire after each prosthesis trial. 
Subjects’ scores for swallow questions for each individual voice prosthesis on this 
questionnaire were totaled.  A lower score indicated a better experience with 
swallowing.  The prosthesis with the lowest swallow score for each subject was 
extracted from the data and considered as subject “best” for swallowing.  Following 
examination of individual FEES exams on different voice prostheses for each subject, 
raters indicated which prosthesis they considered “best” for swallowing for each 
subject.  Subject “best” prosthesis for swallow and rater “best” prosthesis for swallow 
was compared using kappa.  Cramer’s v was used to analyse whether an association 
existed between subject and rater “best” prosthesis for swallow.  Analysis revealed 
kappa of 0.074.  As kappa is >0.6, no agreement between subjects and raters 
regarding best prosthesis for swallow was observed.  Cramer’s v of 0.307 was 
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obtained.  As this value is not close to 0, no association between subjects and raters 
regarding best prosthesis for swallow was observed.  The hypothesis that subjects and 
raters will agree on best prosthesis for swallow was therefore rejected. 
 
For each parameter of hypothesis 4, a consensus score for amount of residue observed 
on each voice prosthesis on each swallow consistency for each subject was calculated 
from the ratings of each clinician.  This was calculated by measuring agreement for 
whether or not residue is present.  If residue was present, agreement for amount of 
residue was measured. Consensus score was calculated from 2 or more raters, when 
no consensus was achieved, this was indicated within the data.  
Each continuous consensus value was then checked for normal distribution using P-P 
plots, see appendix.  Once normal distribution was confirmed, repeated measures of 
analysis of variance was chosen as the method of analysis.  
 
Hypothesis 4  
There is no difference between prostheses on the degree of residue observed 
by expert raters on the following parameters of liquid and food consistencies 
and specific anatomical locations: 
 Thin liquid residue on the voice prosthesis  
 Puree residue on the voice prosthesis  
 Soft residue on the voice prosthesis 
 Solid residue on the voice prosthesis  
 Thin liquid in the oesophagus  
 Puree in the oesophagus  
 Soft in the oesophagus 
 Solid in the oesophagus 
Parameter 1 
There is no difference between the degree of thin liquid residue observed on different 
voice prostheses as judged by expert raters.  
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Results from the analysis for this hypothesis are outlined in Table 3.6. 
 
Table 3-6: Repeated measures of Analysis of Variance – Thin liquid residue 
on voice prosthesis 
Type III Tests of Fixed Effects indicated there is a significant difference between 
prostheses on the degree of thin liquid residue on the voice prosthesis (prostype 
p=0.00, <.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
40.45 4.24 33.95 31.84 49.07 
Blom Singer Low 
Pressure 
31.19 3.76 35.3 23.55 38.83 
Blom Singer 
Classic 
Indwelling 
31.19 3.76 35.3 23.55 38.83 
Blom Singer 
Advantage 
44.944 3.305 35.695 38.240 51.648 
Provox Non 
Indwelling 
39.37 3.78 31.25 31.67 47.08 
Provox Vega 41.67 3.73 23.56 33.96 49.37 
 
The classic indwelling voice prosthesis has the least residue on thin liquids and the 
advantage has the most.  As there is a significant difference in the degree of residue 
on each prosthesis, this parameter is rejected for thin liquids. 
 
As repeated measure of variance indicated significance for degree of residue on this 
question, post hoc analysis using the Bonferroni procedure was undertaken to see 
exactly where differences lay in the data, see Table 3.7.  Pairwise comparisons were 
undertaken as each participant used each prosthesis.  This analysis revealed 
significant mean differences (p <0.5) for this data on the following pairs:  
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Table 3-7: Post hoc pair wise comparisons – thin liquid residue on the voice 
prosthesis 
Pairs p Mean 
difference  
Prosthesis with higher score  
Blom Singer Low pressure vs.  
Blom Singer Classic 
Indwelling 
0.049 9.339 Blom Singer Low Pressure  
Blom Singer Classic 
Indwelling vs. Blom Singer 
Advantage 
0.000 13.758 Blom Singer Classic Indwelling 
Blom Singer Classic 
Indwelling vs. Provox NID 
0.015 8.187 Blom Singer Classic Indwelling 
Blom Singer Classic 
Indwelling vs. Provox Vega 
0.024 10.482 Blom Singer Classic Indwelling 
 
Parameter 2 
There is no difference between the degree of puree residue observed on different voice 
prostheses as judged by expert raters. 
Results from the analysis of this hypothesis is outlined in Table 3.8 
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Table 3-8: Repeated measures of Analysis of Variance – Puree residue on 
voice prosthesis 
Type III Tests of Fixed Effects indicated there was not a significant difference 
between prostheses on the degree of puree residue on the voice prosthesis (prostype 
p=0.11,>05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
48.83 3.42 30.63 41.85 55.8 
Blom Singer Low 
Pressure 
48.56 4.39 37.4 39.67 57.45 
Blom Singer 
Classic 
Indwelling 
50.2 4.72 39.77 40.65 59.75 
Blom Singer 
Advantage 
58.82 3.77 40.44 51.21 66.44 
Provox Non 
Indwelling 
55.76 4.22 38.09 47.21 64.32 
Provox Vega 49.86 4.34 34.53 41.05 58.67 
 
 
 
The Blom Singer low pressure has the least amount of puree residue and the Blom  
Singer Advantage the most.  However, as the difference in degree of puree residue on 
different prostheses is not significant, the parameter is accepted.  
Parameter 3  
There is no difference between the degree of soft residue observed on different voice 
prostheses as judged by expert raters. 
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Results for the analysis of this hypothesis is outlined in Table 3.9 
 
Table 3-9: Repeated measures of Analysis of Variance – Soft residue on 
voice prosthesis 
Type III Tests of Fixed Effects indicated there was a significant difference between 
prostheses on the degree of soft residue on the voice prosthesis (prostype p=0.01, 
<0.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
57.02 4.56 35.36 47.76 66.27 
Blom Singer Low 
Pressure 
49.89 4.66 35.65 40.43 59.34 
Blom Singer 
Classic 
Indwelling 
46.76 4.73 34.8 37.16 56.37 
Blom Singer 
Advantage 
49.17 4.21 39.85 40.66 57.69 
Provox Non 
Indwelling 
58.09 4.39 37.76 49.19 66.98 
Provox Vega 43.32 4.67 25.49 33.71 52.94 
 
 
 
The Provox Vega voice prosthesis has the least soft residue on the voice prosthesis 
and the Provox NID has the most followed by the Blom Singer duckbill.  As there is a 
significant difference in the degree of residue on each prosthesis, the parameter is 
rejected. 
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As repeated measure of variance indicated significance for degree of residue on this 
question, post hoc analysis using the Bonferroni procedure was undertaken to see 
exactly where differences lay in the data.  Pair wise comparisons were undertaken as 
each participant used each prosthesis.  This analysis revealed no significant mean 
differences (p <0.5) for this data.  It is possible to have a post hoc test that contradicts 
the main (omnibus) test.  This can occur when there are 2 groups that are nearly 
different to the others in the post hoc test but are different when considered in the 
omnibus test. 
Parameter 4 
There is no difference between the degree of residue observed on different voice 
prostheses on solid as judged by expert raters. 
Results for this analysis are outlined in Table 3.10  
Table 3-10: Repeated measures of Analysis of Variance – solid residue on 
voice prosthesis 
Type III Tests of Fixed Effects indicated there was a not a significant difference 
between prostheses on the degree of solid residue on the voice prosthesis (prostype 
p=0.532,>0.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
50.93 3.9 33.99 43.01 58.85 
Blom Singer Low 
Pressure 
50.35 4.47 33.65 41.26 59.44 
Blom Singer 
Classic 
Indwelling 
43.30 4.46 39.16 34.29 52.32 
Blom Singer 
Advantage 
50.97 3.99 40.19 42.91 59.04 
Provox Non 
Indwelling 
50.68 4.39 39.46 41.8 59.57 
Provox Vega 47.38 4.67 33.6 37.89 56.87 
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The Blom Singer classic indwelling has the least amount of solid residue on the voice 
prosthesis and the Blom Singer Advantage the most.  However, as the difference in 
the degree of solid residue on different prostheses is not significant, the parameter is 
accepted.  
Parameter 5 
There is no difference between the degree of residue observed in the oesophagus on 
thin liquids as judged by expert raters. 
The results for this analysis are outlined in Table 3.11 
 
Table 3-11: Repeated measures of Analysis of Variance – Thin liquid 
residue in the oesophagus 
Type III Tests of Fixed Effects indicated there was a not a significant difference 
between prostheses on the degree of liquid residue in the oesophagus (prostype 
p=0.379,>0.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
44.47 3.61 30.88 37.12 51.83 
Blom Singer Low 
Pressure 
43.88 3.13 40.88 37.57 50.2 
Blom Singer 
Classic 
Indwelling 
40.27 2.91 41.03 34.39 46.15 
Blom Singer 
Advantage 
44.14 3.06 41.00 37.96 50.32 
Provox Non 
Indwelling 
42.64 3.41 41.43 35.76 49.53 
Provox Vega 44.15 3.22 31.68 37.59 50.72 
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The Blom Singer classic indwelling has the least amount of residue and the Blom 
Singer duckbill the most.  However, as the difference in degree of thin liquid residue 
in the oesophagus is not significant, the parameter is accepted.  
 
Parameter 6. 
There is no difference between the degree of residue observed in the oesophagus on 
puree as judged by expert raters. 
The results for this analysis is contained in Table 3.12 
 
 
Table 3-12: Repeated measures of Analysis of Variance –  puree residue in 
the oesophagus 
Type III Tests of Fixed Effects indicated there was a not a significant difference 
between prostheses on the degree of puree residue in the oesophagus (prostype 
p=0.133,>0.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
53.3 2.79 35.56 47.64 58.96 
Blom Singer Low 
Pressure 
53.89 3.94 41.02 45.94 61.85 
Blom Singer 
Classic 
Indwelling 
58.7 3.92 40.71 50.79 66.62 
Blom Singer 
Advantage 
56.73 2.91 41.00 50.85 62.62 
Provox Non 
Indwelling 
51.41 3.19 40.88 44.95 57.86 
Provox Vega 51.06 4.03 36.05 42.88 59.23 
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The Provox Vega has the least amount of residue and the Blom Singer low pressure 
the most.  However, as the difference in the degree of puree residue in the oesophagus 
is not significant, the parameter is accepted.  
 
Parameter 7. 
There is no difference between the degree of residue observed in the oesophagus on 
soft as judged by expert raters. 
Results of this analysis are outlined in Table 3.13 
 
Table 3-13: Repeated measures of Analysis of Variance – Soft residue in the 
oesophagus 
Type III Tests of Fixed Effects indicated there was a significant difference between 
prostheses on the degree of soft residue in the oesophagus (prostype p=0.00, <0.05) 
 
 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
60.11 3.80 32.02 52.37 67.85 
Blom Singer Low 
Pressure 
46.61 3.64 39.66 39.26 53.97 
Blom Singer 
Classic 
Indwelling 
50.30 3.72 38.42 42.78 57.82 
Blom Singer 
Advantage 
50.76 3.95 38.76 42.76 58.76 
Provox Non 
Indwelling 
54.22 3.88 37.62 46.36 62.07 
Provox Vega 40.8 3.63 33.98 33.42 48.17 
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The Provox Vega has the least amount of soft residue in the oesophagus and the Blom 
Singer duckbill the most.  As the difference in the degree of oesophagus residue in the 
oesophagus is significant, the parameter is rejected.  
 
As repeated measure of variance indicated significance for degree of residue on this 
question, post hoc analysis using the Bonferroni procedure was undertaken to see 
exactly where differences lay in the data.  Pair wise comparisons were undertaken as 
each participant used each prosthesis.  This analysis revealed significant mean 
differences (p <0.5) for this data on the pairs in Table 3.14: 
 
 
Table 3-14: Post hoc pair wise comparisons – soft residue in the oesophagus 
Pairs p Mean difference  Prosthesis with higher score  
Blom Duckbill vs.  
Provox Vega 
0.001 19.311 Blom Singer Duckbill 
Provox NID vs. 
Provox Vega 
0.041 13.420 Provox NID 
 
 
 
Parameter 8. 
There is no difference between the degree of residue observed in the oesophagus on 
solid as judged by expert raters. 
The results for this analysis are outlined in Table 3.15 
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 Table 3-15: Repeated measures of Analysis of Variance – Solid residue in 
the oesophagus  
 Type III Tests of Fixed Effects indicated there was a not a significant difference 
between prostheses on the degree of solid residue in the oesophagus (prostype p=0.63, 
0.05) 
Prosthesis type Mean SE df 95% confidence 
interval 
Lower 
bound  
Upper 
bound 
Blom Singer 
Duckbill 
48.8 3.47 33.89 41.74 55.86 
Blom Singer Low 
Pressure 
44.6 3.49 39.68 37.53 51.67 
Blom Singer 
Classic 
Indwelling 
50.06 3.35 41.00 43.29 56.82 
Blom Singer 
Advantage 
48.34 3.43 41.00 41.40 55.28 
Provox Non 
Indwelling 
51.10 3.26 39.74 44.50 57.70 
Provox Vega 49.14 4.29 36.87 40.45 57.82 
 
 
 
The Blom Singer low pressure has the least amount of residue and the Provox NID 
the most.  However, as the difference in amount of solid residue in the oesophagus is 
not significant, the parameter is accepted.  
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3.3.5 Discussion 
 
This study focused on an investigation of whether voice prostheses have an effect on 
swallowing ability.  Since the development of the first widely commercially available 
voice prosthesis (Blom and Singer, 1979, Singer and Blom, 1980), there are now a 
wide range of voice prostheses available each with their own individual 
characteristics.  Part of the voice prosthesis sits within the oesophagus and the 
configuration of the oesophageal flange differs across each prosthesis.  Despite 
patients’ reports of changes in swallowing ability with some voice prostheses, there 
has been no previous research in to this area.   
 
3.3.5.1 Subject preference for a voice prosthesis for swallowing 
 
The first objective of this study was to investigate whether subjects had a preference 
for a voice prosthesis for swallowing.  Results indicated that scores were equally 
distributed among voice prostheses for swallowing and that subjects did not perceive 
one voice prosthesis as best for swallow.  This was judged using a 5-point self-
evaluation swallow Likert questionnaire.  The formulation of this questionnaire was 
directly based on patient feedback describing what makes a prosthesis work well for 
swallow.   Subject preference for voice prosthesis was therefore based on the answers 
to questions involving comfort when swallowing, whether food gets stuck, whether 
the voice is wet after swallow and whether extra water is required.  The feeling of 
food getting stuck when swallowing can indicate an obstruction to bolus flow during 
swallow.  A “wet” voice post swallow can indicate food or secretion residue on the 
voice prosthesis.  The need for extra liquid when swallowing can suggest reduced 
motility and the presence of residue within the reconstructed throat.  The questions 
chosen for the self-evaluation swallow questionnaire used in this study reflect issues 
identified in other research.  Poor motility has been described as a feature of post 
laryngectomy swallow (Ward et al., 2002) as has the need to wash food down with 
liquid (Maclean et al., 2009d).  A recently published study (Govender et al., 2012) 
identified food sticking in the throat as a symptom of post laryngectomy swallow. 
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Although some individual subjects commented strongly that certain voice prostheses 
were easier to swallow with than others, the analysis of the group as a whole indicated 
that scores were equally distributed and no one voice prosthesis or prostheses 
emerged as preferential for swallowing.  A recent study (Hancock et al., 2012) of 
patient perception of indwelling voice prostheses for the purposes of voice noted a 
high degree of diversity in patient responses and indicated that patients do not 
perceive all indwelling prostheses as equal.  Given that patients themselves 
sometimes report significant differences amongst voice prostheses for both voice and 
swallow, it may be of relevance to trial different voice prostheses individual patients 
within the clinical setting.  This study was limited by the fact that voice prostheses 
were trialled for a relatively short period of time (approximately 30-40 minutes).  
Subjects tried a range of different food consistencies with each voice prosthesis 
during endoscopic swallow evaluation.  However, this type of evaluation is not as 
functional as a patient self-evaluating swallow performance with a voice prosthesis 
over a number of days or weeks while eating meals at home or in social situations.  It 
may be of benefit for future research in this area to evaluate differences in swallowing 
amongst voice prostheses with a voice prosthesis in place for a prolonged period of 
time. 
3.3.5.2 Rater choice of best prosthesis for swallow for each subject. 
 
The second objective of this study was to investigate whether expert raters consider 
one voice prosthesis as best for swallow for subjects.  Frequency analysis of best 
prosthesis based on consensus scores from 3 expert raters indicated that the Blom 
Singer Low pressure and Classic Indwelling were most frequently chosen as best 
prosthesis for swallow.  Neither the Blom Singer Advantage nor the Blom Singer 
Duckbill was chosen even once as the best prosthesis for swallow for an individual 
subject.  The results of this analysis should be interpreted cautiously given the 
subjective nature of the task and that for a majority of the sample (68.3%), there was 
no consensus amongst the expert raters for best prosthesis for swallow.  Of the limited 
number of studies which have compared voice prostheses, two (Delsupehe et al., 
1998, Ward et al., 2011) included perceptual evaluation of voice quality by expert 
raters.  The first study (Delsupehe et al., 1998) found that perceptual rating of the 
Blom Singer Classic Indwelling and Provox 1 was similar for both prostheses.  The 
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second (Ward et al., 2011) found that perceptual analysis favoured the Vega over the 
Blom Singer Classic Indwelling.  To date, no other study has examined expert rater 
analysis of patient swallow performance with different voice prostheses.  
Laryngectomy patients need to use voice prostheses on a daily basis. Patient 
perception of the performance of different voice prostheses for swallow and voice is 
of paramount importance.  However, it would extend knowledge to pursue further 
research into the area of clinician analysis of patient swallow performance with 
different voice prostheses. 
3.3.5.3 Comparison of subject and expert rater agreement on best prosthesis for 
swallow 
 
The next objective of this study was to investigate whether subjects and raters agreed 
on best prosthesis for swallow.  There was no agreement between subjects and raters 
on this question.  In addition, no association between subjects and raters regarding 
best prosthesis for swallow was observed.  A previous study (Ward et al., 2011) using 
the Provox Vega with the Blom Singer Classic Indwelling, compared patient and 
clinician perceptions of both prostheses.  (Ward et al., 2011) found that of the 15 
subjects who reported their voice was less effortful with the Provox Vega, clinicians 
also rated 10 (67%) of these as having a less effortful voice with the Provox Vega.  
Although (Delsupehe et al., 1998) study involved both perceptual ratings by clinicians 
and patient perception of the Blom Singer Classic In dwelling and Provox 1 
prosthesis, no direct comparison between clinicians and patients was analysed.  
Further research into comparison of subject and rater perception of different voice 
prostheses may be of benefit in facilitating a better understanding of issues important 
to the laryngectomy patient and providing better patient choice in the clinical setting. 
 
3.3.5.4 Differences between voice prostheses in the degree of residue in the 
anatomical locations of (i) the voice prosthesis and (ii) oesophagus. 
 
The final aim of this study was to investigate in an objective manner whether there is 
a difference between voice prostheses in terms of the degree of residue on the voice 
prosthesis and in the oesophagus.  Clearly, factors other than the voice prosthesis, 
such as anatomy and type and amount of food consistency, can influence the amount 
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of residue experienced by a laryngectomy patient.  However, in this study, the effect 
of voice prostheses was measured across the same group of subjects with type and 
amount of food consistencies strictly controlled.  Expert raters were asked to judge 
the degree of residue on liquid, puree, soft and solid consistencies.  Results indicated 
a significant difference in amount of residue on thin liquids on the voice prosthesis 
and on soft on both the voice prosthesis and in the oesophagus.  There was least thin 
liquid residue on the voice prosthesis on the Blom Singer Classic Indwelling and most 
on the voice prosthesis on the Blom Singer Advantage.  There was least soft residue 
on the voice prosthesis on the Provox Vega and most in the oesophagus on the Provox 
NID.  There was least soft residue in the oesophagus on the Provox Vega and most in 
the oesophagus on the duckbill. From the perspective of patients, the Blom Singer 
Advantage was least likely to be perceived as best for swallow and it had the most 
residue with soft which differs to the findings of the expert raters. 
There has been no previous research into the effect of voice prostheses on 
swallowing.  However, previous studies have identified dysphagia issues post 
laryngectomy that suggests the residue occurs.  These issues include poor motility 
(Ward et al., 2011), the need to use liquid to wash food down (Maclean et al., 2009d), 
food sticking in the throat (Govender et al., 2012) and having to swallow many times 
to get food down (Govender et al., 2012).  As previously discussed in the background 
to this chapter, the oesophageal configuration of each prostheses trialled in this study 
is different.  Anecdotally, patients have reported food sometimes getting stuck on the 
voice prosthesis especially on soft and solid consistencies.  In post laryngectomy 
patients, residue particularly on the voice prosthesis but also in the oesophagus, may 
pose a risk of aspiration, particularly if the patient is trying to talk and eat at the same 
time.   
The finding of a significant difference in the degree of residue between various voice 
prostheses in both the oesophagus and on the voice prosthesis on soft food is 
consistent with patient reports in the clinical setting.  Anecdotally, patients who notice 
a change in swallow with different voice prosthesis find their swallow is altered most 
on thicker consistencies such as soft and solid.  While significant differences between 
degree of residue on various voice prostheses in the anatomical locations of both the 
oesophagus and the voice prosthesis were noted on soft rather than solid, this may 
have been influenced by the type of food consistencies trialled.  Banana, which is 
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relatively sticky, was used as a soft consistency with digestive biscuit used as a solid 
consistency.  The use of a solid consistency such as bread or meat, (which clinically 
laryngectomy patients report as the most difficult solid consistencies to swallow) may 
have yielded a different result.   
Both the Provox Vega and the Blom Singer Classic Indwelling were found to have 
least residue.  In common with the Provox NID and the Blom Singer Low Pressure 
voice prostheses, the oesophageal end of the Provox Vega has a flap surrounded by a 
hood that protrudes slightly into the oesophagus.  However, the Provox Vega contains 
a recessed and angled flap, which is totally encased by the prosthesis hood and is 
designed to minimise direct exposure of the prosthesis to the oesophagus. It is 
possible that this characteristic may help minimise residue. The Blom Singer Classic 
Indwelling features an entirely flat oesophageal flange.  It shares this feature with the 
Blom Singer Advantage voice prosthesis, however the latter has a significantly larger 
oesophageal flange than the Blom Singer Classic Indwelling.  It is possible that the 
characteristic of a small flat oesophageal flange may help to minimise residue because 
there are no areas of the flange, such as a hood, which can catch residue.  It is possible 
that individual characteristics of different voice prostheses may affect swallow 
behaviour.  Further research is required to ascertain whether individual voice 
prostheses contain features that influence swallowing behaviour. 
A strength of this study is that is includes the perspective of both expert Speech and 
Language Therapists and patients on whether voice prostheses have an effect on 
swallowing ability.  Laryngectomy patients form a small number of the population, so 
this study, as with others in the field, is limited by small sample size.  This study is 
also limited by the fact that patients had a short opportunity only to try each voice 
prosthesis for swallowing.  Results from patients may have been different if they had 
the opportunity to try each prosthesis for a number of days or even weeks over a 
number of mealtimes. 
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3.4 Conclusions 
 
Subjects did not perceive one prosthesis as best for swallow.  Similarly, raters failed 
to achieve consensus on best prosthesis for swallow for most patients. Therefore 
subjectively, there appears to be little or no overall difference between prostheses for 
ease of swallowing.  However, individual patients did notice differences and so 
individual choice when trialling prostheses may be important.  As there is so little 
agreement among expert raters, it would appear that patients’ subjective experience of 
swallowing is the most appropriate criteria to use in making the choice of prosthesis. 
This study provides some preliminary evidence that the Blom Singer Classic 
Indwelling and Provox Vega voice prostheses may be associated with lower residue 
levels than other voice prostheses as measured by expert raters.  Both these prostheses 
have characteristics that may help minimise residue. However, further research is 
required to investigate the characteristics, if any, of individual voice prostheses and 
how these characteristics might affect swallowing behaviour.   
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Chapter 4. Double blind study evaluating the effect of 
different voice prostheses on voice quality  
4.1 Summary 
 
This chapter describes an investigation of the effect of different voice prostheses on 
voice quality. The purpose of section 4.2 is to outline the background to the 
evaluation of voice after laryngectomy and to describe the different the methods and 
challenges of analysing voice.  Section 4.3 describes the voice prostheses used in this 
study.  Section 4.4 describes the development of a patient self-evaluation 
questionnaire to assess patients’ preferred voice prosthesis. Section 4.5 describes the 
main study, which involved experts’ raters’ evaluation voice using an auditory 
perceptual scale, the Sunderland Tracheosophageal Voice Perceptual Scale. Finally 
section 4.5.5 summarises the conclusions from this body of work. 
 
 
4.2 Introduction 
Laryngectomy involves the removal of the larynx in its entirety removing an essential 
part of the apparatus for speech (Angel et al., 2011) (see section 1.1 The 
Laryngectomy procedure for details).  Several options for the restoration of voice 
after laryngectomy are available including electro larynx, oesophageal speech and 
surgical voice restoration (SVR) with a voice prosthesis (see section 1.3 
Communication after laryngectomy for details).  The latter is considered the gold 
standard for rehabilitation after laryngectomy (Kazi et al., 2009a) (Hancock et al., 
2012) and offers the patients the possibility of rapidly and easily acquired fluent 
alaryngeal speech (D’Alatri et al., 2012).  Achieving functional communication with a 
voice prosthesis after laryngectomy helps the patient to overcome the handicap of not 
having a larynx and increases acceptability of the procedure for the patient and their 
family (D’Alatri et al., 2012).  The ultimate objective of SVR is to provide the patient 
with the optimal (i.e. least dysphonic sounding) voice possible without a larynx 
(Hurren et al., 2009b).  However, optimal alaryngeal voice and SVR voice is difficult 
to define (Hurren et al., 2009a).  Evaluation and measurement of voice quality 
outcomes after laryngectomy is important in determining the effectiveness of different 
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treatment modalities (Angel et al., 2011) such as oesophageal speech, SVR speech 
and electro larynx.  Since the development of the Blom Singer voice prosthesis 
(Singer and Blom, 1980), numerous improvements have been made to prosthesis 
design and functionality (Hancock et al., 2012).  The increase in the choice of voice 
prostheses has led to the need to evaluate and measure outcomes with different 
designs to facilitate placement of the optimum prosthesis for each individual patient.   
 
Evaluation of voice post laryngectomy has been greatly influenced by comparisons 
with voice and speech of normal laryngeal speakers (Doyle and Eadie, 2005).  The 
evaluation of voice quality in those with a larynx enables the clinician to obtain a 
comprehensive overview of an individual voice and to identify and define the extent 
of the voice problem (Carding et al., 2000).  This process usually involves quantifying 
the severity of the vocal dysfunction and identifying the component features that 
characterise the dysphonia (Carding et al., 2000). The basic protocol for functional 
assessment of laryngeal voice includes aerodynamic measures, acoustic analysis, 
video stroboscopic evaluation, perceptual evaluations and patient self-assessment 
(Dejonckere et al., 2001).  However, voice outcome measurement in patients with a 
larynx has focused on the three following areas: 
 Acoustic analysis 
 Auditory perceptual evaluation 
 Patient self-evaluation 
 
Each of these areas has been subjected to extensive research in laryngeal voice 
(Carding et al., 2009) and has had a concomitant influence on the study of alaryngeal 
voice.  Research into alaryngeal voice in each of these areas is summarised below. 
 
  
219 
 
 
4.2.1 Acoustic analysis of tracheosophageal voice 
 
This section outlines the production of laryngeal and alaryngeal voice, together an 
explanation of the components of voice sound waves. This is followed by a discussion 
of the acoustic analysis techniques used in alaryngeal voice. 
 
Acoustic analysis involves the physical analysis of sound waves (voice) through 
instrumentation (Hartman, 1979).  Instrumentation may involve processing signals 
from sound using techniques as diverse as classic spectography to statistics on sound 
wave microstructure (Maryn et al., 2009).  Conventionally, voice is produced when 
sufficient lung air pressure builds beneath the vocal folds to force them apart.  The 
sudden release of air pressure causes a vibration at the vocal folds and the production 
of sound waves, see figure 4.1. 
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Laryngeal voice production.   
 
Figure 4-1: Laryngeal Voice Production 
 
 
 
Post laryngectomy voice is produced when the stoma is covered and air is directed 
through the voice prosthesis to the repaired vibratory segment, see figure 4.2.  As with 
the vocal folds, a sudden release of air pressure causes vibration at the vibratory 
segment resulting in the production of sound waves.  The vibratory segment is 
sometimes alternatively called the neoglottis or the pharyngoesophageal segment.   
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Figure 4-2: Alaryngeal voice production 
 
 
 
4.2.1.1 Components of sound waves 
 
The components of sound waves are described to distinguish the different types of 
acoustic measures used to describe laryngeal and alaryngeal voice.  Sound waves 
consist of areas of high pressure (compressions) and low pressure (rarefactions) 
(Ladefoged, 1962).  Three factors are used to describe sound waves, (i) wave length, 
(ii) frequency and (iii) amplitude.  These factors are used to perform acoustic analysis 
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of voice.  Wavelength refers to the distance from one compression to the next 
adjacent compression or from one rarefaction to the next adjacent rarefaction.  When 
a wavelength repeats itself a number of times, each complete repetition is called a 
cycle. 
 
Illustration of sound waves 
 
 
Figure 4-3: Illustration of sound waves 
 
 
 
Frequency of sound is determined by the wave length and rate at which cycles occur 
(Ladefoged, 1962).  A low frequency will be perceived as a deep voice with a low 
pitch.  A high frequency will be perceived as high-pitched voice.  Amplitude is the 
increase or decrease of air pressure at a given point during a sound.  The energy 
derived from amplitude results in intensity or loudness of sound (Ladefoged, 1962).  
A low intensity sound will be perceived as quiet voice, a high intensity sound as loud 
voice. 
 
223 
 
4.2.1.2 Acoustic analysis of the voice signal in alaryngeal speakers 
 
Acoustic analysis of the voice signal in patients with a larynx involves computerised 
measurement of specific properties of the sound wave form (Carding et al., 2000).  
Properties measured usually include:  
 Jitter described as cycle to cycle frequency perturbation (Carding et al., 2009) 
or varying pitch in the voice 
 Shimmer described as cycle to cycle amplitude perturbation (Carding et al., 
2009) or varying loudness in the voice 
 Harmonics to noise ratio described as an expression of periodic to periodic 
sound (Carding et al., 2009).  Fundamental frequency refers to the lowest 
frequency of a sound wave emanating from a vibratory source.  Most 
vocalisations are composed of fundamental frequencies with multiple tones or 
harmonics. 
 
There is a rich body of literature concerning acoustic analysis of the alaryngeal voice 
signal.  The loss of the larynx and resultant use of a voicing source, which is not 
produced by the vocal folds, fundamentally alters the acoustic signal elicited.  Early 
research focused on using objective acoustic measures to determine how effective 
alaryngeal voice was compared to voice produced with a larynx and focused 
specifically on oesophageal voice production (Curry and Snidecor, 1961, Weinberg 
and Bennett, 1972, Diedrich, 1968).  Following the development of a viable voice 
prosthesis (Blom and Singer, 1979, Singer and Blom, 1980), research began to 
include acoustic measures of tracheosophageal voice. 
 
A seminal early study (Robbins et al., 1984) quantified acoustic measures of 
alaryngeal voice.  This study investigated tracheosophageal voice produced with 
Blom Singer voice prosthesis and oesophageal voice.  Both of these methods were 
compared to normal laryngeal voice production.  The study involved 45 subjects 
equally divided into the 3 methods of voice production described.  The purpose of this 
study was to compile comprehensive frequency, intensity and durational data from 
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tracheosophageal, oesophageal and laryngeal voice samples.  A secondary objective 
of this study was to provide clinicians with an acoustic database that could facilitate 
preliminary development of treatment plans for tracheosophageal speakers.  Audio 
recordings for each subject included (i) maximum duration /a:/ at a conversational 
loudness level and comfortable pitch, (ii) reading first paragraph of the Rainbow 
passage (Fairbanks, 1960).  10 frequency, 7 intensity and 12 durational acoustic 
measures were elicited from each audio recording. Instrumentation used in this study 
included digital sampling to produce waveforms and a graphic level recorder to 
provide tracings of amplitude by time.  Measures of frequency and duration indicated 
that tracheosophageal voice was more similar to normal laryngeal voice than 
oesophageal voice.  Intensity measures indicated that tracheosophageal voice was 
more intense than both normal and oesophageal voice.  The increased intensity of 
tracheosophageal subjects was attributed to the increased pulmonary air pressure 
required to stimulate the vibratory segment, together with the relative ease of 
augmenting exhalatory air flow through tracheostomal respiration compared to 
conventional respiration. 
 
Another early study (Blood, 1984) examined fundamental frequency measurements 
and voice sound pressure levels in 10 tracheosophageal speakers, 10 oesophageal 
speakers and 10 normal laryngeal speakers  during 3 phonation tasks.  
Tracheosophageal speakers were found to have a fundamental frequency 
approximately 25Hz higher than oesophageal speakers.  Intensity levels for laryngeal 
and tracheoesophageal speakers were found to be similar.  A subsequent study 
(Pindzola and Cain, 1989) examined durational measures (maximum phonation time, 
speech rate) and frequency characteristics (jitter, average fundamental frequency and 
fundamental frequency range) in 5 tracheosophageal speakers, 5 oesophageal 
speakers and 15 laryngeal speakers.  Tracheosophageal speakers were similar to those 
with a larynx in terms of maximum phonation time; speech rate, jitter, average 
fundamental frequency and fundamental frequency range but were less efficient in 
phrase grouping.  Tracheosophageal speakers were superior to oesophageal speakers 
on maximum phonation time, speech rate and phrase grouping but no significant 
difference was seen on pitch perturbation, average fundamental frequency and 
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fundamental frequency range.  Instrumentation in this study included the Visi-
Pitch/Apple IIE for the analysis of frequency features. 
 
Another later study (Qi and Weinberg, 1995) to quantify tracheosophageal voice 
examined 10 oesophageal speakers, 12 tracheoesophageal speakers and 10 age 
matched controls.  All alaryngeal subjects were described as proficient speakers with 
high intelligibility. Each subject had a circumferentially vented mask placed on their 
face to record volume velocity during production of several repetitions of the vowel 
/a: / at a comfortable and constant level.  Voicing source waveforms were elicited 
from these samples for all oesophageal speakers, tracheosophageal speakers and 
controls using a software package (Ocean) developed by the laboratory for this study.  
While the sound waves of the normal control speakers were found to be homogenous 
with the expected quasi-periodic triangular shape, the waveforms of both 
tracheosophageal speakers and oesophageal speakers were not homogenous with wide 
variability in appearance. 
 
This early research on acoustic measures provided objective insight into the 
differences between normal voice, tracheosophageal voice and oesophageal voice and 
highlighted the superiority of tracheoesophageal voice quality over oesophageal 
methods.  This research also found that tracheosophageal voice differs significantly 
from the sound produced by the normal larynx.  However, it was acknowledged that 
the ultimate arbiter of a successful alaryngeal voice, (regardless of whether it is 
produced by tracheosophageal or oesophageal means), is how an individual speaker is 
noticed as not being different by the listener (Eadie and Doyle, 2004).  Previous 
research (Shipp, 1967) examining the potential relationship between acoustic 
measures and listener judgements of communication proficiency in oesophageal 
speakers, had found that increased pitch levels in oesophageal speakers had elicited 
better listener judgements for acceptability of voice.  This data also suggested that 
acoustic measures of tonal duration, respiratory noise rating, percentage of periodic 
phonation, percentage of silence influenced listener judgements of oesophageal voice.  
However, additional investigations (Hoops and Noll, 1969) into the relationship 
between acoustic variables of oesophageal voice and listener judgements of 
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communication found that measures of fundamental frequency, frequency variation, 
degree of aperiodicity and vocal intensity were not related to communication 
effectiveness.  The somewhat contradictory findings of these two studies provided an 
initial insight into the unique and complex nature of alaryngeal voice and it’s 
perception by the listener.  Research (Hoops and Noll, 1969) on oesophageal voice 
appeared to indicate that what is represented graphically or numerically as acoustic 
measures may not be what is heard by the listener.  Once initial studies into acoustic 
measures of tracheosophageal voice had established that meaningful measures could 
be extracted, subsequent studies investigated whether acoustic measures demonstrated 
differences in voice quality, which could be perceived by listeners.  The most 
significant of these studies are outlined below. 
 
 
4.1.1.3 Studies combining acoustic and perceptual measures in alaryngeal speakers 
 
The main objective of an innovative study published in the late 1990s (van As et al., 
1998) was to investigate whether the voice quality of laryngectomy patients and 
normal controls, as determined by perceptual evaluation, could be correlated with 
acoustic parameters.  This study (van As et al., 1998) compared 21 total laryngectomy 
patients who all communicated with a Provox voice prosthesis with 20 normal 
controls.  Subjects were asked to sustain /a: / at a comfortable pitch and loudness for 3 
seconds and to count for 3 seconds.  20 raters not familiar with tracheosophageal 
speech were asked to perceptually evaluate sustained /a: / samples for both patients 
and controls using a set of seven semantic scales (ugly-beautiful, unsteady-steady, 
weak-powerful, dull-clear, breathy-not breathy, low-high, shrill-deep).  Semantic 
categories used were taken from a previous scale (Nieboer et al., 1988) developed  for 
oesophageal voice.  Acoustic analyses were performed with the Computerised Speech 
Lab (CSL) software programme and the Multidimensional Voice Programme 
(MDVP) of the 4300 Kay Elemetrics external module Kay Elemetrics Corp, Lincoln 
Park, NJ, USA.  The CSL contains 3 pitch analyses and the MDVP measures 29 voice 
parameters including pitch, frequency and amplitude perturbation, voice breaks and 
sub harmonics (van As et al., 1998).  Once pitch extraction analyses on the CSL were 
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found not to be reliable for the assessment of laryngectomy voices, further acoustic 
analysis was undertaken with the MDVP only.  Notably, 30% of the voice samples 
extracted from laryngectomy patients could not be analysed or had only very shorts 
parts of data that were analysable on the MDVP.  These voice samples were reported 
to be low in pitch and fell out of the pitch range analysis of the MDVP. 
 
Results indicated (van As et al., 1998) there was a difference in perceptual evaluation 
between total laryngectomy subjects and normal controls.  Laryngectomy voices were 
judged more ugly, unsteady, weak, dull, breathy, low and abnormal than normal 
controls.  All acoustic parameters differed significantly between patients and controls 
except for fundamental frequency (pitch), which was similar for both groups.  
Overall, acoustic analysis indicated that laryngectomy voices were more deviant than 
controls.  Results indicated that correlations were low or moderate between acoustic 
measures and perceptual evaluation. 
 
A subsequent study (Finizia et al., 1999) compared voice and speech function in 12 
male laryngectomy subjects with a tracheosophageal voice prosthesis and 12 male 
laryngeal cancer subjects treated with radical radiotherapy for organ preservation.  10 
subjects without laryngeal disease formed a normal control group.  Acoustic measures 
were extracted from audio samples of subjects reading aloud an 89 word story and 
maximum duration of /a: / on exhalation at conversational loudness and at a 
comfortable pitch.  Acoustic measures extracted were (i) Fundamental frequency, (ii) 
absolute F0 perturbation, (iii) speech rate and (iv) maximum phonation time.  
Recordings were analysed with the speech analysis software, Soundswell (Soundswell 
Acoustics HB, Stockholm, Sweden).  Perceptual analysis was undertaken by 10 
listeners unfamiliar with tracheosophageal voice or irradiated voice who rated voices 
on 3 parameters (i) speech intelligibility, (ii) voice quality and (iii) speech 
acceptability.  The two patient groups and the normal controls also self-judged their 
own voices according to 3 perceptual parameters utilised by the listeners.  The self-
assessment of tracheosophageal speakers indicated speech intelligibility was 
significantly lower when compared with irradiated subjects and normal controls. No 
significant differences were found between tracheosophageal speakers and irradiated 
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subjects on acoustic measures but significant differences were found in perceptual 
measures.  Listeners judged tracheosophageal speakers significantly lower than 
irradiated patients in speech intelligibility, voice quality and speech acceptability.  
This perception of tracheosophageal speakers as different has implications for the 
social interaction and adjustment of laryngectomy patients.   
 
The studies described which combined acoustic and perceptual measures in 
tracheosophageal speakers demonstrated a low to moderate correlation between both 
types of measures (van As et al., 1998) and a perceptual difference in 
tracheosophageal speakers compared to irradiated subjects despite no difference 
detected on acoustic measurements (Finizia et al., 1999).  These findings suggested 
that perceptual evaluation potentially provides more relevant information for the 
rehabilitation of communication after laryngectomy than acoustic measures.  
However, the acoustic measures in both studies were taken from models established 
largely for laryngeal speakers.  It could also be argued that further development and 
definition of appropriate acoustic parameters specific to alaryngeal patients and 
particularly tracheosophageal subjects may result in more accurate acoustic 
measurement and improved agreement with perceptual measures.  In addition, the 
perceptual attributes and acoustic measures used in both studies lack a direct physical 
correlate to each other and may be too different in nature to allow agreement.  The 
need to continue to improve the accuracy of the appropriate acoustic measures led to 
the development of a classification system of post laryngectomy voicing into different 
types in much the same manner as disordered laryngeal voices (Titze et al., 1995).  In 
addition, the findings that the MDVP was limited in the analysis of acoustic samples 
of alaryngeal patients (van As et al., 1998) (CrevierBuchman et al., 1996) resulted in 
increasing exploration of alternative instrumentation to analyse the tracheosophageal 
voice.  Studies, which have attempted to classify post laryngectomy tracheosophageal 
voice, are examined together in the next section, with research exploring alternative 
methods of acoustic analysis in this patient group. 
 
 
229 
 
4.1.1.4 Parameters for the objective classification of post 
laryngectomy voicing 
 
Attempts to categorise acoustic measures of alaryngeal voices have included the use 
of instrumentation including spectrograms and peripheral auditory models.  This work 
is outlined in the following paragraphs. 
 
Narrow band spectrograms were proposed to determine the overall acoustic 
characteristics of tracheosophageal voice and to develop a classification system for 
tracheosophageal voice in an important study (van As-Brooks et al., 2006).  Acoustic 
signal types, based on spectrograms have been determined for the categorisation of 
normal laryngeal voices (Titze et al., 1995, Sprecher et al., 2010) and have helped 
guide further acoustic analysis.  The aim of this study was to develop a system of 
acoustic signalling typing that is perceptually relevant, can evaluate the entire range 
of tracheosophageal speakers and can serve as the underlying basis of further acoustic 
measures in this patient population.  Spectrograms were analysed from 39 
laryngectomy patients who communicated with a Provox II voice prosthesis and 
categorised into 4 acoustic signal types: 
 Type 1 – Stable and harmonic.  Stable signal for a full 2 seconds, clear 
harmonics up to 1000 Hz 
 Type II Stable and at least one harmonic.  Stable signal for a full 2 seconds, at 
least one stable harmonic for a full 2 seconds 
 Type III Unstable or partly harmonic.  Unstable signal with harmonics 
throughout full 2 seconds, absence of harmonics for less than 1 second 
 Type IV Barely harmonic.  Complete absence of harmonics, partial absence of 
harmonics for more than 1 second. 
This study acknowledges the significant variability in anatomical presentation of the 
subjects recruited to this study.  30 had a standard laryngectomy and 9 required 
pharyngeal reconstruction.  It was reported that visual differences between narrow 
band spectrograms were obvious and that classification of spectrograms into 4 
acoustic signal types outlined above was easily achieved.  The 4 acoustic signal types 
demonstrated a significant relationship with overall perceptual judgement of 
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tracheosophageal voice quality.  In addition, the relationship between acoustic signal 
types and Harmonics to Noise ratio (HNR) and Band Energy Difference (BED) 
acoustic measures in the study confirmed that signal types could help indicate the 
need for more detailed acoustic analysis.   
 
Evidence to support the reliability of the acoustic type criteria developed in this study 
was confirmed in a further study (D'Alatri et al., 2012) which found a significant 
correlation between acoustic signal types and perceptual judgements of pleasantness 
of post laryngectomy voice.  This study showed that the Van As-Brooks acoustic 
signal types are useful for acoustic analysis and give a good impression of the overall 
quality of voice. 
 
A multi institutional study (vanGogh et al., 2005) investigated whether acoustical 
tracheoesophageal voice analysis could be successfully categorised using objective 
criterion.  This study involved 66 total laryngectomy subjects from 4 different 
European Institutions and utilised spectography to measure acoustic parameters.  
Subjects used a Gronigen, Blom Singer, Provox or Traissac voice prosthesis.  
Acoustical analysis of a sustained /a: / at a level slightly higher than conversational 
phonation was undertaken for each subject.  Acoustical analysis of spectography 
involved 6 features: (i) fundamental frequency, (ii) Intensity, (iii) F0 stability, (iv) 
Harmonics to Noise Ratio in low and mid frequencies, (v) high frequency noise and 
(vi) F0 salience.  Perceptual ratings were undertaken by 10 naïve raters using a set of 
modified semantic scales (Nieboer et al., 1988) (weak–strong, low pitch–high pitch,  
deviant–nondeviant, gurgling-nongurgling,  tense–not tense, and breathy–
nonbreathy).  The acoustical analysis protocol undertaken in this study resulted in the 
categorisation of tracheoesophageal voice into 3 categories based on F0 salience.  
These 3 categories were: 
 Good phonations with low-frequency harmonics and noise taking over at 
higher frequencies (F0 salience above 11 dB); 
 Moderate phonations consisting of repetitive bursts of sound energy with low 
repetition rate and a weak periodicity due to high levels of noise even at the 
low frequencies (F0 salience between 7 dB and 11 dB); 
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 Poor phonations with no detectable fundamental frequency or envelope 
periodicity (F0 salience below 7 dB). 
 
Acoustical parameters of good and or moderate (79%) tracheosophageal voices 
correlated well with perceptual analysis of voice samples supporting the validity of 
these parameters.  However, these categories have not been widely utilised in the 
research literature.   
 
A further attempt to provide parameters for the objective classification of 
“substitution” voicing (voicing without 2 vocal folds) was undertaken.  Instead of 
using spectography, this study used a peripheral auditory model with a built in 
fundamental frequency (pitch) extractor (Moerman et al., 2004b) to provide acoustic 
analysis of voice samples.  This study (Moerman et al., 2004b) included voice and 
speech samples from 68 subjects.  Subjects included tracheosophageal voice after 
laryngectomy (n-53), oesophageal voice after laryngectomy (n-14) and voice after 
partial front lateral laryngectomy (n-5) and 6 normal controls.  Objective category 
parameters were computed based on selection of 10 milli second auditory frame level 
outputs of the peripheral auditory model extracted from short voice and speech 
samples provided by subjects.  These parameters were (i) percentage of voiced 
frames, (ii) average voicing evidence, (iii) voicing length distribution and (iv) 
fundamental frequency shimmer.  Each subject also underwent perceptual analysis of 
voice and speech samples by 10 Speech Pathology students.  Perceptual parameters 
judged were hyper/hypotone, fluency, voice onset, additional noise, intonation, 
speech rate, intelligibility and general impression.  Correlations between objective 
and perceptual parameters were low and it appeared that intensive training may be 
required to effectively use the objective category parameters described in this study 
and they have not been widely adopted. 
 
With the exception of the categories of signal types developed by Van As and 
colleagues (van As et al., 1998), attempts to categorise tracheosophageal voice based 
on acoustic measures have failed to gain significant traction.  This may be due to the 
variability in the type of voice signal achieved by laryngectomy patients with 
tracheosophageal voice (Moon and Weinberg, 1987, van As-Brooks et al., 2006).  
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While one study (van As-Brooks et al., 2006) has explicitly stated that the 
tracheosophageal subjects recruited had not all undergone standard laryngectomy with 
a proportion requiring pharyngeal reconstruction, anatomical details of subjects in 
other studies (vanGogh et al., 2005, D'Alatri et al., 2012, Moerman et al., 2004b) 
discussed have not been so clearly defined.  Some studies had subjects with a number 
of different voice prostheses (vanGogh et al., 2005) or used the same subjects for both 
oesophageal and tracheosophageal voice samples (Moerman et al., 2004b).  It is 
possible that the heterogeneity of tracheosophageal speakers in terms of factors such 
as anatomy, history of chemo radiotherapy, type of voice prosthesis may preclude 
categorisation of signal types in the same manner as that of individuals with a larynx. 
 
 
4.1.1.5 Exploration of alternative types of instrumentation for acoustic evaluation 
of tracheosophageal voice. 
 
The use of spectography (van As-Brooks et al., 2006, vanGogh et al., 2005) and a 
peripheral auditory model (Moerman et al., 2004b) have already been described 
within the context of research involving objective classification of tracheosophageal 
voice.  The development of computerised instrumentation to refine and improve the 
acoustical analysis of tracheosophageal voice has continued in recent years and will 
be described below. 
 
One study (Deore et al., 2011) used the hardware and software of Dr. Speech (Tiger 
DRS Inc., Seattle, WA, US) for the acoustic analysis of tracheosophageal voice.  
Voice parameters of 30 total laryngectomy patients +/- partial pharyngectomy with 
primary closure were compared with 30 normal controls.  All subjects communicated 
with a Blom Singer voice prosthesis.  Subjects were asked to sustain /i: / at a 
comfortable pitch and loudness for at least 5 seconds and to sustain /i: / at comfortable 
pitch and loudness after a maximal deep inspired breath (Maximum Phonation Time).  
Acoustic analysis of voice parameters included F0 (which is the lowest frequency or 
first harmonic of a of a sound wave (Deore et al., 2011)), jitter, shimmer, HNR 
(Harmonic Energy to Noise Energy Ratio) and Maximum Phonation Time (MPT).  
Poorer values and more variability were seen on acoustic analysis of all voice 
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parameters for total laryngectomy patients compared to normal controls.  Average 
fundamental frequency for laryngectomy subjects (110.3Hz) was lower than that of 
controls (114.04Hz), mean jitter for laryngectomy subjects was higher (2.18%) than 
controls (0.18%), mean shimmer for laryngectomy subjects was higher (6.77%) than 
controls (0.95%), mean HNR for laryngectomy subjects was lower (11.41) than 
controls (25.03) and mean MPT for laryngectomy subjects was lower (6.87 seconds) 
than for controls (23.87 seconds).  Differences between groups were all statistically 
significant.   It is notable, that in contrast to other studies (Robbins et al., 1984, Qi and 
Weinberg, 1995, van As et al., 1998, Finizia et al., 1999, D'Alatri et al., 2012, 
vanGogh et al., 2005), this study used a prolonged /i:/ for acoustic measures rather 
than /a:/.  The use of /i: / as opposed to /a: / may increase tension within the vibratory 
segment.  This study did not use auditory perceptual measures but concluded that 
objective and quantifiable measures may be useful in substantiating subjective 
perception of voice quality after laryngectomy. 
 
A recent study (Bocklet et al., 2012) employed a data driven computer model to 
perform an acoustic short time analysis of a read out text and predict different voice 
and speech criteria based on regression.  A speaker model based on this information is 
then built.  These speaker models act as a clustered representation of acoustic 
properties of a person’s voice and are therefore characteristic for speakers with 
different kinds and degrees of pathological conditions.  The system was evaluated on 
two groups (i) 77 subjects with partial removal of the larynx and (ii) 54 total 
laryngectomy subjects who communicated with a Provox voice prosthesis.  Each 
speaker was also perceptually rated by 5 experts on 3 criteria: strain, voice quality and 
intelligibility.  Correlations were found for each group between the computer 
modeling system and the mean value of the 5 raters.  This study concluded that the 
computer modeling system could serve as a validated objective support for acoustic 
voice and speech analysis. 
 
The use of spectography, computer models and software has facilitated the 
development of instrumentation used for the acoustic measurement of 
tracheosophageal voice.  It is notable that one study (Deore et al., 2011) found an 
association between the durational measure of  MPT and history of surgical myotomy.  
This represents the first study attempting to find an association between acoustic 
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measures and the underlying physiology of tracheoesophageal speakers.  Further 
research into may prove beneficial in the future. 
 
 
4.2.2 Acoustic measures - conclusions 
 
The preceding section has outlined how tracheosophageal voice is produced and has 
introduced the components of sound waves, which are used for acoustic analyses.  
Early work (Robbins et al., 1984) (Blood, 1984, Pindzola and Cain, 1989, Qi and 
Weinberg, 1995) into the acoustic measures of tracheosophageal voice not only 
established the superiority of this method to oesophageal voice, but also highlighted 
the differences between tracheosophageal voice and voice produced with a larynx has 
been described.  The subsequent change in focus from the sound produced to how the 
tracheosophageal speaker communicates led to research into the links between 
acoustic and perceptual measures (van As et al., 1998, Finizia et al., 1999).  The need 
to more accurately define acoustic measures used in tracheosophageal voice led to 
attempts to categorise alaryngeal voices (van As-Brooks et al., 2006, Moerman et al., 
2004a, vanGogh et al., 2005) and the development of improved instrumentation 
(Deore et al., 2011, Bocklet et al., 2012, Moerman et al., 2004b, van As-Brooks et al., 
2006, vanGogh et al., 2005). 
 
The acoustic variables of pathological voice differ from the speech of healthy persons 
with a larynx.  As is evident, most work on acoustic analyses after laryngectomy 
focus on the evaluation of fundamental frequency and related features such as jitter, 
shimmer, intensity and MPT.  Information of this type was valuable to the clinician 
and the individual patient because it provided some comparative index for measuring 
and monitoring progress or lack thereof (Doyle and Eadie, 2005).  However, much 
research into acoustic measures essentially provides descriptive data from strong 
alaryngeal speakers and excludes those unable to produce oesophageal or 
tracheosophageal voice.  In doing so, research on acoustic measures may fail to reflect 
what the average laryngectomy speaker does when they communicate.  In addition, 
apart from notable exceptions (e.g. (van As et al., 1998, van As-Brooks et al., 2006) 
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objective data from acoustic measures often fails to specify whether subjects had total 
laryngectomy or extended laryngectomy surgery.  Surgical variation such as the 
presence or absence of a flap has critical importance on the physiological capacity of 
the post laryngectomy voice regardless of mode (Doyle and Eadie, 2005). 
 
A further crucial limitation is that acoustic measures have been drawn from well-
established work on subjects with a larynx and are often dependent on the reliable 
extraction of F0, the lowest frequency or first harmonic of a periodic signal (Deore et 
al., 2011).  However, alaryngeal voices are often aperiodic (Qi and Weinberg, 1995) 
and contain a high percentage of noise components (vanGogh et al., 2005).  It may 
not be possible to adequately process a highly pathological voice (Bocklet et al., 
2009, Bocklet et al., 2012) such as that of a post laryngectomy speaker with acoustic 
analysis designed for use with laryngeal voices.  Limitations also lie in the fact that 
acoustic analyses of the tracheosophageal patient are often extracted from single 
sustained vowels only (Bocklet et al., 2009).  Evidence exists that that acoustic 
analyses from connected speech are more reliable (Halberstam, 2004) and that 
analysis of a spontaneous speech or read out text is more meaningful for the 
evaluation of communication (Bocklet et al., 2009).  Perhaps the most significant 
limitation of acoustic measures in tracheosophageal voice is the failure to demonstrate 
a strong correlation with perceptual measures (van As-Brooks et al., 2006, Finizia et 
al., 1999).  Acoustic measures ultimately reflect the sound of the voice not the ability 
to communicate (Oridate et al., 2009).  The limitations of using acoustic measures to 
judge tracheosophageal voice prompted an exploration of alternative means of 
analyzing tracheosophageal voice.  The next section will describe research into the 
ability of the tracheosophageal patient to communicate through the use of auditory 
perceptual measures. 
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4.2.3 Auditory perceptual analysis of tracheosophageal voice 
 
Although most of the empirical research concerning laryngeal voice has focused on 
acoustic measures of frequency, intensity and duration, these measures do not 
necessarily indicate how well an individual communicates in a social situation.  
Research has indicated that the impact of voice alteration after laryngectomy may 
result in decreased social acceptance (Deshmane et al., 1995), reduced intelligibility 
(Evitts et al., 2010), and communication problems with unfamiliar people (Nalbadian 
et al., 2001).  Auditory perceptual rating involves an expert listener judging a voice 
sample according to different parameters (Carding et al., 2000) which may include 
intelligibility, voice quality and acceptability (Doyle and Eadie, 2005).  These 
parameters assume much more of social context than acoustic measures (Doyle and 
Eadie, 2005).  As previously described in section 4.1.1.3 (Studies combining acoustic 
and perceptual measures), one of the first studies (van As et al., 1998) to combine 
acoustic measures with perceptual scales used a semantic category scale (Nieboer et 
al., 1988) which had previously been developed for use with oesophageal voice to 
judge perceptual attributes of tracheosophageal voice.  A further study (Finizia et al., 
1999) combining acoustic and perceptual measures of tracheosophageal voice used a 
categorical scale to judge (i) speech intelligibility, (ii) voice quality and (iii) speech 
acceptability.  However, there are a number of well-established voice quality rating 
scales which provide perceptual parameters for the patients with a larynx including 
the Buffalo Voice Profile (Wilson, 1987), the Vocal Profile Analysis Scheme (Laver, 
1980), Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS) scale (Hirano, 
1981), and Consensus Auditory Perceptual Evaluation of Voice (Kempster et al., 
2009).  Of these, the strongest validity and reliability has been established for the 
GRBAS (De Bodt et al., 1997, Wuyts et al., 1999).  The GRBAS has been 
recommended as part of a routine voice assessment not only on the basis of its high 
validity and strong reliability but also good sensitivity to change and excellent utility 
ratings (Carding et al., 2009).  The GRBAS has 5 parameters (Grade, Roughness, 
Breathiness, Asthenia, Strain) each of which is scored using a 4-point ordinal scale (0 
- normal, 1- mild, 2 – moderate, 3 – Severe).  The GRBAS baseline refers to that of a 
normal laryngeal voice, which is physiologically and anatomically unobtainable after 
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laryngectomy.  Nonetheless, the GRBAS has been used to assess auditory perceptual 
aspects of tracheosophageal voice in several studies.  These studies will be described 
below. 
 
 
4.1.2.1 Use of the GRBAS to analyse tracheosophageal voice 
 
An early study (Omori and Kojima, 1999) utilised the GRBAS for perceptual 
evaluation of tracheosophageal voice.  This study examined vibratory patterns of the 
neoglottis using videostroboscopy in 30 post laryngectomy patients with Bivona voice 
prostheses.  The purpose of this study was to ascertain the underlying neoglottic 
(vibratory segment) conditions that could cause failure of tracheosophageal 
phonation. The subjects were recorded sustaining “e” during videostroboscopy 
examination.  This recording was perceptually judged by 3 otolaryngologists, using 
the GRBAS scale.  A relationship was found with irregular GRBAS findings and poor 
neoglottic condition. 9 subjects were found to have irregular neoglottic vibration.  2 
with incomplete glottic closure were rated as “breathy” on the GRBAS scale, 4 with 
multiple contacts of the mucosal wall of the PE segment were judged as “rough” on 
the GRBAS scale and 3 with tight neoglottic closure had “strain” on the GRBAS. 
 
Electroglottography based videostroboscopy was used to assess anatomical and 
morphological characteristics of the pharyngoesophageal segment in 52 laryngectomy 
patients speaking with a Blom Singer voice prosthesis (Kazi et al., 2009b). This study 
also involved use of the GRBAS.  Videostroboscopy was possible in 46 subjects with 
the neoglottis assessable in 26 patients.  A strobe effect was elicited in only 9 patients 
because of the highly variable and irregular nature of alaryngeal voice.  Subjects were 
asked to read a standard phonetically balanced passage.  This was rated by 2 
experienced Otolaryngologists who used the GRBAS scale together with an Overall 
Judgement of Voice Quality (OVQ) scale.  The latter was a 3-point scale devised by 
the authors of the study, allowing voices to be categorised as good, reasonable or 
poor.  Only the Grade parameter on the GRBAS was used for correlation in this study 
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as it has been reported (Bhuta et al., 2004) to be the most reliable/consistent of all the 
GRBAS parameters.  An equal number of subjects (n-13) were judged to be in the G1 
category of the GRBAS and the good voice category of the OVQ.  There was a 
statistically significant correlation between G1 GRBAS/good OVQ scores and little or 
no saliva and visible mucosal vibrations on opposite walls of the neoglottis on 
stroboscopy.  There was, however, no correlation between voice quality and vibratory 
segment, regularity of vibration, presence of mucosal wave and vibratory segment 
mucosa all of which are commonly measured parameters derived from 
videostroboscopy.  This raised concerns about the justification for subjecting patients 
to the relatively invasive technique of stroboscopy. 
 
One study (Kazi et al., 2006d) combined  use of the GRBAS with objective 
videofluroscopy to evaluate the pharyngoesophageal segment during voicing using a 
quantitative e tool (JRuler pro version 3.0; Spadix Software, USA).  This tool is a 
virtual, transparent, free rotating precision millimeter ruler that sits on the DVD 
screen without obscuring underlying details.  Objective parameters of neoglottis 
measured with the e tool included (i) length of neoglottis at rest and during phonation, 
(ii) minimal neoglottic distance at rest and (iii) maximal subneoglottic difference at 
rest and during phonation.  These measurements were correlated with perceptual 
evaluation findings using the GRBAS.  The pharyngoesophageal segment was 
assessed in 42 total and extended laryngectomy subjects who communicated with a 
Blom Singer voice prosthesis.  Subjects were imaged using videofluroscopy as they 
sustained /i: / at a comfortable pitch and loudness.  Each subject was then also 
recorded reading a standard phonetically balanced passage without videofluroscopy.  
Two experienced Otolaryngologists used the GRBAS to judge recordings of each 
subject reading.  Significant correlation was only seen between G1 score on the 
GRBAS and one objective parameter minimal neoglottic distance at phonation 
elicited from videofluroscopy using the e tool.  This study concluded that objective 
videofluroscopy using an e tool for measurement continues to have shortcomings. 
 
A further study (Kazi et al., 2006a) undertook a multidimensional assessment of 
female tracheosophageal speech.  This study involved electroglottographic and 
acoustic analysis of voice using the Laryngograph Tool (Laryngograph Ltd, London 
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UK), perceptual analysis using the GRBAS and questionnaire assessment using the 
University of Washington Quality of Life scale and the Voice Handicap Index (VHI). 
10 male and 10 female laryngectomy patients all of whom used a Blom Singer voice 
prosthesis were recruited.  The voice recording protocol required each patients to say 
/i/ at a comfortable pitch for 5 seconds, sustain /i/ at comfortable pitch and loudness 
after a maximal breath and read a phonetically balanced passage.  Two experienced 
Otolaryngologists rated the voice recordings of each subject using the GRBAS scale 
and the previously described Overall Judgement of Voice Quality Scale (OVQ) (3-
point scale allowing voice to be categorised at good, reasonable or poor).  Inter rater 
reliability for GRBAS scores was strong in this study, ranging from 0.89-0.96 ICC.  
Comparison of GRBAS scores among the groups did not show any difference 
between male and female laryngectomy patients.  Similarly, there were no gender 
differences on electroglottographic scores and quality of life scores were comparable 
between genders.  However, female laryngectomy patients exhibited greater voice 
handicap when asked to provide a self-assessment of voice using the Voice Handicap 
Scale (VHI).  The VHI in relation to its use as a self-evaluation tool for laryngectomy 
patients will be discussed in further detail in section  4.2.4 Self-evaluation of voice 
 
The preceding studies have described the use of the GRBAS scale as a means of 
measuring the perceptual aspects of tracheosophageal voice.  Each of these studies 
has combined perceptual measures with various types of imaging instrumentation 
(stroboscopy (Omori and Kojima, 1999, Kazi et al., 2009b), videofluroscopy (Kazi et 
al., 2006d), electroglottograph (Kazi et al., 2007b) and spectography (Schindler et al., 
2012).  One study (Omori and Kojima, 1999) found that the subjects with irregular 
neoglottis vibration also had irregular findings of breathiness, roughness or strain on 
the GRBAS.  A later study (Kazi et al., 2009b) using only the “Grade” parameter of 
the GRBAS found a statistically relationship between this and mucosal vibrations on 
opposite walls of the neoglottis on stroboscopy.  The GRBAS has been used to 
demonstrate a lack of perceptual gender differences as part of a multidimensional 
assessment of male and female tracheosophageal speakers (Kazi et al., 2006a).  More 
recently, the GRBAS has been used to demonstrate increased perceptual voice 
impairments for total laryngectomy compared with partial laryngectomy (Schindler et 
al., 2012). 
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Justifiably, the use of the GRBAS for the perceptual measurement of 
tracheosophageal voice has been influenced by the fact that this tool is well 
established in the realm of the evaluation of laryngeal voice.  However, while each of 
these studies (Omori and Kojima, 1999, Kazi et al., 2009b, Kazi et al., 2006a, Kazi et 
al., 2006d, Schindler et al., 2012) has successfully used the GRBAS to measure 
perceptual aspects of tracheosophageal voice, the parameters of Grade, Roughness, 
Breathiness, Asthenia and Strain are based on a model of laryngeal voice.  It has been 
indicated that use of the GRBAS to measure perceptual aspects of tracheosophageal 
voice is suboptimal because of the fundamental differences in tracheosophageal and 
laryngeal voice (Hurren et al., 2009a).  These fundamental differences have been 
attributed to the larger mass and reduced fine motor control of neoglottis (Blom et al., 
1995) (which is the phonatory source of alaryngeal voice), compared to the vocal 
folds, (the phonatory source of laryngeal voice).  Some perceptual features such as 
tone and extraneous noise when covering the stoma to produce voice are unique and 
central to tracheosophageal voice quality and are not included in the GRBAS scale.  
Studies which have used the GRBAS (Omori and Kojima, 1999, Kazi et al., 2009b, 
Kazi et al., 2006a, Kazi et al., 2006d, Schindler et al., 2012) or other perceptual scales 
(van As et al., 1998, Finizia et al., 1999) have failed to specify an anchor baseline so 
it in unclear whether raters have compared voice stimuli to that of normal laryngeal 
voice or optimal tracheosophageal voice.  The GRBAS was considered for this study 
but the limitations described were considered too significant to justify its use. 
 
 
4.1.2.2 Sunderland Tracheoesophageal Voice Perceptual Scale (STOPS) 
 
The Sunderland Tracheosophageal Voice Perceptual scale (STOPS) was developed as 
a perceptual rating scale specifically for tracheosophageal voice (Hurren et al., 
2009a).  Currently, it is the only laryngectomy specific perceptual scale available and 
is the subject of another doctoral thesis. This section describes the STOPS and 
justifies its use in this study.  The Sunderland Tracheosophageal Voice Perceptual 
Scale (STOPS) for professional raters is a 14-item questionnaire divided into two 
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domains: (i) Voice quality parameters (6 items), and (ii) Parameters not related to 
voice quality (7 items) and an overall score voice rating. 
 
Voice quality parameters include perceptual voice tonicity, strain, wetness, 
impairment of volume, impairment of social acceptability of voice and whisper.  Key 
studies have indicated that tracheoesophageal voice quality is largely determined by 
tone of vibration of the neoglottis or vibratory segment (Perry, 1989, vanAs, 2001).  
The perceptual voice tonicity parameter is measured on an 11 point bipolar semantic 
scale reflecting the continuum of tone (Perry, 1989) from hypotonic to hypertonic 
(Hurren et al., 2009a).  As stenotic voice occurs only in the absence of tone it is 
measured with a separate arm to the tone scale (Hurren et al., 2009a).  As stenosis is 
either present or absent, it is not rated along a graded continuum.  For each individual 
voice sample, only one arm of the scale is chosen by a rater.  Each of the remaining 5 
items in the voice quality parameters domain are measured on a 4 point equally 
appearing interval scale 0 (optimal tracheosophageal voice quality), 1 (mild), 2 
(moderate) and 3 (severe). 
 
Parameters not related to voice quality include impression of intelligibility, stoma 
blast, impairment of fluency, impairment of articulatory precision, positive features of 
articulation, accent and poor reader.  Each of these parameters, with the exception of 
positive features of articulation is measured on a 4 point equally appearing interval 
scale 0 (optimal tracheosophageal voice quality), 1 (mild), 2 (moderate) and 3 
(severe).  Positive features of articulation are measured on an alternatively worded 4 
point equally appearing interval scale 0 (neutral), 1 (good), 3 (excellent), and 4 
(outstanding). 
 
The parameter ‘overall grade” is measured using a four point interval scale 0 = 
Excellent; 1 = Good; 2 = Adequate; 3 = Poor.  This design is similar to the GRBAS 
scale (Hirano, 1981) except that the value 0 represents optimal tracheosophageal 
voice quality as opposed to “normal” laryngeal voice quality. 
 
The STOPS was developed as means of overcoming the major conceptual and 
methodological problems inherent in other studies of tracheosophageal voice.  These 
problems include often poorly defined terminology and impressionistic vocabulary 
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(vanAs, 2001).  The STOPS includes specific and clear guidance to define 
terminology used for each question.  In addition, the STOPS defines the anchor 
baseline of questions as optimal tracheosophageal voice rather than normal laryngeal 
voice.   
 
55 total laryngectomy subjects provided pre-recorded voice samples which were 
judged by 12 Speech and Language Therapists and 10 Ear Nose and Throat surgeons.  
The group of 12 Speech and Language Therapist include a sub group of 5 expert 
specialist raters.  Inter and intra rater agreement was examined for the parameters of 
overall grade of voice and neoglottal tonicity.  Good inter and intra rater agreement 
was achieved for the overall grade parameter.  While good intra rater reliability was 
attained for the neoglottal tonicity parameter, inter rater reliability for this parameter 
was moderate.  However, when ratings for both parameters were examined on the 
basis of raters’ profession and expertise, the expert SLT group (n = 5) achieved 
superior range and mean coefficients for both intra and inter rater agreement on 
overall grade of voice and neoglottal tonicity.  The expert SLTs were the sole group 
to achieve ‘good’ agreement for inter-rater tonicity.  This study also indicated a clear 
relationship between overall grade and perceived tonicity. 
 
The aim of this study was to find out whether voice prostheses differ in their effect on 
voice and swallow and if so to recommend the best voice prosthesis to optimise both 
functions.  In order to measure the effect of different voice prostheses on voice, it was 
decided to use an auditory perceptual tool to allow 3 experts clinicians to judge voice 
on each individual voice prosthesis.  Research in the area of perceptual 
tracheosophageal voice evaluation remains significantly limited.  As the focus of this 
study is on voice prostheses, the STOPS was chosen because it was designed 
specifically for use with laryngectomy patients who communicate with a voice 
prosthesis.  A further advantage of the STOPS is the use of tracheosophageal voice as 
a baseline for evaluation rather than normal laryngeal voice.  Additionally, the use of 
clear terminology and the provision of specific guidance for rating each item increase 
the ease of use of this scale for both clinicians and those involved in research as 
raters.  The STOPS is the only perceptual voice evaluation available in the area of 
tracheoesophageal voice evaluation.  It shows promising validity and reliability and is 
clinically relevant. 
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The next section examines a final area of voice outcome measurement, the importance 
of patient self-evaluation in judging tracheosophageal voice quality. 
 
 
4.2.4 Self-evaluation of voice 
 
Auditory perceptual evaluation of voice after laryngectomy usually includes a 
judgment by clinicians and sometimes by naïve raters (Eadie and Doyle, 2004).  
Acoustical analysis provides a computerised measurement of specific properties of 
the voice.  Both tools provide important information about communication outcome 
post laryngectomy.  However, auditory perceptual evaluation and acoustical analysis 
often omit information on the impact of disease on the patient’s daily life.  Patient 
based voice specific outcome measures can potentially provide more information than 
the biological and physiological variables that are associated with voice and voice 
production (Rosen et al., 2004) It is ultimately the patient’s perception of their post 
treatment status that is of greatest importance (Moukarbel et al., 2011).  The growing 
interest in health related quality of life (as discussed in section Chapter 5 5.2. 
Background) has resulted in the development of a number of reliable and valid scales 
such as the UW-QOL (Weymuller et al., 2001), FACT General and Head and Neck 
Module (Cella et al., 1993) EORTC Core Quality of Life Questionnaire and the Head 
& Neck module (EORTC QLQ-C30 & EORTC QLQ-H&N35) (Aaronson et al., 
1993, Bjordal et al., 1994).  Each of these scales examines the impact of head and 
neck cancer on daily life.  They all include questions addressing voice and 
communication, however, typically these questions are limited in number and do not 
address issues specific to laryngectomy patients.  Patient self-reporting of voice has 
been explored as a means of measuring outcomes in patients with a larynx who have a 
voice disorder.  Most of the research activity in patients with a larynx has 
concentrated on examining tools such as the Voice Handicap Index (Jacobson et al., 
1997), the Voice Performance Questionnaire (Carding and Horsley, 1992, Carding et 
al., 2009), the Voice Related Quality of Life scale (V-RQOL) (Hogikyan and 
Sethuraman, 1999) and the Voice Symptom scale (Deary et al., 2003). This work has 
influenced the area of alaryngeal voice outcome measurement. The Voice Handicap 
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Index, Voice Related Quality of Life scale and the Voice Symptom scale (VoiSS) 
have been used to facilitate patient self-reporting of voice post laryngectomy.  
Additional laryngectomy specific scales such as the SECEL and Voice Prosthesis 
Questionnaire have also facilitated self-reporting of post laryngectomy voice.  Each of 
these tools will now be described. 
 
4.1.3.1 Voice Handicap Index 
 
The Voice Handicap Index (VHI) was developed as patient based self-assessment tool 
for the measurement of voice handicap (Jacobson et al., 1997).  The tool consists of 
30 items equally distributed over 3 domains: functional, physical and emotional 
aspects of voice disorders.  The functional subscale includes statements which 
describe the ‘impact of a person’s voice disorders on his or her daily activities”.  The 
emotional subscale includes items that indicate the patient’s “affective responses to a 
voice disorder”.  The physical subscale is statements that relate to what the developers 
of the VHI thought were “patient’s self-perceptions of laryngeal discomfort and the 
voice output characteristics” (Jacobson et al., 1997, Rosen et al., 2004).  Each 
question can be scored from 0-4, with 4 indicating the greatest degree of handicap.  
The maximum score is 120.  Scores over 60 indicate a severe degree of handicap, 
scores between 31 and 60 reflect a moderate degree of handicap and scores below 30 
suggest a minimal voice handicap (Jacobson et al., 1997).  Although predominantly 
used with laryngeal voices, the VHI was designed to assess all types of voice 
disorders including tracheosophageal voice difficulty (Rosen et al., 2004).  The 
overall aim of the VHI is to quantify the patient’s perception of handicap occurring as 
a result of his or her vocal function (Rosen et al., 2004).  Numerous studies (Franic et 
al., 2005, Benninger et al., 1998, Webb et al., 2007, Biddle et al., 2002) have 
established adequate reliability and validity of the VHI and the instrument is 
considered a “gold standard” (Kasper et al., 2011) in the field of self-evaluation of 
voice disorders.  
 
The VHI Index 10 was developed as a shortened version of the original VHI (Rosen 
et al., 2004) as a response to observations that the VHI was time consuming to 
complete and score and contained redundant information (Deary et al., 2004).  The 
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VHI Index 10 was formed from the 10 most robust VHI items using item analysis and 
clinical consensus (Rosen et al., 2004).  The questions on the VHI Index 10 are 
distilled into the 3 subscales of the original VHI (functional, physical, emotional) 
(Deary et al., 2004) resulting in a scale that can be easily and promptly self-
administered (Rosen et al., 2004).  The VHI Index 10 has been reported to have good 
utility, validity (Rosen et al., 2004) and internal consistency (Deary et al., 2004).  The 
VHI Index 10 has been proposed as a more robust instrument than the original VHI 
with the capability to replace the latter (Rosen et al., 2004). 
 
Although the VHI was designed to be appropriate for use with tracheosophageal 
voice, there are a limited number of studies utilising this tool with the laryngectomy 
population.  Those studies that do exist will be described below. 
 
An early study (Stewart et al., 1998) examined the relationship between voice related 
functional status and global health status in 80 male subjects who had completed 
treatment for laryngeal cancer.  Treatment included (i) Total laryngectomy n- 17, (ii) 
Radiotherapy n-24 and (iii) both Total laryngectomy and Radiotherapy (n-39).  
Outcomes were measured with the Medical Outcomes study 36 item short form health 
survey (SF-36) (Ware et al., 1993) and the VHI and included subjects being asked 
about their self-perceived overall health status.  Pre-treatment Speech Language 
Pathology records were reviewed to retrieve the results of pre-treatment assessment of 
potential for successful voice rehabilitation after treatment for all groups.  When 
divided into groups of those who had a laryngectomy (n-56) and those who had not 
had a laryngectomy (n- 24) emotional and functional voice handicap scores were 
significantly higher in those who had undergone a laryngectomy.  There were no 
significant differences in VHI between those who had undergone adjuvant 
radiotherapy (n-39) and those who had not (n-17).  This study also examined the 
subset of total laryngectomy subjects who had a voice prosthesis (n-23) and compared 
these with subjects treated with radiotherapy only (n-24).  Physical voice handicap 
scores did not differ significantly between these groups but emotional and functional 
scores were lower in subjects receiving radiotherapy.  However, there was 
considerable overlap in VHI scores between both groups with many patients who had 
a voice prosthesis showing less voice handicap than patients treated with 
radiotherapy.  Correlations between pre-treatment prediction of eventual voice 
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outcome made by a Speech Language Pathologist and VHI subscales were low 
indicating pre-treatment estimation of voice outcome was a poor predictor of patient 
self-rated outcome.  An important conclusion of this study was that some aspects of 
voice handicap are not necessarily worse in patients who have undergone total 
laryngectomy.  This study refuted the common perception that preserving the larynx 
will result in improvements in verbal communication. 
 
The stated aim of one study (Moerman et al., 2004a) was to investigate the adequacy 
of the VHI for laryngectomy patients.  This study investigated 45 laryngectomy 
patients, 38 of who communicated with a voice prosthesis while the remaining 7 used 
oesophageal speech (n-5) or oesophageal type speech (n-2) as a consequence of the 
use of colon to replace the oesophagus (2).  Subjects were allowed to leave questions 
unanswered rather than making a forced choice if they found that certain questions 
were irrelevant to their particular situation.  In an attempt to accommodate the 
variability that would result from unanswered questions, the study authors created a 
specific scoring system for the VHI.  Results indicated that 18% of patients left 
questions F5 (“My family has difficulty hearing me when I call them throughout the 
house”), P13 (“My voice sounds dry and croaky”) and F22 (“My voice problems 
cause me to lose income”) unanswered.  It is suggested that these questions are 
problematic or not relevant for the laryngectomy population. The novel scoring 
system utilised in this study found that the scores of laryngectomy patients were 
comparable to those with laryngeal dysphonia.  
 
A study (Sewnaik et al., 2005) compared quality of life in salvage partial (n-12) and 
total laryngectomy (n-11) patients following recurrence of laryngeal carcinoma after 
initial treatment with radiotherapy. This study involved 3 questionnaires 1) EORTC 
Quality of Life Questionnaire (QLQ)-C30 Dutch version 3.0, 2) EORTC-H & N 35, 
and 3) the Voice Handicap Index.  As with the previous study described (Moerman et 
al., 2004a), this study (Sewnaik et al., 2005) found that the laryngectomy subjects had 
VHI scores comparable to patients with laryngeal dysphonia. 
 
The VHI questionnaire was used to investigate voice handicap in 20 male 
laryngectomy patients who communicated with a Provox voice prosthesis (Schuster et 
al., 2004).  The VHI scores attained by the laryngectomy group were significantly 
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higher than in those with functional (psychosocial) dysphonia but differed only 
slightly from those with organic laryngeal dysphonia.  Interestingly, when individual 
VHI scores of laryngectomy patients were examined, values ranged from scores 
similar to a person without a voice disorder to a maximum handicap score of 101.  
This finding reflects the often large variability in communication skills observed in 
the laryngectomy population.  This study concluded that perceived vocal handicap 
had clinical value in assessing well-being after laryngectomy. 
 
The VHI was used to investigate self-assessed vocal handicap of laryngectomy 
subjects using Surgical Voice Restoration (SVR) (tracheoesophageal voice) compared 
with those using non SVR (non tracheosophageal voice methods including 
oesophageal voice, electro larynx, writing and mouthing) in a study of 53 male 
laryngectomy subjects, 26 in the SVR group and 27 in the non SVR group (Evans et 
al., 2009).  Mean total VHI score for the SVR group and non SVR group was 39.3 
(SD 32) and 45.8 (SD 19.1) respectively.  There were no statistically significant 
differences in VHI scores between both groups although a slight improvement in the 
emotional domain scores for the SVR group was observed.  The authors suggest that 
the finding of similar VHI scores for both groups reflects careful patient selection for 
each postoperative communication option.  The confounding factors of age and time 
since surgery did not have a statistical effects on scores. 
 
The effect of voice impairment across physical, emotional and functional domains in 
a study of 54 laryngectomy subjects who communicate with a voice prosthesis was 
investigated (Kazi et al., 2007b).  This study used two voice specific questionnaires, 
the Voice Related Quality of Life (V-RQOL) short form and the VHI long form.  All 
subjects communicated with a Blom Singer voice prosthesis.  The mean overall score 
for the group on the VHI scale was 40.9 (SD 21.8).  On the subscales, mean 
functional score was 15.8 (SD 7.7), mean physical score was 13.6 (7.2) and mean 
emotional score was 11.6 (SD 8.9).  Age, radiation and chemotherapy were associated 
with higher VHI scores.  Both VHI and V-RQOL scores were strongly correlated and 
both gave similar useful information about functional, physical and emotional aspects 
of vocal disability in laryngectomy.  However, this study indicated that neither 
questionnaire has a statement pertaining to tone of voice, a feature found to be 
important for laryngectomy patients in a previous study (Kazi et al., 2005).  In 
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addition, question F10 on the VHI (My voice problem causes me to lose income) may 
not be relevant for laryngectomy patients who have retired and this may affect the 
scoring system.  It is noted that both scales have a closed format restricting the 
addition of suggestions or comments. 
 
The use of the VHI as a self-evaluation tool for laryngectomy patients has highlighted 
important aspects of voice outcomes in this population.  Emotional and functional 
subscale scores of the VHI were found to be higher in laryngectomy patients 
compared to non-laryngectomy patients in one study (Stewart et al., 1998).  However, 
this also study indicated that refuted the assertion that preserving the larynx will result 
in improved verbal communication with many patients with a voice prosthesis 
showing less handicap than patients who had undergone radiotherapy.  In addition this 
study showed clinicians, in this case, Speech Language Pathologists were poor 
predictors of eventual outcome when compared with patient self-evaluation of 
outcome using the VHI highlighting the importance of the latter.  Later studies 
(Moerman et al., 2004a, Sewnaik et al., 2005) found that VHI scores of laryngectomy 
patients were comparable to those with laryngeal dysphonia although the former used 
an unconventional scoring system for the VHI to do so.  A study (Schuster et al., 
2004) that distinguished between organic and functional dysphonia found that VHI 
scores of laryngectomy patients differed only slightly from patients with organic 
dysphonia but were higher than those with functional dysphonia.  This study 
highlighted the variability in communication skills found in laryngectomy patients. 
An interesting study (Evans et al., 2009) found no statistical difference in VHI scores 
between those using tracheosophageal voice compared with other non-surgical voice 
restoration methods.  VHI scores were found to be strongly correlated with V-RQOL 
scores confirming the impact of voice disorders on quality of life.   
 
While use of VHI with laryngectomy patients has improved understanding and 
emphasised the importance of patient self-evaluation after laryngectomy, the VHI tool 
has not been without criticism in this population.  Even though the VHI was designed 
to be used with any patient with a voice problem including laryngectomy patients, one 
study (Moerman et al., 2004a) found that some questions on the VHI were 
problematic or not relevant to post laryngectomy patients.  The relevance of certain 
questions to laryngectomy patients was also queried in a further study (Kazi et al., 
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2007b) and the inability to include comments or suggestions was considered a 
disadvantage of the tool.  It is notable that despite the VHI’s purported suitability for 
laryngectomy patients, it does not contain any questions related to consistency of 
alaryngeal voice, wetness of alaryngeal voice due to pooling of saliva or swallowed 
liquid.  Issues specific to different modes of laryngeal communication such as having 
to cover a stoma to produce tracheosophageal voice, inject air to produce oesophageal 
voice or placement of an electro larynx are similarly not included. 
 
 
4.1.3.2 The Voice Related Quality of Life (V-RQOL) 
 
The Voice Related Quality of Life (V-RQOL) scale is a self-administered 10 item, 5 
point Likert scale which contains 2 domains: Physical Function domain (6 questions) 
and Social Emotional domain (4 questions) (Hogikyan and Sethuraman, 1999).  The 
V-RQOL measures the subjective burden elicited by a voice disorder (Kazi et al., 
2007b).  Lower scores indicate lower voice related quality of life. In contrast to the 
VHI, the V-RQOL has a standardised overall score which helps quantify the 
magnitude of voice related problems experienced by the patient (Moukarbel et al., 
2011).  The V-RQOL has been validated, proven to be reliable and responsive to 
change (Hogikyan and Sethuraman, 1999).  It has been used to evaluate vocal 
disability in a variety of populations (Moukarbel et al., 2011).  To date the V-RQOL 
has not been used extensively with laryngectomy patients (Moukarbel et al., 2011).  
The studies that have utilised this tool will be described below. 
 
One study (Fung et al., 2005) included the V-RQOL as one of the measures used to 
compare organ preservation subjects with those who had undergone salvage 
laryngectomy.  The V-RQOL was completed by 56 patients who were alive and free 
of disease at a minimum follow up of 8 months.  37 subjects had an intact larynx and 
19 had undergone salvage laryngectomy.  Mean overall V-RQOL scores of 
laryngectomy subjects (65.4 SD 23.3) was significantly lower than both the mean 
scores for organ preservation subjects (80.3 SD 20.08) and normative scores 
(Hogikyan and Sethuraman, 1999) (98.0 SD 3.9).  This finding was consistent across 
social emotional and physical function domains.  No differences in mean overall V-
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RQOL scores between early and late salvage laryngectomy subjects were observed.  
The authors of this study suggest that although the toxic effects of the chemo 
radiation involved in organ preservation have an adverse effect on vocal function, 
results are still better than in the salvage laryngectomy group.  This study emphasised 
the importance of measuring function and quality of life through tools such as the V-
RQOL, to help gauge the overall effect of aggressive therapy protocols and their 
added toxicities. 
 
An investigation was undertaken of patient perceptions of voice outcome using 
different methods of communication post laryngectomy using the V-RQOL 
(Moukarbel et al., 2011).  This study reflects a previously described study (Evans et 
al., 2009) in examining laryngectomy subjects’ communication with a voice 
prosthesis, electro larynx and oesophageal speech.  However, this study (Moukarbel 
et al., 2011) sub classified the non-voice prosthesis subjects in contrast to the previous 
study (Evans et al., 2009).  While the reliability and validity (Hogikyan and 
Sethuraman, 1999) was an important consideration in choosing the V-RQOL, its 
brevity compared to the VHI was also beneficial.  This study indicated that the V-
RQOL was simple for patients to complete increasing patient compliance with the 
task.  In addition, the brevity of the V-RQOL facilitated data analysis and 
interpretation within the clinical setting. Modes of post laryngectomy communication 
included electro larynx (n-18), oesophageal speech (n-15) and tracheosophageal 
speech (n-42).  Mean overall V-RQOL scores for the electro larynx, oesophageal 
speech and tracheosophageal speech were 53.5, 69.7 and 76.5 respectively.  These 
findings indicated significant differences between means for the groups.  In pair wise 
comparisons of V-RQOL outcomes, tracheosophageal speakers were better than those 
who communicated with an electro larynx.  There was no difference between 
tracheosophageal speakers and oesophageal speakers.  Only electro larynx speakers 
showed a positive correlation with time after surgery and older age.  The findings 
indicated that oesophageal speech, when achievable, is a viable communication 
option after laryngectomy. 
 
Both the V-RQOL and the VHI (long form) were used to retrospectively investigate 
the effect of vocal impairment in 54 disease free laryngectomy subjects who 
communicated with a Blom Singer voice prosthesis (Kazi et al., 2007b).  Mean 
251 
 
overall V-RQOL score for the group was 62.5 (SD 24.5) with mean overall VHI score 
of 40.9 (SD 21.8) achieved.  A strong correlation was found between the overall score 
of both tools.  Age was found to be a significant predictor of outcomes with a higher 
voice handicap in the younger age group.  No statistically significant differences were 
found between scores of women and men although scores for the former tended to be 
higher.  Interestingly, radiotherapy and chemotherapy were associated with a higher 
level of voice handicap.  This finding may be influenced by the fact that patients with 
advanced stage disease tend to have these treatments but further research is required 
in this area.  The overall V-RQOL and VHI scores found in this study were consistent 
with previous studies (Schuster et al., 2004, Weinstein et al., 2001, Oridate et al., 
2009, Fung et al., 2005) although overall V-RQOL score was lower than that found 
by Moukarbel and colleagues (Moukarbel et al., 2011) 
 
A recent study (Oridate et al., 2009) examined patient perceived voice related quality 
of life based on the V-RQOL and the VHI-10 (shortened voice handicap index) in 
subjects who had received different definitive treatment methods for laryngeal cancer.  
Subject groups included (i) Radiotherapy (n-63), (ii) chemo radiotherapy (n-29), (iii) 
laser surgery under laryngomicroscopy (n-14) and (iv) total laryngectomy (n-27).  
Subjects completed V-RQOL and VHI-10 at a median of 38 months post treatment 
(range 1-248 months).  A highly significant correlation was found between both 
instruments.  Laryngectomy patients had the lowest mean overall V-RQOL and VHI-
10 scores at 68.4 (SD 22.4) and 11.26 (SD 7.17) respectively compared to other 
groups.  The mean overall V-RQOL score in this study for laryngectomy patients was 
comparable to previous findings (Fung et al., 2005, Moukarbel et al., 2011).  It is 
notable that the means of communication for laryngectomy subjects was not specified 
in this study.   
 
The V-RQOL facilitates self-evaluation of voice function as it relates to quality of 
life.  One study (Fung et al., 2005) indicated that mean overall scores on the V-RQOL 
were significantly lower for laryngectomy patients not only when compared to 
normative scores but also with organ preservation patients.  In contrast to a similar 
study (Evans et al., 2009) comparing tracheosophageal speakers with other modes of 
post laryngectomy communication using the VHI, tracheosophageal speakers were 
found (Moukarbel et al., 2011) to have better V-RQOL scores than those who used an 
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electro larynx.  Nonetheless, a strong correlation has been found between both the 
VHI and V-RQOL tools (Kazi et al., 2007b) and the VHI-10 and V-RQOL (Oridate et 
al., 2009).  The V-RQOL had been praised for its brevity, ease of patient completion 
and data analysis but its use in the laryngectomy population remains limited largely 
because this tool was specifically designed for patients with a larynx who have a 
voice problem.  As with the VHI, the V-RQOL does not contain questions specific to 
the laryngectomy population such as covering a stoma to produce voice with a 
prosthesis or injecting air to produce oesophageal voice or placement of an electro 
larynx. 
 
 
4.1.3.3 Voice Symptom Scale  
 
The Voice Symptom Scale (VoiSS) was developed as a patient derived inventory of 
voice symptoms (Jones et al., 2006).  Over 800 patients were involved in the 
development of the scale which is extensively validated and has been demonstrated to 
be psychometrically robust (Wilson et al., 2004).  The final stage of psychometric 
analysis culminated in the development of a 30-item questionnaire categorised into 3 
components: Impairment (15 items), Emotional (8 items) and Physical (7 items).  The 
VoiSS yields a score from 1-120 with a higher score reflecting a greater severity of 
dysphonia and poorer quality and life (Jones et al., 2006).  To date, the VoiSS has 
been used in a single large study of laryngectomy patients aimed at quantifying the 
detrimental effect of radiotherapy on functional outcome (Robertson et al., 2011).  To 
assess voice, swallowing and quality of life, the VoiSS, MDADI and UW-QOL 
questionnaires were returned by the final cohort of 179 laryngectomy patients, who 
were at least a year post surgery. Of these 179 subjects, 26 had been treated with 
primary laryngectomy, 88 received postoperative radiotherapy and 65 had undergone 
salvage laryngectomy after failed organ preservation. 156 (87.1%) communicated 
with a voice prosthesis.  The overall median Total VoiSS score for the group was 44 
(range 7-120).  Patients with a voice prosthesis had a significantly better median Total 
VoiSS scores and significantly better scores in the Impairment VoiSS domain than 
those laryngectomy patients using other forms of communication.  This finding 
contrasts with a previous study (Evans et al., 2009) concluding that SVR and non 
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SVR outcomes are similar. Laryngectomy subjects with a voice prosthesis treated 
with primary laryngectomy alone also had significantly better median VoiSS scores 
than both salvage laryngectomy subjects and subjects treated with primary 
laryngectomy and adjuvant radiotherapy.  This study demonstrated no difference 
between mean Total VoiSS score of laryngectomy patients and published (Wilson et 
al., 2004) mean Total VoiSS score  of patients with benign laryngeal disease raising 
the possibility that voice outcome in laryngectomy patients with a voice prosthesis is 
better than expected or that the tool is not sensitive enough for use with the 
laryngectomy population. 
 
The fact that the VoiSS involved over 800 patients in its development is to be lauded 
and suggests that its components contain questions of high relevance to voice patients.  
The one study (Robertson et al., 2011) that involves the use of the VoiSS with 
laryngectomy patients for self-evaluation, shows potential with this population.  
However, the VoiSS, as with the V-RQOL, was designed for use with patients who 
have voice problems but who have a larynx.  As with the VHI and V-RQOL, the 
VoiSS fails to address issues to specific to alaryngeal patients such as consistency of 
voice, wetness of voice, having to occlude a stoma to produce tracheosophageal 
voice, having to inject air to produce oesophageal voice or placement of an electro 
larynx. 
 
 
4.1.3.4 Self Evaluation of Communication Experiences after Laryngectomy SECEL 
 
The self-evaluation of communication experiences after laryngectomy (SECEL) 
(Blood, 1993) is the only self-evaluation tool developed specifically to address the 
needs of how postlaryngectomy patients adjust to their new voice.  825 laryngectomy 
patients were contacted to participate during development, validation and reliability 
stages of the SECEL (Blood, 1993).  These patients were drawn from the ‘Lost chord’ 
laryngectomy support clubs in the USA.  Data from 533 subjects was returned and 
considered usable.  The SECEL is a 35 item scale has been determined to be valid and 
reliable with good internal consistency (Blood, 1993).  34 of the 35 items are 
aggregated into three subscales: (i) General describing general attitudes about being 
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relaxed or calm and acknowledgement of the illness and treatment (5 items), (ii) 
Environmental which focuses on how the patient experiences his or her voice in 
different environments (14 items) and (iii) Attitudinal which describes feelings about 
self-perceptions and perceptions of others (15 items) (Johansson et al., 2008).  Each 
of these 34 items is rated on a 4-point scale ranging from 0 (never) to 3 (always).  The 
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 item asks “Do you talk the same amount now as before your laryngeal cancer?”  
This question has 3 response categories (yes, more, less) and is not included in the 
scoring system.  Scoring of subscales is carried out by simple addition with individual 
subscale scores being added to give a SECEL Total score ranging from 0-102.  The 
higher the score, the greater the perceived communication dysfunction.  Well-adjusted 
subjects had a mean score of 36.  It was recommended scores above 60 indicated a 
poorly adjusted patient who may require in-depth counselling about communication 
and adjustment. 
 
There is limited research on the use of the SECEL but one Swedish study (Johansson 
et al., 2008) described an adaptation of the SECEL to allow for its use with patients 
who receive different treatments for laryngeal cancer in addition to laryngectomy.  
This adaption involved rewording two items in the original scale that specifically 
addressed experiences after laryngectomy.  The aim of this large longitudinal study 
was to investigate the sensitivity to change of the Swedish SECEL (S-SECEL) 
addressing communication dysfunction in patients treated for laryngeal cancer.  100 
subjects were initially included in the study.  Participants answered 3 questionnaires  
(S-SECEL, Hospital Anxiety and Depression scale (HAD) (Zigmond and Snaith, 
1983) and the EORTC QLQ-C30 (Aaronson et al., 1993) with the QLQ-H&N35 
(Bjordal et al., 2000) about health related quality of life on 6 occasions during a 
follow up time of 1 year.  71 subjects completed the study, 5 of these were 
laryngectomy patients.  The S-SECEL scores demonstrated an increase in speech 
dysfunction between baseline and one month on all subscales.  From 2 months and 
throughout the year, a continuous decrease in perceived dysfunction was observed on 
all subscales and the Total Scale.  Changes between baseline and 12 months were 
statistically significant for all subscales indicating sensitivity to change over time.  
The S-SECEL showed convergent results when compared to the 2 other established 
questionnaires used in the study.  It was noted that the S-SECEL is shorter than the 
EORTC QLQ-C30 and the QLQ-H&N35 and could be a valuable clinical tool for the 
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evaluation of communication dysfunction for all patients with laryngeal cancer 
irrespective of treatment modality. 
 
The SECEL was also used in a study examining communication adjustment of 
laryngectomy patients in Turkey (Evitts et al., 2011).  This study included 52 subjects, 
19 of whom had a Total Laryngectomy, 10 had a supracricoid laryngectomy and the 
remaining 23 had laryngeal conservation surgeries (12 supraglottic surgery, 6 
frontolateral surgery, 5 vertical surgery).  Of the 19 total laryngectomy subjects, 11 
were tracheosophageal speakers, 7 were oesophageal speakers, 1 used an electro 
larynx to communicate.  Each subject completed a Turkish translation of the SECEL.  
Mean rank subscale scores of the SECEL showed less positive results for 
Supracricoid and Total laryngectomy subjects compared to the laryngeal conservation 
surgeries.  The effect of type of speech following laryngeal cancer was also 
investigated with a significant difference observed for the environmental subscale of 
the SECEL.  Within the environmental subscale, mean ranks were 21.89 for 
Conservation surgery group (best), 27 for electro larynx speakers, 30 for 
tracheosophageal speakers and 42.64 for oesophageal speakers (worst).  When 
SECEL scores for all three modes of alaryngeal communication were combined and 
compared with scores for conservation surgery techniques, a significant difference 
was observed between environment, attitude and total score.  Conservation surgery 
consistently had more favourable outcomes on the SECEL than alaryngeal 
communication following total laryngectomy.  Supraglottic laryngectomy patients 
were shown to have the most favourable scores on the SECEL in this study reflecting 
the fact that this technique preserves vocal folds. 
 
The strength of the SECEL lies not only in its established validity and reliability but 
also in the large number of patients involved in its development together with its 
uniqueness as a self-evaluation tool designed specifically with laryngectomy in mind.  
Although the Swedish study (Johansson et al., 2008) contained a small number of 
total laryngectomy patients, it did demonstrate that the SECEL-S was sensitive to 
change with a continuous decrease in perceived dysfunction from 2 months 
throughout the year observed on all subscales and the Total Scale.  The Turkish study 
(Evitts et al., 2011) found a significant difference on the environmental subscale for 
type of speech following cancer with oesophageal speakers achieving the worst scores 
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and those with conservation surgery, the best scores.  This study is also found that 
conservation surgery consistently had more favourable outcomes on the SECEL than 
alaryngeal communication following total laryngectomy.  The length of SECEL and 
the absence of questions related to speaking with a voice prosthesis limited the use of 
this scale in this study. 
 
 
4.3.3.5 Voice Prosthesis Questionnaire 
 
Functional communication with a voice prosthesis after laryngectomy is now 
considered the gold standard of rehabilitation for post laryngectomy patients.  There 
are now an array of voice prostheses available that have been developed to reduce 
incidence of candida (Leder et al., 2005a), (Hilgers et al., 2003a) increase lifespan of 
the prosthesis (Op de Coul et al., 2000) and facilitate self-changing (Hancock et al., 
2005).  Problems related to the life of the voice prosthesis (Leder and Erskine, 1997a, 
Leder et al., 2005a) (Op de Coul et al., 2000), voice prosthesis function (Knott and 
Lewin, 2012), voice prosthesis leakage (Lewin et al., 2012, Lorenz et al., 2011) and 
tracheosophageal puncture (Knott and Lewin, 2012) continue to challenge patients 
and those clinicians providing follow up care.   
 
It is noteworthy that until the development of the Voice Prosthesis Questionnaire 
(VPQ) (Kazi et al., 2005), no patient administered questionnaire existed in the field of 
surgical voice restoration after laryngectomy.  The VPQ was developed to provide a 
comprehensive valid and reliable assessment of communication in laryngectomy 
patients who have a voice prosthesis (Kazi et al., 2005).  The questionnaire was 
developed based from patient input during focus groups as well as input from an 
expert panel of Head and Neck Surgeons and Speech and Language Therapists and a 
literature review (Kazi et al., 2006c).  The VPQ consists of 45 questions that assess 
voice prosthesis and related issues, humidification and hands free system (Kazi et al., 
2006c).  The reliability and validity of the VPQ was investigated in 51 total 
laryngectomy patients (37 male and 14 female) and compared with the VRQOL 
(Hogikyan and Sethuraman, 1999) and the UW-QOL v4 (Hassan and Weymuller, 
1993, Rogers et al., 2002).  Internal consistency reliability was found to be strong and 
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test re test reliability indicated that 75% of subjects had a score on re test that was 
within 1 point of their original score.  Convergent construct validity and criterion 
validity were established on comparison with the UW-QOLv4 and VRQOL 
respectively.  The VPQ was reported to have a low respondent burden.  Although 
each question on the VPQ elicits important information, they do not contribute 
equally to set up a global score.  It was highlighted that further research is required to 
facilitate development to incorporate a global score and investigate correlations with 
objective and perceptual evaluations.  The VPQ was considered for use with this 
study but the questionnaire length was considered to be too burdensome for subjects 
who would be required to answer it up to 6 times for each potential voice prosthesis.   
 
 
Voice prostheses used in this study 
The voice prostheses chosen for this study are all commercially available in the UK 
and represent the range of voice prostheses most frequently used within clinical 
settings in the UK.  Voice prostheses used in this study are described in this section.  
There are two broad categories of prostheses; exdwelling and indwelling.  The 
differences between these categories are explained in this section together with a 
description of each individual voice prosthesis used. 
 
 
Exdwelling voice prostheses 
The first widely available voice prosthesis (Blom and Singer, 1979, Singer and Blom, 
1980) developed by Blom and Singer was designed as an exdwelling device.  An 
exdwelling (or non-indwelling) voice prosthesis has the potential to be maintained by 
a patient who can take the prosthesis out for cleaning and then reinsert it (Hancock et 
al., 2005) sometimes as often as every 3-4 days if necessary (Leder and Erskine, 
1997c).  An exdwelling prosthesis is usually secured to the skin of the neck by taping 
the safety strap to prevent accidental aspiration (Hancock et al., 2005) or otherwise 
loss of prosthesis by inadvertent removal or expectoration.  Complications of 
exdwelling voice prostheses include not only the aforementioned accidental aspiration 
(Andrews et al., 1987b, Geraghty et al., 1996) but also incorrect insertion (Leder and 
Erskine, 1997a) resulting in the formation of a false tracheoesophageal passage or 
incomplete insertion resulting in closure of the oesophageal side of the 
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tracheosophageal puncture.  Despite these complications, many patients who 
successfully learn how to maintain and change their voice prosthesis, value the ability 
to independently manage their device with periodic rather than frequent hospital 
visits. 
 
 
Indwelling voice prostheses 
Indwelling voice prostheses were first introduced in the early 1980s (Nijdam et al., 
1982).  These prostheses were designed for extended wear of up to 6 months at a time 
(Leder and Erskine, 1997c) and are replaced by a trained clinician only (Hancock et 
al., 2012).  As this type of voice prosthesis eliminates the need for patients to change 
their own device, it is suitable for use with patients with reduced manual dexterity, 
reduced cognitive capacity and visual acuity (Hancock et al., 2012).  This prosthesis 
does not involve taping a safety strap to the neck and therefore may be more 
comfortable for patients (Leder and Erskine, 1997a) and may facilitate more effective 
use of a hands free or humidification exchange device (Balm et al., 2011).  The 
indwelling prosthesis has been reported to reduce complications associated with non-
indwelling devices such as inadvertent aspiration or incorrect insertion (Andrews et 
al., 1987a) (Geraghty et al., 1996, Leder and Erskine, 1997b).  Complications reported 
with indwelling voice prostheses include peripheral leakage (Furuta et al., 2005) 
although this is process is likely to be multifactorial (Hutcheson et al., 2012) and may 
also be associated with exdwelling devices.  A further complication of indwelling 
voice prostheses may be premature leakage and reduced life span secondary to fungal 
colonisation because it remains in situ for a longer time than exdwelling devices 
(Graville et al., 1999). 
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4.4 Development of a self-evaluation scale of voice prosthesis 
experience for tracheosophageal speakers. 
 
4.4.1 Introduction 
 
Since there was no suitable self-evaluation tool already available I needed to develop 
a tool for use in this study. I was interested in involving patients in this part of the 
study to gain greater insight into their perspective on what makes a voice prosthesis 
work successfully.  To this end, I wanted to develop a self-evaluation questionnaire 
for voice and swallow that was appropriate to the task and was not overly burdensome 
for patients to complete.  The opinion of the laryngectomy subjects who participated 
in this study was considered of fundamental importance in investigating whether 
voice prostheses differ in their effect on voice and swallow.  The ability to 
communicate effectively is paramount to the ability to successfully negotiate the 
activities of daily life.  Voice prostheses are placed into the TEP on a semi-permanent 
basis and are removed only for cleaning or replacement.  This is in contrast to other 
medical devices such as contact lens, dentures, limb prostheses, which may be 
removed for part of the day.  As voice prostheses are used continuously, 
laryngectomy patients are frequently very aware of even minor changes to their voice 
prosthesis and are best placed to judge individual devices.  Typically, laryngectomy 
patients have limited involvement in the choice of their prosthesis.  An individual 
laryngectomy’s voice prosthesis is generally chosen by their clinical team and this 
choice may be necessarily motivated by the product provided by the hospital that they 
attend 
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4.3 Description of voice prostheses used in this study 
 
 
Figure 4-4: Illustration of voice prostheses used in this study. 
(A) Provox NID (B) Provox Vega (C) Blom Singer Advantage (D) Blom Singer 
Classic, Indwelling (E) Blom Singer Low Pressure (F) Blom Singer Duckbill 
 
 
A.  Provox NID  
The Provox NID is a non-indwelling voice prosthesis designed to allow safe 
replacement by patients themselves (Hancock et al., 2005).  It was introduced in 
2005.  It comes in diameters of 17fg (French Gauge) and 20fg and is available in 
lengths 6mm, 8mm, 10mm, 12mm, 14mm and 18mm.  The prosthesis, safety strap 
and flap are moulded into one piece of silicone rubber with the internal flap seat 
made of fluoroplastic.  A safety medallion is attached to prevent accidental 
aspiration or ingestion.  The prosthesis comes with an introducer insertion device.  
The prosthesis is prepared by placement into this device and is then inserted into 
the TEP in an anterograde fashion through the tracheostoma following lubrication 
with a small amount of water-based gel.  Patient satisfaction with the Provox NID 
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has been reported to be favourable (Hancock et al., 2005). 
 
B.  Provox Vega 
The Provox Vega is an in-dwelling silicone voice prosthesis with a recessed and 
angled flap which is totally encased by the prosthesis hood minimising direct 
exposure of the prosthesis to the oesophagus (Hancock et al., 2012). It was 
introduced in 2010.  It comes in 3 diameters: 17fg, 20fg and 22.5fg and is 
available in lengths 4mm, 6mm, 8mm, 10mm, 12.5mm, 15mm.  The Vega is 
inserted into the TEP in an anterograde fashion through the tracheostoma by 
means of a preloaded, single step insertion tool, the SmartInserter.  This prosthesis 
has demonstrated good clinical feasibility (Hilgers et al., 2010b, Hilgers et al., 
2010a) and patient satisfaction (Hancock et al., 2012) 
 
C.  Blom Singer Low Pressure 
The Blom Singer low pressure voice prosthesis is an exdwelling silicone device 
with a flap that lies within a prosthesis hood.  It was introduced in 1983.  This 
prosthesis was designed to offer less airway resistance (Weinberg and Moon, 
1986b, Weinberg and Moon, 1986a) for  voicing when compared to the duckbill 
voice prosthesis and therefore may be less effortful for some patients to use.  This 
prosthesis comes in 16fg and 20fg diameters and is available in lengths 6mm, 
8mm, 10mm, 12mm, 14mm, 18mm, 22mm and 25mm for both diameters with an 
additional length of 28mm available in 16fg diameter only.  The low pressure 
voice prosthesis is prepared before insertion with the placement of a clear gel cap 
(Blom et al., 1994) on the oesophageal end to facilitate atraumatic anterograde 
placement within the TEP through the tracheostoma.  The Blom Singer low 
pressure voice prosthesis has been well established as a surgical voice restoration 
device since the early 1980s (Blom et al., 1986b) 
 
D. Blom Singer Duckbill 
The Blom Singer duckbill voice prosthesis is an exdwelling silicone device with a 
“bullet” shaped nose containing at slit at the oesophageal end rather than a flap.  
This slit extends into the oesophagus and opens to allow air to pass to the 
vibratory segment.  This prosthesis is available in 16fg diameter only but comes in 
6mm, 8mm, 10mm, 12mm, 14mm, 16mm, 18mm, 20mm, 22mm, 25mm and 
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28mm lengths.  No insertion devices or special preparation is required.  It is 
simply lubricated with a small amount of water-based gel and is placed in the TEP 
in an anterograde manner through the tracheostoma.  This prosthesis was the first 
commercially available prosthesis developed by Dr. Blom and Dr. Singer (Blom 
and Singer, 1979, Singer and Blom, 1980) and continues to endure in the clinical 
realm today. 
 
E. Blom Singer Classic Indwelling 
The Blom Singer Classic indwelling voice prosthesis is an indwelling clinician 
placed silicone voice prosthesis introduced in 1994.  It features an entirely flat 
oesophageal flange, which contains a flap allowing air to be re directed towards 
the vibratory segment for voicing.  It incorporates a radio opaque ring in the 
oesophageal flange for visualisation during x-ray.  This prosthesis comes in 16fg 
and 20fg diameters and is available in 4mm, 6mm, 8mm, 10mm, 12mm, 14mm, 
16mm, 18mm, 20mm and 22mm lengths for secondary and replacement insertion.  
A sterile version of this prosthesis is also available for primary placement of the 
voice prosthesis during surgery to perform a tracheosophageal puncture.  It is 
prepared with the placement of a clear gel cap (Blom et al., 1994) on the 
oesophageal end to facilitate atraumatic anterograde placement within the TEP 
through the tracheostoma.  Patient satisfaction with this prosthesis has been 
reported to be favourable (Leder and Erskine, 1997c) 
 
F. Blom Singer Advantage 
The Blom Singer Advantage is an indwelling clinician placed silicone voice 
prosthesis available since 2003.  This prosthesis incorporates silver oxide 
embedded into the silicone which is intended to reduce biofilm formation, reduce 
the need for antifungal agents and prolong prosthesis life span (Leder et al., 
2005a).  The first generation of this prosthesis featured a titanium ring in the shaft 
(hard valve assembly) and for copyright reasons was not available in the UK.  The 
second generation does not have the titanium ring (soft valve assembly) and is 
available in the UK.  The prosthesis features a larger oesophageal flange than 
other Blom Singer devices.  This oesophageal flange is flat and contains a 
recessed flap that opens to allow redirected air reach the vibratory segment for 
voicing.  The prosthesis comes in both 16fg and 20fg diameters and is available in 
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4mm, 6mm, 8mm, 10mm, 12mm, 14mm, 16mm and 18mm lengths.  It is prepared 
for insertion by hand folding the oesophageal flange into a clear gel cap to 
facilitate atraumatic anterograde placement within the TEP through the 
tracheostoma.  This prosthesis has been demonstrated to provide an extended life 
span for standard indwelling device users with documented premature device 
failure due to colonisation together with enhanced user satisfaction (Leder et al., 
2005a) 
 
 
4.4.2 Objective 
Develop a scale to allow laryngectomy patients to provide a self-evaluation of their 
experiences with different voice prostheses 
 
4.4.3 Methods 
 
4.4.3.1 Subjects 
 
I sampled the opinions of 20 patients in a pre-recruitment survey attending the weekly 
Head and Neck Outpatient clinic at Imperial College Healthcare Trust between March 
24
th
 and May 5
th
 2010.   
 
4.4.3.1.1 Inclusion criteria  
 
Women and men who had undergone either total laryngectomy or extended 
laryngectomy and who had undergone surgical voice restoration with a voice 
prosthesis in situ.  
 
4.2.3.1.2 Exclusion Criteria 
 
Subjects without voice prostheses, documented cognitive dysfunction, less than 3 
months post-surgery or completion of postoperative radiation treatment  
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4.2.3.2 Study process 
 
I explained the purpose of this part of the study and asked patients to tell me what 
they considered made a voice prosthesis work well for voice and swallowing.   
 
4.2.3.2.1 Analysis 
Responses were taken in note form for later thematic analysis.  
 
4.4.4 Results 
 
The following themes emerged 
 
Swallow 
 Comfort while swallowing a range of food and not just liquid 
 Length of time it takes to swallow 
 Voice being “wet” after eating or drinking and the negative effect this has on 
socialising. 
 Food getting stuck during swallowing 
 The need to take extra water sometimes to clear food which has been stuck to 
allow the voice prosthesis to function 
Voice 
 Effort it takes to speak with some prostheses 
 The importance of other people being able to understand what a laryngectomy 
says when they use a new or different prosthesis 
 A prosthesis that produces a consistent voice rather than one that “stops” and 
“starts” is crucial 
 Voice needs to sound pleasant 
 Voice needs to be loud enough to be heard to be heard not just in a quiet clinic 
room but over traffic, background music or conversation 
 Appearance of the voice prosthesis matters. 
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All patients surveyed indicated that if they were to participate in a study requiring 
several prosthesis changes and swallow evaluations, they would like to complete a 
short, rather than overly lengthy questionnaire after each prosthesis trial.  Patients 
surveyed explained that they preferred a Likert style questionnaire to a tick box or 
visual analog format 
 
4.4.5 Conclusions 
 
From these results I developed an 11 question Communication and Swallowing with a 
Voice Prosthesis questionnaire, (see appendix 13).  This questionnaire had 5 questions 
based on swallowing and 6 questions based on voice.  Responses were measured on a 
5-point Likert scale and the questionnaire contained an additional blank sheet for any 
further comments.  The questionnaire was designed to be self-completed by the 
patient. 
 
 
4.5 Effect of different voice prostheses on voice quality 
 
4.5.1 Objectives 
 
 To investigate whether expert raters objectively consider one prosthesis as 
best for voice for subjects using auditory perceptual analysis with the STOPS 
rating scale. 
 To investigate whether expert raters consider one prosthesis as best for voice 
on a subjective rating of best overall voice prosthesis for each subject. 
 To investigate whether subjects have a preference for a prosthesis for voice on 
a self-evaluation of voice prosthesis experience. 
 To investigate whether subjects express an overall preference for a voice 
prosthesis 
 To investigate whether subjects and raters agree on best prosthesis for voice. 
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  
4.5.2 Hypotheses  
 
1. Clinicians will have a good level of inter rater agreement when they use the 
STOPS to rate each individual voice prosthesis. 
2. Analysis of STOPS scores will indicate no difference between 6 voice 
prostheses for each individual question of the STOPS. 
3. Analysis of STOPS scores will indicate no difference between individual 
questions of the STOPS for a specific type of voice prosthesis. 
4. Analysis of raters ’choice of best prosthesis for each subject will not 
identify an overall best prosthesis for voice. 
5. Scores for individual voice prostheses on patient self-evaluation will be 
equally distributed and will not indicate a preference for an individual 
voice prosthesis. 
6. Analysis of subjects’ choice of overall best prosthesis will not identify an 
overall best prosthesis 
7. Clinicians and subjects will not agree on best prosthesis for voice 
4.5.3 Methods 
4.5.3.1 Study plan  
 
The main methods for this study have been previously described in chapter 3, section 
3.3.3 Methods.  In addition the following data was also collected.   
 
42 subjects who have had a laryngectomy were screened and consented for part 2 of 
this study.  Each of the subjects agreed to attend 2 appointments within a 7-day period 
and trial up to 6 voice prostheses.  1 subject was excluded because he failed to attend 
the second appointment 
 
40 subjects attended 2 appointments within a 48-hour period with one subject 
attending 2 appointments within a 72-hour period.   
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Visit 1 
Each subject’s voice prosthesis was initially removed.  The length and diameter of the 
removed prosthesis was noted.  During this first appointment the tracheoesophageal 
puncture (TEP) was sized and 3 prostheses in the appropriate size were selected.  
Randomised selection was made from the following prostheses: Provox NID (Atos 
Medical, Horby, Sweden), Provox Vega (Atos Medical, Horby, Sweden), Blom Singer 
Duckbill (InHealth Technologies, California, USA), Blom Singer Low Pressure 
(InHealth Technologies, California, USA), Blom Singer Classic Indwelling (InHealth 
Technologies, California, USA) and Blom Singer Advantage (InHealth Technologies, 
California, USA).  Randomisation for all prostheses was performed for each subject 
using the “Research Randomizer” programme on the website 
http://www.randomizer.org/.  Based on randomised selection, the initial 3 prostheses 
in the randomisation sequence were chosen for placement during the initial 
appointment.  Subjects could see the voice prosthesis but they were not told the name 
of the prosthesis or the manufacturer.  Each prosthesis was placed according to 
individual manufacturer’s instructions including use of the gel cap insertion system 
for Blom Singer prostheses.  The absence of central and peripheral leakage for each 
individual prosthesis was confirmed by asking each subject to take 3 sips of a cup of 
200ml water coloured with 2ml of Silver Spoon blue food colouring (British Sugar 
PLC).  The following protocol was then followed: 
5 For each prosthesis trial, subjects first had a Speedlink SL-8691-SBK spes clip on 
metal microphone (Speedlink, Weertzen, Germany) attached to their clothing 10 
cm lateral to the stoma on the opposite side to the hand used to occlude the 
stoma during voicing.  All subjects produced voice by occluding their stoma 
rather than depressing a humidification exchange device or using a hands free 
attachment.  Subjects read a short version of the Rainbow passage, (a 
phonetically balanced passage typically used in voice assessment, (Fairbanks 
1960 see appendix), before eating to prevent liquid or food negatively altering 
voice quality.  This was recorded onto a Sony ICD-PX820 Digital Voice 
Recorder with flash 2 GB (Sony, Weybridge, UK) in MP3 format to be rated 
later by experts 
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6 After each prosthesis trial, the subject was asked to rate their experience of 
swallow and voice quality using a 5 point Likert Self Evaluation questionnaire 
with 5 questions relating to swallow and 6 relating to voice, (see appendix 
Patient self-evaluation voice and swallow part 2)  
Steps 1-5 were then repeated with the remaining 2 prostheses.  Once the last 
prosthesis has been removed, the prosthesis that the subject had in situ on arrival was 
replaced.  The subject’s follow up appointment time and date was confirmed. 
 
Visit 2  
Each subject’s voice prosthesis was initially removed and the first of the remaining 2 
prostheses in the randomisation sequence (if the subject had a 20fg prosthesis 
diameter measurement) or the remaining 3 prostheses in the randomisation sequence 
(if the subject had a 16fg prosthesis diameter measurement) was placed.  The 
procedure described in visit 1 (section 4.x) was then repeated. 
The patient was then asked to indicate their favourite overall voice prosthesis. 
 
 
4.5.3.2 Methods of data collection 
Recordings of voice samples with individual voice prostheses were extracted in MP3 
format and transferred to Final Cut Pro (Apple, California, USA) to allow titles to be 
added to indicate anonymised subject number and anonymised voice prosthesis letter.  
Voice samples were then exported to 3 Verbatim 4GB pinstripe USB memory sticks 
(Verbatim, Surrey, UK).  Raters were blinded to subject, prosthesis type, gender, type 
of laryngectomy surgery (extended laryngectomy or standard total laryngectomy) and 
history of radiotherapy and chemotherapy. 
Voice samples were posted to 3 expert Speech and Language Therapy raters along 
with blank numbered and lettered STOPS forms which corresponded to each voice 
sample for each subject.  Raters also received and were asked to complete a form 
indicating which prosthesis in their opinion was “best” overall for voice for each 
subject.   
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4.5.3.3 Training of raters 
Each Speech and Language Therapy rater had at least 5 years’ experience specialising 
in the communication and swallowing rehabilitation of post laryngectomy and other 
head and neck cancer patients.  All three raters had completed a Macmillan Advanced 
Laryngectomy Rehabilitation course, which involved attending 3 x 2 full day modules 
over a period of 1 year.   
Each rater participated in 3 hours of training with the investigator in the use of the 
STOPS.  This training took place during two conference calls of 90 minutes length.  2 
weeks before the first conference call, each rater received a copy of the STOPS 
Professional Rater scale and guidance notes together with a copy of journal article 
related to development of the rating scale (Hurren et al., 2009a).  10 audio samples of 
anonymised laryngectomy patients reading the Rainbow Passage were also sent to 
each rater.  Raters were asked to review all the material sent but not to rate any of the 
voice samples until the conference call.  5 audio samples were rated together using the 
STOPS scale during the first conference call and 5 during the second conference call.  
During training and subsequent email correspondence, queries about individual items 
on the STOPS scale were raised.  These questions were discussed with the main 
author of the STOPS.  Clarifications were passed onto all 3 raters regardless of how 
many raters had initially raised a query.  Questions raised and clarifications provided 
are outlined below 
 
General question.  I know you informed your expert raters of the speaker’s gender 
before they listened to the laryngectomy voice sample.   Did you also provide details 
of surgery, i.e. Total Laryngectomy/jejunum/pectoralis major etc?  
Author clarification: I didn’t give any indication of surgery type so as not to 
influence or give clues regarding tonicity from surgery. 
 
Q9 Stoma blast.  In the guidance, this is termed “stoma noise”.  In discussing this, 
we thought that there is a difference between stoma “blast” and stoma “noise”.  We 
thought that stoma blast could refer to the noise a patient gets when they fail to 
occlude the stoma fully, whereas stoma noise would include poor occlusion but also 
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noisy inhalation when occluding.  Should we include noisy inhalation as part of this 
parameter and which term would you prefer us to use?  
Author clarification: It was clarified that stoma “noise” was the better term and 
raters proceeded with stoma “noise “rather than stoma “blast”.  Discrepancy 
between rating scale and guidance notes was corrected to ensure consistency. 
 
Q10 Impairment of fluency.  Does impaired fluency include disco-ordination of 
respiration and voicing?  
Author clarification: Fluency includes disco-ordination of respiration and voicing 
(i.e. patients does not occlude the stoma adequately and wastes air).  Fluency refers 
to the number of syllables per breath so not occluding adequately and wasting air 
counts as poor fluency.  
 
Q10 Impairment of fluency.   This seems to relate more to fluency in terms of 
total fluidity of speech then as opposed to dysfluency (as we identify in stammering), 
is that correct? 
Author clarification Yes, this is correct. 
 
 Q14 Poor Reader.   Some of the subjects were unable to read so the rainbow 
passage was read out loud and repeated after the investigator.   Clearly, these 
subjects were poor readers but is this parameter referring to reading aloud ability 
rather than ability to read?   Would you suggest we just indicate parameter 14 as not 
applicable for these few subjects who were unable to read and repeated the passage 
after the investigator? 
Author clarification:  The poor reader parameter was meant to try to control for 
other factors influencing judgement not related to voice quality.  I would agree with 
putting not applicable for those subjects unable to read. 
 
All 3 raters returned completed STOPS rating scales to the investigator within 4 
months of training. 
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4.5.3.4 Statistical Analysis 
 
The Statistical Advisory Service at Imperial College London provided a power 
calculation which determined sample size.  Data was entered and analysed in IBM 
SPSS (Statistical Product and Service Solutions) version 20 (IBM Armonk, New 
York) for both the STOPS scale and the Self Evaluation Patient Questionnaire for 
Voice and Swallow.   
 
4.5.4 Results 
 
The aim of this study was to establish whether one prosthesis is considered best for 
voice by expert raters and subjects.  Expert raters undertook auditory perceptual 
analysis of voice data using the STOPS scale as well as a subjective indication of 
which prosthesis they thought was best overall for voice for each individual subject.  
Individual subjects undertook a self-evaluation of each voice prosthesis using a Likert 
questionnaire and also subjectively indicated the prosthesis they simply considered as 
best overall without specifying voice or swallow.  Results for both raters’ analysis and 
subjects’ analysis are presented below. 
 
 
Auditory perceptual analysis by clinicians using the STOPS  
Hypothesis 1 
Clinicians will have a good level of inter rater agreement when they use the STOPS to 
rate each individual voice prosthesis.   
Inter rater reliability for the STOPs was established as a precursor to investigating 
whether there was a difference among STOPs scores across each voice prosthesis 
trialled by each subject.  
The STOPS consists of 13 questions (Q1, Q3, Q4, Q5, Q6, Q7, Q8, Q9, Q10, Q11, 
Q12, Q13, Q14), which are rated from 0-3 on an interval scale.  Q2 of the stops is 
rated on an 11 point bipolar semantic scale; see Appendix STOPS Professional Rater 
272 
 
Scale.  Intra correlation coefficients (ICC) were used to analyse reliability of interval 
scale questions.  Kappa was used to assess reliability of bipolar semantic scale.  Both 
analyses are described below. 
 
 
 
Reliability of Interval Scale data from STOPS 
In order to answer hypothesis 3, intra correlation coefficients (ICC) 2 way mixed 
model were used for Q1, Q3, Q4, Q5, Q6, Q7, Q8, Q9, Q10, Q11, Q12, Q13, Q14.  A 
2 way mixed model was chosen as each subject was assessed by the same set of raters 
who have been purposely and not randomly selected.  Raters are considered a fixed 
effect and subjects a random effect in the 2 way mixed model.  The analysis was 
repeated by prosthesis for each of the 14 questions of the STOPS except for Q2.  As 
question 2 had 12 possible answers compared to 4 for other questions, the answers to 
question 2 were recoded.  Hypotonic 5, 4, 3, 2, 1 These results are presented in Table 
4.1 Intra correlation coefficients (ICC) analysis of rater reliability STOPS.  As 
the majority of questions (Q1, Q3, Q4, Q5, Q6, Q7, Q8, Q9, Q10, Q13, and Q14) 
demonstrated a good level of inter rater agreement, hypothesis 3 was accepted for 
these questions. 
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Table 4-1: Intra correlation coefficients (ICC) analysis of rater reliability 
STOPS 
Stops  Blom 
Singer 
Duckbill 
Blom 
Singer 
Low 
pressure 
exdwelling 
Blom 
Singer 
Classic 
Indwelling 
Blom 
Singer 
Advantage 
Provox 
NID 
Provox 
Vega 
Q1 
Overall  
0.702 ICC 
0.778 CA 
0.728 ICC 
0.802 CA 
0.778 ICC 
0.836 CA 
0.706 ICC 
0.755 CA 
0.801 ICC 
0.88 CA 
0.776 ICC 
0.838 CA 
Q3 
Strain 
0.739 ICC 
0.82 CA 
0.652 ICC 
0.785 CA 
0.757 ICC 
0.831 CA 
0.684 ICC 
0.803 CA 
0.764 ICC 
0.847 CA 
0.695 ICC 
0.806 CA 
Q4 
Wetness 
0.674 ICC 
0.735 CA 
0.540 ICC 
0.609 CA 
0.768 ICC 
0.813 CA 
0.624 ICC 
0.694 CA 
0.717 ICC 
0.765 CA 
0.715 ICC 
0.779 CA 
Q5 
Volume 
0.778 ICC 
0.79 CA 
0.796 ICC 
0.805 CA 
0.874 ICC 
0.889 CA 
0.758 ICC 
0.783 CA 
0.844 ICC 
0.855 CA 
0.820 ICC 
0.843 CA 
Q6 
Social 
acceptability 
0.79 ICC 
0.807 CA 
0.742 ICC 
0.766 CA 
0.849 ICC 
0.863 CA 
0.76 ICC 
0.788 CA 
0.845 ICC 
0.863 CA 
0.588 ICC 
0.64 CA 
Q7 
Whisper 
0.847 ICC 
0.85 CA 
0.682 ICC 
0.677 CA 
0.827 ICC 
0.834 CA 
0.828 ICC 
0.845 CA 
0.847 ICC 
0.864 CA 
0.862 ICC 
0.868 CA 
Q8 
Intelligibility 
0.726 ICC 
0.841 CA 
0.624 ICC 
0.756 CA 
0.728 ICC 
0.836 CA 
0.649 ICC 
0.799 CA 
0.75 ICC 
0.861 CA 
0.645 ICC 
0.798 CA 
Q9 
Stoma Blast 
0.896 ICC 
0.913 CA 
0.896 ICC 
0.886 CA 
0.804 ICC 
0.839 CA 
0.827 ICC 
0.867 CA 
0.849 ICC 
0.874 CA 
0.758 ICC 
0.788 CA 
Q10 
Fluency 
0.546 ICC 
0.68 CA 
0.626 ICC 
0.765 CA 
0.641 ICC 
0.76 CA 
 
0.626 ICC 
0.762 CA 
0.683 ICC 
0.808 CA 
0.639 ICC 
0.774 CA 
Q11 
Articulatory 
precision 
0.436 ICC 
0.469 CA 
0.66 ICC 
0.664 CA 
0.378 ICC 
0.424 CA 
0.597 ICC 
0.604 CA 
0.508 ICC 
0.552 CA 
0.563 ICC 
0.606 CA 
Q12 
Paralingusitics 
0.689 ICC 
0.732 CA 
0.731 ICC 
0.758 CA 
0.593 ICC 
0.644 CA 
0.52 ICC 
0.573 CA 
0.683 ICC 
0.723 CA 
0.583 ICC 
0.641 CA 
Q13 
Accent 
0.87 ICC 
0.871 CA 
0.843 ICC 
0.846 CA 
0.825 ICC 
0.831 CA 
0.821 ICC 
0.825 CA 
0.825 ICC 
0.828 CA 
0.863 ICC 
0.865 CA 
Q14 
Poor reader 
0.956 ICC 
0.963 CA 
0.939 ICC 
0.954 CA 
0.935 ICC 
0.959 CA 
0.928 ICC 
0.954 CA 
0.787 ICC 
0.820 CA 
0.933 ICC 
0.953 CA 
 
 
An ICC of above 0.6 is considered to provide a good indication of agreement.  ICC of 
above 0.6 was observed between raters for each prosthesis on a majority of questions 
demonstrating a good level of agreement.  Questions, which did not reach an ICC of 
0.6, are highlighted in greyscale.  Agreement was not observed on Q4 for the Blom 
Singer Low pressure voice prosthesis only.  However, as the ICC for this question 
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approaches agreement for Blom Singer Low pressure voice prosthesis, the question 
was retained for further analysis.  Similarly, agreement is not reached for Q10 
Fluency on a single prosthesis, the duckbill.  However, this value also approaches 
reliability and was retained as a question for further analysis.  
 
Agreement is poor for Q11 Articulatory precision except for the low-pressure 
prosthesis.  Agreement was reached amongst raters for only 3 of the voice prostheses 
(Blom Singer Duckbill, Blom Singer Low pressure and Provox NID) on Q12 
paralinguistics question.  As agreement was poor for both Q11 and Q12, hypothesis 3 
was rejected for these questions and they were excluded from further analysis. 
 
Reliability of Q2 Bipolar Semantic Scale data from STOPS 
In order to answer hypothesis 3, data was recoded into 4 categories as follows: 
 Hypotonic 5, 4, 3, 2, 1 was recoded as 1 
 Tonic 0 was recoded as 2 
 Hypertonic 5, 4, 3, 2, 1 was recoded as 3 
 Stenosis 5 was recoded as 4 
Reliability was calculated using kappa to see whether raters agreed 2x2  
 Rater 1x Rater 2 
 Rater 1x Rater 3 
 Rater 2 x Rater 3   
 
 
Analysis was conducted for agreement by prosthesis type by splitting data by 
prosthesis type and then using cross tabs for kappa analysis by rater 2x2.  Results of 
this analysis are outlined in table 4.2, 4.3 and 4.4. 
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Table 4-2: Agreement between rater 1 and rater 2 for prosthesis type Q2 
STOPS 
Prosthesis type Kappa 
Blom Singer Duckbill -0.09 
Blom Singer Low Pressure  0.26 
Blom Singer Classic Indwelling 0.28 
Blom Singer Advantage 0.20 
Provox NID 0.18 
Provox Vega 0.1 
 
Table 4-3: Agreement between rater 1 and rater 3 for prosthesis type Q2 
STOPS 
Prosthesis type Kappa 
Blom Singer Duckbill 0.32 
Blom Singer Low Pressure  0.05 
Blom Singer Classic Indwelling 0.15 
Blom Singer Advantage 0.05 
Provox NID 0.27 
Provox Vega 0.13 
 
 
Table 4-4: Agreement between rater 2 and rater 3 for prosthesis type Q2 
STOPS 
  
Prosthesis type Kappa 
Blom Singer Duckbill -0.03 
Blom Singer Low Pressure  -0.00 
Blom Singer Classic Indwelling -0.02 
Blom Singer Advantage 0.06 
Provox NID 0.07 
Provox Vega -0.03 
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As agreement between raters was poor for Q2 Tonicity across voice prostheses, 
hypothesis 3 was rejected for Q2 Tonicity and this question was excluded from 
further analysis. 
 
 
Hypothesis 2  
Analysis of STOPS scores will indicate no difference between 6 voice prostheses for 
each individual question on the STOPs.   
 
This null hypothesis was investigated to ascertain whether raters considered one voice 
prosthesis as best for voice when using auditory perceptual judgements of voice 
samples for up to 6 voice prostheses from individual subjects. 
  
The average of raters’ scores was first determined for each question.  Data was split 
into groups of prostheses so that scores between voice prostheses could be analysed 
for each question.  Quartiles were calculated for each question and statistical analysis 
was undertaken using K Related samples.  This method is similar to the repeated 
measures ANOVA but does not require normality.  Results showed p>0.05 was 
observed for each question.  This finding indicated there was no difference between 
average ratings for each prosthesis on each question analysed on the STOPS.  This 
finding indicated that there was no one voice prosthesis that had a better average 
rating on any question of the STOPS.  The null hypothesis was therefore accepted 
with raters not able to identify a best overall prosthesis for voice based on auditory 
evaluation using the STOPS. These results are outlined for each question of the 
STOPS chosen for analysis in table 4-5. 
 
Table 4-5: Difference on average rating on STOPS question for each 
prosthesis 
 
Q1 average     
 P50 P25 P75 P 
Type of prosthesis    0.958 
Duckbill 1.33 1.00 2.00  
Low pressure exdwelling 1.67 0.83 2.00  
Classic indwelling 1.33 1.00 1.67  
Advantage 1.33 1.00 2.00  
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NID 1.33 1.00 2.00  
Vega 1.33 1.00 2.00 
 
 
 
 
Q3 average     
 P50 P25 P75 P 
Type of prosthesis    0.716 
Duckbill 1.16 0.66 1.66  
Low pressure exdwelling 1.00 0.66 1.33  
Classic indwelling 1.00 0.33 1.33  
Advantage 1.00 0.42 1.33  
NID 1.00 0.66 1.66  
Vega 1.00 0.66 1.58  
 
Q4 average     
 P50 P25 P75 P 
Type of prosthesis    0.847 
Duckbill 0.833 0.83 1.66  
Low pressure exdwelling 0.66 0.33 1.33  
Classic indwelling 0.66 0.33 1.33  
Advantage 0.66 0.33 1.33  
NID 1.00 0.33 1.66  
Vega 1.00 0.66 1.58  
 
Q5 average     
 P50 P25 P75 P 
Type of prosthesis    0.989 
Duckbill 0.66 0.33 1.0  
Low pressure exdwelling 0.33 0.00 1.33  
Classic indwelling 0.50 0.00 1.33  
Advantage 0.66 0.08 1.25  
NID 0.33 0.00 1.0  
Vega 0.50 0.33 1.25  
 
Q6 average     
 P50 P25 P75 P 
Type of prosthesis    0.656 
Duckbill 1.33 1.00 2.91  
Low pressure exdwelling 1.33 0.66 1.83  
Classic indwelling 1.00 1.00 1.66  
Advantage 1.33 1.00 1.66  
NID 1.33 1.00 2.25  
Vega 1.33 1.00 2.25  
 
 
Q7 average     
 P50 P25 P75 P 
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Type of prosthesis    0.993 
Duckbill 1.66 0.00 0.66  
Low pressure exdwelling 0.33 0.00 1.00  
Classic indwelling 0.33 0.00 0.66  
Advantage 0.33 0.00 0.92  
NID 0.33 0.00 1.00  
Vega 0.33 0.00 0.66  
 
Q8 average     
 P50 P25 P75 P 
Type of prosthesis    0.832 
Duckbill 0.66 0.33 1.33  
Low pressure exdwelling 0.33 0.33 1.00  
Classic indwelling 0.33 0.33 0.92  
Advantage 0.66 0.33 1.00  
NID 0.66 0.33 1.25  
Vega 0.66 0.33 1.0  
 
 
 
 
 
Q9 average     
 P50 P25 P75 P 
Type of prosthesis    0.723 
Duckbill 1.33 1.00 2.00  
Low pressure exdwelling 1.33 1.00 1.66  
Classic indwelling 1.00 1.00 1.66  
Advantage 1.33 1.00 2.00  
NID 1.66 1.00 2.00  
Vega 1.33 1.00 1.66  
 
Q10 average     
 P50 P25 P75 P 
Type of prosthesis    0.822 
Duckbill 0.66 0.33 1.00  
Low pressure exdwelling 0.66 0.16 1.00  
Classic indwelling 0.66 0.08 1.00  
Advantage 0.66 0.83 1.00  
NID 0.66 0.33 1.25  
Vega 0.66 0.33 1.33  
 
Q13 average     
 P50 P25 P75 P 
Type of prosthesis    0.977 
Duckbill 0.33 0.83 1.25  
Low pressure exdwelling 0.33 0.33 1.50  
Classic indwelling 0.66 0.33 1.50  
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Advantage 0.50 0.33 1.00  
NID 0.66 0.33 1.58  
Vega 0.66 0.33 1.66  
 
 
 
Q14 average     
 P50 P25 P75 P 
Type of prosthesis    0.977 
Duckbill 0.00 0.00 0.33  
Low pressure exdwelling 0.00 0.00 0.33  
Classic indwelling 0.33 0.00 0.33  
Advantage 0.33 0.00 0.33  
NID 0.00 0.00 0.33  
Vega 0.16 0.00 0.33  
 
 
 
Hypothesis 3 
Analysis of STOPS scores will indicate no difference between individual questions of 
the STOPS for a specific type of voice prosthesis. 
 
Hypothesis 2 examined whether there is a difference between voice prostheses on 
individual questions of the STOPS.  Hypothesis 3 was investigated to discover 
whether there is a difference between individual questions on the STOPS for a 
specific type of voice prosthesis.  If one question had a higher rating for an individual 
voice prosthesis, then the parameter being rated was better for that prosthesis.  Data 
was first split into groups by prosthesis.  Dataset was first split to allow data to be 
compared by groups of prosthesis type.  Quartiles were elicited through descriptives 
analysis.  Statistical analysis was undertaken using k related samples.  p <0.05 
indicating a prosthesis with significantly higher scores on the STOPS.  The null 
hypothesis was accepted.  These results are outlined in Table 4-6. 
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Table 4-6: Difference between individual questions of the STOPS for a 
specific type of voice prosthesis.  
   
Duckbill     
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.33 1.00 2.00  
Q3 average 1.17 0.67 1.67  
Q4 average 0.83 0.33 1.67  
Q5 average 0.67 0.33 1.00  
Q6 average 1.33 1.00 1.92  
Q7 average 0.17 0.00 0.67  
Q8 average 0.67 0.33 1.33  
Q9 average 1.33 1.00 2.00  
Q10 average 0.67 0.33 1.00  
Q13 average 0.33 0.08 1.25  
Q14 average 0.00 0.00 0.33  
 
 
 
 
  
Low pressure      
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.66 0.83 2.00  
Q3 average 1.00 0.66 1.33  
Q4 average 0.66 0.33 1.33  
Q5 average 0.33 0.00 1.33  
Q6 average 1.33 0.66 1.83  
Q7 average 0.33 0.00 1.00  
Q8 average 0.33 0.33 1.00  
Q9 average 1.33 1.0 1.66  
Q10 average 0.66 0.16 1.00  
Q14 average 0.00 0.00 0.33  
 
 
  
Classic 
indwelling 
   
 
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.33 1.00 1.66  
Q3 average 1.00 0.33 1.33  
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Q4 average 0.66 0.33 1.33  
Q5 average 0.50 0.00 1.33  
Q6 average 1.00 1.00 1.66  
Q7 average 0.33 0.00 0.66  
Q8 average 0.33 0.33 0.92  
Q9 average 1.00 1.00 1.66  
Q10 average 0.66 0.08 1.00  
Q11 average 0.00 0.00 0.33  
Q14 average 0.33 0.00 0.33  
  
 
 
Advantage     
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.33 1.00 2.00  
Q3 average 1.00 0.416 1.33  
Q4 average 0.66 0.33 1.33  
Q5 average 0.66 0.08 1.25  
Q6 average 1.33 1.00 1.66  
Q7 average 0.33 0.00 0.92  
Q8 average 0.66 0.33 1.00  
Q9 average 1.33 1.00 2.00  
Q10 average 0.66 0.08 1.00  
Q13 average 0.50 0.33 1.0  
Q14 average 0.33 0.00 0.33  
  
 
 
Provox NID     
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.33 1.00 2.00  
Q3 average 1.00 0.66 1.66  
Q4 average 1.00 0.33 1.66  
Q5 average 0.33 0.00 1.00  
Q6 average 1.33 1.00 2.25  
Q7 average 0.33 0.00 1.00  
Q8 average 0.66 0.33 1.25  
Q9 average 1.66 1.00 2.00  
Q10 average 0.66 0.33 1.25  
Q13 average 0.66 0.33 1.58  
Q14 average 0.00 0.00 0.33  
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Provox Vega     
 P50 P25 P75 P 
Question    <0.0001 
Q1 average 1.33 1.00 2.00  
Q3 average 1.00 0.66 1.58  
Q4 average 1.00 0.66 1.58  
Q5 average 5.00 0.33 1.25  
Q6 average 1.33 1.00 2.25  
Q7 average 0.33 0.00 0.66  
Q8 average 0.66 0.33 1.00  
Q9 average 1.33 1.00 1.66  
Q10 average 0.66 0.33 1.33  
Q13 average 0.66 0.33 1.66  
Q14 average 0.16 0.00 0.33  
  
 
 
 
Auditory perceptual Analysis – Raters’ choice of overall best prosthesis for voice 
 
Hypothesis 4 
Analysis of raters’ choice of best prosthesis for each subject will not identify an 
overall best prosthesis for voice.   
 
First, a consensus score for best voice prosthesis for voice for each subject was 
calculated from the ratings of each clinician.  Consensus score was calculated from 
the prosthesis that 2 or more raters considered best for voice.  When no consensus 
was achieved, this was indicated within the data.  Frequency analysis for choice of 
“best” prosthesis based on consensus scores from Clinicians’ is presented in table 4.7.  
This analysis indicates that the Blom Singer Classic Indwelling was most frequently 
chosen (7.3% of sample) as best prosthesis for voice by clinicians with the Provox 
Vega (2.4% of sample) least frequently chosen.  For 8 subjects, there was no 
consensus between clinicians regarding best prosthesis for voice. 
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Table 4-7:  Frequency analysis of Clinician consensus of best prosthesis 
for voice 
Prosthesis  Frequency Percentage of sample 
Duckbill 4 3.3% 
Low pressure  5 4.1% 
Classic indwelling 9 7.3% 
Advantage 7 5.7% 
Provox NID 5 4.1% 
Vega 3 2.4% 
No best prosthesis 8 6.5% 
 
 
Patient self-evaluation of voice using “Communication with voice prostheses 
questionnaire” 
Hypothesis 5 
Scores for individual voice prostheses on patient self-evaluation will be equally 
distributed and will not indicate a preference for an individual voice prosthesis. 
 
6 questions relating to voice from a “Communication and Swallowing with voice 
prostheses self-evaluation questionnaire” were scored.  Scores from each voice 
question were then added to provide a total voice score for each prosthesis for each 
individual subject.  The higher the score achieved, the more negatively subjects 
evaluated voice.  This data represented a single factor, repeated measures design with 
6 experimental conditions.  Therefore this data required analysis using the non-
parametric measure Friedman Two Way Analysis of Variance by Ranks.  Median 
descriptive scores were elicited for each prosthesis.  Median descriptive scores and 
Friedman test results are indicated in Table 4.8. 
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Table 4-8:  Median descriptive scores and Friedman test results 
 
Descriptive Statistics 
 N Percentiles 
25th 50th (Median) 75th 
Duckbill score voice 26 17.2500 20.5000 24.0000 
Low pressure score voice 26 13.0000 15.0000 17.2500 
Classic indwelling score 
voice 
26 12.0000 13.0000 16.2500 
Advantage score voice 26 13.0000 14.0000 17.2500 
Non indwelling score voice 26 10.0000 14.0000 16.0000 
Vega score voice 26 12.0000 14.0000 16.5000 
 
 
Test Statistics 
N 26 
Chi-Square 23.571 
df 5 
Asymp. Sig. .000 
a. Friedman Test 
 
 
As the Friedman p is <0.05, the null hypothesis of equality of scores is rejected.  
Scores are not equally distributed for voice.  The higher the score, the more negative 
the experience with voicing.  Subjects therefore preferred the Blom Singer Classic 
Indwelling most for voice (P50=13) closely followed by the Vega (P=14), NID 
(P=14) and Advantage (P=14).  The duckbill was least preferred for voice (P50=21).  
 
 
Patient self-evaluation – Subjects’ choice of overall best prosthesis  
 
Hypothesis 6 
Analysis of subjects’ choice of overall best prosthesis will not identify an overall best 
prosthesis  
 
Frequency analysis of patient self-evaluation of best overall prosthesis indicated that 
subjects most frequently chose the Provox NID as their best overall voice prosthesis 
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and the duckbill as the least frequently chosen overall best voice prosthesis.  This 
finding rejects the null hypothesis.  Results of frequency analysis of self-evaluation of 
best overall voice prosthesis are presented in Table 4.9 with percentage results for 
Provox NID highlighted in greyscale.  
 
Table 4-9: Frequency analysis of self-evaluation of best overall voice 
prosthesis 
Prosthesis  Frequency Percentage of sample 
Duckbill 2 4.9% 
Low pressure  6 14.6% 
Classic indwelling 5 12.2 % 
Advantage 5 12.2% 
Provox NID 13 31.7% 
Vega 10 24.2% 
 
 
Hypothesis 7 
Clinicians and subjects will not agree on best prosthesis for voice 
 
Data from consensus scores for best prosthesis for voice for each subject was 
calculated from the ratings of each clinician indicating their choice of best overall 
prosthesis for voice for each subject.  This data was compared with total voice score 
for each prosthesis for each subject calculated from patient self-evaluation of voice 
using “Communication with voice prostheses questionnaire”.  Kappa coefficient of 
Cramer’s V was used for analysis to compare date from raters and patients.  The 
kappa value elicited from this analysis was -0.086 indicating poor agreement overall 
between subjects and raters for best prosthesis for voice.  The null hypothesis was 
therefore accepted.  However, it is noted that despite the lack of overall agreement, 
both clinicians and subjects most frequently chose the Blom Singer Classic 
Indwelling as “best” prosthesis for voice. 
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4.5.5 Discussion 
4.3.4.1 Expert raters agreement using the STOPS  
As discussed in the introduction, there are significant limitations to the use of acoustic 
measures to analyse voice quality in post laryngectomy patients.  Auditory perceptual 
rating involves an expert listener judging a voice sample according to different 
parameters (Carding et al., 2000).  Expert raters were asked to perceptually analyse 
voice samples of the same group of subjects across a range of different voice 
prostheses using the STOPS.  Reliability was first investigated to ascertain whether 
there was a good level of agreement among all 3 raters when using the STOPS to 
perceptually judge voice.  A good level of agreement was observed on most of the 
questions of the STOPS.  Reliable questions on the STOPS were (Q1- Overall voice 
rating, Q3-Strain, Q4 Wetness, Q5 Impairment of volume, Q6 Impairment of social 
acceptability of voice, Q7 Whisper, Q8 – Impairment of Intelligibility, Q9 Stoma 
Blast, Q10 Impairment of Fluency, Q13 Accent, Q14 Poor reader).  Questions with 
poor reliability were Q2 – Perceptual Voice Tonicity, Q11- Impairment of articulatory 
precision and Q12 – Positive features of articulation (paralinguistics/diction).  Q2 
relates to tonicity of the vibratory segment or the amount of pressure used to produce 
alaryngeal voice.  Clinically, a patient with a tonic voice will be able to produce fluent 
sound of adequate intensity without effort.  A tonic voice has been defined as the 
ability to sustain /a:/ for 10 seconds and produce 10-15 syllables per breath (Lewin et 
al., 1987) or to sustain /a:/ 8 seconds and count from 1-15 on one breath (Blom et al., 
1998).  The bipolar semantic scale used in the STOPS reflects the continuum of tone 
identified by (Perry, 1989.  Stenotic voice reflects and absence of tone.  Stenosis is 
either present or absent and does not reflect a continuum {Hurren, 2009 #789).  The 
complexity of tone necessitated a more detailed rating scale with stenosis measured 
on a separate arm (Hurren et al., 2009a).  A previous study (Hurren et al., 2009a) 
examined inter rater agreement between 12 Speech and Language Therapists and 10 
ENT surgeons for Q2 of the STOPS.  While inter rater agreement was only moderate 
for the raters as a whole, it was good for the subgroup of Speech and Language 
Therapists.  Inter rater agreement was poor for three expert Speech and Language 
Therapist raters in this study, each of whom had demonstrated a strong understanding 
of tone within training sessions.  The poor inter rater reliability found for Q2 in this 
study may reflect complexity of the scale used to measure this question.  
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Q11- Impairment of articulatory precision demonstrated poor rater agreement.  This 
parameter measures the degree of the lack of precision or “slurring” in speech.  Lack 
of articulatory precision can be influenced by a number of factors including fatigue 
and sometimes accent.  During training of expert raters, Q11 was not identified as one 
that needed further clarification.  However, the guidance provided for rating this 
parameter refers to a baseline of 1-2 on the Vocal Profile Analysis Scale (see 
Appendix for details).  As the experience of the expert raters involved in this study 
was predominantly with head and neck cancer rather than with voice, it is possible 
that they were less familiar with the defined baseline, which used the Vocal Profile 
Analysis scale as a reference.  This factor may have accounted for the poor rater 
agreement on this question.  The final question to demonstrate poor rater agreement 
was Q12 Positive features of articulation (paralinguistics/diction).  Positive features of 
articulation refer to diction, intonation or pause features that have an overall positive 
effect but are not part of the voice signal, (see appendix for guidance for STOPS 
scale).  The guidance provided for this question acknowledges this is a parameter that 
is difficult to define succinctly.  However, Q12 was not identified during training as 
one that required further definition.  Poor rater agreement on this question and on Q11 
may simply reflect the complexity of assessing articulation in subjects such as 
laryngectomy patients, who present with an underlying disordered voice, 
 
 
4.3.4.2 Expert raters preference for a voice prosthesis for voice on perceptual 
evaluation  
 
The next objective was to investigate whether expert raters objectively consider one 
voice prosthesis as best for voice for subjects on perceptual evaluation using the 
STOPS rating scale.  Analysis of STOPS scores indicated no difference between 6 
voice prostheses for each individual question on the STOPs nor between individual 
questions on the STOPS for a specific type of voice prosthesis.  Therefore, raters were 
unable to identify one prosthesis as best for voice despite using a scale for which they 
had already demonstrated good agreement.  The use of acoustic measures to judge 
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voice quality after laryngectomy has been criticised primarily because the acoustic 
variables of a pathological voice such as a laryngectomy, differs greatly form that of a 
healthy person for whom acoustic measures were defined.  Acoustic measures are 
often elicited from a single sustained vowel rather than from a sample of connected 
speech (Bocklet et al., 2009).  Acoustic measures therefore reflect the sound of the 
voice and not the ability to communicate (Oridate et al., 2009) and do not reflect how 
well and individual communicates in a social situation.  As previously mentioned, 
auditory perceptual measures of voice involves an expert listener judging a voice 
sample according to different parameters (Carding et al., 2000).  As typically these 
parameters include intelligibility, voice quality and acceptability, they assume much 
more of a social context (Doyle and Eadie, 2005) than acoustic measures.  However, 
the judgement of expert clinicians is not necessarily any more reflective of real life 
than acoustic measures.  A clinician who is familiar with laryngectomy patients may 
become desensitised to the abnormalities of the alaryngeal voice.  A clinician’s 
judgement may therefore not reflect the impact of the disease on day-to-day life 
despite the knowledge of the patient’s surgery and the use of a laryngectomy specific 
scale.  The expert raters involved in this study were a making auditory perceptual 
judgements on voice samples of a standard reading passage and did not have access to 
any information about nonverbal communication including facial expression and 
gesture.  These factors were all controlled to allow raters to make judgements about 
different voice prostheses based solely on the voice sample, which they were 
presented.  Further research is required to investigate auditory perceptual judgements 
of naïve raters when judging voice quality.  Further research is also required to 
facilitate analysis of more connected, conversational speech rather than the analysis of 
a single phoneme (acoustic measures) or a standard reading passage (auditory 
perceptual analysis).  
 
 
4.3.4.3 Rater preference for a “best” overall voice prosthesis for voice 
One of the objectives of this study was to investigate whether raters’ choice of best 
prosthesis for each subject identified an overall best prosthesis for voice.  A 
consensus score was then calculated.  For 8 subjects, (38% of the sample) there was 
no consensus between clinicians regarding best prosthesis for voice.  Frequency 
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analysis revealed that when consensus was agreed amongst raters, the Blom Singer 
Classic Indwelling was most frequently chosen (7.3% of sample) as best prosthesis 
for voice by clinicians with the Provox Vega (2.4% of sample) least frequently 
chosen.  This question represents a subjective judgment of voice quality reflecting 
individual raters’ bias and opinion and results should be interpreted cautiously. 
 
 
4.3.4.4 Subject preference for a prosthesis for voice 
 
The next objective was to investigate whether subjects have a preference for a 
prosthesis for voice based on self-evaluation of voice prosthesis experience. As 
discussed in the introduction patient based voice specific outcome measures can 
potentially provide more information than the biological and physiological variables 
that are associated with voice and voice production (Rosen et al., 2004).  It is 
ultimately the patient’s perception of their post treatment status that is of greatest 
importance (Moukarbel et al., 2011).  Self-evaluation scales have been developed for 
use with patients with a larynx.  These include the VHI (Jacobson et al., 1997), the V-
RQOL (Hogikyan and Sethuraman, 1999) and the VOISS (Jones et al., 2006).  The 
VHI was designed for use primarily with those with a larynx although it was designed 
to be suitable for use with tracheoesophageal speakers.  Although each of these tools 
has been used with laryngectomy subjects, they fail to address some of the specific 
voice issues that laryngectomy patients face.  The SECEL (Blood, 1993)was 
developed specifically for laryngectomy patients.  However, it has not been used 
widely possibly because its length limits its use in the clinical setting.  In addition, the 
SECEL fails to address voice prosthesis related issues.  While the VPQ (Kazi et al., 
2005) was designed specifically for laryngectomy patients, it contains 45 questions 
and this was considered overly burdensome for subjects participating in this study, the 
majority of whom would have needed to complete this scale six times.  A self-
evaluation of voice patient questionnaire was designed for this study based on 
experiences identified by patients as important when considering new voice 
prosthesis.  Patients therefore judged experience with voice based on the amount of 
effort they had to use, others being able to be understood, consistency of voice, 
pleasantness of voice, loudness of voice and appearance of voice prosthesis.  
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Using these criteria in the self-evaluation of voice questionnaire, results indicated that 
subjects did have a preference for voice prosthesis for voice production.  Most 
patients are currently not provided with a choice of voice prosthesis.  They use the 
prosthesis recommended by their clinician or which their hospital supplies.  The 
finding, that subjects, when faced with a choice of voice prostheses, have preferences 
is important.  It signifies that patients as end users of these devices should have access 
to a choice of prostheses and be involved in making that choice.  The Blom Singer 
Classic indwelling was the most preferred prosthesis for voice with the Blom Singer 
Duckbill least preferred.  The Blom Singer Duckbill was the first widely 
commercially available voice prosthesis.  Since the inception of this voice prosthesis, 
lower pressure voice prostheses became available which were designed to allow 
patients to speak with less effort.  The Blom Singer Duckbill remains a widely used 
voice prosthesis today.  It is relatively low cost exdwelling voice prosthesis, which 
patients can easily learn to place themselves if necessary.  The Blom Singer Classic 
indwelling voice prosthesis is a voice prosthesis that may only be placed by a trained 
clinician and is designed to remain in situ for up to 6 months.  Several patients 
commented that they liked this prosthesis because it was clear in colour and therefore 
more discreet in appearance.  There have been a small number of studies (Pauloski et 
al., 1989, VanDenHoogen et al., 1996, Delsupehe et al., 1998, Hancock et al., 2005, 
Ward et al., 2011, Hancock et al., 2012) comparing voice prostheses (Chapter 3.2.3 
Studies comparing voice prostheses).  However, except for (VanDenHoogen et al., 
1996) which compared 3 voice prostheses, all of these studies have compared just two 
voice prostheses.  In addition, only some of these studies included patient self-
evaluation, (Delsupehe et al., 1998, Hancock et al., 2005, Ward et al., 2011).  
Hancock, 2012 #711.  This study is the first to investigate a broad range of voice 
prostheses and has indicated that patients have a preference for the Blom Singer 
Classic and that the Blom Singer Duckbill is least preferred.  This study is also unique 
in that subjects themselves were instrumental in deciding which criteria would be 
used to self-evaluate voice prostheses.  Further research is now required with large 
numbers of subjects to analyse which properties of individual voice prostheses were 
most influential in determining preference for a voice prosthesis  
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4.3.4.5 Patient preference for “best” overall voice prosthesis 
 
Subjects also indicated a preference when simply asked to identify a “best” overall 
voice prosthesis.  In considering this question, subjects were not asked to consider 
prostheses in terms of voice or swallow but simply to consider their favourite.  
Considering overall “best” prosthesis, subjects also expressed a preference but this 
time for the Provox NID with the least favourite being the Blom Singer Duckbill.  
The Provox NID is an exdwelling voice prosthesis, which patients can learn to change 
themselves.  It is unique amongst the prostheses trialed in that it is blue in colour.  
Several older patients commented that they found this colour easier to see than clear 
prostheses such as the Blom Singer Classic Indwelling, the Blom Singer Advantage 
and the Provox Vega.  Several patients also commented that this prosthesis would be 
easier to clean because it was more visible.  These findings concur with  (Hancock et 
al., 2005) which found that that the Provox NID was easier to clean in situ than the 
Blom Singer Low Pressure.  The study by (Hancock et al., 2005) was an initial study 
of a new voice prosthesis.  As a consequence of patients reporting poor visibility of 
the Provox NID on this study(Hancock et al., 2005), blue was added to this prosthesis 
to increase its visibility.  It is likely that a number of factors influence patients’ choice 
of a “best” prosthesis.  Based on comments from patients during the study, these 
factors often extend beyond voice and swallow to include appearance of the 
prosthesis, ability to clean and whether it requires a visit to the hospital to be replaced 
by a clinician.  One of the objectives of this study was to investigate whether subjects 
expressed a preference for a voice prosthesis.  Further research is now required to 
investigate the factors beyond voice and swallow that influence patients’ choice of a 
“best” prosthesis.  (Hancock et al., 2005).  The identification of these factors could 
lead to improved patient choice in the clinical realm and potentially could enhance 
design of future voice prostheses. 
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4.3.4.6 Subject and raters’ agreement on best prosthesis for voice. 
The final objective of this study was to investigate whether subjects and raters agree 
on best prosthesis for voice. 
 
Subjects chose the Blom Singer Classic Indwelling as “best” for voice based on self-
evaluation of prosthesis experience.  This choice was different to the prosthesis 
chosen as best overall by subjects (Provox NID) reflecting the fact those factors other 
than voice quality such as appearance, ability to visualise and ease of cleaning may be 
considered when a subject chooses a best overall voice prosthesis.  Raters also chose 
the Blom Singer Classic Indwelling as overall best for voice by raters.  This prosthesis 
is the same as that chosen by subjects based on the findings of a self-evaluation 
questionnaire for voice.  However, overall agreement was poor when statistically 
analysed.  It is not entirely surprising that raters and subjects do not have a good level 
of agreement when considering best prosthesis for voice.  Subjects have to use the 
voice prosthesis on a daily basis and factors such as ease of visibility and ease of 
cleaning may be ultimately more important than voice quality.  Clinicians such as the 
3 expert raters in this study have much expert knowledge about the characteristics of 
each prosthesis, how they are inserted and how much they cost.  Nonetheless, 
clinicians do not have a personal knowledge of voice prosthesis use.  Ultimately, it is 
the opinion of the patient regarding the best voice prosthesis for their needs that has 
greater relevance to an individual’s care than the opinion of the clinician. 
Strengths of this study include the use of an auditory perceptual scale, the STOPS, 
which was designed specifically for use with laryngectomy patients, uses 
tracheosophageal voice rather than normal voice as a baseline and provides specific 
and clear guidance for scoring each item.  A further strength of this study is the 
inclusion of the perspectives of both experts and patients.  The study is limited by 
small sample size but also by the fact that patients had the opportunity to try different 
voice prostheses for a limited time only.  Results of the patient perspective on 
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different prostheses may have been altered if they had each prosthesis in for a number 
of days or weeks. 
 
4.5.6 Conclusions 
 
This study has indicated that there is good inter rater agreement for the majority of 
questions on the STOPS scale.  The STOPS was used as an auditory perceptual tool 
for expert raters to analyse potential differences between voice prostheses for the 
purposes of voicing.  No differences were identified using the STOPS.  Expert raters 
were also asked to subjectively indicate which prosthesis, in their opinion, was best 
for voice for each individual subject.  The Blom Singer Classic Indwelling was most 
frequently chosen as best for voice by raters.  However, there was a lack of consensus 
amongst raters for 38% of the sample. 
 
Subjects indicated they had a preference for the Blom Singer Classic Indwelling voice 
prosthesis for the purposes of voice based on self-evaluation of voice prosthesis 
experience.  However, when subjects were asked to indicate which prosthesis they 
preferred overall, they most frequently chose the Provox NID indicating that several 
factors other than voice including appearance and ease of cleaning may have 
influenced this choice.  Finally there was a poor overall level of agreement between 
raters and subjects regarding best prosthesis for voice.  Nonetheless, raters most 
frequently chose the Blom Singer Classic Indwelling as best for voice when choosing 
an overall ‘best” prosthesis for voice for each patient which reflects the choice of 
subjects on self-evaluation. 
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Chapter 5. Quality of life after laryngectomy 
5.1 Summary 
 
This chapter reports on an exploration of quality of life after laryngectomy, including 
a description of a pre-recruitment survey to choose the most appropriate QoL tool for 
this patient group. Section 5.2 provides a background to this topic and a discussion of 
quality of life topics available. As there is no specific quality of life available for 
laryngectomy patients, section 5.5 outlines a pre recruitment survey of patients to 
ascertain which tool was best suited to the needs of this group.  Section 5.6 describes 
the main study which is an investigation of quality of life after laryngectomy using 
the MD Anderson Dysphagia Inventory (MDADI), University of Washington Quality 
of Life scale UOW QOLv4 and the Functional Oral Intake Scale.  Section 5.7.5 
summarises this body of work in the conclusion 
 
 
5.2. Background 
 
While there have been major advances in the treatment of head and neck and other 
cancers, the disease still causes significant suffering to those who are cured (Elmiyeh 
et al., 2010) (Kazi et al., 2010).  No illness exists in a vacuum, cancer patients often 
experience multiple physical, psychological and social problems concurrently (Sayed 
et al., 2009b).  The disabilities that can arise from a diagnosis of cancer may vary 
according to site of involvement, stage of disease and method of treatment (Hanna et 
al., 2004).   
Quality of life can be defined as the perceived discrepancy between the reality of 
what an individual has and the concept of what a person wants needs or experiences.  
(Morton and Izzard, 2003).  There are significant functional and physical changes 
after laryngectomy that affect communication, swallowing, respiration and airway 
management (Bickford et al., 2013).  Each of these changes can have a profound 
impact on quality of life.  In contrast to other head and neck cancer patients, 
laryngectomy patients can present with additional quality of life impairments that are 
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specific to their surgery, e.g. loss of smell, production of excess mucus from a neck 
stoma and a leaking voice prosthesis.  
The description of laryngectomy patients as being so severely impaired in ability to 
function or live normal lives (Harwood and Rawlinson, 1983) influenced the 
increasing popularity of organ preservation techniques as an initial treatment option.  
An early study (Terrell et al., 1998) was instrumental in suggesting that laryngectomy 
subjects have less satisfactory quality of life compared to those  undergoing organ 
preservation treatment.  This study (Terrell et al., 1998) was a follow up to the 
seminal VA study (Wolf et al., 1991) comparing induction chemotherapy and 
radiotherapy with laryngectomy surgery followed by radiotherapy.  The follow up 
study (Terrell et al., 1998) compared 25 subjects who had undergone laryngectomy 
surgery and post-operative radiotherapy with 21 organ preservation subjects who had 
been treated with chemo radiation and radiotherapy.  Mean length of follow up was 
10.4 years.  Those with intact larynges were found to have less body pain, better 
scores on the SF36 Mental Health scale and better emotion scores on the University 
of Michigan Head and Neck instrument (HNQOL) than laryngectomy subjects.  28% 
of the laryngectomy subjects were depressed compared with 13% of the organ 
preservation subjects.  This study lent significant weight to the arguments for organ 
preservation as a more acceptable treatment alternative to removal of the larynx.  
A later study also highlighted the negative effects of laryngectomy surgery (Singer et 
al., 2005).  This study of 189 patients who had been treated with a laryngectomy 
between 1970 and 2001 indicated that 23% presented with mental disorders.  The 
most frequently occurring disorder was alcohol dependency (8%) followed by 
affective disorders (7% major depression, 5 % minor depression).  It was noted that 
only one patient was receiving appropriate treatment. 
However the literature also reflects views that are in opposition to laryngectomy as a 
procedure with overwhelmingly negative consequences for the patient.  A prominent 
study (Morton, 1997) followed 46 subjects with laryngeal cancer at diagnosis and at 
intervals of 3, 12 and 24 months following diagnosis.  Subjects completed a general 
health questionnaire and a life satisfaction scale at each time interval.  Of the 46 
subjects seen initially at diagnosis, 30 were treated with radiotherapy, 15 were treated 
with total laryngectomy and 1 had a hemilaryngectomy.  44, 41 and 31 subjects were 
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available for follow up at 3, 12 and 24 months respectively.  By 12 months, 6 of the 
subjects initially treated with radiotherapy required a salvage laryngectomy resulting 
in 51% of subjects presenting with a total laryngectomy.  By 24 month follow up 58% 
of the sample had a total laryngectomy.  Results indicated that coughing, swallowing 
and speech problems after laryngectomy are greater than those experienced by 
patients receiving radiotherapy (Morton, 1997).  However, these difficulties 
experienced by laryngectomy subjects did not translate into differences expressed in 
life satisfaction and psychological distress.  With regard to psychological functioning 
and general well-being, no major quality of life differences existed between patients 
treated surgically and those receiving radiotherapy.   
A further study (Deleyiannis et al., 1999b), administered the University of 
Washington Quality of Life scale (UW QOL) to 25 consecutive subjects undergoing 
total laryngectomy pre surgery and 12 and 24 months post-surgery.  13 of these 
patients had primary laryngectomy, 8 required laryngectomy following recurrence 
after radiotherapy and 4 required laryngectomy following recurrence after chemo 
radiotherapy.  This study found that while loss of speech is disabling and 
laryngectomy is disfiguring, only a minority of patients reported speech or appearance 
as being “somewhat important” to their overall quality of life.  This study also found 
that when laryngectomy patients were asked to rate their health at 2 years post 
laryngectomy compared with one year prior to diagnosis, that 60% has the same or 
better health post laryngectomy with 30% indicating their health was much better post 
laryngectomy.  This study noted that the ability to adaptively cope might contribute to 
favourable QOL outcomes reported by laryngectomy patients.  This study also 
suggests that functional limitations do not necessarily translate into worsening of 
overall quality of life.   
While clinicians may perceive reduction in severity of physical symptoms to be 
important, patients may place more emphasis upon restoring family relationships or 
engaging in leisure activities (Kazi et al., 2010).  This is illustrated in a study (Mohide 
et al., 1992) which compared the importance of quality of life dimensions elicited 
from 20 post laryngectomy patients and 20 healthcare professionals.  Subjects in both 
groups were asked to identify what they considered to be important quality of life 
variables after recovery from laryngectomy and to rank and rate each one on a visual 
analog scale.  Health professionals indicated that impaired communication, self-image 
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esteem as the two most important quality of life dimensions.  Patients ranked tracheal 
mucous and interference with social activities as the two most critical quality of life 
dimensions.  This research indicated that responses of healthcare professionals do not 
always correlate with patient priorities.  The use of quality of life measures may help 
capture information that on the surface appears to have little clinical relevance but 
might explain disease severity and ability to cope (Kazi et al., 2010).  Quality of life 
data has an important role in allowing healthcare professionals become more 
responsive to the needs and concerns of the laryngectomy patient and to allow patient 
problems to be screened, identified and prioritised.   
This section has highlighted that the sequelae of the treatment for head and neck 
cancer can cause disabilities that affect quality of life despite a cure being achieved.  
It has been highlighted that laryngectomy patients, in contrast to other head and neck 
patients, experience specific issues such as loss of smell, production of excess mucous 
from a neck stoma and dealing with a leaking voice prosthesis.  The lack of consensus 
on how laryngectomy affects quality of life was discussed.  One perspective 
indicating that laryngectomy patients are unable to live a normal life has been 
outlined.  The landmark Veterans Affairs study (Terrell et al., 1998) emphasised that 
those subjects with intact larynges were found to have less body pain, better scores on 
the SF36 Mental Health scale and better emotion scores on the University of 
Michigan Head and Neck instrument (HNQOL) than laryngectomy subjects.  This 
study also highlighted a higher rate of depression in laryngectomy subjects, a finding 
echoed in a later study (Singer et al., 2005).  However, a further study (Morton, 1997) 
found that although laryngectomy patients experience more coughing, swallowing 
and speech issues than organ preservation patients, these issues did not translate into 
differences in life satisfaction and psychological distress between the two groups.  
The study by (Deleyiannis et al., 1999b) examined laryngectomy subjects only and 
did not provide a comparison with those with intact larynges.  Nonetheless, the 
majority of subjects in this study reported the same or better, or much better health as 
measured by the UW QOL scale.  The discrepancy between health professionals 
perception of important quality of life variables and that of laryngectomy patients is 
illustrated in the study by Mohide and colleagues (Mohide et al., 1992).  The 
importance of quality of life scales in allowing issues that cause concern to patients to 
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be discussed, even if these issues seems of limited clinical relevance, has been 
underlined.  
The next section describes the different head and neck cancer specific and dysphagia 
specific quality of life scales that were considered for use with laryngectomy patients 
for the purposes of this study.   
 
 
5.3. Quality of life scales considered for use with laryngectomy 
patients 
 
This study required the choice of an appropriate instrument to investigate quality of 
life after laryngectomy.  In choosing a quality of life instrument, it is essential that the 
instrument measures what it purports to measure, that it responds to change and is 
reliable (Villaseca et al., 2005). Although there is a number of quality of life scales 
available for head and neck cancer (see table 5.1 below) there are no scales specific to 
laryngectomy patients.  It was important therefore to involve laryngectomy patients 
themselves in choosing a QOL scale that would be best suited to their needs.  The 
next section describes the quality of life scales currently available which were 
considered for use with laryngectomy subjects in this study. 
The MDADI (Chen et al., 2001) is a questionnaire that examines quality of life 
specifically in dysphagic head and neck cancer patients.  This scale is relatively short 
and is used frequently in clinical settings.  The UW QOLv4 (Rogers et al., 2002) is a 
tick box questionnaire designed specifically for use with head and neck cancer 
patients.  Despite, its length, the UW QOLv4 is also popular for use within clinical 
settings.  The SWAL-QOL (McHorney et al., 2000) is a well validated quality of life 
scale specific to swallowing.  It was initially developed as a 93-item questionnaire, 
which was subsequently reduced to 43 items.  To date, it has not been used 
extensively with head and neck cancer patients.  The EORTC QLQ C30 (Aaronson et 
al., 1993) is a questionnaire of quality of life specific to head and neck cancer that has 
been translated into several languages.  It is supplemented by disease specific 
modules for other areas of the body.  The EORTC QLQ H&N35 (Bjordal et al., 1994) 
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is designed to be used in conjunction with the EORTC QLQ C30.  The EORTC QLQ 
H&N35 addresses quality of life specifically in head and neck cancer patients.  It is 
currently being revised in answer to criticisms that it fails to address the side effects 
related to treatment regimens combining surgery and chemo radiation.  In contrast to 
the other quality of life scales described in this section, the HNQOL (Terrell et al., 1997) is 
an interviewer administered multidimensional quality of life questionnaire.  It is not 
currently used extensively within clinical settings in the UK.  These scales are 
outlined in further detail in Table 5.1 
 
Table 5-1: Description of the currently available QOL measures considered 
for use with laryngectomy patients. 
 
Scale 
(abbreviation) 
Reference  
 
Description Comments 
MDADI 
(MD 
Anderson 
Dysphagia 
Inventory) 
Chen et al 2001 20 statements related to 
dysphagia. 
4 subscales:  
Global, emotional, 
functional, physical 
Designed specifically for HNC (Head and Neck Cancer) 
Validated and reliable for HNC population (Chen et 
al., 2001). 
Widely used in clinical settings 
Self-administered 
Short and easy for patients to complete 
UW QOL v4 
(University of 
Washington 
Quality of 
Life Scale 
version 4) 
Rogers et al 2002 3 distinct parts: 
A) 12 questions one for 
each of these domains: 
pain, appearance, 
activity recreation, 
swallowing, chewing, 
speech, shoulder, taste, 
saliva, mood, anxiety 
 
B) Review of 3 most 
important domains as 
listed above over past 7 
days 
 
C) 3 general questions 
about current QOL, 
health related QOL, 
overall QOL over past 7 
days 
 
Designed specifically for HNC 
Validated and reliable for HNC population 
(Weymuller et al., 2001) 
Widely used in clinical settings 
Self-administered 
Long and often complex for patients to complete 
SWAL-QOL 
(Swallowing 
Mc Horney et al 2000 44 items assessing 10 
QOL concepts 
Not designed specifically for HNC 
Sensitive for differences in severity of dysphagia. 
Validated and reliable (McHorney et al., 2002) 
300 
 
Quality of 
Life 
Used in clinical settings but not widely 
Long and often complex for patients to complete 
 
EORTC QLQ 
C30 
European 
Organisation 
for Research 
and 
Treatment of 
Cancer 
Quality of 
Life 
Questionnaire 
Aronson et al 1993 30 questions 
 
6 functional scales 
3 symptom scales 
Global health status 
5 single items 
Developed specifically for cancer 
Validated and reliable (Singer et al., 2009) 
Moderately complex for patients to complete 
Used in clinical settings but not widely 
EORTC QLQ 
H&N35 
European 
Organisation 
for Research 
and 
Treatment of 
Cancer 
Quality of 
Life 
Questionnaire 
Head and 
Neck 35 
Bjordal et al 2000 35 questions 
  
7 multiple item scales 
11 single items 
Developed specifically for HNC 
Validated and reliable (Singer et al., 2009) 
Moderately complicated for patients to complete 
Used in clinical settings but not widely 
HNQOL 
Head and 
Neck Quality 
of Life 
Instrument 
Terrell et al 1997 37 questions 
4 domains (eating, 
communication, pain, 
emotion) 
Developed specifically for HNC  
Validated and reliable (Terrell et al., 1997) 
Not used in clinical settings in recent years 
 
 
5.4. Other quality of life scales considered for use with laryngectomy 
patients 
 
As there was no laryngectomy specific quality of life scale available, consideration 
was given to other quality of life scales available that may be suitable for use in this 
study.  These scales are now described. 
The SF36 v2 (Ware et al., 2000) is a psychometrically-based physical and mental 
health summary measure and a preference-based health utility index.  The SF12 v2 
(Ware et al., 1996) is a shorter version of the SF 36 v2.  The shorter length of the SF 
12 v2 can make it an attractive clinical tool.  However it has fewer levels than the 
SF36 v2 resulting in potentially less precise scores than the SF36 v2.  It was 
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considered more appropriate for head and neck cancer patients to use a scale that 
captured some of the unique quality of life impairments experienced by this group 
which neither the SF36 v2 nor the SF12 v2 contain.  The Functional Assessment of 
Cancer Therapy Scale – general (FACT-G) (Cella et al., 1993) was developed in 
North America.  Its focus is on patients having treatment for cancer and as all of the 
patients recruited to this study have completed treatment, it was not considered to be 
suitable.  The Functional Living Index of Cancer (FLIC) (Schipper et al., 1984) 
covers a broad range of quality of life issues related to cancer.  Reliability has 
however, largely been based on breast cancer (Laenen and Alonso, 2010) so this tool 
was not considered appropriate.  A further limitation of the FACT-G, and the FLIC is 
that they are largely disease specific (in this case cancer) instruments rather than 
instruments that are specific to the site of disease.  The EQ-5D – EuroQOL is a 
standardised measurement of health status tool developed to provide a simple generic 
measure of health for clinical and economic appraisal (Rabin et al., 2011).  This tool 
was reviewed and was not chosen because it is not specific to cancer.  The 
characteristics of each of these tools are described in Table 5.2  
 
Table 5-2:  Other QOL scales considered for use with laryngectomy patients 
Scale (abbreviation) Reference  
 
Description Comments 
SF36 v2 Ware et al 2000 36 questions yielding 
8 scale profile 
Physical and mental 
health summary measure 
Lengthy to complete 
Not cancer specific 
SF12 v4 Ware et al 1996 12 questions yielding an 
8-scale profile. 
Assesses functional 
health and well being 
Used extensively in 
clinical practice. 
Not cancer specific 
FACT-G Cella et al 1993 28 item scale 
Measures QOL in cancer 
patients 
Focused on patients 
receiving cancer 
treatment. 
Not HNC specific 
Not widely used in 
current clinical practice 
FLIC Schipper et al 1984 22 item scale 
Measures broad range of 
Limited reliability 
302 
 
QOL related to cancer Not HNC specific 
Not widely used in 
current clinical practice 
EQ-5D –  3L EuroQOL Rabin & de Charro 2001, 
Rabin et al 2011 
5 item tick box 
descriptive system 
measuring mobility, self 
care, usual activities, 
pain/discomfort, 
anxiety/depression 
Visual Analog Scale for 
self-related health 
measurement 
Widely validated and 
used 
Neither cancer nor head 
and neck cancer specific 
 
 
5.5. Pre recruitment survey of Quality of Life scales 
This section explains the rationale for choosing QOL scales used in the main study 
and the methods used in surveying patients about their preference for QOL scales.  
 
5.5.1. Aim:   
 
The purpose of this survey was to establish which QOL scale is most appropriate to 
measure the aspects of QOL that laryngectomy patients feel are most important to 
them. 
 
5.5.2. Methods:  
 
Subjects: 
Subjects were selected over a period of 5 weeks between July 15
th
 and August 19
th
 
2010.  10 subjects were consecutively sampled as they attended the joint head and 
neck clinic at Charing Cross Hospital during the time frame specified.   
Subjects were selected on the basis of having had a total or extended laryngectomy 
and were not excluded because of age or gender or whether they were undergoing 
active treatment (radiotherapy +/-chemotherapy) at the time of selection.  All 10 
subjects were surveyed about the length of time it took them to complete each 
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questionnaire and whether they would be happy to complete more than one scale as 
part of a research project.  In addition, all 10 participants were surveyed about 
whether the scales presented to them covered a reasonable range of difficulties 
encountered in living life with a laryngectomy. 
 
Process: 
10 laryngectomy subjects consented to participate in this study during a routine visit 
for clinical treatment.  Each participant was presented with the following QOL tools: 
 University of Washington – Quality of Life Scale v4 
 MD Anderson Dysphagia Inventory 
 Swallowing Quality of Life Questionnaire 
 
The patients were asked to complete each tool and then they were interviewed, using 
a semi-structured interview technique.  The aim of this interview was to elicit which 
tool each patient felt best described the issues they faced.  Patient opinions were also 
sought about the tools’ feasibility and acceptability, taking into account issues such as 
time to complete, relevance of the questions asked, ease of completion and so on.  
 
Reponses were recorded in note form, then transcribed and later analysed using 
simple thematic analysis.  
 
5.5.3. Results 
 
Face validity for MDADI and UW QOL v4 was good and content validity appeared 
adequate.  While all 10 participants in this pre survey indicated that no scale covered 
the entire range of difficulties encountered in living life as a laryngectomy, 70% 
thought the MDADI and UW QOL v4 scales reflected their needs more closely than 
the SWAL-QOL and expressed a preference for using these tests.  However, subjects 
indicated that some characteristics of their swallow were missing on the MDADI such 
as included food getting stuck, food being regurgitated, the difficulties encountered 
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when trying to eat and talk at the same time and the difficulties encountered when the 
voice prosthesis leaks during meals.  100% of subjects surveyed thought that the UW 
QL scale v4 was appropriate for their needs and indicated that they thought it was 
important to have a survey that focused on the impact of their disease on their 
everyday life as well as on their swallowing.  However, on the UW – QOL v4, 
subjects also commented that there were no questions about their ability to smell, 
appearance in relation to having a neck stoma and ability to cope with mucus 
production.  However, the MDADI and UW QOL v4 were identified as covering the 
essential elements between them.  80% of patients expressed a preference for the 
MDADI tool over the SWAL-QOL as they thought it better reflected their 
impairments and concerns about swallowing.  70% also indicated that they preferred 
the MDADI because it was shorter and took less time to complete than the SWAL-
QOL.  100% of subjects surveyed indicated that completing two quality of life scales 
as part of a research project was acceptable and would not cause undue burden.  
 
Patient involvement was crucial in substantiating the use of both quality of life scales 
chosen for this research study.  As the MDADI scale focuses on quality of life 
impairments related to swallowing difficulty, there was a need to use a scale that 
reflected other parts of quality of life including emotional, physical and functional 
aspects.  The UW QOL v4 examines areas of functioning other than swallowing.  The 
burden of completing 2 quality of life scales could potentially be significant for 
subjects in this study so it was important for patient input to confirm that the use of 
both the MDADI and the UW QOLv4 scales was acceptable. 
 
The two chosen QOL measures are included in the appendix. 
 
5.5.4. Discussion 
 
Subjects chose the MDADI and the UW QOL v4 as most appropriate for reflecting 
their needs.  However, subjects indicated clearly that neither tool met all of their 
needs.  Subjects indicated that they experienced specific problems with swallowing 
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and that these were not included on the MDADI.  Symptoms mentioned included 
“food getting stuck”.  While there is limited literature describing specific symptoms 
of swallowing post laryngectomy, the experience of food getting stuck is consistent 
with a symptom of dysphagia post laryngectomy identified by both clinicians and 
patients during the development of the SOAL, a laryngectomy specific questionnaire 
to investigate swallow function (Govender et al., 2012).  Subjects also mentioned that 
regurgitation was a swallowing difficulty they encountered and which was not 
included on the MDADI.  Regurgitation is described in a previous seminal study 
(Ward et al., 2002) as an early symptom of dysphagia observed amongst 
pharyngolaryngectomy subjects.  All of the subjects participating in this pre 
recruitment survey had undergone total laryngectomy.  It is possible that nasal 
regurgitation is a symptom encountered by all post laryngectomy patients and not just 
those who have undergone extended surgery.  Difficulty with eating and talking at the 
same time has not been identified in the literature as a symptom of dysphagia after 
laryngectomy.  However, anecdotally, it is a symptom that patients frequently 
mention within the clinical setting.  Patients have reported that this symptom can limit 
social activities.  Voice prosthesis leakage is well documented (Lewin et al., 2012, 
Starmer et al., 2011, Starmer et al., 2009, Wierzchowska and Burduk, 2011) in the 
literature as a complication of surgical voice restoration.  This is a specific issue that 
laryngectomy patients with voice prostheses may encounter.  A leaking voice 
prosthesis may cause aspiration of liquid into the trachea.  Should a laryngectomy 
specific dysphagia quality of life questionnaire be developed, the inclusion of a 
question regarding voice prosthesis leakage may be of benefit. 
On the UW-QOLv4, subjects highlighted the lack of inclusion of questions related to 
loss of ability to smell and quality of life.  Changes in smell post laryngectomy and 
attempts to rehabilitate this sense have been described in the literature (Hilgers et al., 
2000, Risberg-Berlin et al., 2006).  Presence of a neck stoma has been described as 
having impact on respiration and mucous production (Hilgers et al., 1991, Hilgers et 
al., 2003b) and is usually rehabilitated with the use of a Humidification Exchange 
System that is placed on the stoma (Brook et al., 2013, Scheenstra et al., 2011).  
However, there is less literature on the effect of a stoma on body image and the effect 
of mucous production on quality of life.   
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5.5.5. Conclusions 
 
While neither the MDADI nor the UW QOLv4 scales include all of the specific issues 
that laryngectomy patients experience, there is agreement in the literature with using 
these tools with the post laryngectomy population.  Both tools have been used in other 
studies with laryngectomy patients (Kazi et al., 2006b), (Robertson et al., 2011), 
(Vilaseca et al., 2006).  In the absence of availability of laryngectomy specific quality 
of life scales, the MDADI and UW-QOLv4 appear to be the most appropriate of the 
current tools available for use with this population. 
 
 
5.6. Quality of life after laryngectomy 
 
This section describes the study examining swallow and quality of life outcomes after 
laryngectomy. 
 
5.6.1. Aim 
 
This prospective study aimed to investigate the effect of laryngectomy on swallow 
and quality of life outcomes after laryngectomy. 
 
5.6.2. Objectives: 
 
 To establish oral intake level for each subject using the Functional Oral Intake 
Scale (FOIS). 
 To establish level of self-reported dysphagia amongst subjects 
 To analyse quality of life outcomes using the MDADI and UOW QOLv4 
questionnaires in post laryngectomy patients. 
 To investigate the existence of correlations between MDADI and UOW QOLv4 
subscale scores and age and time since surgery. 
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 To determine if there is a difference between groups on variables (including 
gender, myotomy, surgical closure technique, salvage surgery, radiotherapy, 
chemotherapy and self-report of dysphagia) for MDADI and UOW QOLv4 
scores. 
 
5.6.3 Hypotheses  
1.There is a linear association between age and MDADI and UOW QOLv4 
subscale scores. 
2.There is a correlation between time since surgery and MDADI and UOW 
QOLv4 subscale scores 
3.There are no differences in score distribution for gender on MDADI and UOW 
QOLv4 tools. 
4.There are no differences in score distributions for myotomy history on the 
MDADI and UOW QOL v4 tools. 
5.There are no differences in score distribution for surgical closure technique on 
the MDADI and UOW QOLv4 tools. 
6.There are no differences in score distribution for salvage surgery on the MDADI 
and UOW QOL v4 tools. 
7.There are no differences in score distribution for history of radiotherapy on the 
MDADI and UOW QOLv4 tools. 
8.There are no differences in score distribution for chemotherapy history on the 
MDADI and UOW QOL v4 tools. 
 9. There are no differences in score distribution for presence or absence of self-
reported swallowing difficulty on the MDADI and UOW QOL v4 tools. 
5.6.4. Methods 
 
Subjects were recruited from Speech and Language Therapy outpatient clinics at 
Imperial College Healthcare NHS Trust, and were invited to complete the MD 
Anderson Dysphagia Inventory (MDADI) and the University of Washington Quality 
of Life Scale v4 (UOW QOLv4). . 
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5.6.4.1 Inclusion criteria 
 
Women and men who had undergone either total laryngectomy or extended 
laryngectomy, and who had undergone surgical voice restoration with a voice 
prosthesis in situ.  
 
5.6.4.2. Exclusion Criteria 
 
Subjects without voice prostheses, documented cognitive dysfunction, less than 3 
months post-surgery or completion of postoperative radiation treatment or 
chemotherapy or unable to easily tolerate placement of flexible nasendoscope. 
 
5.5.5. Process 
 
Following agreement to participate in this study, the MDADI and UW QOL v4 scales 
were posted to prospective subjects 2 weeks before they attended their research study 
appointment.  Subjects were given the option to either complete the questionnaires 
before they attended, or alternatively to complete it with the investigator’s assistance 
prior to undergoing investigation.  The latter option was offered to allow subjects with 
reading and writing difficulties an opportunity to have questions read out loud by the 
investigator.  This also allowed subjects with questions about either the MDADI or 
UW QOLv4 scale the opportunity to have queries answered by the investigator.  
During attendance at their research appointment, subjects were also asked whether 
they experienced difficulty with swallowing and were asked to describe their diet 
level.  Responses to these questions were recorded.  
 
5.5.6. Demographic data 
 
The investigator designed a questionnaire to collect detailed personal demographics 
(age, gender, marital status), surgical demographics (date of surgery, surgeon, type of 
laryngectomy surgery, whether myotomy had been performed, type of neck 
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dissection, interventions such as Botox, dilation etc.), hospital, and any adjuvant 
therapies such as radiotherapy, through interviewing subjects.  Information gathered 
from subjects was supplemented with information from Medical and Speech and 
Language Therapy notes. 
 
 
5.6.7. Outcome measures 
5.6.7.1. Presence of dysphagia 
 
Subjects were asked to indicate dysphagia through the use of self-report.  Maclean et 
al (Maclean et al., 2009b) advocated the use of dysphagia self-report with 
laryngectomy patients and suggested that the definition of dysphagia should 
encompass any change in the ability to swallow and /or the need to change the texture 
of diet post-surgery.  Subjects were asked whether they had noted any change in their 
ability to swallow and/or the need to change the texture of their diet following 
laryngectomy surgery.  Binary responses (yes/no) to this question were recorded. 
 
5.6.7.2. Assessment of diet level using Functional Oral Intake Scale (FOIS) 
 
The Functional Oral Intake Scale (FOIS) is a validated 7 item scale which allows the 
description of the functional level of a patient’s actual daily oral intake of food and 
liquid (Crary et al., 2005).  The FOIS was initially developed for use with stroke 
patients who experienced dysphagia.  It has been well validated and robust reliability 
has been demonstrated (Crary et al., 2005).  The FOIS has subsequently been used 
with other patient groups including those degenerative neurological disease (Maria et 
al., 2010) and head and neck cancer (Pendley et al., 2010).  The FOIS has not 
previously been used with laryngectomy patients.  There is no standard tool currently 
used to measure oral intake in laryngectomy patients.  The FOIS includes provision 
for modification of either food or liquid and swallow compensations.  Items 1-3 relate 
to varying degrees of non-oral feeding, with items 4-7 relating to varying degrees of 
oral feeding without non oral supplementation.  The latter includes diet modifications 
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and patient compensations while focusing on what the patient consumes by mouth on 
a daily basis.  The FOIS is scored by the clinician who can obtain information from a 
variety of sources including medical charts, dietary journals and verified patient 
reports (Crary et al., 2005).  
 
5.6.7.3. Quality of Life Tools 
 
Subjects were asked to complete two QOL tools; the MD Anderson Dysphagia 
Inventory (MDADI) and the University of Washington Quality of Life scale version 4 
(UW QOL v4).  Details of these tools can be found in Table 5.1 and a copy of each 
tool is available in the appendix. 
 
5.6.7.4. MD Anderson Dysphagia Inventory (MDADI) 
 
The MD Anderson Dysphagia Inventory is a self-administered swallow outcome 
questionnaire developed for use with head and neck cancer patients.  It has been 
rigorously validated (Chen et al., 2001). 
The MDADI consists of 20 questions.  For each of these questions, there are 5 
possible responses (strongly agree, agree, no opinion, disagree, and strongly 
disagree).  2 questions; E7 (I do not feel self-conscious when I eat) and F2 (I feel free 
to out and eat with my friends, neighbours) are scored on a scale 1 for strongly 
disagree to 5 for strongly agree.  All other items are scored on a scale of 1 for strongly 
agree to 5 for strongly disagree. 
The first question (My swallowing limits my day to day activities) looks at the level 
of disability experienced because of swallowing difficulty.  This question is a global 
assessment of how swallowing affects an individual’s overall daily routine and 
represents a general overall assessment of swallow related quality of life (Chen et al., 
2001).  This question is scored individually and then multiplied by 20 to obtain a 
global functioning score with a range of 20 (extremely low functioning) to 100 
(normal functioning).  The other 19 questions are categorised into emotional, 
functional and physical subscales.  The emotional subscale question examines the 
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individual’s affective or emotional responses to dysphagia, the functional subscale 
questions assesses the impact of the individual’s swallow on his or her daily life with 
the physical subscale representing self-perception of the swallowing difficulty.  Each 
subscale score is summed, the mean is calculated and multiplied by 20 to obtain a 
subscale score with a range of 20 (extremely low functioning to 100 (normal 
functioning).  The sum total score, the MD Anderson Dysphagia Inventory Total 
Score is calculated by summing each of the 19 questions across each subscale 
(emotional, functional and physical) and calculating an average. 
 
5.6.7.5. The University of Washington Quality of Life scale version 4 (UOW QOL 
v4) 
 
The U0W QOL v4 is a self-administered head and neck cancer specific questionnaire 
that has been well validated for use with head and neck cancer patients.(Rogers et al., 
2002) 
The University of Washington Quality of Life Scale v4 has 4 sections.  Scoring of 
each section is based on discrete ordinal responses.  For scores scaled from 0-100, 0 
represents the worst possible response and 100 the best possible response.  The first 
section contains 12 questions representing the following domains: pain, appearance, 
activity, recreation, swallow, chewing, speech, shoulder function, taste, saliva, mood 
and anxiety.  The domains of pain, appearance, activity and mood have 5 possible 
responses yielding a score of 0-100.  The domains of swallowing, speech, shoulder, 
taste and anxiety have 4 possible responses again yielding a score of 0-100.  Chewing 
is the only domain limited to 3 possible responses yielding a score from 0-100. 
The second section lists the 12 domains outlined in the first section and asks the 
patient which, of up to three, of the domains have been most important over the past 7 
days.  If a domain is chosen as important, this is scored as 1, otherwise it is scored as 
0.  The third section consists of 3 “general (global) questions”.  The first question asks 
the patient to compare current quality of life to that of the month before they 
developed cancer.  This question has 5 possible responses yielding a score from 0-
100.  The second question asks the patient to judge their health related quality of life 
over the past 7 days.  This question has 6 possible responses again yielding a score 
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from 0-100.  The third question asks the patient to rate their overall quality of life 
during the past 7 days by reflecting on everything that contributes to their personal 
well-being.  This question has 6 possible responses and yields a score from 0-100.  
The fourth section gives patients the opportunity to comment about other issues 
(medical or non-medical) that are important to quality of life and have not been 
adequately addressed by the UOW QOL v4  
 
5.6.8. Statistical Analysis 
 
The Statistical Advisory Service at Imperial College London provided a power 
calculation, which determined sample size.  Data was entered and analysed in IBM 
SPSS (Statistical Product and Service Solutions) version 20 (IBM Armonk, New 
York).  Questionnaire responses to MDADI and UOW QOLv4 were reported 
descriptively as medians and ranges as the data was not normally distributed.  As the 
data extracted was not normally distributed, non-parametric statistics were used for 
analysis of correlations.  Spearman’s rho was used to calculate correlations between 
the normally distributed continuous variables of age and the non-normally distributed 
MDADI and UOW QOL v4 scores.  Spearman’s rho was also used to analyse the 
correlation between the non-normally distributed variable of time since surgery and 
the non-normally distributed MDADI and UOW QOL v4 scores.  Between group 
comparisons of the following variables: gender, myotomy, surgical closure technique, 
salvage surgery, radiotherapy, chemotherapy and self-report of dysphagia with non-
normally distributed MDADI and UOW-QOL v4 scores were analysed using the 
Mann-Whitney u test for groups with 2 categories or Kruskal-Wallis tests for groups 
with 3 categories. 
 
5.6.8. Results 
 
50 subjects were recruited to this study.  There was 100% response rate to the QoL 
questionnaires.  30 of these subjects were recruited during part 1 of this PhD study.  
The remaining 20 were those recruited to the part 2 of this PhD study who had not 
participated in part 1 
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5.6.8.1. Demographics 
 
The study sample consisted of 82% male (n=41), 18% female (n=9). These 
percentages were consistent with that of the head and neck cancer population in the 
UK (CancerResearchUK, 2011).  Results for age and time to surgery are shown in 
Table 5.3 and further information on surgical demographics are summarised in Table 
5.4. 
  
Table 5-3: Mean age and time since surgery 
Characteristic Median Mean SD SE Min Max 
Age (months) 793.44 
(66.12 
years) 
801.64 
(66.80 
years) 
105.13 14.86 516 (43 
years) 
1017 
(84.75 
years) 
Time since 
surgery 
(mths) 
82.5 
(6.87 
years) 
101.4 
(8.45 
years) 
82.1 11.61 4 348  
(29 
years) 
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Table 5-4: Demographic information: details of subjects 
data N (%) 
Gender  
Male  
Female 
 
41 (82%) 
9 (18%) 
Ethnicity Black/Black British 5 (10%) 
White 40 (80%) 
Asian or Asian British 1 (2%) 
Other ethnic groups 4 (8%) 
Marital status Single 12 (24%) 
Married/long term partnership 32 (64%) 
Divorced 2 (4%) 
Widowed 3 (6%) 
Separated 1 (2%) 
Surgery Total Laryngectomy 36 (72.%) 
Pectoralis Major Flap 7 (12%) 
Jejunum 4 (8%) 
Jejunum and pectoralis major flap 2 (4%) 
Radial forearm flap 1 (2%) 
Myotomy Yes 34 (68%) 
Myotomy not applicable 12 (24%) 
Unknown 3 (6%) 
Chemical neurectomy 1 (2%) 
Closure Horizontal 33 (67.3%) 
Circumferential 12 (22.4%) 
Unknown 5 (10.2%) 
Neck dissection Bilateral 15 (30.6%) 
Unilateral 9 (18.4%) 
None 19 (36.7%) 
Unknown 7 (14.3%) 
Radiotherapy History Pre-operative XRT 23 (46%) 
Postoperative XRT 20 (40%) 
Pre and postoperative XRT 2 (4%) 
None 5 (10%) 
Chemotherapy History 
 
Pre op chemo 8 (16%) 
Post op chemo 2 (4%) 
No chemo 40 (80%) 
Salvage Yes 26 (52%) 
No 24 (48%) 
TL only 5 (10%) 
Post op XRT only  20(40%) 
XRT/Chemo Pre op XRT/Chemo  26 (52%) 
Post op XRT/Chemo 19 (38%) 
None 5 (10%) 
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5.5.8.2. Self-report of dysphagia 
 
Responses to this question indicated that 22% (n = 11) of the sample said they had no 
difficulty swallowing and 78% (n= 39) stated they had experienced swallow difficulty 
after laryngectomy 
 
5.5.8.3. Functional Oral Intake Scale (FOIS) 
 
The data on diet level is shown in Table 5.5 No subject was dependent on enteral 
feeding but only 22% (n = 11) achieved total oral intake with no restrictions.  
Therefore 78% had some restriction to their oral intake.  This mirrors subjects’ 
responses when asked to state whether they had difficulty swallowing after 
laryngectomy. 
Table 5-5: Summary of Functional Oral Intake Scale results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOIS score FOIS diet level n 
 
1 No oral intake 0 
2 Tube dependent with minimal 
inconsistent oral intake 
0 
3 Tube supplements with 
consistent oral intake 
0 
4 Single consistency oral intake 1 (2%) 
5 Multiple consistency oral 
intake with special preparation 
18 (36%) 
6 Oral intake avoiding specific 
food or liquid items 
20 (40%) 
7 Oral intake with no 
restrictions 
11 (22%) 
316 
 
 
5.5.8.4. Quality of life outcomes: 
 
All scores for the QoL measures were not normally distributed therefore median 
scores are reported. 
5.5.8.4.1 Results of MD Anderson Dysphagia Inventory (MDADI) 
 
Median MDADI scores for the group are reported in Table 5.6 (individual scores for 
each subject on the MDADI is included in the appendix).  
 
Table 5-6: MDADI scores 
 Emotional score Functional Score  Physical Score MDADI Global 
score  
MDADI Total 
score 
Median score 
(min-max) 
73.3 (36.7-100) 76.0 (28.0-100) 68.8 (30.0-100) 80 (20.0-100) 71.0 (33.7-100) 
 
 
 
 
 
Results of the University of Washington Quality of Life v4  
 
Median composite scores for the group are reported in Table 5.7 
 
 
 
Table 5-7: Median composite scores UOW QOL v4 
 
 Composite 
score 
Physical 
Composite 
Score  
Social Emotional 
Composite Score 
Median score 
(min-max) 
82.5 (22.91-
195.41) 
78.91 (31.66-
100 
68.8 (30.0-100) 
 
 
Guidance for both scoring and presentation of UW QOL v4 has been provided by the 
authors of the scale (Lowe and Rogers, 2012).  The presentation of domain scores, 
global questions results and importance question results below is based on this 
guidance.   
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Domain scores  
 
Domain scores are presented in Table 5.8.  For each domain the table gives the 
number of subjects with each score, along with the mean, standard deviation (SD), 
standard error (SE), maximum and minimum for each score.  The shaded area denotes 
values that do not exist.  The final column shows that percentage selecting the best 
possible response (100).  This sample had the lowest percentages of best scores for 
the domains of appearance, activity, recreation and speech, suggesting these domains 
were the most problematic for the group. 
 
 
 
 
 
 
 
 
Table 5-8: Domain scores of UW QOL v4 
 
 
Domains n 0 25 30 50 70 75 100 Mean % 
Best 
score 
(of 
100) 
SE SD Min Max 
Pain 50 0 1  9  3 37 88 74.% 3.05 21.57 25 100 
Appearance 50 1 2  13  22 12 71.04 24% 3.22 22.79 0 100 
Activity 50 2 1  22  14 11 65.5 22% 3.49 24.68 0 100 
Recreation 50 2 2  10  27 9 69.5 18% 3.29 23.3 0 100 
Swallowing 50 0  1  27  22 82.4 44% 2.36 16.72 30 100 
Chewing 50 1   17   32 81 64% 3.74 26.51 0 100 
Speech 50 2  8  29  11 67.4 22% 3.62 25.61 0 100 
Shoulder 50 2  7  8  33 81.4 66% 4.24 30.3 0 100 
Taste 50 2  13  10  25 71.8 50% 4.24 32.86 0 100 
Saliva 50 1  5  15  29 82 58% 3.6 25.47 0 100 
Mood 50 1 3  9  15 22 77 44% 3.63 25.67 0 100 
Anxiety 50 1  4  11  34 85.8 68% 3.46 24.5 0 100 
 
 
 
UOW QOL v4 Global Question 
 
The UOW QOLv4 asks 3 global questions, one how about patients feel relative to 
before they developed cancer, one about their health related quality of life and one 
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about their overall quality of life.  Note one subject did not answer any of these 
questions, as she had not been diagnosed with cancer.  Rather this patient had 
dysphagia secondary to treatment for a subglottic stenosis and had undergone a 
laryngectomy to facilitate swallowing and prevent chronic aspiration.  Results of the 
global question are presented in Table 5.9.  The table gives the number of subjects 
with each score, along with the mean, standard deviation (SD) and standard error (SE) 
and minimum and maximum for each score.  The shaded areas denote values that do 
not exist.  The percentage selecting the best responses (top 3 responses for each 
question) is presented in the final column. 
 
 
Table 5-9: Global questions scores – UW QOL v4 
 
Question N 0 20 25 40 50 60 75 80 100 Mean % Best 
scores* 
SE SD Min Max 
A. Health 
related 
QOL 
compared 
to month 
before 
you 
developed 
cancer 
49 4  9  12  12  12 59.69 73.4% 4.54 31.79 0 100 
B.Health 
related 
QOL 
during 
past 7 
days 
49 1 3  7  17  19 2 62.5 77.5% 3.03 21.21 0 100 
C. 
Overall 
QOL 
during 
past 7 
days 
49 1 2  5  18  18 5 66.53 83.6% 3.05 21.36 0 100 
 
Key to ratings: 
A: (0) Much worse (25) Somewhat worse (50) About the same (75) Somewhat better (100) Much 
better 
B: (0) Very poor (20) Poor (40) Fair (60) Good (100) Outstanding 
C: (0) Very poor (20) Poor (40) Fair (60) Good (100) Outstanding 
* Best scores: Q.A % scoring 50, 75 or 100 Q.B & Q.C % scoring 60, 80 or 100 
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UOW QOL V4 Importance question 
 
This question asks which 3 domain issues were the most important during the past 7 
days.  Results are presented as numbers and percentages of patients choosing each 
domain and are ranked in order.  The 3 most important domains were speech, swallow 
and activity respectively, see Table 5.10. 
 
 
 
 
 
 
 
Table 5-10: Importance question scores UW QOLv4 
 
UW-QOL N pts choosing the 
domain 
% pts choosing the 
domain 
Rank order 
Speech 19 38% 1 
Swallow 15 30% 2 
Activity 11 22% 3 
Pain 10 20% 4 
Taste 8 16% 5 
Shoulder 7 14% 6 
Mood 7 14% 7 
Saliva 5 10% 8 
Recreation 4 8% 9 
Chewing 3 6% 10 
Anxiety 2 4% 11 
Appearance 3 6% 12 
 
 
“Significant” problem results using domains from UW QOLv4 
 
UW QOL v4 responses have been compared to 12 other more in-depth questionnaires 
(Armstrong et al., 2001), and  clinically relevant UW-QOL cut off criteria were 
derived.  An algorithm was suggested to trigger cut offs that define a significant 
problem on each quality of life domain (Lowe and Rogers, 2012).  See appendix for 
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details of algorithm.  This algorithm was applied to the cohort in this study and the 
results are summarized in the table below.  The most significant problems that 
emerged for the sample in this study using the algorithm were activity, speech and 
taste, see Table 5.11. 
 
 
Table 5-11: Significant problem percentage scores – UW QOL v4 
 
UW-QOL n n domain n importance n with 
significant 
problem 
% with 
significant 
problem 
Pain 50 10 10 20 40% 
Appearance 50 16 2 17 34% 
Activity 50 25 11 36 72% 
Recreation 50 13 4 17 34% 
Swallowing 50 1 14 15 30% 
Chewing 50 1 3 4 8% 
Speech 50 10 18 28 56% 
Shoulder 50 9 7 16 32% 
Taste 50 15 8 23 46% 
Saliva 50 6 5 11 22% 
Mood  50 13 7 20 40% 
Anxiety 50 5 2 7 14% 
 
 
Other issues important to quality of life  
 
The final question in the UW QOL v4 invites the patient to describe any other issues 
(medical or non-medical) that are important to their quality of life which have not 
been adequately addressed by the questions within the UW QOL scale.  44% of 
subjects responded to this question and indicated a broad range of quality of life 
subjects not covered adequately by the UW QOL v4 scale.  A simple thematic 
analysis of responses was undertaken.  Responses fell into 6 categories: 
communication, social, physical, swallowing, stoma and other.  Details of the 
responses in each category are shown below. 
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Communication 
 Can’t shout. 
 It bothers me when people turn around to take a look when I talk 
 I speak now very different to how I used to speak 
 Worried about effect on wife, she phones from work each day and I knock to 
answer yes because I have difficulty speaking. 
 Speech is not consistent, keeps coming and going. 
 I have difficulty getting used to the change in talking and the effort involved 
 My only concern is speech question where the options for response are too 
wide.   
 I can’t be understood on the phone 
 Quality of voicing, other people’s reactions.   
 Not being able to use the phone is one thing which has a major adverse impact 
on my life 
 I can’t be understood on the phone 
 I can’t talk to my parents on the phone, as they can’t understand me.  I can’t 
ring up the bank about my credit card, which doesn’t work anymore.  I can’t 
talk to the BT engineer/call centre when my Internet goes down.  I am isolated 
now from people that I don’t see face to face  
 Communication in noisy environments and with a group of people talking is 
difficult and also difficult with people who are hard of hearing.   
 Leakage of prosthesis makes me suicidal.   
 Anxiety about personal safety when out alone, not being able to shout if 
involved in an argument 
 I sound like a man 
 
Social 
 I’ve lost so many friends because of this. 
 People feel embarrassed for me. 
 My life is better than I expected it to be 
 Used to play soccer, now I have had to take up bowls 
 I lose my temper much more easily and I get frustrated and tired. 
 Pressure on family, because you’re sick, they keep wondering if you’re ok.   
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 After operation, I am looking to my life much more tolerated, optimistic and 
positive.  I keep myself in high morale.  I do not let anything make me upset 
or disappointed. 
 I wouldn’t go to a concert, afraid of coughing 
 So many things are out of my reach now and I have to ask others for help.   
This causes me acute depressive feelings, more so than the loss of other 
facilities like swimming, singing or reading aloud to my grandson.  I would 
love to go back to work but I can’t  
 I mostly sit at home, reading books, writing diary, watching TV 
 Laughing sounds strange 
 
Physical 
 Swimming, I can’t do this anymore.  I get teased about not being able to swim 
 I liked to garden and I can’t garden, I have to watch another person gardening 
and doing it all wrong 
 Can’t laugh, can’t run around with grandkids, can’t take grandkids swimming 
 Swimming 
 Sense of smell has disappeared; this is difficult because of cooking.  
 Running is difficult 
 Lying flat in bed is difficult 
 Bad hips, nothing I can think of 
 Secretions, managing mucous 
 Issues with hips, mucous, breathing, cramps and back pain 
 Dealing with mucous is difficult 
 Problem can be too much saliva rather than not enough 
 
Swallow 
 Reflux, getting sick. 
 Lack of teeth 
 Have to have spicy food, bland is no good 
 I have more saliva than usual not less. 
 Family worry if in case I’m choking.  
 Issues with swallowing 
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Stoma 
 By and large, I can do most of the things I wish to do viz gardening, walking 
in the countryside, eating out with friends and pursuit of personal hobbies.  I 
dress normally with collar and tie, as is my wont.   
 There are issues of visual perception by other people when open necked. 
 The only things I can’t do are swim and have my neckwear open.   
 Neck more sensitive, I have sensation of being stung my nettles, no smell 
 Issues with mucous not addressed 
 
Other  
 This questionnaire excludes age, some of the falloff in activity and recreation 
is due to the aging process.   
 Questions concerning cancer are not relevant in my case. 
 This questionnaire is not meaningful to me, as I did not have cancer. 
 
Correlations 
 
Correlations were examined between various subscale scores of both the MDADI and 
UOW QOLv4 scales to explore whether a relationship exists between both tools.   
The results of these analyses are presented below.   
 
Hypothesis 1 
There is a linear association between age and MDADI and UW QOL v4 subscale 
scores. This relationship was explored to investigate whether quality of life 
scores improve with age  
 
Correlations between MDADI and UOW QOL v4 subscale scores and age 
Spearman correlation coefficients were used to assess the existence of linear 
associations between age of subjects and components of MD Anderson Dysphagia 
Inventory and University of Washington Quality of Life scale v4.  The components of 
the MD Anderson Dysphagia Inventory examined were: i) the MD Anderson 
Dysphagia Inventory Total Score, ii) MD Anderson Global score The components of 
324 
 
the University of Washington Quality of Life scale v4 examined were: i) University 
of Washington Quality of Life Scale v4 Composite Score, ii) University of 
Washington Quality of Life Scale v4 Physical composite score, iii) University of 
Washington Quality of Life Scale v4 Social Emotional composite score, see Table 
5.12). 
 
 
Table 5-12: Linear associations between age and subscales of the MD 
Anderson Dysphagia Inventory and the University of Washington Quality of 
Life v4 scale  
*indicates statistically significant result p < 0.05. 
 Age 
 rho P 
MDADI Total score 0.256 >0.0005 
MDADI Global score 0.114 >0.0005 
MDADI Emotional 
score 0.293 >0.0005 
MDADI Functional 
score 0.312 <0.0005* 
MDADI Physical score 0.306 <0.0005* 
UOW composite score  0.229 <0.0005* 
UOW Physical 
composite 0.247 >0.0005 
UOW Social Emotional 
composite 0.141 >0.0005 
 
 
A linear association was noted between age and i) MD Anderson Dysphagia 
Inventory Emotional score, ii) MD Anderson Dysphagia Inventory Functional score 
and iii) UOW QOL composite score (see Table 5.12). 
 
Hypothesis 2 
There is a correlation between time since surgery and MDADI and UOW 
QOLv4 scores. 
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This was explored to investigate whether quality of life scores improve as time since 
surgery increases.  There is some evidence (List et al., 1996) to support patients 
developing adaption and coping strategies as time elapses after surgery.   
Correlations between MDADI and UOW QOLv4 subscale scores and time since 
surgery 
Spearman correlation coefficients were used to assess the existence of linear 
associations between time since surgery and components of MD Anderson Dysphagia 
Inventory and University of Washington Quality of Life scale v4.  The components of 
the MD Anderson Dysphagia Inventory examined were: i) the MD Anderson 
Dysphagia Inventory Total Score, ii) MD Anderson Global score iii) MD Anderson 
Dysphagia Inventory Emotional score, iv) MD Anderson Dysphagia Inventory 
Functional score, v) The MD Anderson Dysphagia Inventory Physical score.  The 
components of the University of Washington Quality of Life scale v4 examined were: 
i) University of Washington Quality of Life Scale v4 Composite Score, ii) University 
of Washington Quality of Life Scale v4 Physical composite score, iii) University of 
Washington Quality of Life Scale v4 Social Emotional composite score, iv) (see 
Table 5.13 . 
 
Table 5-13: Linear associations between time since surgery and subscales of 
the MD Anderson Dysphagia Inventory and the University of Washington 
Quality of Life v4 scale.  
* indicates statistical significance p < 0.05 
 Time since surgery  
 rho P 
MDADI Total score 0.355 <0.0005* 
MDADI global score 0.404 <0.0001* 
MDADI Emotional 
score 0.449 <0.0001* 
MDADI Functional 
score  0.397 <0.0001* 
MDADI Physical score 0.376 <0.0001* 
UOW composite score  0.321 <0.0005* 
UOW Physical 
composite 0.460 <0.0001* 
UOW Social Emotional 
composite 0.42 >0.0005 
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A positive linear association was noticed between time since surgery and i) MD 
Anderson Dysphagia Inventory total score ii) MD Anderson Dysphagia Inventory 
global score iii) MD Anderson Emotional Score, iv) MD Anderson Functional score, 
v) MD Anderson Physical score, vi) University of Washington Quality of Life Scale 
v4 Composite Score, vii) University of Washington Quality of Life Scale v4 Physical 
composite score, viii), University of Washington Quality of Life Scale v4 Swallow 
domain score, ix) University of Washington Quality of Life Scale v4 chewing domain 
score, x) University of Washington Quality of Life Scale v4 Taste domain score (see 
Table 5.13). 
 
Differences between groups 
The following variables were examined for differences between groups for scores on 
the MDADI and UOW QOLv4: gender, myotomy, surgical closure technique, salvage 
surgery, radiotherapy, chemotherapy and self-report of dysphagia.  Statistical analysis 
involved splitting the data file into the variable of interest so that groups within each 
variable could be compared.  As data was not normally distributed, descriptive 
statistics of median, 1
st
 and 3
rd
 quartile for each variable were extracted.  The median 
value represents the score that 50% of subjects received less than, the 1
st
 quartile 
represents the score that 25% of subjects received less than and the 3
rd
 quartile 
represents the score that 75% of subjects received less than.  As the continuous data 
from the MDADI and UOW QOL v4 scores were not normally distributed, each 
grouping variable was then analysed using the non-parametric tests, mann whitney u 
test for groups with 2 categories and kruskal wallis h test for groups of 3 categories. 
 
Hypothesis 3 
There are no differences in score distribution for gender on MDADI and UOW 
QOLv4 tools. 
 
This hypothesis was explored to investigate whether there is a gender difference in 
quality of life scores.  There has been limited research in this area.  However, it has 
been suggested by a previous study (Lee et al., 2010) that quality of life scores are 
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worse for females than for males.  Females may experience more limitations to their 
quality of life.  The voice quality of female patients with a tracheosophageal voice 
prosthesis tends to be low in pitch because the vocal folds have been replaced as a 
vibratory segment by the pharyngoesophageal segment.  The voice produced by the 
pharyngoesophageal segment more closely approximates a male rather than a female 
voice.  Anecdotally female patients have reported distress at being mistaken for a 
male when they use the telephone.  In addition, female laryngectomy patients may 
struggle more with the cosmesis issues that arise as a result of having a tracheostoma 
Gender 
Differences between scores for gender did not reach statistical significance.  
Therefore the null hypothesis was accepted.  However, males tended to have higher 
scores regarding MDADI total score, Global score, Emotional score, Functional Score 
and Physical score, as compared to females (Table 3).  In particular, 50% of males 
have MDADI total score less than 72.3 (range 52.63 to 74.20) vs. a MDADI total 
score of 60 (range 52.63 to 74.20) or less for 50% of females.  Also, 50% of males 
have a MDADI physical score less than 70 (range 52.5 to 80) vs. a MDADI physical 
score of less than 57.5 (range 50 to 75) for 50% of females, see Table 5.14 
 
Table 5-14: Differences in scores distribution between males and females.  
Results presented as median (IQR). 
Median (IQR). Males  
(Median, (1st, 3rd quartile) 
Females 
(Median, (1st, 3rd quartile) 
P 
MDADI total score 72.63 (62.1, 77.89) 60 (52.63, 74.20) 0.168 
MDADI global 
score 
80 (40, 100) 40 (40, 70) 0.091 
MDADI emotional 
score 
76.6 (66.6, 80) 56.66 (48.33,73.33) 0.045 
MDADI functional 
score  
76 (66, 82) 64 (54,80) 0.176 
MDADI physical 
score 
70 (52.5, 80) 57.5 (50, 75) 0.283 
UOW Composite 
score 
985 (837,1070) 935 (655-1002.5) 0.138 
UOW Physical 
Composite  
83.3 (66.2, 90.83) 73.33 (65.41, 82.49) 0.230 
UOW Social 
emotional 
composite 
82.5 (70.41-91.66) 82.5 (50.41, 91.66) 0.585 
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Hypothesis 4.  
There are no differences in score distributions for myotomy history on the 
MDADI and UOW QOLv4 tools. 
 
Myotomy is a surgical procedure undertaken during initial laryngectomy, which 
facilitates optimum communication and swallowing rehabilitation.  The importance of 
including the procedure of myotomy during laryngectomy was explained in chapter 1.  
This hypothesis was investigated to ascertain whether those who had undergone 
myotomy had a difference in quality of life scores when compared with those without 
a myotomy.  
Differences between scores did not reach statistical significance for history of 
myotomy; therefore the null hypothesis is accepted.  However, scores were higher for 
those subjects who had undergone myotomy on 2 components on the MDADI (Global 
and Physical score) and 2 on the UOW QOL (Composite and Physical composite).  
50% of those who had undergone a myotomy had a MDADI global score of 80 or less 
(range 40 to 100) vs. 50% of those without a myotomy had a MDADI global score of 
50 or less (range 40 to 80). 50% of those who had undergone a myotomy had a 
MDADI physical score of 72.5 or less (range 47.5 to 80) vs. 50% of those without a 
myotomy had a MDADI physical score of 61.25 or less (range 56.25 to 69.37).  50% 
of those who had undergone a myotomy had a UOW composite score of 960 or less 
(range 820 to1070) vs. 50% of those without a myotomy had a UOW composite score 
of 922 or less (range 816.75 to 1031.25) for those without a myotomy.  50% of those 
who had undergone a myotomy had a UOW physical composite score of 81.66 or less 
(range 66.83 to 90.83) vs. 50% of those without a myotomy had a composite score of 
70 or less (range 65 to 83.95 see Table 5.15  
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Table 5-15: Differences in scores distribution according to myotomy history 
(Yes, No, unknown). Results presented as median (IQR). 
 Myotomy  
 Yes  
(Median, (1st, 3rd 
quartile) 
No 
(Median, (1st, 3rd 
quartile) 
Unknown 
(Median, (1st, 3rd 
quartile) 
P 
MDADI total score 72.63 
(54.73,78.94) 
69.47 (58.68, 
73.41) 
71.57 
(63.15),  
0.791 
MDADI global score 80  (40,100) 50 (40,80) 80 (80,800) 0.263 
MDADI emotional 
score 
73.33 (53.33-
80) 
73.31 
(54.99,76.64) 
73.3 (73.33 
at 25
th
 
percentile) 
0.586 
MDADI functional 
score  
76 (60-84) 74 (66,80) 80 (72 at 25
th
 
percentile) 
0.461 
MDADI physical 
score 
72.5 
(47.5,80) 
61.25 (56.25, 
69.37) 
70 (65 at 25
th
 
percentile) 
0.642 
UOW Composite 
score 
960 (820-
1070) 
922 (816.75 
1031.25) 
1045 (1035) 0.297 
UOW Physical 
Composite  
81.66 (66.83, 
90.83) 
70 (65, 83.95) 90.83 (72.5 
at 25
th
 
percentile) 
0.208 
UOW Social 
emotional composite 
79.16 (70, 
91.66) 
81.24 (57.7, 
91.66) 
83.33 (83.33 
at 25
th
 
percentile) 
0.583 
 
 
Hypothesis 5 
There are no differences in score distribution for surgical closure technique on 
the MDADI and UOW QOLv4 tools. 
Surgical Closure Technique 
Closure techniques after surgery broadly reflect the type of surgery undergone by 
patients.  In this study, subjects with extended laryngectomy surgery are more likely 
to have a circumferential closure, while most of those who have had removal of the 
larynx only had a horizontal closure.  Different types of extended surgery techniques 
have been discussed in detail in chapter 1.  Patients with extended surgery tend to 
have more complex rehabilitation needs and more difficulty achieving a functional 
tracheosophageal voice and swallow.  This hypothesis was investigated to ascertain 
whether those with circumferential closure and extended surgery have different 
quality of life scores than subjects with horizontal closure and standard total 
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laryngectomy surgery.  Differences between scores did not reach statistical 
significance for closure technique; therefore the null hypothesis is accepted.  
However, those subjects who had undergone extensive surgery with circumferential 
closure tended to have lower scores than those who had undergone removal of the 
larynx only with horizontal closure.  In particular, 50% of those with a circumferential 
closure had a MDADI global score of 50 (range 40 to 80) or less vs. 50% of those 
with a horizontal closure had a MDADI global score of 80 or less (range 40-100).  It 
is also notable that 50% or less of those with a circumferential closure had a UOW 
Physical composite score of 73.33 (range 65.62 - 93.08) or less vs. 50% of those with 
a horizontal closure had a UOW physical composite score of 81.66 or less  (range 
66.24 - 90.41) for those with a horizontal closure, see Table 5.16. 
 
Table 5-16: Differences in scores distribution according to surgical closure 
technique (Horizontal, Circumferential, Unknown). Results presented as 
median (IQR). 
 Closure technique  
 
Horizontal 
(Median, (1st, 3rd 
quartile) 
Circumferential 
(Median, (1st, 3rd 
quartile) 
Unknown 
(Median, (1st, 3rd 
quartile) 
P 
MDADI total score 
72.63 (57.36, 
78.67) 
69.47 
(58.68,73.41) 
71.57 (50.52, 
88.94) 
0.792 
MDADI global score 80 (40,100) 50 (40,80) 80 (60, 90)  0.268 
MDADI emotional 
score 
73.33 
(54.99,80) 
73.31 (54.99-
76.64) 
73.33 (61.66- 
98.3) 
0.596 
MDADI functional 
score  
76 (62-84) 74(66, 80) 80 (50-100) 0.587 
MDADI physical 
score 
72.5 (48.75-
78.75) 
61.25 (56.25-
69.37) 
70 (52.5-90) 0.665 
UOW Composite 
score 
960 (825-
1067.5) 
922.5 (818.75, 
1031.25) 
1045 (880-
1097.5) 
0.367 
UOW Physical 
Composite  
81.66 (66.24, 
90.41) 
73.33 (65.62, 
83.95) 
90.83 (60.83, 
93.08) 
0.332 
UOW Social 
emotional composite 
79.16 (68.33, 
89.58) 
81.24 (57.7, 
91.66) 
83.33 (77.49, 
95.41) 
0.524 
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Hypothesis 6. 
There are no differences in score distribution for salvage surgery on the MDADI 
and UOW QOL v4 tools. 
 
Salvage Surgery 
Where possible, organ preservation is pursued as the first treatment option and as an 
alternative to laryngectomy surgery for advanced laryngeal cancer.  Organ 
preservation has been discussed in detail in chapter 1 and in recent years, usually 
involves concomitant radiotherapy and chemotherapy.  However, should patients 
experience recurrence after chemo radiotherapy, laryngectomy surgery is often 
recommended.  Surgery can be more complex in the patient with a history of chemo 
radiation and these patients sometimes have more complex rehabilitation needs.  This 
hypothesis was investigated to ascertain whether there was a difference in quality of 
life scores in those who had had a salvage laryngectomy compared to those with 
primary laryngectomy surgery. 
Differences between scores did not reach statistical significance regarding whether 
salvage surgery had been undertaken or not, therefore the null hypothesis was 
accepted.  Those with salvage surgery tended to have lower scores except for the 
UOW composite score.  UOW composite scores were marginally higher for those 
with salvage surgery.  50% of those with salvage surgery had a UOW composite score 
of less than 975 (range 820-1066.25) vs. 50% of those without salvage surgery had a 
UOW composite score of 965 (range (835-1055) or less, see Table 5.17. 
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Table 5-17: Differences in scores distribution according to salvage (no vs. 
yes). Results presented as median (IQR). 
 Salvage  
 
Yes  
(Median, (1st, 3rd quartile) 
No 
(Median, (1st, 3rd quartile) 
P 
MDADI total score 
67.89 (52.63, 
78.14) 
73.13 (64.47, 77.89) 0.431 
MDADI global score 80 (40,100) 80 (40,80) 0.863 
MDADI emotional 
score 
71.65 (52.47, 80) 76.6 (70.82-80) 0.144 
MDADI functional 
score  
72 (59, 80) 80 (65,83) 0.252 
MDADI physical 
score 
67.5 (50, 76.25) 70 (55.62, 79.37) 0.697 
UOW Composite 
score 
975 (820-1066.25) 965 (835-1055) 0.969 
UOW Physical 
Composite  
75.83 (66.24, 88.7) 83.73 (66.66, 90) 0.690 
UOW Social 
emotional composite 
80.83 (62.28, 92.7) 82.91(72.28, 90.62) 0.853 
 
 
 
Hypothesis 7  
There are no differences in score distribution for history of radiotherapy on the 
MDADI and UOW QOLv4 tools. 
 
Radiotherapy 
Radiotherapy before or after laryngectomy surgery can lead to tissue damage, which 
occurs as a consequence of destruction of endothelial cells lining small blood vessels 
in the neck (Glastonbury et al., 2010).  This tissue damage results in ischaemia, 
oedema, inflammation and fibrosis.  Fibrosis has been described as contributing to 
dysphagia in head and neck cancer patients (Pauloski, 2008).  This hypothesis was 
examined to investigate whether there was a difference in quality of life scores in 
those who had a history of radiotherapy.  Differences between scores did not reach 
statistical significance regarding radiotherapy history; therefore the null hypothesis 
was accepted.  However, those subjects who did not have radiotherapy tended to have 
better scores on both MDADI and UOW QOL v4 than subjects with a history of 
radiotherapy.  This was notable on MDADI total score where 50% of those with a 
333 
 
history of radiotherapy had a score of 69.47 or less (range 57.89 to 77.36) vs. 50% of 
those without a history of radiotherapy had a score of 78.94 or less (range 64.18 to 
95,78). On the MDADI global score, 50% of those with a history of radiotherapy had 
a score of 80 or less (range 40, 80) compared to 50% of those without a history of 
radiotherapy who had a score of 100 or less (range 60,100).  In addition, MDADI 
functional score indicated 50% of subjects with radiotherapy had a score of 76 (range 
62, 80) or less, compared to 50% of subjects without a history of radiotherapy who 
had a score of 84 or less (range 72,92).  50% of subjects with a history of radiotherapy 
had a UOW Social Emotional Composite score of 79.16 or less (range 66.03 to 91.66) 
vs.50% of those without a history of radiotherapy had a score of 87.5 or less (range 
78.7 to 97.9), see Table 5.18.   
Table 5-18: Differences in scores distribution according to radiotherapy 
history (Yes, No).  Results presented as median (IQR). 
 Radiotherapy  
 
Yes 
(Median, (1st, 3rd quartile) 
No 
(Median, (1st, 3rd quartile) 
P 
MDADI total score 
69.47 
(57.89,77.36) 
78.94 (64.18, 95.78 0.108 
MDADI global score 80 (40-80) 100 (60-100) 0.132 
MDADI emotional 
score 
73.33 (53.33-80) 80 (64.98-96.66 0.214 
MDADI functional 
score  
76 (62,80) 84 (72,92) 0.115 
MDADI physical 
score 
65 (52.5, 75.25) 77.5 (58.75-92.50) 0.159 
UOW Composite 
score 
960 (815,1050) 1055 (955.1095) 0.140 
UOW Physical 
Composite  
76.66 (65.41, 90) 88.33 (77.9, 89.58) 0.267 
UOW Social 
emotional composite 
79.16 (66.24, 
91.66) 
87.5 (78.74, 97.9) 0.140 
 
 
Hypothesis 8  
There are no differences in score distribution for chemotherapy history on 
MDADI and UOW QOL v4 tools. 
 
 
Sequelae of chemotherapy include mucositis (inflammation and ulceration of mucous 
membranes of digestive tract) (Fury et al., 2012, Ampil et al., 2012) which can make 
swallowing painful.  In addition, patients undergoing chemotherapy may experience 
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taste changes (Ravasco, 2005).  Both mucositis and taste changes can have a negative 
impact of swallowing rehabilitation during and immediately post treatment.  Longer-
term effects of chemotherapy on swallowing function are poorly understood at present 
but it is possible that patients with a history of chemotherapy may have more quality 
of life difficulties than those without a history of chemotherapy.  This hypothesis 
examined whether there is a difference in quality of life scores regarding history of 
chemotherapy.  
Only 18% (n = 18) of the cohort had a history of chemotherapy.  The differences 
between groups for chemotherapy did not reach significance, therefore the null 
hypothesis is accepted.  Scores were higher on all components of the MD Anderson 
Dysphagia Inventory and the University of Washington QOL v4 analysed except for 
UOW Social Emotional composite.  50% of those with chemotherapy had a score of 
78.33 or less (range 64.99 to 95.83) vs. 50% of those who had not had radiotherapy 
had a score of 82.5 or less (70.2 to 91.66), see Table 5.19. 
 
Table 5-19: Differences in scores distribution according to chemotherapy 
history (Yes, No).  Results presented as median (IQR). 
 
 Chemotherapy  
 
Yes 
(Median, (1st, 3rd quartile)) 
No 
(Median, (1st, 3rd quartile)) 
P 
MDADI total score 
72.63 (58.94, 
87.36) 
70.52 (57.89, 77.88) 0.804 
MDADI global score 80 (40, 100) 80(40, 80) 0.411 
MDADI emotional 
score 
76.6 (56.66, 81.63) 73.33 (54.99, 80) 0.980 
MDADI functional 
score  
76 (56, 94) 76 (64, 80) 0.921 
MDADI physical 
score 
70 (53.75-85) 65(52.5, 76.5) 0.568 
UOW Composite 
score 
985(762.5, 1112.5) 965 (832.5, 1055) 0.728 
UOW Physical 
Composite  
83.33 (65.83, 
89.16) 
77.5 (66.66, 90) 0.747 
UOW Social 
emotional composite 
78.33 (64.99, 
95.83) 
82.5 (70.41, 91.66) 0.901 
 
 
335 
 
Hypothesis 9  
There are no differences in score distribution for presence or absence of self-
reported swallowing difficulty on MDADI and UOW QOLv4 tools  
 
Self-report of dysphagia 
Laryngectomy patients who self-report dysphagia may experience the necessity to 
modify their diet (Ward et al., 2002) or may avoid eating in restaurants or other social 
situations (Maclean et al., 2009d).  It is possible that quality of life scores are lower in 
patients who self-report dysphagia as a result of changes to eating habits.  This 
hypothesis examines whether there is a difference in QOL scores in those subjects 
whom self-report a presence or absence of dysphagia.  
Differences in scores reached statistical significance on the UOW Composite, the 
UOW Physical Composite and the UOW Social Emotional Composite scores; 
therefore the null hypothesis is rejected.  The UOW Composite yielded a score of 935 
(range 800, 1040) or less for 50% of subjects with dysphagia vs. a score of 1070 or 
less (range 1035, 1120) for 50% of those subjects without dysphagia.  The UOW 
Physical Composite indicated a score of 75 or less (range 63.33, 86) for 50% of 
subjects with dysphagia vs. a score of 88.33 or less (range 83.30, 90.83) for subjects 
without dysphagia.  On the UOW Social Emotional Composite, 50% of subjects with 
dysphagia scored 79.16 or less (range 63.33, 87.5) vs. 50% of subjects without 
dysphagia scored 95 or less (range 85.33, 100).  While differences between other 
MDADI and UOW QOL scores based on presence or absence of self-report of 
dysphagia did not reach statistical significance, scores were generally lower when 
subjects self-reported dysphagia, see Table 5.19. 
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Table 5-20: Differences in scores distribution according to self-report of 
dysphagia (Yes, No). Results presented as median (IQR). 
 * indicates statistical significance p < 0.05 
 Reports dysphagia  
 
Yes 
Median, (1st, 3rd quartile) 
No 
Median, (1st, 3rd quartile) 
P 
MDADI total score 
69.47 (54.73, 
77.89 
73.64 (71.57, 78.94) 0.137 
MDADI global score 60 (40, 80) 80(80, 100) 0.155 
MDADI emotional 
score 
73.33 (53.3, 80) 73.33 (70, 80) 0.481 
MDADI functional 
score  
72 (60, 80) 80 (76, 84) 0.143 
MDADI physical 
score 
65 (50, 75) 72 (67.5, 80) 0.098 
UOW Composite 
score 
935 (800, 1040) 1070 (1035, 1120) 0.001* 
UOW Physical 
Composite  
75 (63.33, 86) 88.33 (83.30, 90.83) 0.011* 
UOW Social 
emotional composite 
79.16 (63.33, 87.5) 95 (85.33, 100 0.002* 
 
 
5.7 Discussion 
The first objective of this study was to establish oral intake level of subjects using the 
FOIS.  While 22% of subjects were on a normal diet, 78% had limitations to their 
intake of food and liquid.  While no subject was dependent on enteral tube feeding 
and only one subject was limited to oral intake of a single consistency, 40% had to 
avoid specific food or liquids and 36% could tolerate multiple consistencies of oral 
intake but required these to be specially prepared.  These findings confirm that 
dysphagia is an issue for laryngectomy patients. 
 
5.7.1 Self report of dysphagia and FOIS 
 
A further objective of this study was to establish the level of self-reported dysphagia 
based on a definition of any change in the ability to swallow and /or the need to 
change the texture of diet post-surgery (Maclean et al., 2009d).  78% of subjects on 
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this study self-reported dysphagia using this definition.  78% of subjects were also 
judged to have limitations to their intake of food and liquid as demonstrated on the 
FOIS.  There was perfect agreement between the subjects’ self-reporting dysphagia 
and those subjects who were judged to have limitations to their food and liquid intake 
on the FOIS.  The incidence of dysphagia in this study is therefore 78%.  This is 
similar to the 72% incidence reported in a larger previous study (Maclean et al., 
2009d) , which also employed the technique of patient self-reporting.  There is some 
discrepancy in the literature regarding the incidence of dysphagia post laryngectomy.  
The incidence has been reported to be as low as 17% (Balfe, 1990).  This study 
defined dysphagia as material remaining in the pharynx after swallow.  A later study 
(Ward et al., 2002) used the broader definition of dysphagia post laryngectomy as any 
inability to manage a full diet of normal consistencies.  This study found that up to 
42% of laryngectomy patients have long-term dysphagia.  It is possible that patient 
self-reporting provides a more accurate indication of dysphagia incidence.  The FOIS 
has not previously been used to measure post laryngectomy dysphagia.  The finding 
of perfect agreement between the FOIS and subjects self-reporting of dysphagia and 
the positive linear association found between FOIS and scores on the MDADI and 
UOW QOL v4 supports the consideration for further use of the FOIS with this patient 
group. 
The objective of analysing QOL outcomes using the MDADI and UOW QOL v4 was 
achieved.  A comparison of scores observed on the MDADI on this study with other 
studies utilising this tool and involving laryngectomy will initially be discussed.  This 
will be followed by a discussion comparing scores observed on the UOW QOLv4 on 
this study with other studies utilising this tool and involving laryngectomy. 
The current literature provides only a limited body of evidence describing the use of 
the MDADI with laryngectomy patients (Robertson et al., 2011, Kazi et al., 2006b).  
The MDADI results (median total score, median global score, median emotional 
score, median functional score and median physical score reported in this study 
largely reflect those found by a previous study (Robertson et al., 2011) with the 
exception of the global MDADI score which is higher at 80 in this study compared to 
60 in (Robertson et al., 2011).  The findings of this study also reflects lower MDADI 
scores (mean total score, mean global score, mean functional score, mean physical 
score) than found in a previous study by Kazi et al (Kazi et al., 2006b).  However, 
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mean emotional score in this study was higher than that found by Kazi et al (Kazi et 
al., 2006b).  Although variables such as numbers recruited, mean age and time since 
surgery are similar, the lower scores in this study are likely to reflect the higher 
percentage of subjects requiring pharyngeal reconstruction 26% vs. 21.8% requiring 
pharyngeal reconstruction in Kazi et al (Kazi et al., 2006b).  The findings of this 
study, that of (Robertson et al., 2011) and (Kazi et al., 2006b) are summarised in the 
following Table 5.21. 
 
Table 5-21: Summary comparison of scores on the MDADI with other 
studies involving laryngectomy 
Reference N= M: F Age Time 
since 
surgery 
(mths) 
Total 
score 
 Global  Emotional Functional  Physical 
This study 50 83%: 17% 66.9 
median 
(range 
43-
84.75) 
Mean 
66.8 
96 
median 
(range 
12-324) 
Mean 
69.15 (sd 
15.7) 
 
Median 
70.52 
 
Mean 
68.2 (SD 
25.8).  
 
Median 
80 
 
Mean 71.3 
(SD 16.4)  
 
 
Median 
73.33 
 
Mean 
72.81 (SD 
17.4)  
 
Median 
functional 
76  
Mean 
65.9 (SD 
15.8)  
 
Median 
physical 
67.5 
Robertson 
et al 2011 
179 79%: 21% Median 
age 68 
years 
(range 
41-90) 
 
Median 
96  
(Range 
12-324) 
 
Median 
67.4 
Median 
60 
Median 70 Median 72 Median 
65 
Kazi et al 
2006 
62 74%: 16% Mean 
64.7 
years 
(SD 
9.4%) 
Mean 90 
(range 1-
276) 
Mean 
77.7 (SD 
16.6) 
 
Mean 
79.4 (SD 
22.2) 
 
Mean 77.7 
(SD 17.8) 
 
Mean 81.3 
(SD 15.9) 
 
Mean 
physical 
score 
74.1 (SD 
18) 
 
Compared to the MDADI, there is greater body of literature utilising the UOW QOL 
v4 scale with laryngectomy.  The mean composite score of 76.1 found in this study 
reflects that of 76.62 found by Eadie and Bowker 2012 (Eadie and Bowker, 2012) in 
their larger study of laryngectomy patients.  However, the mean composite score in 
this study is lower than that found by Kazi et al 2007 (Kazi et al., 2007a), although 
this may be due to the higher percentage of subjects requiring pharyngeal 
reconstruction with flaps in this study (26% vs. 21.8%).  Although type of 
reconstruction is not specified in Kazi et al 2007 (Kazi et al., 2007a), this study’s 
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lower scores may be attributed to the relatively high percentage (12%) of subjects 
requiring extensive reconstruction of the oesophagus with jejunum or jejunum and 
pectoralis major flap.  The median average composite score of 80.62 in this study is 
higher than that of 72.9 found in a much larger study (Robertson et al., 2011).  The 
composite score for the group in an earlier study by Villaseca et al 2005 (Villaseca et 
al., 2005) is 979.02, similar to that of 919.4 found in this study.  It is noted that 
(Villaseca et al., 2005) reported a composite score as opposed to a median composite 
score hence the higher numbers indicated. 
Although, several studies (Kazi et al., 2007a, Eadie and Bowker, 2012, Villaseca et 
al., 2005, Robertson et al., 2011) using the UOW QOL v4 with laryngectomy patients 
have reported a composite score, it is worth noting that since the addition of anxiety 
and mood domains to the UOW QOL v4, the use of the UOW composite score has 
not been recommended (Rogers et al., 2002, Lee et al., 2010).  Recent work (Rogers 
et al., 2010a) has suggested it is appropriate to use the Physical composite subscale 
and the Social Emotional composite subscales in preference to an overall composite 
score.  In a large recent study, (Maclean et al., 2009b) it was reported that 
laryngectomy patients with dysphagia had both a lower mean physical subscale 
composite score and a lower social emotional subscale composite score than those 
without dysphagia.  The difference between groups reached statistical significance.  
While the differences between those with dysphagia and those without dysphagia in 
this study did not reach statistical significance, those with dysphagia had lower mean 
physical subscale scores and lower mean social emotional scores than those who did 
not report dysphagia.   
The importance question asks which 3 domains were most important to the patient 
during the past 7 days. Results indicate these to be speech, swallow and activity. A 
previous study (Thomas et al., 2008) of oropharyngeal cancer patients has indicated 
that patients who score 70 or less on the swallowing domain score require further 
assessment of swallowing and tend to have lower scores on the MDADI. The authors 
of this study suggested that a cut off of below 70 on the swallowing domain of the 
UW QOLv4 could be regarded as a quick screening tool for dysphagia.  It is notable 
that on the swallowing domain question, only 2% (n=1) of the sample of this study 
achieved a score of 70 or less.  Nonetheless, when asked which domains were of 
greatest importance over the past 7 days, the domains of speech, swallowing and 
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activity were identified.  It is possible that the swallow domain question on the UW 
QOLv4 may not adequately capture the degree of swallowing dysfunction 
experienced by laryngectomy patients.  The domains identified as of greatest 
importance over the past 7 days by this study, reflect the findings of Robertson et al 
2011 (Robertson et al., 2011).  Villaseca et al 2005 (Villaseca et al., 2005) and Kazi et 
al 2007 (Kazi et al., 2007a) both identified speech, appearance and activity as the 
domains of greatest importance to the subjects in their studies.  While Palmer and 
Graham 2004 (Palmer and Graham, 2004) found that the ability to communicate had 
the strongest association with better quality of life, this correlation has not been 
identified by other studies (Villaseca et al., 2005).  It has been suggested (DeSanto et 
al., 1995) that the presence of a stoma and the interference that this causes to social 
activities may cause greater concern to laryngectomy patients than communication 
impairment. 
The mean global score on the UOW QOL v4 is derived from the question 
“considering everything in your life that contributes to your personal wellbeing, rate 
your overall quality of life during the past 7 days”.  This score was reported on a 
previous study (Eadie and Bowker, 2012) as 68.66 and is similar to the mean global 
score of 66.53 attained on this PhD study.  The findings of this study and that of 
(Eadie and Bowker, 2012, Robertson et al., 2011), (Maclean et al., 2009a), (Kazi et 
al., 2007a, {Villaseca, 2005 #445) are summarised in Table 5.21 
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Table 5-22: Summary comparison of scores on the UOW QOLv4 with other 
recent studies involving laryngectomy 
Reference N= M: F Age Time 
since 
surgery 
(mths) 
Global 
score 
Composite 
score 
Physical 
mean score 
Social 
/Emotional 
score 
Most important 
QOL issues over 
past 7 days 
This 
study 
50 83%: 
17% 
66.9 
median 
(range 
43-
84.75) 
Mean 
66.8 
96 
median 
(range 
12-324) 
Mean 
66.53 
(sd 
21.36) 
 
Mean 
composite 
919.4 (sd 
188.69) 
range 275-
1145  
 
Median 
composite 
967 
 
Mean av 
composite 
76.1 
 
Median av 
composite 
80.62 
 
 
 
 
 
75.87 (SD 
15.92)  
Min 31.66 
Max 100 
Mean 82.85 
(SD 19.06) 
Min 4.16-
Max 100 
 
 
Speech n18 
36.7% 
Swallow n14 
28.6% 
Activity n11 
22.4% 
 
Eadie and 
Bowker 
2012 
67 76%:14% Mean 
63 
years 
old 
(range 
44-89)  
 
Mean 
84 
months 
post TL 
(range 
9-
33mths) 
Mean 
global 
score 
68.66 
sd 
18.16 
 
Mean 
composite 
score 
76.62 (SD 
13.53) 
 
   
Robertson 
et al 2011 
179 79%:21% Median 
age 68 
years 
(range 
41-90) 
 
Median 
96  
(Range 
12-324) 
 
 Median 
av. 
composite 
72.9 
(28.3-100 
  Speech n 76 
(42.5%) 
Swallowing n 67 
(37.4% 
Activity n 49 
(27.3%) 
 
Maclean 
et al 2009 
110 89%:11%       Swallowing, 
speech, activity 
Kazi et al 
2007 
55 80%;20% 66 
years 
(40-84) 
  
81 93-
28) 
  Mean 
composite 
score 81.3 
 
 
  Speech, 
appearance and 
activity  
Villaseca 
et al 2005 
62 54%:46% Mean 
64.7 
years 
(SD 
9.4%) 
Mean 
90 
(range 
1-276) 
 Mean 
composite 
score 
979.02 
(range 
550-1175) 
  Speech, 
appearance, 
activity 
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5.7.2 Additional quality of life issues identified by laryngectomy patients on the 
UOW QOL v4. 
The Swallow Outcome After Laryngectomy (SOAL) has recently been developed and 
has undergone preliminary validation (Govender et al., 2012).  While this tool is 
promising, it is still awaiting full validation.  At present therefore, there are no 
validated quality of life scales for use specifically with laryngectomy patients.  It has 
been noted (Maclean et al., 2009b) that the UW QOLv4 focuses on addressing 
patients’ perceived changes to functions of daily living and therefore maybe more 
accurately described as a measure of functioning rather than quality of life.  As can be 
observed in the responses to the final question of the UOW QOL v4, 44% of 
laryngectomy patients indicated that there were several areas of quality of life 
important to them that had not been addressed by either of the scales used in this 
study.  These responses were broadly categorised into communication, social, 
physical, swallow, stoma and other.  Some studies have argued that the loss of an 
ability to communicate in a conventional manner after laryngectomy does not 
necessarily translate into worse overall quality of life (Deleyiannis et al., 1999a) 
(DeSanto et al., 1995).  However, it is clear from the responses to the final question of 
the UOW QOL v4 that the subjects in this study were concerned about being unable 
to shout, having inconsistent speech quality, dealing with a leaking prosthesis, being 
unable to be heard on the phone and being perceived as having a male voice.  It would 
appear from these responses as though laryngectomy patients can suffer a certain 
amount of social isolation and embarrassment after laryngectomy.  In terms of 
physical responses, it is notable that issues with mucous production were mentioned 
by 3 subjects with a further 3 subjects indicating issues with swimming.  Within the 
category of head and neck cancer patients, laryngectomy patients are unique in having 
a permanent open stoma.  While swimming is possible with the use of the Larked 
Swimming device (Darvill, 1983), the  cost, need to accurately fit the device, and 
need for expert instruction for use has limited the use of the Larkel.  Smell or 
olfaction is altered after laryngectomy because of the changes in respiration and the 
loss of airflow through the nose.  While it is possible to rehabilitate olfaction 
(Risberg-Berlin et al., 2006) (Hilgers et al., 2000, Hilgers et al., 2002), it may be that 
rehabilitation of communication, respiration and swallowing may be prioritised over 
olfaction.  This is an area that clearly is an issue for many laryngectomy patients and 
one not addressed by either the UOW QOLv4 or the MDADI.  5 subjects responded 
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that that the presence of a stoma had not been adequately addressed by the UOW 
QOL v4.  It is notable that issues expressed regarding the stoma included not only that 
of mucous but also of appearance, the need to cover the stoma and the attention that a 
stoma can sometimes command.  2 subjects in this study highlighted that laryngeal 
cancer was not the reason for their laryngectomy and therefore the questions relating 
to quality of life and cancer were not relevant.   
 
5.7.3 Correlations 
 
An objective of this study was to investigate the existence of correlations between 
MDADI and UOW QOLv4 subscale scores and age and time since surgery.  Positive 
linear associations were noted between age and the MDADI emotional, functional and 
subscale scores but not with subscale scores on the UOW QOL.  These findings 
suggest both variables of age and subscale scores on the MDADI are changing at the 
same rate so when age increases, scores increase or decrease at the same rate at each 
point.  Time since surgery was also positively associated with most MDADI and 
UOW QOL subscale scores, again suggesting both variables are changing at the same 
rate.  Further longitudinal investigation into the effects of age and time since surgery 
on quality of life scores on tools such as the MDADI and UOW QOLv4 would be 
beneficial. 
 
5.7.4 Differences between groups on quality of life scores 
 
A final objective of this study was to determine if there is a difference between groups 
on variables (including gender, myotomy, surgical closure technique, salvage surgery, 
radiotherapy, chemotherapy and self-report of dysphagia) for MDADI and UOW 
QOLv4 scores.  Most of the differences between groups were not significant and one 
of the factors that may have limited this analysis is the small sample size.  
Laryngectomy patients are a relatively small and heterogeneous group but it may be 
possible in a further study to recruit larger numbers and to determine the effect of 
344 
 
factors such as gender, myotomy, surgical closure technique, salvage surgery, 
radiotherapy, chemotherapy and self-report of dysphagia in more detail. 
 
5.7.4.1 Gender  
 
Laryngeal cancer is more common in men with current trends indicating a male 
female ratio of 5:1 in the UK (CancerResearchUK, 2011).  This reflects the gender 
ratio of this study.  This study found that men tended to have higher scores on the 
MDADI and UOW QOL scales than women although the differences did not reach 
statistical significance.  A large study (Robertson et al., 2011) of 179 subjects with a 
male female ratio of 3.7:1 found that males achieved a significantly better composite 
quality of life score on the UOW QOLv4 than females.  No gender differences were 
noted on MDADI scores.  A study (Kazi et al., 2007a) of quality of life using the 
UOW QOLv4 on 55 laryngectomy subjects found no statistical difference in 
composite scores in relation to gender.  A further study (Kazi et al., 2006b) of 
swallowing outcomes after laryngectomy in 62 subjects indicated no significant 
difference in MDADI scores in relation to gender.  Because the incidence of laryngeal 
cancer is so much greater in men, there has been a paucity of studies looking at 
specific quality of life outcomes according to gender.  An exception is a study (Lee et 
al., 2010) which examined gender differences in health related quality of life after 
laryngectomy using the European Organisation for Research and Treatment of Cancer 
Core Questionnaire version 3.0a (EORTC QLQ-C30) and the disease specific Head 
and Neck Module (QLQ-H&N35).  This study (Lee et al., 2010) investigated 22 
males and 21 female laryngectomy subjects and found that males had significantly 
higher global status/quality of life than females and higher physical, emotional, 
cognitive and social functioning.  There was also a general trend for female 
laryngectomy subjects to have higher symptom/impairment levels.  Given the 
difficulties that some female laryngectomy patients have encountered with a 
tracheosophageal voice that can be devoid of feminine features and dressing to 
accommodate a neck stoma, further research into the specific quality of life 
impairments experienced by females would be of benefit. 
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5.7.4.2 Myotomy 
 
As previously described in chapter 1, (section 1.1 The Laryngectomy procedure) 
myotomy is recommended during laryngectomy surgery to optimise outcomes (Scott 
et al., 1993, Blom and Singer, 1981, Bayles and Deschler, 2004, OpDeCoul et al., 
2003).  Most of the research looking at laryngectomy outcomes in relation to 
myotomy has focused on communication as opposed to swallowing.  However, 
myotomy has the effect of reducing the force of the upper oesophageal peristaltic 
wave creating an air reservoir at the top of the oesophagus for voice (Bayles and 
Deschler, 2004), which in turn will increase the width of the oesophageal lumen for 
swallowing.  Better communication and swallowing could be reasonably expected to 
result in better quality of life outcomes.  This study found higher scores for those with 
a myotomy on the MDADI global score, MDADI Physical score, UOW QOL 
composite score and UOW Physical composite score but none of these differences 
reached statistical significance reflecting previous findings (Kazi et al., 2006b).  It is 
notable that the majority of patients without myotomy in this study had undergone 
extended laryngectomy surgery which negated the need for a myotomy. 
 
5.7.4.3 Surgical Closure  
 
The type of surgical closure technique used during laryngectomy surgery reflects the 
extent of disease and whether a patient requires an extended procedure.  In this study 
a significant proportion of subjects (28%) had extended surgery requiring a flap.  
22.4% of subjects had circumferential surgical closure technique documented 
indicating extended surgery.  10.2% of subjects had no documentation of closure 
techniques.  As factors such as increased tumour size and extent of disease influence 
extent of surgery, it is reasonable to suggest that those patients who require extended 
laryngectomy surgery may have less positive outcomes than those requiring a 
standard total laryngectomy.  There is a lack of literature investigating the quality of 
life outcomes in the specific group of laryngectomy patients who undergo extended 
surgery.  One possible reason for this is the heterogeneity of this group, which may 
include patients with a number of different flaps including radial forearm flap, 
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pectoralis major flap, jejunum flap and gastric pull up.  A previous study (Kazi et al., 
2006b) which included subjects with extended laryngectomy surgery and type of 
surgical closure technique was found not to correlate with subscale scores of the 
MDADI.  A later study, (Kazi et al., 2007a) found that those with circumferential 
closures had slightly lower similar median composite scores on the UOW QOL v4 
compared to those with horizontal closures.  It is noted that subjects with T shaped 
pharyngeal closure had a significantly higher mean composite score (89.2) compared 
to horizontal closure (81.9) or circumferential closure.  In addition, the score for the 
swallowing domain question of the UOW QOL v4 scale was significantly lower in 
those with circumferential PE segment closures (Kazi et al., 2007a). 
 
5.7.4.4 Organ Preservation and Salvage Surgery 
 
51% of subjects in this study had undergone salvage laryngectomy surgery following 
earlier attempts to treat laryngeal cancer using organ preservation methods.  The 
publication of a landmark study (Hillman et al., 1998) indicated that organ 
preservation patients achieved better intelligibility and communication profile scores 
than laryngectomy patients after 5 years although no difference was seen between 
groups  in voice outcomes after 10 years (Pendley et al., 2010, Terrell et al., 1998).  
This study (Hillman et al., 1998)  was influential in organ preservation being 
advocated in preference to primary laryngectomy.  However, this study (Hillman et 
al., 1998) has also received criticism because less than one third of patients in this 
study used tracheosophageal communication and over half used an electrolarynx.  
Today over 90% of laryngectomy patients routinely achieve communication through 
surgical voice restoration techniques (Frowen and Perry, 2001).  Surgical voice 
restoration techniques are considered not only to be an extremely viable method of 
communication post laryngectomy but also to be the gold standard for treatment for 
this group (Elmiyeh et al., 2010).  It is possible that with the higher levels of post 
laryngectomy patients now successfully using surgical voice restoration, that voice 
outcomes post laryngectomy have now significantly improved when compared with 
voice outcomes in those undergoing organ preservation.  The relevance of the study 
(Hillman et al., 1998) to contemporary clinical practice is further limited by the high 
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percentage of laryngectomy patients (75%) receiving adjuvant radiotherapy despite 
primary staging of less  than or equal to T3 disease and 57% having N0 (no nodal 
involvement).  Current practice suggests that primary surgery alone is appropriate 
treatment for T3 laryngeal disease without specific clinical and pathological features 
(British Association of Otolaryngologists, 2002).  In contrast to the subjects involved 
in (Hillman et al., 1998), many T3 laryngeal cancer  patients today who proceed to 
becoming laryngectomy patients are not affected by the toxicities involved in 
adjuvant radiotherapy.  . 
 
A central tenet of organ preservation is that it offers a reasonable expectation of 
curing laryngeal disease and avoiding laryngeal surgery.  However, survival rates for 
laryngeal cancer have deteriorated in the last 20 years (Hoffman et al., 2006) in the 
US where evidence supporting organ preservation originated.  It has been pointed out 
(Robertson et al., 2011) that the rise in organ preservation has resulted in the 
reduction of primary laryngectomy and an increase in salvage laryngectomy as a 
consequence of recurrent disease.  Those with salvage surgery had lower scores on 
both the MDADI and UOW QOL v4 scale.  This study confirmed the findings of 
(Robertson et al., 2011) which found that patients with salvage surgery experience the 
worst functional outcome of all laryngectomy patients.  Organ preservation is 
discussed further in Chapter 1, section 1.6.1.1 Non-surgical organ preservation vs. 
Total laryngectomy 
 
5.7.4.5 Radiotherapy and chemotherapy 
 
Subjects in this study with a history of radiotherapy had worse scores on both the 
MDADI and UOW QOLv4 than those without radiotherapy although these 
differences did not reach statistical significance.  In general those with chemotherapy 
had similar scores on both the MDADI and UOW QOL v4 as those without 
radiotherapy.  90% of the sample in this study had radiotherapy while 20% had 
chemotherapy suggesting comparison between both groups requires careful 
interpretation given their unbalance relative to the number of subjects recruited.  A 
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previous influential study (Paleri et al., 2001) comparing HNQOL scores in  irradiated 
laryngectomy patients with those who had been treated by surgery alone failed to 
demonstrate an adverse effect treatment effect of radiotherapy.  This study involved 
29 subjects, 59% of whom had received radiotherapy.  No correlations were observed 
between subscale scores on the UOW QOL v4 scale (Kazi et al., 2007a) in a study of 
55 subjects, 72% of whom had received radiotherapy.  This study also examined a 
combined group of radiotherapy and chemotherapy subjects on the basis that the 
effects of both treatments are similar on patients and again failed to find any statistical 
differences between groups.  A further study (Kazi et al., 2006b) of 62 subjects, 55% 
of whom had received post-operative radiotherapy and a further 9% who had received 
chemo radiation found that neither radiotherapy nor a combination of chemo 
radiotherapy affected MDADI scores although the authors suggest this may be due to 
the fact that most patients in this study were at least 7 years post either radiotherapy 
or chemo radiotherapy.  Eadie and Bowker 2012 (Eadie and Bowker, 2012) examined 
a number of quality of life scales (The ways of coping with cancer – WOC-CV, the 
Voice Related Quality of Life (V-RQOL) scale and the UOW QOL) composite and 
global QOL scores.  They found a weak relationship between radiotherapy, UOW 
global and composite scores and V-RQQL but caution that this result needs to be 
interpreted with caution given that 84% had received radiation limiting the strength of 
their findings.   
 
No study has found a significant relationship between chemotherapy alone and 
functional outcomes after chemotherapy.  This reflects the fact that laryngectomy 
patients are unlikely to undergo chemotherapy alone but rather radiotherapy or a 
combination of radio and chemotherapy.  Only two studies have found a significant 
relationship between radiotherapy and functional outcomes after radiotherapy.  One 
study (Villaseca et al., 2005) examined 49 subjects (81% had undergone radiotherapy 
with a further 14% having undergone chemotherapy).  This study found that 
radiotherapy significantly negatively influenced speech outcome on the UOW QOL 
v4 scale.  A further study (Robertson et al., 2011) indicated that radiotherapy had a 
highly significant and detrimental effect on functional outcome after laryngectomy.  
This study examined scores from both the MDADI and UOW and the VoiSS (Voice 
Symptom Scale) and had a large study sample of 179 with 85.4% undergoing 
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radiotherapy pre or post operatively.  This study may offer a more accurate picture of 
functional outcomes post laryngectomy because of the large numbers involved. 
 
5.7.4.6 Reports of dysphagia 
 
A previous study (Frowen et al., 2009) made an important distinction between 
different types of swallow dysfunction; impairment and activity limitation.  An 
impairment is a deviation from normal swallow function usually evaluated with an 
instrumental assessment such as a barium swallow, videofluroscopic swallow, or 
FEES.  Swallow impairment may include delayed initiation of swallow reflex or 
aspiration.  However, activity limitation as it applies to swallow dysfunction includes 
an individual’s ability to safely manage oral intake without recourse to diet 
modification or use of compensatory swallow strategies.  Activity limitation is 
commonly measured through clinician rating scales and patient self-report.  While 
dysphagia may not have necessarily determine quality of life after laryngectomy, it 
may negatively impact functioning and psychological well-being (Maclean et al., 
2009b) in such a manner that activity is limited.  One of the first studies (Armstrong 
et al., 2001) to investigate the impact of swallowing on quality of life after 
laryngectomy found that 42% reported that their difficulties  prevented them from 
eating out in public 6 months after surgery.  Recent years have seen a move away 
from measuring general quality of life to a more health related quality of life which 
measures the effect of disease and it’s treatment on a patient’s perceived level of well-
being (Maclean et al., 2009b, Eadie, 2003).  Quality of life must therefore be 
measured from the patient’s perspective rather than the clinician’s (Sayed et al., 
2009a).  Those with a swallow dysfunction self-reported as a manifestation of activity 
limitation had lower scores on the MDADI as expected.  However, those who 
reported dysphagia also had lower scores on the UOW QOL v4.  Those with 
dysphagia had a significantly lower UOW composite score than those without 
dysphagia.  The lower UOW Physical and UOW Social Emotional scores seen in 
patients with dysphagia approached significance and reflects that seen in the study by 
(Maclean et al., 2009b).   
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Strengths of this study include the use of both a swallow specific quality of life tool, 
the MDADI and a more general quality of life tool the UW QOLv4.  However, this 
study is limited by small sample size and heterogeneity of the sample which limited 
analysis of correlation and differences between groups for factors such as myotomy, 
surgical closure, salvage surgery, radiotherapy, chemotherapy and self-report of 
dysphagia.  In addition, this study was limited by the lack of availability of a quality 
of life tool designed specifically for laryngectomy patients. 
 
5.7.5 Conclusions 
 
The area of quality of life as it relates to head and neck cancer patients has evolved 
into a more organised and scientific discipline (Sayed et al., 2009a).  However, the 
field remains limited by the use of retrospective data, small sample sizes and studies 
from single centres.  These factors reduce generalisability of results (Maclean et al., 
2009b).  In the area of laryngectomy, research into quality of life after has also been 
limited by a lack of specific questionnaires to capture the particular needs of this 
patient group which distinguish them from other head and neck cancer patients.  
While this study could have been improved by a larger sample size and recruitment of 
subjects from multiple centres, it nonetheless has highlighted some of the specific 
issues experienced by laryngectomy patients such dealing with mucus, difficulty 
speaking on the phone, dealing with a leaking voice prosthesis, inability to shout, 
inability to swim and loss of smell.  The findings of this study indicate that further 
research may be required to develop a laryngectomy specific quality of life scale. 
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Chapter 6. Conclusion 
 
 
6.1 Introduction 
This thesis focuses on three areas of rehabilitation post laryngectomy: (i) Swallowing, 
(ii) Voice and (iii) Outcomes - Quality of Life.   These areas were introduced in the 
first chapter and research into each area was discussed in detail in subsequent 
chapters.  The aim of this chapter is to draw together the results of this research and 
provide a holistic overview of rehabilitation post laryngectomy.  Areas of future 
research are also addressed. 
 
 
6.2  Swallowing 
Research into swallowing post laryngectomy over the last decade has indicated that 
dysphagia is an issue for many patients. This is in contrast to previously held views 
that the lack of aspiration risk in this population precluded the development of 
significant dysphagia. While dysphagia is now recognised as an area that requires 
rehabilitation for many laryngectomy patients, there is still limited research into the 
best evaluation tool and the symptoms of dysphagia experienced by this population.  
Videofluroscopy is often used as a dysphagia evaluation tool with post laryngectomy 
patients.  However, there are no protocols in existence for the use of this tool and 
there are no rating scales outlining the appropriate parameters to observe.   
A central part of this research was to investigate whether FEES could be used as 
alternative tool to videofluroscopy with the laryngectomy population and to develop a 
rating scale suitable for use with both tools. This research was outlined in chapter 2. 
FEES has not previously been used to evaluate swallowing in this patient population, 
although its use is well established in other populations with dysphagia. A rating scale 
was developed which included anatomical and physiological parameters relevant to 
post laryngectomy swallowing in addition to assessing residue located in the 
neopharynx, on the voice prosthesis and in the oesophagus. The scale was formulated 
for use with both videofluroscopy and FEES.  Results of this study indicated that 
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FEES provided greater identification than videofluroscopy of voice prosthesis type 
and secretions.  FEES was similar to videofluroscopy in identifying pseudoepiglottis 
and reflux/regurgitation. Videofluroscopy provided greater identification and 
visualisation of degree of residue in the neopharynx compared to FEES.  FEES was 
more consistent or the same as videofluroscopy in identifying and indicating degree 
of residue on the voice prosthesis on thin liquids, soft and solid consistencies.  
Videofluroscopy was more consistent in identifying and indicating degree of residue 
on the voice prosthesis on puree.  FEES was more consistent than videofluroscopy in 
indicating degree of residue in the oesophagus on thin liquid.  FEES was more 
consistent or the same as videofluroscopy for identifying and indicating degree of 
residue in the oesophagus on puree, soft and solid consistencies.   
It was crucial to the investigation of whether FEES could be used as an alternative 
tool to videofluroscopy to discover whether this tool was acceptable for patients. One 
of the potential issues with FEES is that it is an invasive tool that requires a flexible 
scope passed through the nose.  The majority of patients reported that having a 
flexible scope passed through the nose was comfortable and the majority also 
indicated that they either preferred FEES to videofluroscopy or had an equal 
preference for both tools. 
These results establish FEES as an alternative tool to videofluroscopy for the 
evaluation of swallowing post laryngectomy.  FEES offers advantages in the clinical 
setting because it is more readily available than videofluroscopy and involves no 
radiation exposure so can be repeated multiple times as necessary.  The ability to 
repeat swallow evaluation is of particular importance to monitor progress if a 
treatment programme of exercises is implemented or if a surgical procedure is 
performed to improve swallowing. 
Secretions were observed on FEES but not on videofluroscopy.  Patients have 
reported that secretions in their throat can negatively affect swallowing as well as 
causing a “wet” voice. It is possible that these secretions represent pooled saliva but 
further research would be of benefit to investigate the cause of these secretions and 
the effect that they have on swallowing. 
Swallow research in this study next investigated whether voice prostheses have an 
effect on swallowing. This area was the focus of chapter 3. This is not an area that has 
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previously been researched although patients report clinically that they sometimes 
notice a difference in swallowing when they try a new voice prosthesis.  FEES was 
used to evaluate swallowing on up to 6 different voice prostheses with each subject.  
On patient self-evaluation, scores were evenly distributed for swallowing for each 
voice prosthesis suggesting voice prostheses do not affect swallowing.  However, 
some individual patients reported differences between voice prostheses for 
swallowing. Raters provided a subjective opinion of overall best prosthesis for 
swallow for each subject based on observing FEES evaluations. Raters most 
frequently chose the Blom Singer Classic Indwelling but were unable to reach a 
consensus for the majority of the sample.  Raters also judged best prosthesis for 
swallow based on differences of amount of residue observed on the voice prosthesis 
and in the oesophagus. Raters and subjects did not show agreement for best prosthesis 
for swallow. Differences were observed on thin liquid residue on the voice prosthesis 
with the Blom Singer Classic Indwelling having the least residue and the Blom Singer 
Advantage the most.  Differences were also observed on soft residue on the voice 
prosthesis with the Provox Vega presenting with the least residue and the Provox NID 
the most. Differences were also noted on soft residue in the oesophagus with the 
Provox Vega presenting with the least residue and the Blom Singer duckbill the most.  
This research indicates that for some patients, voice prostheses may affect 
swallowing. Further research is required to investigate whether characteristics of the 
distal end of the individual voice prosthesis may have characteristics that affect 
swallowing and lead to increased residue.  At present, patients are not given a choice 
of voice prostheses although some indicate changes in swallowing when they try a 
new prosthesis.  It is possible that individual patients may experience better 
swallowing with a different prosthesis and may benefit from being provided with an 
opportunity to try different prostheses. 
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6.3 Communication 
 
The investigation of the effect of different voice prostheses on voice quality was 
described in chapter 4.  Voice was evaluated by raters on up to 6 different prostheses 
using the STOPS scale.  Good inter rater reliability was established for all questions 
of the STOPS except those concerning tonicity (Q2), articulatory precision (Q11) and 
paralingusitics (Q12).  Raters were not able to identify a best prosthesis for voice on 
the STOPS.  Raters were also asked to give their subjective opinion on best prosthesis 
for voice for each subject.  This indicated that the Blom Singer Classic Indwelling 
was best for voice but there was no consensus between raters for a best voice 
prosthesis for voice quality for 8 subjects in the sample.  On patient self-evaluation, 
the Blom Singer Classic Indwelling was most preferred for voice and the Blom Singer 
Duckbill least preferred.  However, when asked subjectively to indicate the prosthesis 
that they considered best overall, patients chose the Provox NID with the least 
favourite the Blom Singer Duckbill.  Subjects and raters did not agree on a best 
prosthesis for voice. 
This research indicates that there are differences between voice prostheses in voice 
quality as judged on patient self-evaluation.  At present, most laryngectomy patients 
are not offered a choice of prostheses and many hospital departments supply voice 
prostheses from one manufacturer only.  This research indicates that the provision of 
patient choice for voice prostheses is important in ensuring that individual patients 
achieve optimum rehabilitation for communication after laryngectomy.   
Future research in this area could investigate patient experience with voice prostheses 
in situ for a longer period of time.  It would also be beneficial to explore the factors 
other than voice and swallow that influence patient preference for a voice prosthesis.  
These may include colour, visibility and ease of cleaning. 
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6.4 Outcomes – Quality of Life 
 
Finally, chapter 5 investigated quality of life following survival from laryngectomy 
surgery to treat advanced cancer. This study found that 78% of subjects self-reported 
dysphagia. In addition, 78% of subjects experienced restrictions to oral intake on the 
FOIS. Both findings confirm that dysphagia is a significant rehabilitation issue for 
post laryngectomy patients.  This study used two quality of life scales designed for 
head and neck cancer: (i) MDADI and (ii) UOW QOLv4.  This study had similar 
scores on the MDADI to (Robertson et al., 2011) and lower scores to those found by 
(Kazi et al., 2006b).  It is noted that this study had a higher percentage of patients 
with extended surgery and pharyngeal reconstruction compared to an earlier study 
(Kazi et al., 2006b).  Scores on this study for the UOW QOL v4 were broadly similar 
to those found by (Robertson et al., 2011, Eadie and Bowker, 2012) but lower than 
that found by Kazi (Kazi et al., 2007a). The issues of speech, swallow and activity 
that were most important to the group over the last 7 days reflect the findings of 
(Robertson et al., 2011).   
The small sample size and heterogeneity of the group limited analysis of correlation 
and differences between groups for factors such as myotomy, surgical closure, 
salvage surgery, radiotherapy, chemotherapy and self-report of dysphagia. 
This study highlighted the limitations of quality of life scales designed for head and 
neck cancer patients with the laryngectomy population.  Laryngectomy patients have 
specific quality of life issues that are different to other head and neck cancer patients.  
These were identified by subjects in this study as dealing with mucous, coping with a 
neck stoma, not being able to swim, dealing with a leaking voice prosthesis, 
difficulties speaking on the phone, being unable to shout in an emergency and loss of 
sense of smell. 
Future research in this area could investigate in further detail the specific quality of 
life issues experienced by laryngectomy patients.  Research could then focus on the 
development and validation of a quality of life scale that includes the issues that are 
most relevant to quality of life post laryngectomy 
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. 
6.5 Conclusions 
 
The research included in this thesis demonstrates the complexities of rehabilitation 
post laryngectomy.  There has been a long and fruitful history of research into 
rehabilitation after laryngectomy.  Until recent years, most of this research has 
focused on optimising communication post laryngectomy.  This is, without question, 
a vitally important area of rehabilitation for the laryngectomy population.  However, 
as knowledge has developed, both swallowing and quality of life are now equally 
important areas to be addressed with this unique population.  Laryngectomy patients 
undergo radical surgery which is often life changing and successful rehabilitation is 
key to the successful adjustment to life post-surgery. 
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Appendix 1: Patient self-evaluation questionnaire – preference for swallow 
evaluation tool 
 
Patient self-evaluation swallow questionnaire study 1 
Xray exam vs Scope exam 
 
Please think about the questions below with your clinician 
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    Strongly agree  
 
 
 
 
 
   Agree  
 
 
 
 
  Neutral  
 
 
 
 Disagree  
 
 
Strongly disagree  
       
 
 
1. Having a scope in my nose is uncomfortable 1 2 3 4 5 
2. I am worried about being exposed to radiation 
during xray swallow tests 
1 2 3 4 5 
3. I find barium easy to swallow 1 2 3 4 5 
4. I like having real food during swallow tests 1 2 3 4 5 
5. I prefer having a swallow test with a scope in 
my nose 
1 2 3 4 5 
6. I prefer having a swallow test using xray 1 2 3 4 5 
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Appendix 7: Patient Information Sheet – Study 1 
 
 
Patient Information Sheet - Study 1  
Part 1:  
This research study will look at swallowing after Laryngectomy (removal of the voice 
box). The study will look at 2 different tools for examining swallowing. The first tool is 
Videofluroscopy which uses a moving x-ray to examine swallowing and the second is 
Fiberoptic endoscopy which uses a small thin tube (scope) placed in the nose and 
attached to a camera to examine swallowing. This study will attempt to find out which 
tool works best for Laryngectomees.  
Study Title  
An examination of the clinical utility of Fiberoptic Endoscopic Evaluation of 
Swallowing (FEES) as an evaluation tool in Laryngectomy and an investigation of the 
effect of different voice prostheses on swallow, voice function and quality of life after 
Laryngectomy.  
Study Title (Short)  
Comparing x-ray with a small thin tube (scope) placed in the nose to examine 
swallowing after Laryngectomy.  
Clinical Investigator  
Margaret Coffey  
Invitation  
We would like to invite you to take part in a research study. Before you decide you  
need to understand why the research is being done and what it would involve for 
you.  
Please take time to read the following information carefully. Talk to others about the  
study if you wish.  
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part.  
Part 2 gives you more detailed information about the conduct of the study).  
Ask us if there is anything that is not clear or if you would like more information. Take  
time to decide whether or not you wish to take part.  
What is the purpose of the Study?  
There is no standard tool used to examine swallowing after Laryngectomy. We want 
to study 2 examination tools (xrayx-ray and endoscopy) that have been used to look 
at swallowing in other patients with Head and Neck cancer to see which one works 
best for Laryngectomy patients. The study will also have an educational purpose in 
that it will be included in work for a PhD.  
Why have I been included?  
You have been approached to take part in this study as you have had a 
Laryngectomy and attend for follow up care at Imperial College HeathcareHealthcare 
NHS trust. There will be approximately 30 other Laryngectomy patients taking part in 
this study.  
404 
 
Do I have to take part?  
It is up to you to decide. We will describe the study and go through this information  
sheet, which we will then give to you. We will then ask you to sign a consent form to  
show you have agreed to take part. You are free to withdraw at any time, without  
giving a reason. This would not affect the standard of care you receive.  
What will happen to me if I take part?  
You will be asked to attend for a one-off visit. This visit will take place in the x-ray 
department at Charing Cross Hospital and will last approximately 60 minutes. The 
researcher will have access to your medical notes and these will be reviewed before 
the swallow examination.  
You will be asked whether you have any food allergies. You will be positioned in the 
x-ray machine. The researcher will then gently place a small small thin tube (scope) 
through your nose and into your throat. This small thin tube (scope) will be held in 
place for the duration of the examination by the researcher. You will be facing the 
researcher at first. The device to record the x-ray examination and the endoscopic 
examination will be turned on. The examinations will be saved onto a computer to be 
transferred to a DVD later. Below on the left is a still picture of how the recorded x-
ray part of the swallow will look like. And on the right, a still picture of how the 
recorded endoscopic part of the swallow will look like.  
You will then be given 3 trials each of the following consistencies to swallow:  
 
 
na piece)  
 
 
You will then be turned 45 degrees to left to allow the researcher to look at your 
swallow from a different angle. You will then be given 1 trial each of the following 4 
consistencies.  
 
e (applesauce flavour)  
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the researcher to see it on the x-ray examination. Once you have swallowed each of 
the trials, the researcher will gently remove the small thin tube (scope) from your 
nose and will ask you step away from the x-ray machine.  
You will then be asked to complete a short questionnaire about your experience 
during the swallow examination. After this questionnaire is filled out you will have an 
opportunity to ask the researcher any questions you may have. Once questions have 
been answered your participation in this study will be completed and you will be free 
to leave.  
Usually you would just have an x-ray examination to assess your swallow but this 
study will involve using both ray swallow and endoscopic swallow tools at the same 
time to assess your swallow. You will not be excluded from any treatment you might 
need by participating in this study. You will be followed up as part of your ongoing 
care after participating in this study by your Speech and Language Therapist.  
The type of study you will be involved in is one called a “prospective observational 
design”. This involves the researcher using both swallow examination tools in the 
same way with each participant to gather information about which one is best.  
Expenses  
Each participant in this study will be given £20 to contribute towards travel expenses.  
What will I have to do?  
You will attend for a one-off appointment in the x-ray department. It is important that 
you continue to attend all other scheduled appointments with the Speech and 
Language Therapy Department.  
What is the procedure that is being tested?  
Fiberoptic Endoscopic Evaluation of Swallowing (FEES) which is a tool used to 
assess swallowing in other patients with Head and Neck cancer such as tongue, lip 
and throat. This tool uses a small thin tube (scope) passed through the nose to look 
at the throat. This tool will be compared with Videofluroscopy (moving x-ray) which is 
also a tool used to assess swallowing in other Head and Neck cancer patients.  
What are the alternatives?  
At present, there is no alternative tool for the assessment of swallowing ability after 
Laryngectomy.  
What are the possible disadvantages of taking part?  
Radiation exposure is a disadvantage of taking part in this study, however the 
radiation exposure involved will be limited to a safe level and radiation safety 
procedures will be followed at all times. There is a risk of nose bleeding and fainting, 
which can occur when a small thin tube (scope) is placed in the nose. Recent 
research suggests that this risk is minimal. Should any adverse effects occur during 
this study, the examination will be stopped immediately.  
What are the side effects of taking part in this study?  
It is possible that barium mixed in the food swallowed during the assessment of 
swallowing may cause the voice prosthesis to become blocked resulting in temporary 
loss of voice. This should be easily resolved by cleaning the voice prosthesis. If any 
unexpected side effects occur, the examination will be stopped immediately.  
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Ionising radiation exposure  
X-ray swallow exams involve the use of radiation. This study has been reviewed by 
Dr Donald Mc Robbie, Radiation Safety Officer at Imperial College Healthcare Trust. 
The average dose area product for this procedure locally is 4.8 Gy cm2. This is 
equivalent to 89 days of UK average background radiation and carries an average 
adult risk of 1 in 66,000 of fatal cancer. This is considered a minor risk.  
Benefits of taking part in this study?  
This study will increase understanding of which assessment tools for swallowing are 
appropriate for use after Laryngectomy. We cannot promise the study will help you 
but the information we get from this study may help improve the treatment of people 
with Laryngectomy.  
What happens when the study stops?  
You will continue to be followed by your Speech and Language Therapist and will 
have access to any treatments that are identified as beneficial to you during the 
course of the study.  
What if there is a problem?  
Any complaint about the way you have been dealt with during the study or any  
possible harm you might suffer will be addressed. The detailed information on this is  
given in Part 2.  
Will my taking part in this study be kept confidential?  
Yes. We will follow ethical and legal practice and all information about you will be  
handled in confidence. The details are included in Part 2.  
If the information in Part 1 has interested you and you are considering participation,  
please read the additional information in Part 2 before making any decision.  
Part 2  
What if relevant new information becomes available?  
Sometimes we get new information about the treatment being studied. If this 
happens, your research clinician will tell you and will discuss whether you should 
continue in the study. If you decide not to carry on, your research clinician will make 
arrangements for you to continue your care. If you decide to continue in the study, 
she may ask you to sign an updated consent form. If this happens, your research 
clinician might consider you should withdraw from the study. She will explain the 
reasons and arrange for your care to continue. If the study is stopped for any other 
reason, we will tell you and will make arrangements to continue your care.  
What will happen if I don’t want to carry on with the study?  
You can withdraw from the treatment at any time and we will make arrangements for 
your care to continue. Any data gathered during the study will be placed with your 
medical records and will not be used as part of the research study.  
What if there is a problem?  
If you have a complaint about any aspect of this study, contact Margaret Coffey at 
0203 311 1760 who will do her best to answer your questions. If you remain unhappy 
and wish to complain formally, you can do so through the NHS complaints 
procedure. Details about this can be obtained from the hospital site.  
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.  
Harm  
Imperial College London holds insurance policies which apply to this study. If you 
experience serious and enduring harm or injury as a result of taking part in this study, 
you may be eligible to claim compensation without having to prove that Imperial 
College is at fault. This does not affect your legal rights to seek compensation.  
f you are harmed due to someone’s negligence, then you may have grounds for a 
legal action. Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you have been treated during the course of this study then you 
should immediately inform the Investigator Margaret Coffey, Speech and Language 
Therapist on 0203 311 1761. The normal National Health Service complaint 
complaints mechanisms are also available to you. If you are still not satisfied with the 
response, you may contact the Imperial AHSC Joint Research Office.  
Will my taking part in this study be kept confidential?  
Information collected about you during this research will be kept confidential and may 
be shared with other researchers on the team. Any information about you that leaves 
the hospital will have your name and address removed so that you may be 
recognized from it. The data collected from questionnaires and examinations will be 
kept in a password protected computer and a locked cupboard in the Speech and 
Language Therapy Department at Charing Cross Hospital. Margaret Coffey will be 
personally responsible for the safety and security of the data and only investigators 
involved during the study will have access to the data.  
Involvement of General practitioner/Family doctor  
With your permission we will inform your GP about your participation in this study. .  
What happens to the results of the research study?  
Once the study is completed, it is planned to submit it as part of a PhD project, 
present findings at scientific conferences and publish results in a scientific journal. 
Please be assured that you will not be identified in any report, talk or publication.  
Who is organizing and funding this research.  
This research has been organized by Imperial College London. This research has 
been funded through a Clinical Doctoral fellowship for Nursing and Allied Heath 
Professionals from the National Institute of Health Research (NIHR).  
Who has reviewed this study?  
All research in the NHS is looked at by an independent group of people called a 
research ethics committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed by the South West Research Ethics Committee 2. .  
Thank you for your time and co operation.  
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Margaret Coffey  
Speech and Language Therapist,  
Head and Neck/Oncology  
Charing Cross Hospital,  
Imperial College Healthcare NHS Trust,  
Fulham Palace Road,  
London W6 8RF  
Ph 0203 311 1761  
Fax 0203 311 7610  
Email Margaret.coffey@imperial.nhs.co.uk  
Version 8 06/05//2010 
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Appendix 8: Patient Information Sheet – Study 2 
 
Patient Information Sheet   - Study 2 
 
Part 1: 
This research study will compare swallowing and voice quality after Laryngectomy 
with different voice prostheses using a tool called Fiberoptic Endoscopic Evaluation 
of Swallowing Fiberoptic Endoscopic Evaluation of Swallowing involves placing a 
small thin tube (scope) in the nose which is attached to a camera to examine 
swallowing.  This study will attempt to find out which voice prosthesis works best for 
Laryngectomees. 
 
Study Title  
 
An examination of the clinical utility of Fiberoptic Endoscopic Evaluation of 
Swallowing (FEES) as an evaluation tool in Laryngectomy and an investigation of the 
effect of different voice prostheses on swallow, voice function and quality of life after 
Laryngectomy. 
 
 
Study Title (Short) 
 
Comparing swallowing and voice quality in Laryngectomy using 5-6 different voice 
prostheses. 
 
Clinical Investigator 
 
Margaret Coffey 
 
Invitation 
 
We would like to invite you to take part in a research study.  Before you decide you  
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need to understand why the research is being done and what it would involve for 
you.   
Please take time to read the following information carefully. Talk to others about the  
study if you wish.   
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part.    
Part 2 gives you more detailed information about the conduct of the study).    
Ask us if there is anything that is not clear or if you would like more information.  
Take  
time to decide whether or not you wish to take part.  
  
What is the purpose of the Study?  
There are several voice prostheses available for communication rehabilitation after 
Laryngectomy. Some patients say that certain voice prostheses are easier to swallow 
with than others but there has been no research to date which looks at this. We also 
want to examine whether some voice prostheses are easier to talk with than others.  
The study will also have an educational purpose in that it will be included in work for 
a PhD. 
 
Why have I been included? 
You have been approached to take part in this study as you have a Laryngectomy 
and attend for follow up care at Imperial College Healthcare NHS trust. There will be 
approximately 40 other Laryngectomy patients taking part in this study. 
 
 
 
 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information  
sheet, which we will then give to you. We will then ask you to sign a consent form to  
show you have agreed to take part. You are free to withdraw at any time, without  
giving a reason.  This would not affect the standard of care you receive.   
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What will happen to me if I take part? 
You will be asked to attend for either one or two 90 minute visits.  These visits will 
take place in the Speech and Language Therapy department at Charing Cross 
Hospital. The researcher will have access to your medical notes and these will be 
reviewed before the swallow and voice examination.  
 
At the appointment your current voice prosthesis will be removed and the length of 
your voice prosthesis tract will be measured.  If you have a 20FG voice prosthesis, 
one of each of 5 available prostheses in either 20FG or 19FG will be selected in the 
appropriate length.  If you have a 16FG voice prostheses, one of each of the 6 
available types of prostheses in either 16fg or 17fg will then be selected in the 
appropriate length. The prostheses will be then placed in turn, using the gel cap 
system, in a random order. If you experience any discomfort having all of these 
prostheses placed in one treatment session, your researcher may make a decision to 
split placement of prostheses over two separate appointments. 
 
For each prosthesis trial, you will be asked to read short version of the Rainbow 
passage, (a short passage typically used in voice assessment).  If you do not read 
English, this passage will be translated into your own language.  This reading will be 
recorded to be rated later by the researchers.  You will then be given a short 
questionnaire and asked to rate your voice.  
 
Next the flexible small thin tube (scope) will be passed through your nose, We will 
identify your voice prosthesis so that it can be seen on screen.  Then we will start the 
recording of you swallowing the following liquids and foods: 10ml of thin liquid, 10ml 
of custard or similar puree, banana 1 cm thick and ¼ digestive biscuit.  Each 
consistency will be given 3 times  
You will then be asked to read the rainbow passage again and will be given a short 
questionnaire to tell us about your experience of swallow and voice quality with the 
voice prosthesis in place.  We will then remove the voice prosthesis, place the next 
one and repeat the process above until all 4 or 5 of the voice prostheses available in 
your size have been tried.  
 
Expenses 
Each participant in this study will be given £20 to contribute towards travel expenses. 
 
What will I have to do? 
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You will attend for one or two appointments in the Speech and Language Therapy 
Department.  It is important that you continue to attend all other scheduled 
appointments with the Speech and Language Therapy Department. 
 
What is the device that is being tested? 
Blom Singer and Provox voice prostheses.  
 
What are the alternatives? 
At present, the only alternative range of voice prostheses available are Groningen 
prostheses. 
 
 
 
What are the possible disadvantages of taking part? 
It is possible that you will experience some discomfort during the placement of 
several voice prostheses.  If this occurs, placement of voice prostheses will take 
place over 2 appointments rather than one. There is a risk of nose bleeding and 
fainting, which can occur when a small thin tube (scope) is placed in the nose.  
Recent research suggests that this risk is minimal.  Should any adverse effects occur 
during this study, the examination will be stopped immediately. 
 
What are the side effects of taking part in this study? 
It is possible that food swallowed during the assessment of swallowing may cause 
the voice prosthesis to become blocked resulting in temporary loss of voice.  This 
should be easily resolved by cleaning the voice prosthesis.  
 
Benefits of taking part in this study 
This study will increase understanding of which voice prosthesis works best for 
swallowing and voice after Laryngectomy. We cannot promise the study will help you 
but the information we get from this study may help improve the treatment of people 
with Laryngectomy.  
 
What happens when the study stops? 
You will continue to be followed by your Speech and Language Therapist and will 
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have access to any treatments that are identified as beneficial to you during the 
course of the study. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any  
possible harm you might suffer will be addressed.  The detailed information on this is  
given in Part 2.  
 
Will my taking part in this study be kept confidential? 
Yes.  We will follow ethical and legal practice and all information about you will be  
handled in confidence.  The details are included in Part 2.  
If the information in Part 1 has interested you and you are considering participation,  
please read the additional information in Part 2 before making any decision.  
  
 
 
Part 2 
What if relevant new information becomes available? 
Sometimes we get new information about the treatment being studied. If this 
happens your research clinician will tell you and will discuss whether you should 
continue in the study. If you decide not to carry on, your research clinician will make 
arrangements for you to continue your care.  If you decide to continue in the study, 
she may ask you to sign an updated consent form. If this happens, your research 
clinician might consider you should withdraw from the study. He/she will explain the 
reasons and arrange for your care to continue.  If the study is stopped for any other 
reason, we will tell you and will make arrangements to continue your care. 
 
What will happen if I don’t want to carry on with the study? 
You can withdraw from the treatment at any time and we will make arrangements for 
your care to continue.  Any data gathered during the study will be placed with your 
medical records and will not be used as part of the research study. 
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What if there is a problem? 
If you have a complaint about any aspect of this study, contact Margaret Coffey at 
0203 311 1760 who will do her best to answer your questions. If you remain unhappy 
and wish to complain formally, you can do so through the NHS complaints 
procedure.  Details about this can be obtained from the hospital site.  
 
Harm 
Imperial College London holds insurance policies which apply to this study.  If you 
experience serious and enduring harm or injury as a result of taking part in this study, 
you may be eligible to claim compensation without having to prove that Imperial 
College is at fault.  This does not affect your legal rights to seek compensation. 
 
If you are harmed due to someone’s negligence, then you may have grounds for a 
legal action.  Regardless of this, if you wish to complain, or have any concerns about 
any aspect of the way you have been treated during the course of this study then you 
should immediately inform the Investigator Margaret Coffey, Speech and Language 
Therapist on 0203 311 1761.  The normal National Health Service complaint 
complaints mechanisms are also available to you.  If you are still not satisfied with 
the response, you may contact the Imperial AHSC Joint Research Office.   
 
 
 
 
Will my taking part in this study be kept confidential? 
Information collected about you during this research will be kept confidential and may 
be shared with other researchers on the team. Any information about you that leaves 
the hospital will have your name and address removed so that you may be 
recognized from it.  The data collected from questionnaires and examinations will be 
kept in a password protected computer and a locked cupboard in the Speech and 
Language Therapy Department at Charing Cross Hospital.  Margaret Coffey will be 
personally responsible for the safety and security of the data and only investigators 
involved during the study will have access to the data. 
 
Involvement of General practitioner/Family doctor 
With your permission we will inform your GP about your participation in this study. 
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What happens to the results of the research study? 
Once the study is completed, it is planned to submit it as part of a PhD project, 
present findings at scientific conferences and publish results in a scientific journal.  
Please be assured that you will not be identified in any report, talk or publication. 
 
Who is organizing and funding this research.   
This research has been organized by Imperial College London. This research has 
been funded through a Clinical Doctoral fellowship for Nursing and Allied Heath 
Professionals from the National Institute of Health Research (NIHR). 
 
Who has reviewed this study? 
All research in the NHS is looked at by an independent group of people called a 
research ethics committee to protect your safety, rights, wellbeing and dignity.  This 
study has been reviewed  by the South West Research Ethics Committee 2. 
 
 
 
 
 
 
Thank you for your time and co operation. 
 
Margaret Coffey 
Speech and Language Therapist, 
Head and Neck/Oncology 
Charing Cross Hospital, 
Imperial College Healthcare NHS Trust, 
Fulham Palace Road, 
London W6 8RF 
 
Ph 0203 311 1761 
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Fax 0203 311 7610 
Email Margaret.coffey@imperial.nhs.uk 
 
Version 8  11/02/11 
 
Appendix 9: Consent form study 1 
 
Imperial College London - Consent form Study 1 
 
Centre number 
Study protocol number 
 
Informed consent form for subjects able to give consent themselves 
 
Full title of project: 
 
An examination of the clinical utility of Fiberoptic Endoscopic Evaluation of 
Swallowing (FEES) as an evaluation tool in Laryngectomy and an investigation of 
the effect of different voice prostheses on swallow, voice function and quality of life 
after Laryngectomy. 
 
Study 1 – A comparison of swallow examination using a scope placed in the nose 
with a swallow examination using xray in patients to examine whether using a scope 
is a useful tool to assess swallowing after laryngectomy.  
 
 
Name of principal investigator: Margaret Coffey 
 
Please initial each box below 
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I confirm that I have read and understand the subject information sheet 
dated 17/02/2010 version 3 for the above study and have had the opportunity 
to ask  questions which have been answered fully.     
 
 
I understand that my participation is voluntary and I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected. 
 
I understand that sections of any of my medical notes may be looked at by  
responsible individuals from Imperial College Healthcare NHS Trust  and 
Imperial Colleg London or from regulatory authorities where it is relevant to my 
taking part in this research.   
            
I give permission for these individuals to access my records that are relevant to 
this  
research.   
 
I agree to my audio and visual files recorded during this study to be stored. 
 
 
 
                                                                                                              
                                                                                                                                 
                                                        
The compensation arrangements have been discussed with me 
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 I agree to take part in the above study 
 
 
_____________________          __________________                ________________ 
Name of Subject                                 Signature                                     Date 
 
 
_________________________          __________________                
________________ 
Name of person taking consent           Signature                                    Date 
(if different from Principal Investigator) 
 
 
 
 
_________________________          __________________                
________________ 
Principal Investigator                          Signature                                    Date 
 
 
SOP Ref:  
Consent form V4/part 1 19/02/10 
© Imperial College of Science Technology and Medicine 
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Appendix 10: Consent form study 2 
 
Imperial College London - Consent form Study 2 
 
Centre number 
Study protocol number 
 
Informed consent form for subjects able to give consent themselves 
 
Full title of project: 
An examination of the clinical utility of Fiberoptic Endoscopic Evaluation of 
Swallowing (FEES) as an evaluation tool in Laryngectomy and an investigation of 
the effect of different voice prostheses on swallow, voice function and quality of life 
after Laryngectomy. 
 
Study 2 –Using a small thin tube (scope)  placed in the nose to investigate whether 
different voice prostheses (valves) have an impact on swallowing and voice  
 
 
Name of principal investigator: Margaret Coffey 
 
Please initial each box below 
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I confirm that I have read and understand the subject information sheet 
dated 27/04/2010 version 7 for part 2 study and have had the opportunity to 
ask  questions which have been answered fully.     
 
 
I understand that my participation is voluntary and I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected. 
 
I understand that sections of any of my medical notes may be looked at by  
responsible individuals from Imperial College Healthcare NHS Trust and 
Imperial College London or from regulatory authorities where it is relevant to 
my taking part in this research.   
                                                                                                                                   
                                                                                                                        
I give permission for these individuals to access my records that are                       
relevant to  this research.   
        
                                                                                                                                       
I agree to my audio and visual files recorded during this study to be stored.          
 
 
The compensation arrangements have been discussed with me 
                                                       
I agree to take part in the above study 
 
 
_________________________          __________________                
________________ 
Name of Subject                                 Signature                                     Date 
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_________________________          __________________                
________________ 
Name of person taking consent           Signature                                    Date 
(if different from Principal Investigator) 
 
 
 
 
_________________________          __________________                
________________ 
Principal Investigator                          Signature                                    Date 
 
 
SOP Ref:  
Consent form Part 2/5 26/04/2010 
© Imperial College of Science Technology and Medicine 
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Appendix 11: Expert rating scale for Videofluroscopy and FEES- Study 1 
 
Expert rating swallow scale Videofluroscopy and FEES rating scale for 
Study 1 
ImageNo: 
_________________________________________________________ 
Ratersinitials: 
____________________________________________________________ 
 Indicate what you think about the statement by ticking yes or no or 
making a mark on the line below the question. Please complete a form 
for both FEES and videofluroscopy.   
 
Pre swallow 
 
Q11. Are there secretions present?              
                                                                   Yes          If yes, please rate Q1a 
below  
                 No        If no, please go to Q2 
 
Q21a. Rate degree of secretions:  
                                                                                                                                        
                             
Q32. Is there a pseudoepiglottis present?       Yes          If yes, rate Q2a 
below                         
                                                                                       No          If no, go to Q3 
 
            Severe          Minimal 
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Q42a. How easy is it to identify pseudoepiglottis? 
                                                                             
   
 
 
           
 
Voice prosthesis 
 
Q53. Is the voice prosthesis visible?          
                                                                  Yes         If yes, rate Q3 a,b,c & Q4 
below 
                                                                   No          If no, go to Q5     
 
Q63a. How easy is it to visualize the voice prosthesis?                        
                                                                                  
 
Q64 3b. What type of voice prosthesis can you see? 
                                                                    Duckbill                                                                                                        
                                                                    Low pressure exdwelling                  
                                                                    Classic Indwelling           
                                                                    Advantage 
                                                                    Other         
 
Q65 3c. Which diameter is the voice prosthesis? 16fg                         
                                                                                    20fg                        
Extremely difficult    Extremely easy 
Extremely Easy Extremely Difficult 
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                                                                                   Other                     
 
 
Q66 4. Looking at the position of the voice prosthesis at rest, please 
consider the following statements and tick all that apply:     
                                  Prosthesis is flush against anterior oesophageal 
wall                 
                                  Prosthesis is protruding into lumen                
                                  Prosthesis is touching posterior oesophageal wall     
 
 Phonation  
 
Q7 5. How would you judge overall quality of voice? 
 
                                                                             
 
Q8 6. Would you consider phonatory quality to be tonic?    
                                                                                 No    If no please go to Q6a & 7 
                                                              Yes                                                         If yes please go to Q8      
             
Q9 6a. How would you rate tonicity of voice? 
 
                                                                               
 
 
Q10 7. Is there evidence of spasm                    Yes         
                                                                     No           
 
 
Q11 8. Can you identify the vibratory source?     Yes               If yes, go to Q8a 
                                                                                                                           If no, go to Q9 
                                                                                                      No 
 
  Extremely good Extremely poor 
Extremely Hypotonic Extremely Hypertonic 
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Q12 8a. How easy is it to identify the vibratory source? 
                                                                              
  
 
 
 
 
 
Swallow 
Q13 9. Is there evidence of stricture?   
                                                  Yes             If yes, rate degree of stricture Q9a 
below                               
                                                    No         If no, go to Q10 
 
Q14 9a. What degree of stricture is there? 
                                                                                          
                                                                     
Q15 10. Can the neopharynx be viewed immediately post swallow on thin liquids?  
                                                                                               Yes       If yes, rate Q10a 
below   
                                                                                No        If no, rate Q11     
Q16 10a. Is neopharyngeal residue visible on thin liquids?  
                                                                       Yes       If yes, rate Q10b & c below                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                
                                                                        No           If no, rate Q11 
                                                                            
Extremely easy Extremely difficult 
        Minimal           Severe 
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Q17 10b. How easy is it to identify neopharyngeal residue on thin 
liquids? 
                                                                                          
 
Q1810c. How much neopharyngeal residue is there on thin liquids? 
                                                                                        
 
Q19 11. Is there residue on the voice prosthesis on thin liquids?  
                                                                      Yes            If yes, rate Q11a & b below 
                                                              No         If no, go to Q12 
 
 
 
 
 
 
Q20 11a. How easy is it to identify residue on the voice prosthesis on 
thin liquids? 
                                    
 
 
Q21 11b. How much residue is on the voice prosthesis on thin liquids?                 
                                                                                                       
 
Q22 12. Is there oesophageal residue on thin liquid?   
                                                                         Yes        If yes, rate Q12a & b 
below 
                                                                No          If no, go to Q13 
   Extremely easy Extremely difficult 
     Minimal        Severe 
         Minimal            Severe 
  Extremely easy  Extremely difficult 
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Q23 12a. How easy is it to identify oesophageal residue on thin liquids? 
                                                                                        
 
Q24 12b. How much oesophageal residue is there on thin liquids? 
 
 
Q25 13. Can the neopharynx be viewed immediately post swallow on puree?   
                                                                             Yes          If yes, rate Q13a 
below 
                                                                  No          If no, go to Q14 
 
 
Q26 13a. Is neopharyngeal residue visible on puree?   
                                                                  Yes               If yes, rate Q13b & c below       
                                                          No          If no, go to Q14 
 
Q27 13b. How easy is it to identify neopharyngeal residue on puree? 
                                                                              
 
 
Q2813c. How much neopharyngeal residue is there on puree?  
                                                                                       
  
 
 
Q29 14. Is there residue on the voice prosthesis on puree?   
   Extremely easy Extremely difficult 
       Minimal          Severe 
Extremely easy 
 Extremely difficult 
       Minimal          Severe 
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                                                                        Yes         If yes, rate Q14a & b 
below        
                                                                         No          If no, go to Q15 
 
 
Q30 14a. How easy is it to identify residue on the voice prosthesis on 
puree? 
 
 
Q31 14b. How much residue is on the voice prosthesis on puree?                 
                                                                                                                                                
 
 
Q32 15. Is there oesophageal residue on puree?        
                                                                 Yes               If yes, rate Q15a & b below       
                                                         No          If no, go to Q16 
 
Q33 15a. How easy is it to identify oesophageal residue on puree? 
                                                                              
 
Q34 15b. How much oesophageal residue is there on puree?  
                                                                                       
  
 
 
 
Q35 16.Can the neopharynx be viewed immediately post swallow on soft?  
Extremely easy 
 Extremely difficult 
       Minimal           Severe 
        Minimal         Severe 
      Extremely easy     Extremely difficult 
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                                                                   Yes          If yes, rate Q16a below       
                                                          No         If no, go to Q17 
 
Q3616a. Is neopharyngeal residue visible on soft?  
                                                                    Yes       If yes, rate Q16b & c below                  
                                                           No         If no, go to Q17 
 
 
Q37 16b. How easy is it to identify neopharyngeal residue on soft? 
                                                                              
 
Q38 16c. How much neopharyngeal residue is there on soft?   
                                                                                 
 
 
Q39 17. Is there residue on the voice prosthesis on soft?   
                                                              Yes        If yes, rate Q17a & b  
below        
                                                                No         If no, go to Q18 
 
Q40 17a. How easy is it to identify residue on the voice prosthesis on 
soft? 
 
 
Q41 17b. How much residue is on the voice prosthesis on soft?                 
                                                                                                 
                             
Extremely easy Extremely difficult 
        Minimal           Severe 
        Minimal       Severe 
   Extremely easy  Extremely 
difficult      
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Q42 18. Is there oesophageal residue on soft?     
                                                                        Yes          If yes, rate Q18a & b 
below                  
                                                               No         If no, go to Q19 
 
Q43 18a. How easy is it to identify oesophageal residue on soft? 
                                                                              
 
 
 Q44 18b. How much oesophageal residue is there on soft?   
                                                                                 
 
 
Q45 19. Can the neopharynx be viewed immediately post swallow on solids?  
                                                                             Yes          If yes, rate Q19a 
below 
                                                                   No         If no, go to Q20 
 
Q46 19a. Is there neopharyngeal residue on solid?    
                                                                    Yes            If yes, rate Q19b & c 
below                      
                                                            No              If no, go to Q20 
 
 
Q47 19b. How easy is it to identify neopharyngeal residue on solid? 
                                                                               Extremely easy Extremely difficult 
Extremely easy Extremely difficult 
        Minimal        Severe 
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Q48 19c. How much neopharyngeal residue is there on solid?   
                                                                                 
  
 
Q49 20. Is there residue on the voice prosthesis on solid?    
                                                                        Yes        If yes, rate Q20a & b 
below       
                                                                          No         If no, go to Q21 
 
Q50 20a. How easy is it to identify residue on the voice prosthesis on 
solid? 
 
 
Q51 20b. How much residue is on the voice prosthesis on solid? 
                 
                                                                                     
 
 
Q52 21. Is there oesophageal residue on solid?      
                                                                    Yes            If yes, rate Q22a & b 
below                      
                                                           No           If no, go to Q23 
 
 
Q53 22a. How easy is it to identify oesophageal residue on solid? 
                                                                               
       Minimal           Severe 
Extremely easy Extremely difficult 
         Minimal        Severe 
Extremely easy Extremely difficult 
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Q54 22b. How much oesophageal residue is there on solid?   
                                                                                 
                                         
 
Q55 23. Is there leakage through the voice prosthesis?  
                                                                         Yes        If yes, rate Q23a & b 
below              
                                                                          No         If no, go to Q24 
                         
 
Q56 23a. How easy is it to identify leakage through the voice 
prosthesis? 
                                                                                
 
Q57 23b. How would you rate leakage through the voice prosthesis? 
                                                                                                    
 
 
 
Q58 24. Is there leakage around the voice prosthesis?     
                                                                          Yes        If yes, rate Q24a & b 
below              
                                                               No        If no, go to Q25 
 
Q59 24a. How easy is it to identify leakage around the voice prosthesis? 
                                                                               
Extremely easy Extremely difficult 
        Significant         Minimal 
  Extremely easy Extremely difficult 
       Minimal         Severe 
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Q60 24b. How would you rate leakage around the voice prosthesis? 
                                                                                                     
 
 
 
 
Q61 25. Can you see bolus backflow or reflux?     
                                                             Yes         If yes, rate Q25a & b below      
                                              No        If no, please fill in “other 
observations” . 
 
Q62 25a. How easy is it to identify bolus backflow/reflux? 
                                                                               
 
 
Q63 25b. How would you rate degree of bolus backflow/reflux? 
                                                                                                 
 
 
Other observations 
 
 
 
 
 
 
 
         Minimal       Significant 
Extremely easy 
 
Extremely difficult 
        Minimal     Severe 
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Appendix 12: Expert rating scale for FEES- Study 2 
 
Image No: 
_________________________________________________________ 
Raters initials: 
____________________________________________________________ 
 Indicate what you think about the statement by ticking yes or no or 
making a mark on the line below the question. Please complete a form 
for both FEES and videofluroscopy.   
 
Pre swallow 
 
Q11. Are there secretions present?      Yes          If yes, please rate Q1a 
below  
                No            If no, please go to Q2 
 
Q2 1a. Rate degree of secretions:  
                                                                                                                                                    Severe          Minimal 
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Voice prosthesis 
 
Q3 2. Is the voice prosthesis visible?         Yes         If yes, rate Q2 a,b,c & Q3 
below 
                                                                       No          If no, go to Q4     
 
Q4 2a. How easy is it to visualize the voice prosthesis?                        
                                                                                  
 
 
 
 
*Q5 2b. What type of voice prosthesis can you see? 
                                                                    Duckbill                                                                                                        
                                                                    Low pressure exdwelling                  
                                                                    Classic Indwelling           
                                                                    Advantage 
                                                                    Other         
 
Q6 2c. Which diameter is the voice prosthesis?     16fg                         
                                                                                      20fg                        
                                                                                     Other                     
 
 
Q7 3. Looking at the position of the voice prosthesis at rest, please 
consider the following statements and tick all that apply:     
Extremely Easy Extremely Difficult 
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                                  Prosthesis is flush against anterior oesophageal 
wall                 
                                  Prosthesis is protruding into lumen                
                                  Prosthesis is touching posterior oesophageal wall     
 
Swallow 
Q8 4. Is there evidence of stricture?   
                                               Yes             If yes, rate degree of stricture Q4a 
below                               
                                                 No              If no, go to Q5 
 
 
Q9 4a. What degree of stricture is there? 
                                                                                          
 
                                                                     
 
 
*Q10 5. Is there residue on the voice prosthesis on thin liquids?  
                                                                          Yes       If yes, rate Q5a & b below 
                                                                 No         If no, go to Q6 
 
 
Q11 5a. How easy is it to identify residue on the voice prosthesis on thin 
liquids? 
                                    
 
        Minimal           Severe 
  Extremely easy  Extremely difficult 
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*Q12 5b. How much residue is on the voice prosthesis on thin liquids?                 
                                                                                                       
 
*Q13 6. Is there oesophageal residue on thin liquids?  
                                             Yes        If yes, rate Q6a & b below 
                                        No          If no, go to Q7 
 
 
 
Q14 6a. How easy is it to identify oesophageal residue on thin liquids? 
                                                                                        
 
*Q15 6b. How much oesophageal residue is there on thin liquids? 
 
 
.  
 
*Q16 7. Is there residue on the voice prosthesis on puree?   
     Yes         If yes, rate Q7a & b below        
                                                                  No               If no, go to Q8 
 
Q17 7a. How easy is it to identify residue on the voice prosthesis on 
puree? 
 
 
*Q18 7b. How much residue is on the voice prosthesis on puree?                 
        Minimal         Severe 
         Minimal            Severe 
   Extremely easy Extremely difficult 
       Minimal          Severe 
      Extremely easy     Extremely difficult 
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*Q19 8. Is there oesophageal residue on puree?         
                                                                    Yes               If yes, rate Q8a & b below       
                                                            No          If no, go to Q9 
 
Q20 8a. How easy is it to identify oesophageal residue on puree? 
                                                                              
 
*Q21 8b. How much oesophageal residue is there on puree?  
                                                                                       
  
 
 
*Q22 9. Is there residue on the voice prosthesis on soft?   
                                                                           Yes        If yes, rate Q9a & b 
below        
                                                                  No        If no, go to Q10 
 
Q23 9a. How easy is it to identify residue on the voice prosthesis on 
soft? 
 
 
*Q24 9b. How much residue is on the voice prosthesis on soft?                 
                                                                                                 
                             
 
Extremely easy 
 Extremely difficult 
       Minimal           Severe 
        Minimal       Severe 
   Extremely easy  Extremely 
difficult      
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*Q25 10. Is there oesophageal residue on soft?    
                                                                 Yes       If yes, rate Q10a & b below                  
                                                         No         If no, go to Q11 
 
Q26 Q10a. How easy is it to identify oesophageal residue on soft? 
                                                                              
 
 
*Q27 10b. How much oesophageal residue is there on soft?   
                                                                                 
 
 
 
 
                                                                               
*Q28 11. Is there residue on the voice prosthesis on solid?  
                                                                         Yes        If yes, rate Q11a & b 
below       
                                                                           No         If no, go to Q12 
 
Q29 11a. How easy is it to identify residue on the voice prosthesis on 
solid? 
 
 
*Q30 11b. How much residue is on the voice prosthesis on solid? 
                 
Extremely easy Extremely difficult 
        Minimal        Severe 
         Minimal        Severe 
Extremely easy Extremely difficult 
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*Q3112. Is there oesophageal residue on solid?      
                                                                     Yes            If yes, rate Q12a & b 
below                      
                                                            No           If no, go to Q13 
 
 
Q32 12a. How easy is it to identify oesophageal residue on solid? 
                                                                               
 
 
 
*Q33 12b. How much oesophageal residue is there on solid?   
                                                                                 
                                         
 
 
 
 
Q34 13. Is there leakage through the voice prosthesis? 
                                                                         Yes        If yes, rate Q13a & b 
below              
                                                                           No         If no, go to Q14 
                         
 
Extremely easy Extremely difficult 
       Minimal         Severe 
441 
 
Q35 13a. How easy is it to identify leakage through the voice 
prosthesis? 
                                                                                
 
Q36 13b. How would you rate leakage through the voice prosthesis? 
                                                                                                    
 
 
 
Q37 14. Is there leakage around the voice prosthesis?     
                                                                          Yes        If yes, rate Q14a & b 
below              
                                                                No        If no, go to Q15 
 
Q38 14a. How easy is it to identify leakage around the voice prosthesis? 
                                                                               
 
Q39 14b. How would you rate leakage around the voice prosthesis? 
                                                                                                     
 
 
 
 
 
Q40 15. Can you see bolus backflow or reflux?            
                                                            Yes         If yes, rate Q15a & b below      
                                            No         If no, please fill in “other 
observations” . 
Extremely easy Extremely difficult 
        Significant         Minimal 
  Extremely easy Extremely difficult 
         Minimal       Significant 
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Q41 15a. How easy is it to identify bolus backflow/reflux? 
                                                                               
 
 
Q42 15b. How would you rate degree of bolus backflow/reflux? 
                                                                                                 
 
 
 
 
 
 
 
 
 
 
Other observations/comments 
 
 
       
 
 
 
 
      
 
Extremely easy 
 
Extremely difficult 
        Minimal     Severe 
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Please continue on another sheet if you have further 
comments.   
Thank you for completing this questionnaire!                           
M.Coffey PhD Study 2    
 
Appendix 13: Patient Communication and Swallowing with voice prosthesis 
questionnaire 
         
Communication and Swallowing with Voice Prosthesis 
Please think about the questions below with your clinic 
    Strongly agree  
 
 
 
 
 
   Agree  
 
 
 
 
  Neutral  
 
 
 
 Disagree  
 
 
Strongly disagree  
       
 
 
1. This prosthesis is comfortable to swallow with 1 2 3 4 5 
2. I feel like food is getting stuck when I swallow with this 
prosthesis 
1 2 3 4 5 
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3. It takes a long time to swallow with this prosthesis 1 2 3 4 5 
4. My voice sounds wet after I swallow with this prosthesis 1 2 3 4 5 
5. I need extra water to swallow food with this prosthesis 1 2 3 4 5 
 
1. It takes effort to voice with this prosthesis 1 2 3 4 5 
2. My voice sounds easy for others to understand with this 
prosthesis 
1 2 3 4 5 
3. My voice is consistent with this voice prosthesis 1 2 3 4 5 
4. My voice sounds pleasant with this voice prosthesis 1 2 3 4 5 
5. My voice is loud enough with this prosthesis 1 2 3 4 5 
6. I like the appearance of this prosthesis 1 2 3 4 5 
 
 
 
 
 
